Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCB9	EST122234	ENSG00000150967	"ATP binding cassette subfamily B member 9"	Q9NP78	12	122920951-122981649	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 18.3;Muller glia cells: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.2"	"Group enriched"	"Detected in many"	5	"B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033052, HPA035113, HPA035114"	Approved		Supported	Vesicles		NA	NA			Vesicles		"CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.71e-2)"	3.6	4.2	9.5	3.0	13.1	5.3	3.8	19.7	17.0	2.9	4.0	5.8	2.3	5.0	4.2	9.7	4.7	4.7	4.6	4.6	9.0	11.5	3.3	2.7	3.4	3.1	10.8	10.9	4.7	4.3	6.6	9.9	3.5	9.8	3.5	4.1	3.0	7.7	5.6	3.4	6.0	6.1	3.9	7.5	4.0	4.0	21.3	6.4	2.5	3.6	2.0	3.7	2.9	2.7	6.2	0.4	4.1	0.7	0.5	1.9	1.8	3.4	6.4	3.6	3.4	1.5	3.0	1.7	2.2	3.2	3.9	2.5	2.7	3.9	3.9	2.6	2.2	19.9	3.2	2.6	5.4	1.5	0.8	5.2	16.8	5.3	4.3	1.8	0.8	6.8	4.2	2.2	5.7	1.8	9.6	4.3	3.8	3.3	2.9	2.1	7.7	1.2	1.6	1.1	3.7	6.3	4.7	1.0	3.6	1.9	2.3	3.8	1.2	1.1	8.3	8.0	1.4	9.4	1.1	1.9	2.8	9.7	8.7	6.4	9.4	5.2	1.1	4.9	1.9	15.2	4.1	0.7	0.7	0.8	0.4	1.9	6.2	0.8	0.7	0.4	1.2	1.5	1.4	1.7	0.5	0.3	0.3	0.5	1.8	9.5	13.1	19.7	17.0	9.0	11.5	10.8	10.9	9.8	6.4	6.0	5.8	0.0	2.6	2.9	7.9	2.0	0.0	0.0	3.4	3.5	13.7	4.2	0.0	3.3	7.5	2.5	2.1	0.0	1.3	1.5	2.6	1.6	2.3	0.6	0.9	6.4	1.2	1.8	0.0	18.3	2.6	0.9	5.0	0.0	1.6	20.0	1.9	0.0	2.5	0.9	5.2	6.5	3.1	6.5	3.1	2.8	1.1	2.6	2.2	1.4
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 107.9;Syncytiotrophoblasts: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 19.2;neutrophil: 20.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 13.2;JURKAT: 19.6;MCF7: 16.5;MOLT-4: 15.3;OE19: 27.4;RPMI-8226: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	19.9	36.4	14.2	10.0	17.6	6.2	13.3	15.9	15.3	7.7	12.1	17.8	3.8	15.3	5.6	3.8	4.1	6.5	11.9	9.7	12.4	8.0	8.2	5.6	25.2	23.1	20.8	12.2	6.0	4.7	15.4	11.1	12.0	9.6	6.3	13.5	12.1	13.7	6.7	26.8	15.1	18.6	5.8	7.0	29.4	13.7	1.9	19.5	15.4	8.5	5.2	10.4	12.5	12.6	4.8	1.4	20.5	0.9	3.7	4.0	1.0	0.0	3.0	2.4	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.4	0.0	0.3	0.5	0.0	4.4	0.0	4.2	0.2	5.0	10.0	0.0	9.2	0.0	0.2	1.0	13.2	0.0	2.0	0.0	9.3	19.6	0.0	0.0	0.0	16.5	15.3	0.1	0.7	27.4	5.2	0.2	0.0	12.5	0.0	1.4	11.6	3.0	1.8	6.9	0.0	0.2	2.9	0.4	5.9	0.0	2.5	0.0	0.0	6.8	1.9	0.0	0.0	1.6	0.2	0.9	0.9	19.2	1.8	0.3	3.4	3.1	3.7	3.6	0.6	4.8	3.5	2.9	20.5	3.7	0.1	1.4	4.0	1.0	14.2	17.6	15.9	15.3	12.4	8.0	20.8	12.2	9.6	19.5	6.0	8.0	6.7	6.0	7.9	46.2	7.8	2.5	1.4	5.7	24.4	47.1	5.2	3.3	2.2	3.7	31.7	7.8	0.0	1.1	1.0	4.6	3.8	0.0	0.0	15.2	11.1	3.4	39.9	25.5	4.3	0.3	18.8	3.3	5.4	9.1	14.3	1.5	4.8	1.8	0.9	107.9	6.5	5.2	0.6	0.7	5.8	52.7	12.9	0.9	2.6
ACKR2	"CCBP2, CCR10, CCR9, CMKBR9, D6"	ENSG00000144648	"Atypical chemokine receptor 2"	O00590	3	42804752-42887974	"G-protein coupled receptors, Predicted membrane proteins"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"placenta: 96.2;salivary gland: 74.8"	"Group enriched"	"Detected in many"	10	"Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 7.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.3;NK-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5"	"Group enriched"	"Detected in many"	9	"amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6"	"Not detected"	"Not detected"			"HPA013819, HPA073493"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"HPA013819: AB_1846126, HPA073493: AB_2686610"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.90e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.20e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.13e-4)"	"unprognostic (5.13e-3)"	"unprognostic (3.22e-1)"	"unprognostic (5.58e-3)"	"unprognostic (6.09e-2)"	10.4	0.9	0.4	0.7	0.5	0.4	5.3	0.2	0.4	2.9	1.8	0.1	0.6	0.7	2.0	5.2	2.5	2.4	1.2	1.0	0.5	0.4	1.1	14.5	1.5	1.0	0.5	0.2	0.9	0.7	0.3	0.6	96.2	0.2	1.1	2.0	0.3	74.8	0.4	2.1	2.5	1.0	3.2	0.7	1.1	0.9	1.5	0.1	0.4	3.8	2.3	2.0	3.2	4.1	0.8	0.4	7.3	0.6	2.2	0.4	0.3	0.1	0.0	0.1	0.2	1.5	0.1	32.2	0.0	0.0	0.0	0.0	0.3	0.1	0.7	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.1	10.3	0.2	1.8	0.0	0.1	1.2	0.3	0.3	0.0	0.0	0.0	0.0	0.3	1.3	0.2	0.2	0.2	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.4	4.5	0.1	0.1	0.8	17.2	0.0	1.9	1.7	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	6.5	0.1	0.7	0.2	7.3	0.4	0.5	0.1	0.2	0.1	0.2	0.4	0.8	0.3	0.3	1.0	2.2	0.6	0.3	0.1	0.3	0.4	0.5	0.2	0.4	0.5	0.4	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.6	2.5	1.4	0.0	0.0	2.0	26.5	1.7	0.0	1.9	1.4	2.0	0.0	0.0	87.8	1.8	0.4	2.3	5.8	4.6	1.6	1.7	3.7	0.3	1.1	0.3	0.2	0.0	0.0	0.1	2.5	0.6	0.0	1.1	0.3	0.9	0.0	0.0	4.5	3.3	0.0	61.6	0.5	0.4	0.1
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597237-132618967	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 35.6;salivary gland: 29.0"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 35.7;monocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"	"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 88.7"	"Group enriched"	"Detected in some"	7	"cerebellum: 5.3;pons and medulla: 1.6"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	13.9	1.9	0.3	2.9	0.4	0.5	10.9	0.4	0.4	3.7	8.7	0.2	4.5	16.2	5.6	7.1	5.7	2.6	9.8	7.1	0.6	0.6	6.6	2.0	10.0	2.7	0.6	0.2	2.1	3.0	0.0	8.2	0.7	0.6	5.2	1.2	1.3	29.0	2.0	3.1	10.7	35.6	5.0	0.4	1.5	10.5	3.4	0.1	0.8	1.8	12.8	1.5	8.2	4.5	0.2	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.4	3.4	0.0	14.5	88.7	0.9	2.5	0.0	0.1	1.0	0.0	9.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1	35.7	1.4	0.0	0.4	5.8	1.8	0.7	0.0	1.4	2.3	5.2	5.9	0.2	0.0	0.2	2.1	5.1	1.3	0.0	10.8	0.0	4.1	0.4	0.0	0.0	0.4	1.6	0.0	9.8	0.8	0.0	2.0	0.0	1.7	11.8	0.0	1.1	6.6	0.0	2.5	2.4	3.1	0.0	1.9	0.1	0.0	5.6	0.2	0.0	0.6	1.0
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria		NA	NA			Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.7	9.3	3.2	6.4	9.0	5.5	5.6	5.3	4.3	7.4	6.9	13.6	10.8	9.7	23.9	7.2	17.1	15.2	6.1	13.1	2.5	7.2	10.7	9.7	12.5	13.0	8.1	9.3	9.1	6.4	10.1	7.1	5.1	11.0	4.5	11.4	8.6	12.1	5.2	21.8	13.2	12.1	5.6	15.2	24.9	6.4	5.9	17.4	7.8	8.8	11.0	5.2	11.6	29.8	18.1	5.2	16.4	22.8	5.2	18.3	4.1	9.4	8.7	10.3	15.2	6.1	22.7	9.8	9.7	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1	32.8	13.1	13.4	10.4	5.5	17.5	9.4	10.2	17.4	9.1	12.2	15.7	27.1	54.7	19.6	30.4	8.2	74.4	0.0	18.1	16.7	7.2	11.9	13.9	22.2	24.7	7.9	18.5	11.6	16.5	58.7	9.2	13.0	10.1	26.2	34.3	15.2	19.9	59.6	8.1	57.5	19.5	12.9	8.5	25.9	8.7	6.9	16.2	14.6	27.0	11.6
ACOX2	"BRCACOX, BRCOX, THCCox"	ENSG00000168306	"Acyl-CoA oxidase 2"	Q99424	3	58505136-58537319	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 70.5"	"Cell type enhanced"	"Detected in many"	16	"Hepatocytes: 75.4;Proximal tubular cells: 33.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 25.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 12.5;ASC TERT1: 20.7;fHDF/TERT166: 6.7;Hep G2: 8.0;HSkMC: 13.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038280, HPA064845"	Enhanced		Approved	Vesicles,Cytosol		No	No		190000	Vesicles	Cytosol	"HPA038280: AB_10672623, HPA064845: AB_2685368"	"unprognostic (6.62e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (8.67e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.63e-3)"	4.0	5.3	1.9	3.8	2.5	0.1	3.4	1.6	2.1	4.4	10.2	2.7	9.5	10.0	9.0	6.2	3.8	4.4	4.8	8.8	2.4	1.4	17.1	70.5	2.8	0.7	2.0	1.7	5.1	2.9	3.8	3.0	1.4	4.0	7.2	3.4	11.4	3.0	5.9	4.2	1.7	13.7	10.6	2.5	0.9	2.6	4.0	2.0	1.0	7.7	2.7	1.6	5.4	5.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.5	20.7	3.6	2.3	0.2	0.0	0.3	0.6	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	1.8	0.0	0.0	13.5	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.5	1.6	2.1	2.4	1.4	2.0	1.7	4.0	2.0	3.0	4.3	0.5	7.2	0.6	0.2	14.4	0.0	0.0	1.2	3.5	0.0	0.6	13.3	0.3	0.1	1.1	5.4	0.0	1.7	0.2	5.0	0.8	1.1	75.4	5.3	1.6	2.9	4.3	2.2	1.4	10.0	0.8	0.0	0.0	4.7	10.0	0.5	0.0	8.1	33.8	0.8	6.5	3.4	0.2	0.5	0.3	0.7	0.0	3.6	0.8
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	12.1	27.4	7.5	8.1	9.6	13.9	18.9	10.4	31.0	7.7	10.7	12.6	16.1	5.6	32.2	9.3	13.5	24.8	4.5	11.0	10.2	8.4	5.8	9.6	10.0	11.7	10.7	6.8	27.7	12.1	8.1	5.4	7.9	11.2	14.9	12.2	6.0	15.3	13.5	4.5	22.4	7.7	10.2	4.0	3.9	9.3	24.5	14.4	17.9	32.7	8.1	5.3	11.3	13.2	18.0	17.1	7.8	13.6	10.5	10.1	11.3	77.5	10.0	8.6	18.5	6.1	14.1	13.1	17.6	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9	77.4	49.8	30.6	25.8	23.7	20.2	29.7	30.6	30.8	35.2	76.8	25.5	27.4	1.7	45.7	21.6	61.6	39.3	0.0	27.7	46.7	28.8	75.5	27.9	30.4	56.9	42.9	34.7	76.1	87.0	16.2	16.7	64.0	43.9	13.6	45.8	27.0	37.3	43.2	15.9	20.3	32.7	12.9	28.3	13.6	16.2	19.4	22.2	43.6	33.7	59.6
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759203-78811431	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 31.9"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 9.0;Early spermatids: 3.9;Endothelial cells: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	9	"HMC-1: 77.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA045284: AB_2679285, HPA048453: AB_2680399"	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.0	4.1	0.7	4.1	2.5	0.3	2.8	1.5	1.8	4.3	2.9	1.7	1.4	2.2	8.6	1.9	2.2	1.6	9.9	31.9	1.7	0.6	1.5	0.8	5.3	3.2	1.2	0.7	8.7	1.0	0.4	0.7	4.0	2.3	1.5	0.6	4.4	0.9	1.1	1.8	1.4	2.8	4.5	1.3	4.1	1.7	3.5	2.6	0.3	1.6	1.1	1.4	3.1	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.9	2.2	2.1	2.5	6.2	1.0	0.3	0.3	0.1	0.0	0.0	0.0	1.4	0.1	0.3	0.1	0.1	0.5	0.0	0.0	0.2	0.6	0.1	0.0	2.1	0.0	77.9	1.0	0.6	0.5	0.3	1.6	7.1	0.0	0.0	0.2	1.6	0.0	0.0	1.4	1.4	0.0	0.4	4.9	2.2	0.0	0.1	0.2	0.0	7.1	1.4	0.0	0.1	1.2	0.9	0.1	8.7	2.8	0.3	1.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.5	1.5	1.8	1.7	0.6	1.2	0.7	2.3	2.6	0.0	0.0	0.0	0.1	0.3	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.9	4.5	0.0	0.0	0.0	0.2	3.1	0.2	3.5	0.0	0.6	0.0	0.0	3.1	0.0	2.2	1.4	0.0	1.7	0.0	0.0	1.3	0.2	0.0	1.8	0.0	0.0	0.0	1.6	3.0	1.3	0.1	0.2	0.0	0.0	0.2
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112875-96116245	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.1;EFO-21: 3.3;HAP1: 1.8;NTERA-2: 1.8;SuSa: 3.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "	"unprognostic (6.16e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.93e-4)"	"unprognostic (1.84e-2)"	"unprognostic (5.24e-2)"	"unprognostic (6.80e-5)"	"unprognostic (4.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-2)"	4.9	2.2	0.3	0.4	2.2	1.2	8.1	0.1	0.7	4.5	4.0	1.9	0.2	0.5	1.3	7.5	4.3	0.8	3.2	6.1	0.5		2.9	7.5	0.3	0.2	4.4	0.0	5.0	2.3	1.0	0.0	1.3	3.3	3.3	0.4	0.9	1.8	2.9	8.0	0.3	1.2	2.1	0.6	4.8	0.7	2.6	1.9	0.0	2.1	1.8	0.0	3.8	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.3	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.7	0.0	0.1	1.8	0.1	0.3	0.0	0.0	0.4	0.0	0.3	1.4	0.0	0.0	1.2	0.0	3.1	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.2	1.0	0.0	2.0	0.0	1.4	1.2	1.8	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.0	0.5	0.1	0.4	0.9	0.0	0.0	0.3	0.0	2.4	3.1	0.3	0.0	1.7	0.9	1.7	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	32.3	8.0	0.0	0.2	1.3	0.3	0.0	0.0	0.3
AEBP1	ACLP	ENSG00000106624	"AE binding protein 1"	Q8IUX7	7	44104361-44114562	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, DNA-binding, Repressor"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Cell type enhanced"	"Detected in many"	19	"Fibroblasts: 159.0;Leydig cells: 140.4;Peritubular cells: 478.4;Smooth muscle cells: 174.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 10.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 34.9;BJ: 45.9;BJ hTERT+: 30.3;fHDF/TERT166: 49.3;JURKAT: 34.8;WM-115: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009966, HPA047724, HPA063595, HPA064970"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		2300000	Vesicles	"Nucleoplasm, Cytosol"	"CAB009966: AB_2225690, HPA047724: AB_2680132, HPA063595: AB_2685052, HPA064970: AB_2685394"	"unprognostic (1.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (1.13e-1)"	"unprognostic (7.00e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.31e-9)"	"unprognostic (2.88e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.28e-3)"	46.5	19.0	8.9	23.9	9.5	3.1	90.9	1.7	5.4	78.1	20.5	17.9	15.8	5.8	73.7	39.4	20.7	43.7	47.9	35.4	12.7	6.4	19.6	6.3	35.5	13.0	12.5	10.8	84.8	8.8	2.7	10.9	26.7	17.2	46.1	7.9	33.3	11.9	70.2	11.4	19.7	16.9	42.6	43.7	16.6	17.6	30.6	9.6	48.0	19.6	12.3	7.5	58.2	177.1	2.3	10.5	0.0	0.0	0.2	1.4	0.4	0.1	0.0	10.8	0.0	34.9	12.4	0.2	45.9	30.3	5.2	1.1	0.0	0.0	1.2	5.1	49.3	0.0	0.0	0.5	0.8	2.2	0.1	0.0	3.1	0.0	0.0	9.8	0.0	0.0	18.8	0.0	17.7	0.0	0.2	2.3	34.8	1.9	0.0	0.0	0.0	19.9	3.7	4.6	0.0	0.0	16.5	0.4	0.3	1.2	0.0	1.1	6.1	0.0	0.0	20.1	10.6	0.1	3.3	8.0	0.0	21.3	0.1	0.0	0.2	0.2	24.2	0.1	0.0	28.2	0.0	0.0	0.0	0.4	0.0	0.3	2.1	0.4	0.0	0.0	2.3	1.4	0.8	0.0	0.2	0.0	10.5	0.0	0.4	8.9	9.5	1.7	5.4	12.7	6.4	12.5	10.8	17.2	9.6	0.0	4.5	6.7	5.4	30.7	0.2	15.5	0.0	4.0	2.3	7.0	0.0	1.7	0.0	0.8	2.0	14.4	0.0	0.0	0.0	2.6	159.0	2.4	2.3	0.0	3.1	0.0	0.0	38.6	1.9	9.5	140.4	3.8	81.0	1.0	0.0	0.1	0.7	0.0	478.4	0.6	0.6	38.8	174.1	2.4	4.5	24.0	2.9	0.7	0.0	2.0
AFTPH	"FLJ20080, FLJ23793, MGC33965, Nbla10388"	ENSG00000119844	Aftiphilin	Q6ULP2	2	64524305-64593005	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034990, HPA034991"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Vesicles"	"HPA034990: AB_2674398, HPA034991: AB_10603577"	"unprognostic (7.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.24e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-2)"	"prognostic favorable (2.37e-5)"	"prognostic favorable (8.44e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.83e-4)"	12.4	14.8	18.0	25.8	20.0	11.4	20.8	29.8	22.9	14.9	20.1	9.5	16.7	14.1	12.9	28.6	20.7	14.7	16.9	13.5	15.6	14.5	34.8	20.3	18.7	20.7	12.8	21.4	13.1	19.4	26.8	22.6	9.8	16.3	22.3	21.5	9.8	18.5	17.4	12.2	21.8	19.0	14.7	12.2	17.1	20.0	15.1	16.7	20.0	16.0	9.9	24.7	16.5	20.9	16.4	11.8	21.4	10.2	4.9	9.0	4.2	14.0	9.3	6.9	8.3	9.0	7.7	11.5	8.1	12.1	13.3	10.1	10.7	10.7	20.9	8.0	9.9	15.5	11.4	12.0	11.2	17.4	20.2	6.6	9.9	5.9	12.5	9.5	18.9	17.1	3.8	24.0	8.6	19.8	9.9	10.4	10.6	7.4	19.0	8.2	8.0	10.2	23.2	6.4	26.6	7.0	8.4	11.2	13.5	24.1	15.1	12.9	6.5	8.5	19.6	16.6	9.3	11.8	14.6	8.9	10.0	11.5	8.4	8.9	21.5	12.7	32.2	7.5	21.6	11.0	21.4	6.9	11.6	5.8	6.7	6.9	16.4	7.3	7.0	9.0	14.8	7.0	5.6	12.1	4.9	10.2	11.8	9.0	4.2	18.0	20.0	29.8	22.9	15.6	14.5	12.8	21.4	16.3	16.7	23.8	34.9	38.0	28.0	109.0	24.1	12.2	38.2	36.1	36.4	19.2	19.6	11.7	31.5	20.6	25.3	24.5	36.1	46.7	22.5	9.6	19.7	47.3	45.1	31.0	18.9	35.0	44.7	18.4	49.2	43.0	14.7	40.2	21.9	36.1	37.7	38.6	23.4	40.3	19.4	57.5	29.8	25.8	17.6	30.9	18.8	107.9	22.8	26.7	37.0	44.4
AGFG1	"HRB, RAB, RIP"	ENSG00000173744	"ArfGAP with FG repeats 1"	P52594	2	227472152-227561214	"Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Transport"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 126.0;Late spermatids: 243.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008741	Approved		Supported	Vesicles		NA	NA		28000	Vesicles		"HPA008741: AB_1850752"	"unprognostic (5.76e-2)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (8.73e-3)"	"unprognostic (6.31e-3)"	"prognostic favorable (6.10e-4)"	"unprognostic (9.30e-3)"	"prognostic unfavorable (7.31e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (2.03e-2)"	"unprognostic (5.78e-2)"	"prognostic unfavorable (6.92e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.24e-3)"	43.2	26.4	19.9	27.7	26.5	80.1	34.4	18.1	31.3	16.7	26.2	31.5	15.7	25.6	18.1	16.8	29.3	18.2	23.6	28.2	22.6	19.7	22.7	24.7	35.0	33.0	25.4	20.4	20.9	20.9	25.3	13.8	44.0	24.6	14.0	20.5	18.2	19.7	15.3	21.2	22.8	29.1	23.4	39.2	32.2	19.7	51.5	20.8	26.4	21.0	17.3	30.4	23.5	19.8	5.3	5.2	9.0	8.4	1.6	5.5	2.5	18.4	30.6	16.2	15.8	27.8	20.5	61.5	24.7	23.6	29.6	26.3	24.0	21.3	13.1	18.8	27.0	39.9	19.6	27.8	31.9	38.5	22.1	15.5	29.0	26.6	44.4	29.9	19.6	18.4	12.5	34.2	37.4	35.5	22.7	29.6	13.6	30.3	35.7	35.4	26.3	23.5	17.7	25.3	24.8	16.0	21.7	26.8	9.3	29.4	25.4	15.1	11.8	20.1	26.3	23.4	29.5	11.2	22.4	29.0	25.6	20.4	36.7	21.6	20.7	13.9	18.6	27.7	16.8	29.2	5.4	8.4	2.7	2.6	6.8	5.5	3.0	3.1	2.6	5.2	5.3	2.6	4.7	9.0	1.6	6.4	3.6	3.6	2.5	19.9	26.5	18.1	31.3	22.6	19.7	25.4	20.4	24.6	20.8	23.8	23.4	14.3	21.9	29.5	37.6	18.2	12.7	10.7	19.4	21.0	23.6	25.4	13.3	16.6	126.0	22.9	26.2	23.3	18.3	13.6	22.0	36.7	12.7	18.1	20.8	41.3	32.7	24.5	94.2	243.6	14.4	38.0	18.6	16.2	16.9	42.9	29.4	17.5	11.0	21.9	32.2	19.4	12.3	29.6	16.8	28.1	33.2	15.8	17.2	42.4
AGTRAP	ATRAP	ENSG00000177674	"Angiotensin II receptor associated protein"	Q6RW13	1	11736084-11754802	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 96.5"	"Cell type enhanced"	"Detected in many"	10	"Exocrine glandular cells: 387.3;Kupffer cells: 167.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044120	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA044120: AB_10960748"	"unprognostic (1.08e-3)"	"unprognostic (2.98e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.92e-3)"	"prognostic unfavorable (6.57e-7)"	"unprognostic (4.44e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.89e-2)"	16.5	19.2	8.7	16.6	10.8	65.5	31.0	3.1	10.0	13.0	9.7	16.7	15.6	6.5	10.3	37.0	19.6	28.4	14.5	22.0	8.9	6.9	29.7	11.0	26.4	35.6	14.2	6.6	15.0	27.2	7.9	12.2	15.2	16.5	33.2	5.6	17.1	22.2	13.5	25.3	13.2	8.4	13.4	12.9	31.0	12.3	15.3	10.7	11.4	25.5	12.6	14.6	15.2	26.0	5.2	35.2	85.3	96.5	7.7	21.7	53.1	15.0	18.7	4.7	10.3	7.9	10.1	8.7	7.9	13.7	9.8	8.6	11.9	36.7	1.6	36.2	9.6	24.7	12.8	7.8	37.7	3.1	0.8	17.1	0.4	11.3	14.1	24.7	7.4	18.3	10.0	29.9	32.0	17.0	12.1	13.1	4.8	19.7	14.9	5.5	12.4	3.6	21.9	8.4	6.5	19.1	1.2	4.2	7.5	16.0	1.4	4.1	6.2	14.6	7.4	13.5	6.6	16.8	15.8	7.4	12.6	8.9	19.8	8.4	5.5	6.5	8.8	32.2	53.7	5.8	45.4	96.5	74.3	21.7	47.6	10.8	5.2	8.2	12.9	35.2	4.0	8.8	11.7	85.3	7.7	39.8	2.9	9.6	53.1	8.7	10.8	3.1	10.0	8.9	6.9	14.2	6.6	16.5	10.7	20.8	27.2	6.9	27.5	10.3	0.3	10.1	30.6	56.2	17.0	34.9	5.9	15.2	8.3	87.9	13.0	31.8	6.4	0.0	387.3	71.9	36.4	56.1	84.5	6.6	107.2	3.2	6.9	45.4	167.4	16.3	35.1	52.2	27.0	8.2	11.0	15.6	91.8	24.6	25.5	44.0	5.5	12.9	6.6	3.3	27.5	11.8	11.0	47.5	19.1	21.8
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine-glyoxylate aminotransferase"	P21549	2	240868479-240880502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	172	"liver: 247.3"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 1878.6"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles		NA	NA		5200000	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favorable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	247.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.4	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.8	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.8	28.1	0.0	0.0	7.0	0.0	0.5	19.9	0.0	0.0	0.0	2.6	46.7	1.6	22.7	0.0	0.5	0.0	1878.6	0.2	0.0	8.6	45.4	38.8	0.0	0.9	0.0	0.0	0.0	3.9	0.0	0.2	7.0	0.4	108.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	8.2	1.2	0.0
AIFM2	"AMID, FLJ14497, PRG3"	ENSG00000042286	"Apoptosis inducing factor, mitochondria associated 2"	Q9BRQ8	10	70098223-70132934	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 41.9"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 57.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028961, HPA042309, HPA075576"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Vesicles	"Plasma membrane, Cytosol"	"HPA028961: AB_2672844, HPA042309: AB_10796575, HPA075576: "	"unprognostic (6.62e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.29e-1)"	"prognostic favorable (2.80e-4)"	"unprognostic (7.26e-3)"	"unprognostic (2.57e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.49e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (2.92e-4)"	32.9	7.8	3.1	6.6	5.9	1.3	41.9	5.0	3.7	3.5	9.0	2.1	22.1	7.6	4.5	9.6	9.1	4.0	7.6	19.7	2.8	4.1	10.2	18.2	8.1	4.0	2.9	2.4	7.5	3.6	3.9	3.1	5.2	3.5	6.4	5.9	9.2	5.8	15.2	9.1	2.8	9.9	7.8	3.7	5.9	6.5	3.1	2.1	1.0	10.8	6.4	7.3	11.8	15.7	3.4	0.7	1.5	1.0	7.8	3.5	1.2	8.8	15.4	0.4	4.0	9.3	3.5	0.1	3.5	8.8	7.3	8.3	11.9	17.2	1.3	9.1	4.9	9.7	9.6	4.3	1.2	2.0	17.2	0.7	0.0	9.1	57.7	20.0	0.1	2.2	4.7	2.9	11.7	2.5	4.6	3.2	0.6	6.7	7.6	3.7	11.2	0.4	0.4	1.6	7.1	5.0	0.2	1.4	4.2	3.9	6.5	1.3	0.3	6.5	5.7	10.0	0.6	0.2	2.4	4.0	0.1	9.0	5.4	10.3	5.7	10.6	2.4	4.9	0.3	4.8	1.5	0.9	1.0	3.5	0.8	3.1	3.4	1.2	3.0	0.7	2.9	1.7	2.7	1.0	7.8	1.0	0.5	2.4	1.2	3.1	5.9	5.0	3.7	2.8	4.1	2.9	2.4	3.5	2.1	6.0	13.1	2.2	11.6	2.1	5.5	11.7	10.2	9.4	10.3	17.4	0.0	12.6	3.3	35.2	19.5	2.3	32.9	0.0	19.3	2.5	6.3	12.0	11.5	20.2	10.5	1.6	11.5	2.5	1.8	33.7	4.9	3.5	8.5	59.5	6.0	4.5	31.0	17.5	4.2	11.5	1.7	19.4	13.0	3.2	3.2	1.3	15.6	5.1	9.0	14.8
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 59.8;U-266/84: 31.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favorable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.1	6.6	3.7	4.8	2.6	4.1	6.4	5.5	4.1	2.5	1.9	21.6	5.0	1.3	2.9	7.8	9.7	1.9	0.9	4.0	2.6	4.1	3.5	3.1	4.8	6.2	1.8	1.9	1.0	6.2	2.0	3.3	1.2	3.6	2.8	2.7	1.2	4.9	7.5	3.0	1.6	2.4	3.3	3.0	10.8	1.9	6.3	2.1	11.3	20.7	2.1	2.9	9.1	6.5	5.5	3.2	5.0	1.9	5.2	8.4	1.9	2.1	4.4	59.8	31.1	2.4	2.4	3.9	6.2	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1	3.0	2.6	0.0	0.4	0.3	3.3	0.9	7.6	4.0	5.7	1.8	0.0	0.9	5.0	0.7	8.1	0.8	5.0	0.0	3.3	0.9	1.1	0.6	0.0	17.8	0.9	4.8	4.1	1.3	1.2	18.9	0.6	0.8	0.0	1.8	4.5	10.6	2.4	3.5	2.1	33.2	0.8	0.0	0.5	0.7	0.7	0.5	0.2	0.8	4.0	0.3
AMBN		ENSG00000178522	Ameloblastin	Q9NP70	4	70592256-70607288	"Disease related genes, Predicted secreted proteins"	Biomineralization		"Amelogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"brain: 10.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cervical cancer: 2.6;endometrial cancer: 2.9"	"Region enriched"	"Detected in some"	5	"basal ganglia: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"HEK 293: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036099			Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"	NA	NA			Vesicles	Nucleoplasm	"HPA036099: "															"unprognostic (3.22e-1)"			0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	2.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.1	0.0	1.2	0.2	1.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	10.6	0.0	2.0	0.0	0.4	0.1	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRD13B	FLJ25555	ENSG00000198720	"Ankyrin repeat domain 13B"	Q86YJ7	17	29589769-29614761	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.9"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 23.2;Horizontal cells: 15.9;Late spermatids: 30.2;Leydig cells: 13.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.7;SH-SY5Y: 32.3;SK-BR-3: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051886, HPA063748"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA051886: AB_2681652, HPA063748: AB_2685112"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.10e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (7.58e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (9.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.36e-3)"	8.0	6.6	10.2	4.2	14.3	2.6	12.0	34.9	28.6	7.2	4.2	16.4	2.6	2.7	12.3	3.5	5.4	9.9	7.5	6.4	12.4	9.3	1.7	1.1	3.9	3.6	14.7	10.0	10.5	3.6	5.5	6.9	2.7	7.7	5.2	2.7	3.4	4.8	4.8	8.5	10.0	3.3	8.2	13.7	3.1	3.5	16.1	12.7	2.0	2.8	2.2	2.2	7.2	8.5	0.7	0.3	0.0	0.0	0.1	1.6	0.1	3.7	7.8	8.4	17.8	4.7	4.4	2.7	1.0	0.6	1.4	1.7	3.5	0.6	4.2	3.5	1.6	3.6	13.8	4.9	4.0	0.2	7.0	16.8	2.2	15.4	3.0	1.8	2.0	2.4	4.1	5.3	1.4	2.7	4.8	6.2	7.6	3.5	3.5	1.5	3.5	10.5	5.0	6.7	4.1	6.1	17.0	5.1	11.7	1.7	1.6	28.7	32.3	3.1	24.8	2.8	0.7	4.0	2.5	4.4	3.7	4.1	4.0	3.7	5.8	7.5	5.1	2.6	6.8	2.7	0.0	0.0	0.0	0.2	0.0	0.8	0.7	0.0	1.6	0.3	0.1	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.1	10.2	14.3	34.9	17.5	12.4	9.3	14.7	10.0	7.7	12.7	0.0	0.0	0.0	0.7	1.4	4.4	1.4	0.0	0.0	0.0	0.0	2.0	0.0	1.7	1.4	23.2	1.5	0.0	0.0	0.5	0.1	1.6	1.0	0.0	0.8	0.1	15.9	2.9	1.8	0.0	30.2	13.6	0.0	0.0	0.0	0.5	1.4	0.6	0.0	7.1	0.0	5.0	0.0	1.4	6.0	4.1	1.5	0.1	0.0	1.0	1.1
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 beta 1 subunit"	Q10567	22	29327680-29423179	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 116.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		1000000	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	22.2	25.8	28.0	32.3	35.2	29.9	17.2	37.3	43.1	17.2	23.9	26.5	23.9	32.1	14.8	18.4	46.4	17.7	22.0	16.6	24.4	30.4	24.2	25.8	21.2	37.2	29.4	24.1	12.7	28.4	48.2	31.1	32.3	31.9	27.3	21.8	24.1	29.5	31.2	31.3	34.0	28.7	19.3	22.4	33.0	24.9	23.4	16.7	25.2	21.6	25.5	37.4	25.6	21.0	12.2	16.9	3.1	17.3	4.0	5.8	11.6	26.4	15.1	15.7	16.7	12.0	8.8	19.6	18.6	20.8	22.9	22.0	23.1	10.9	14.6	12.4	21.1	10.8	23.8	22.5	31.4	14.6	18.8	32.8	24.2	19.6	13.1	13.4	34.5	33.6	12.7	11.7	21.9	17.7	10.6	31.8	5.5	16.5	17.9	15.2	28.9	14.6	11.4	12.2	39.2	17.2	27.9	17.3	38.9	16.2	60.2	24.9	17.6	23.1	27.1	11.6	11.2	22.0	15.8	27.4	26.5	16.4	15.1	19.4	19.5	10.1	26.8	18.8	15.1	15.4	0.0	15.5	3.1	5.8	17.3	5.8	10.1	3.9	4.9	16.9	12.2	3.2	3.2	1.7	4.0	17.3	5.2	5.2	11.6	28.0	35.2	37.3	43.1	24.4	30.4	29.4	24.1	31.9	16.7	11.9	16.0	31.4	7.7	6.4	25.7	14.5	28.1	9.4	11.4	21.0	37.3	42.2	19.9	40.6	6.3	16.7	63.6	23.3	35.1	25.4	7.8	16.3	4.7	29.2	116.9	42.9	20.7	41.7	83.2	10.4	10.9	34.0	11.8	26.2	22.1	26.2	48.1	26.4	11.7	18.8	37.8	6.5	6.9	22.1	13.6	8.0	57.1	15.2	26.2	15.2
AP1M2	"AP1-mu2, HSMU1B, mu2"	ENSG00000129354	"Adaptor related protein complex 1 mu 2 subunit"	Q9Y6Q5	19	10572671-10587315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Proximal tubular cells: 243.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"basophil: 5.6;neutrophil: 9.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 35.0;Hep G2: 62.5;MCF7: 53.9;OE19: 31.5;RT4: 33.6;U-2 OS: 35.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054999			Supported	Vesicles		NA	NA			Vesicles		"HPA054999: AB_2682666"	"unprognostic (8.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (2.07e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.23e-2)"	"prognostic favorable (3.73e-6)"	"unprognostic (1.80e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.06e-1)"	1.6	0.2	1.0	6.1	0.7	0.0	9.1	0.6	0.8	7.5	24.5	0.8	44.4	17.3	1.8	20.4	22.2	12.9	34.4	0.6	0.6	0.3	37.3	1.2	10.5	0.6	0.6	0.6	4.7	33.5	16.0	16.1	31.5	0.8	12.5	17.7	0.6	28.4	36.4	1.2	15.3	38.2	1.1	0.6	0.6	20.4	10.3	0.6	3.0	36.6	17.5	14.2	9.6	7.7	0.0	0.3	9.4	1.7	0.0	0.2	3.7	28.6	14.5	0.0	2.1	0.0	0.0	13.6	0.0	0.0	0.4	0.3	35.0	16.9	0.0	13.6	0.2	9.1	20.0	0.0	22.3	0.6	0.1	0.2	1.3	10.2	62.5	0.2	0.0	0.1	0.0	17.0	0.8	0.0	1.0	0.0	0.0	0.0	0.1	0.2	53.9	0.1	0.3	6.5	31.5	0.0	0.5	1.9	0.1	0.5	33.6	14.1	0.0	0.0	24.8	0.1	7.6	25.5	0.0	0.0	0.1	35.3	0.2	0.4	0.0	0.1	0.2	0.0	0.0	0.0	5.6	0.5	3.5	0.0	0.8	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	9.4	0.0	1.7	0.2	0.0	3.7	1.0	0.7	0.6	0.8	0.6	0.3	0.6	0.6	0.8	0.6	26.8	33.3	1.5	17.0	6.2	0.0	0.2	38.2	36.1	26.1	82.0	0.0	109.1	116.0	116.3	36.2	0.7	123.3	0.0	102.6	79.6	2.0	40.6	2.3	0.0	8.5	0.0	71.4	0.6	0.6	14.9	1.4	0.0	3.3	2.8	88.2	0.0	104.4	116.8	0.7	243.3	0.0	0.0	0.9	10.7	2.4	11.4	55.3	3.5	112.5	36.0
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 sigma 1 subunit"	P61966	7	101154400-101161596	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 291.8;Proximal tubular cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	7.6	9.7	30.6	7.9	41.1	3.0	10.8	7.9	45.8	6.8	16.5	6.4	4.6	23.3	6.6	10.6	10.9	8.9	9.3	4.2	22.9	14.6	16.6	15.5	6.7	6.9	12.3	25.3	7.9	8.0	6.3	10.5	10.2	10.1	10.9	14.2	4.6	10.4	6.1	3.5	12.3	18.0	7.9	8.7	7.7	13.2	6.9	9.3	4.7	9.3	7.4	8.5	8.7	6.1	4.4	8.2	2.1	5.5	1.9	5.9	4.2	26.4	21.5	14.5	27.4	10.7	17.6	31.4	17.8	12.1	12.1	12.9	11.5	33.8	5.9	31.1	19.4	23.5	13.2	8.3	27.3	10.8	13.4	13.4	4.0	13.5	14.3	13.2	10.8	20.1	19.7	20.9	11.9	5.2	18.1	17.9	13.4	12.9	24.0	29.9	66.0	9.0	23.4	23.1	39.2	43.4	5.7	6.6	12.4	29.1	22.6	11.4	37.3	10.1	26.8	32.4	24.9	11.8	10.1	18.5	17.5	30.5	6.6	12.2	5.4	11.3	11.4	44.4	12.0	35.1	0.8	5.5	0.5	4.2	4.9	3.7	4.4	5.9	4.7	7.4	3.8	3.5	3.2	2.1	1.9	2.8	8.2	5.5	4.2	30.6	41.1	7.9	35.1	22.9	14.6	12.3	25.3	10.1	9.3	6.0	0.0	18.5	25.1	34.5	26.2	1.1	50.9	0.0	2.3	52.4	7.9	145.9	291.8	115.8	1.0	22.5	124.9	0.0	97.6	75.8	26.7	26.8	5.7	37.6	83.8	28.6	86.6	25.2	24.7	2.0	32.5	23.2	50.6	83.0	83.1	23.6	132.7	74.8	20.5	208.8	16.4	19.4	13.3	10.1	80.0	39.6	50.6	15.2	96.8	26.8
AP1S2	"MRX59, MRXS5, PGS, SIGMA1B"	ENSG00000182287	"Adaptor related protein complex 1 sigma 2 subunit"	P56377	X	15825806-15854931	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 218.0"	"Cell type enhanced"	"Detected in all"	8	"Hofbauer cells: 225.7;Kupffer cells: 390.4;Macrophages: 350.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 49.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 55.2;monocytes: 74.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 67.3;SK-MEL-30: 89.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049894, HPA060945"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA049894: AB_2680939, HPA060945: AB_2684393"	"prognostic favorable (9.86e-4)"	"unprognostic (4.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.47e-3)"	"unprognostic (3.85e-1)"	"unprognostic (2.03e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.53e-6)"	"unprognostic (1.85e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.13e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.47e-2)"	10.1	8.2	21.2	11.7	17.9	12.6	9.7	13.0	17.6	12.0	17.3	9.8	12.6	4.8	25.7	218.0	9.8	5.6	7.0	34.2	12.7	19.9	5.2	5.8	8.9	11.6	16.1	11.8	4.5	4.1	8.2	11.7	13.1	39.7	5.5	8.0	13.3	5.1	13.2	41.4	5.0	8.7	24.9	18.5	14.1	9.9	8.6	11.4	9.8	10.7	8.6	9.6	8.5	5.9	8.2	55.2	12.5	74.9	5.5	8.4	44.8	3.4	2.9	32.5	16.0	6.2	4.1	1.1	10.2	4.8	7.9	10.2	2.1	3.6	5.8	45.5	14.9	14.3	4.0	9.0	2.8	13.3	8.3	14.4	3.5	5.1	3.2	5.4	12.9	3.9	2.4	2.9	7.5	7.7	11.2	15.9	4.7	3.2	67.3	14.3	1.8	3.4	6.8	43.3	1.8	10.7	7.3	23.7	11.8	8.9	0.8	4.0	15.8	4.5	1.4	89.0	23.4	15.2	13.3	8.4	13.6	5.1	18.9	9.5	7.8	17.6	12.3	7.2	5.8	32.9	8.2	74.9	8.0	5.6	67.8	5.4	8.2	5.7	4.5	55.2	7.5	4.1	4.0	12.5	5.5	34.7	17.9	8.4	44.8	21.2	17.9	13.0	17.6	12.7	19.9	16.1	11.8	39.7	11.4	3.0	16.2	80.2	10.9	49.0	31.7	178.0	7.6	1.4	3.4	8.7	11.8	4.7	28.2	12.5	3.9	119.9	7.7	23.3	5.6	16.4	51.9	11.0	77.3	6.4	225.7	11.1	25.8	148.0	390.4	8.9	16.1	350.3	141.7	139.7	7.0	19.0	8.6	11.2	6.7	6.6	34.6	38.8	56.7	25.7	19.4	45.0	4.7	51.1	6.4	5.8
AP1S3		ENSG00000152056	"Adaptor related protein complex 1 sigma 3 subunit"	Q96PC3	2	223751686-223838027	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 60.9;Cytotrophoblasts: 43.1;Urothelial cells: 65.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 56.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA066782	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA066782: AB_2685720"	"unprognostic (9.45e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.80e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.65e-3)"	"prognostic unfavorable (3.36e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.61e-2)"	1.9	1.4	1.6	5.4	3.0	1.8	1.6	2.2	1.9	1.6	1.8	0.2	50.0	3.1	0.8	64.5	5.8	1.7	7.6	1.0	2.3	1.7	7.0	1.9	5.2	3.8	1.1	1.0	0.8	5.1	3.3	6.8	4.6	0.9	2.5	2.0	1.9	4.1	39.6	0.5	1.6	4.1	0.9	1.0	3.1	6.2	1.1	0.4	0.8	10.5	3.1	5.7	8.1	2.9	8.8	5.3	4.9	0.5	0.7	1.6	0.7	9.1	8.6	1.0	3.3	0.5	0.2	4.7	3.8	0.9	1.9	1.7	56.2	7.1	3.6	3.2	0.5	2.0	15.1	2.7	10.4	2.9	5.2	4.4	0.4	13.8	5.7	0.2	1.1	0.4	0.1	11.3	3.4	12.0	4.1	1.3	2.0	0.5	0.8	1.1	3.8	0.1	0.2	1.2	10.5	6.1	1.3	0.0	1.5	17.8	18.0	2.5	0.8	2.0	3.7	1.3	2.2	1.8	1.7	0.7	0.4	2.0	1.0	3.0	3.6	3.1	9.8	1.3	0.4	2.1	4.9	0.5	0.4	1.1	0.3	0.8	8.8	0.5	0.4	2.2	3.5	0.4	0.7	1.9	0.7	0.2	5.3	1.6	0.7	1.6	3.0	2.2	1.9	2.3	1.7	1.1	1.0	0.9	0.4	32.8	7.0	9.5	25.9	3.8	3.2	1.2	0.0	5.3	10.3	10.4	60.9	43.1	8.3	15.5	0.0	1.4	3.8	0.0	16.0	1.5	2.3	25.3	3.5	0.4	4.2	6.4	2.4	0.0	1.9	0.0	0.3	3.4	3.3	11.8	3.2	1.5	29.8	2.9	0.0	2.8	6.2	0.0	1.4	0.2	2.4	3.6	11.0	5.9	3.4	65.3
AP2A1	"ADTAA, CLAPA1"	ENSG00000196961	"Adaptor related protein complex 2 alpha 1 subunit"	O95782	19	49766968-49807113	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 15.8"	"Lineage enriched"	"Detected in all"	4	"monocytes: 15.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004306	Approved		Supported	Vesicles		NA	NA		300000	Vesicles		"CAB004306: AB_2274034"	"unprognostic (4.33e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.85e-3)"	"unprognostic (4.84e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.83e-9)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.72e-3)"	26.5	37.8	23.7	21.7	34.3	40.9	19.8	32.2	58.6	18.4	15.9	22.2	11.5	22.3	25.2	13.1	23.0	23.0	17.9	23.7	21.5	22.0	15.2	31.7	15.3	23.7	20.1	28.2	26.1	22.5	10.3	15.1	29.4	37.6	15.3	9.7	16.5	16.5	18.8	39.6	26.2	22.8	19.8	18.1	22.8	15.8	48.5	14.6	15.5	13.2	14.3	13.5	20.1	18.0	1.1	3.9	3.4	15.8	2.0	1.8	3.0	23.5	34.1	11.8	27.2	21.2	26.0	24.1	28.0	19.2	17.4	18.3	17.5	15.0	10.6	10.7	28.9	14.7	21.5	8.9	20.2	7.4	16.6	20.1	15.6	22.9	18.8	23.4	12.5	26.3	40.8	14.7	19.3	10.1	15.6	20.6	17.7	38.9	14.8	16.4	18.6	13.7	16.6	12.1	22.4	35.2	15.6	27.8	13.4	10.3	30.0	9.0	12.1	30.8	21.4	11.6	13.2	18.0	17.8	28.3	45.4	25.2	18.9	19.8	22.1	27.1	11.1	31.9	18.4	19.0	0.2	3.9	2.6	1.8	10.9	1.3	1.1	1.1	1.1	3.9	0.9	0.9	1.1	3.4	2.0	15.8	1.2	1.5	3.0	23.7	34.3	32.2	58.6	21.5	22.0	20.1	28.2	37.6	14.6	0.0	2.9	15.7	14.9	12.2	41.4	2.6	20.4	0.0	3.4	14.0	41.2	70.4	10.0	14.6	99.3	14.7	36.5	70.0	25.5	27.7	28.2	13.1	9.2	33.4	27.7	47.7	2.4	41.1	43.1	126.6	49.5	20.9	18.6	22.6	13.0	29.2	22.9	17.5	58.0	39.5	27.5	58.2	26.8	43.5	56.7	12.2	202.1	27.1	19.5	19.0
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 alpha 2 subunit"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		93000	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	21.9	11.1	20.2	8.7	20.7	18.4	23.2	50.9	32.4	17.5	13.9	9.5	10.4	16.8	16.3	8.5	12.2	21.5	10.1	14.7	22.6	20.0	19.4	16.3	13.3	18.1	16.1	21.1	11.2	14.7	7.8	15.5	16.3	16.9	15.5	16.3	11.5	21.7	14.7	13.3	16.5	12.0	18.5	18.1	34.5	17.0	16.4	6.7	12.4	12.1	5.0	9.1	10.5	10.5	3.4	3.7	6.8	4.6	3.4	5.4	1.7	5.5	2.5	3.0	8.8	11.4	11.7	7.4	8.0	2.7	4.9	4.0	0.9	6.0	5.8	7.0	9.5	4.6	7.3	7.0	4.4	3.2	4.2	18.3	1.7	7.7	3.1	4.5	2.2	4.2	13.8	4.8	2.4	4.9	12.0	6.8	3.9	5.9	4.5	5.0	0.5	2.0	2.5	1.7	7.1	14.3	3.6	2.0	6.3	7.4	5.1	9.5	8.1	8.9	7.3	1.1	5.3	4.3	0.8	10.6	1.6	1.9	2.2	4.0	3.6	2.9	4.3	3.0	2.9	2.4	3.3	4.6	3.8	3.1	4.6	1.8	1.7	3.2	1.8	3.7	3.4	3.4	3.5	6.8	3.4	3.8	3.7	5.4	1.7	20.2	20.7	50.9	32.4	22.6	20.0	16.1	21.1	16.9	6.7	35.7	17.9	12.7	10.5	12.7	45.7	11.3	22.9	20.1	14.8	59.3	56.9	33.3	33.2	32.3	35.0	28.7	39.6	23.3	15.9	35.6	25.3	20.9	26.5	52.5	68.3	95.3	33.7	81.0	78.2	20.9	31.9	26.9	8.5	30.7	27.3	29.4	24.3	20.1	26.2	42.7	64.8	25.8	14.4	46.9	25.1	9.9	23.8	20.8	32.0	9.7
AP2B1	"ADTB2, CLAPB1"	ENSG00000006125	"Adaptor related protein complex 2 beta 1 subunit"	P63010	17	35578046-35726409	"Cancer-related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 401.9;Late spermatids: 548.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017631, HPA056733, HPA067983"	Approved		Supported	Vesicles		NA	NA		680000	Vesicles		"CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-2)"	20.1	19.9	36.6	16.3	51.3	18.6	27.6	32.8	59.0	27.8	29.8	35.2	17.0	15.1	20.0	33.1	13.1	22.9	20.2	30.3	36.8	36.1	32.9	16.0	23.6	16.0	35.5	39.9	28.7	15.4	75.6	30.0	30.6	40.7	20.0	39.0	21.8	18.7	25.3	23.3	13.1	16.7	26.1	37.0	18.4	21.6	45.3	27.4	18.5	31.5	10.6	20.1	19.6	21.5	12.6	10.7	15.8	15.4	9.5	19.4	10.3	41.7	53.6	27.7	32.3	45.6	50.2	11.8	21.5	33.0	31.7	34.3	29.9	36.6	20.3	19.2	40.1	39.7	39.9	37.7	61.7	45.4	24.3	34.9	27.5	39.2	16.3	26.2	26.5	19.4	31.9	24.5	32.1	48.8	36.4	49.9	26.8	41.7	29.5	49.6	8.4	25.6	12.9	22.2	22.6	38.6	21.6	39.4	14.9	40.0	24.2	22.7	27.9	26.7	9.5	29.4	67.5	38.6	17.9	49.5	24.2	22.3	26.1	32.2	12.5	22.6	19.2	30.9	19.7	25.6	15.0	11.3	15.8	16.6	15.4	17.8	12.6	14.9	14.9	10.6	11.5	6.9	8.7	13.3	9.5	15.1	10.7	19.4	10.3	36.6	51.3	32.8	59.0	36.8	36.1	35.5	39.9	40.7	27.4	14.9	14.2	41.9	22.8	27.6	64.4	50.6	76.5	16.0	37.5	106.4	53.0	23.8	99.5	100.1	401.9	39.3	44.4	233.6	104.0	33.3	37.1	29.2	40.4	56.8	38.2	65.2	68.5	71.2	50.5	548.2	54.4	27.4	15.1	41.5	60.3	48.9	130.3	52.9	64.3	61.5	38.2	58.2	20.0	197.7	60.9	12.8	27.5	41.5	67.8	20.9
AP4S1	"AP47B, CLA20, SPG52"	ENSG00000100478	"Adaptor related protein complex 4 sigma 1 subunit"	Q9Y587	14	31025106-31096450	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039963	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA039963: AB_10795240"	"unprognostic (4.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.79e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (2.20e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.59e-2)"	4.2	6.1	16.6	5.8	18.4	4.8	8.2	15.9	22.2	6.0	6.6	5.9	4.0	3.3	7.3	6.6	4.6	7.0	6.4	8.2	12.2	10.8	7.2	5.6	4.9	10.7	8.5	11.3	10.8	8.0	6.5	7.7	6.3	9.0	5.8	3.9	4.7	5.0	6.5	11.0	4.1	3.8	7.6	7.3	6.9	4.0	16.5	7.3	4.5	8.3	2.4	6.9	5.5	4.4	5.5	4.6	7.0	4.8	11.5	8.8	2.4	7.8	11.2	9.7	2.7	4.2	7.4	7.7	5.1	9.3	8.4	8.7	10.7	13.0	9.1	5.2	6.5	6.5	8.8	6.4	8.9	14.4	7.7	3.7	13.4	4.3	16.8	8.6	11.9	8.2	5.8	5.5	8.2	11.5	5.7	10.0	6.5	6.8	6.3	10.0	11.2	7.8	6.7	11.5	9.1	9.6	8.2	8.9	1.3	9.5	11.3	5.3	5.7	9.3	4.8	13.8	7.0	10.3	5.8	7.8	6.8	5.8	4.7	4.6	7.7	14.2	13.3	3.9	3.8	4.9	7.0	1.8	3.0	3.7	4.8	5.8	5.1	5.7	4.5	1.8	5.5	5.3	6.7	3.7	11.5	3.7	4.6	8.8	2.4	16.6	18.4	15.9	22.2	12.2	10.8	8.5	11.3	9.0	7.3	8.9	7.7	5.1	5.6	3.1	11.2	9.6	7.6	9.4	2.3	5.2	29.5	7.5	5.0	6.8	13.9	5.1	3.6	0.0	4.1	4.4	5.8	3.4	7.0	4.0	6.6	6.4	5.8	11.1	4.5	11.7	6.4	6.6	3.3	6.4	2.3	8.0	3.5	3.7	8.1	6.1	22.8	6.5	5.8	40.9	7.3	2.5	9.6	4.9	4.5	3.9
APEX2	"APE2, APEXL2, XTH2, ZGRF2"	ENSG00000169188	"Apurinic/apyrimidinic endodeoxyribonuclease 2"	Q9UBZ4	X	55000357-55009057	"Enzymes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair"	"DNA-binding, Endonuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA048577			Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"		NA	Yes			"Nucleoplasm, Nucleoli fibrillar center"	Vesicles	"HPA048577: AB_2680448"	"unprognostic (2.90e-2)"	"prognostic favorable (6.17e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (6.13e-7)"	"unprognostic (5.89e-2)"	"unprognostic (4.87e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (7.46e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (6.63e-4)"	11.1	12.8	8.6	12.0	12.3	11.9	10.2	8.7	11.8	10.0	12.3	13.7	8.2	12.3	11.5	12.6	20.8	10.7	13.9	10.6	8.7	7.2	15.4	18.5	10.3	14.2	9.7	6.0	14.4	10.7	10.7	12.7	17.8	8.8	11.0	15.1	9.1	10.4	10.0	10.3	16.7	18.7	10.0	9.9	18.0	10.8	7.7	8.9	21.9	10.6	10.2	27.4	11.6	12.7	6.7	9.4	9.2	9.9	26.6	7.5	6.3	22.0	19.9	7.9	11.4	11.5	7.7	13.4	9.1	12.3	17.7	17.3	10.8	18.6	14.6	14.3	8.6	20.9	16.6	18.0	17.3	13.4	11.8	13.7	17.8	19.8	11.0	7.4	10.9	16.8	7.6	14.2	24.9	9.0	8.4	14.0	15.6	9.1	9.9	13.1	21.5	14.7	14.3	15.6	10.5	24.0	13.1	13.1	15.9	9.5	11.1	7.3	8.0	17.2	20.9	8.8	18.8	16.5	8.5	8.1	10.5	15.3	21.1	11.8	10.4	13.3	12.1	11.2	18.7	12.4	9.2	7.8	8.5	7.5	9.9	6.2	6.1	7.1	7.4	9.4	6.7	6.4	6.2	2.9	26.6	8.3	5.1	7.5	6.3	8.6	12.3	8.7	11.8	8.7	7.2	9.7	6.0	8.8	8.9	3.0	16.9	15.2	10.8	11.4	3.2	4.7	10.2	12.0	9.1	10.4	0.0	43.2	13.3	21.7	0.2	7.7	13.7	70.0	13.2	28.4	7.0	7.8	8.1	10.2	21.2	6.4	5.8	8.6	8.6	0.8	5.5	13.5	0.0	29.7	11.1	5.8	15.0	14.8	8.1	15.8	2.1	19.4	4.4	1.0	10.8	11.0	39.8	15.8	11.3	10.0
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		340000	Vesicles	"Golgi apparatus, Cytosol"	"HPA037573: AB_10696938, HPA044874: AB_2679126"	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	46.9	37.4	26.7	30.3	32.9	15.0	35.7	34.4	38.8	48.8	36.7	37.3	39.9	36.0	39.8	61.6	38.6	32.6	38.0	39.5	28.7	30.6	39.1	61.4	34.0	27.3	30.4	24.7	45.1	65.2	49.7	64.7	46.0	38.3	42.4	39.6	29.3	62.0	46.9	25.8	31.9	47.1	41.9	34.3	34.9	38.1	37.9	29.7	39.0	44.1	29.3	39.2	46.9	42.1	22.7	29.1	46.2	33.0	34.1	39.5	26.7	24.7	20.7	36.3	26.5	44.7	47.8	19.6	62.3	55.4	28.2	33.8	65.2	32.8	26.0	53.5	69.5	40.9	33.4	40.5	36.6	39.4	35.8	18.9	55.9	15.0	35.5	50.8	34.3	32.7	41.6	30.5	46.6	43.5	39.7	42.7	25.8	28.7	36.6	53.1	39.7	30.8	30.5	22.8	51.4	27.7	26.9	35.3	39.6	34.2	26.8	24.9	25.0	34.7	33.8	17.6	35.1	43.0	30.7	39.0	35.7	17.6	33.7	28.8	21.5	19.0	37.9	21.0	32.2	42.3	46.2	26.4	26.3	30.5	33.0	39.5	22.7	30.2	29.3	29.1	20.7	29.1	26.6	23.1	34.1	32.1	24.4	28.3	26.7	26.7	32.9	34.4	38.8	28.7	30.6	30.4	24.7	38.3	29.7	32.8	42.8	17.5	25.2	28.0	19.4	40.3	30.6	48.2	45.5	29.6	3.9	13.9	8.3	32.0	9.5	32.1	50.4	0.0	32.8	30.7	36.6	44.9	38.1	51.8	26.5	17.5	38.6	35.6	36.5	5.6	44.5	24.8	21.9	45.1	66.8	15.7	39.0	28.1	38.9	27.0	11.7	19.4	38.9	40.0	50.4	30.4	25.3	24.9	34.6	42.9
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289793	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Supported	"Nuclear membrane,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	"Nuclear membrane"	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.3	13.8	17.8	16.7	21.8	12.4	10.4	29.2	28.9	16.0	16.6	27.1	15.3	14.8	17.3	17.9	13.4	16.0	20.0	14.3	17.5	17.2	13.7	14.8	13.1	16.6	26.0	19.9	16.7	32.8	13.7	40.9	17.9	19.2	16.2	11.7	20.1	21.3	18.1	10.4	21.9	15.7	14.8	15.9	17.2	21.1	19.9	22.7	11.2	15.0	10.3	15.5	16.0	11.9	7.4	8.2	8.3	12.6	6.6	9.9	7.0	11.2	21.4	9.3	11.1	11.2	12.7	18.3	16.5	13.6	33.6	16.9	50.9	12.6	8.6	15.1	19.8	15.3	15.6	8.5	26.6	10.4	5.6	9.4	6.6	20.7	42.9	17.2	9.9	13.9	10.9	17.2	16.2	9.1	11.9	11.8	9.1	12.0	10.0	9.0	18.5	17.9	9.4	12.4	11.9	18.5	10.1	13.5	8.3	8.3	13.8	10.0	11.0	19.7	21.1	20.6	7.9	15.5	12.8	15.3	20.5	27.9	12.4	13.0	10.2	6.6	9.3	20.8	7.0	12.7	6.9	7.6	8.3	8.8	10.5	9.9	4.8	4.8	8.0	8.2	7.4	4.9	4.6	3.6	6.6	12.6	6.2	5.9	7.0	17.8	21.8	29.2	28.9	17.5	17.2	26.0	19.9	19.2	22.7	20.8	30.7	9.0	5.8	9.0	25.4	10.6	10.2	14.7	13.6	12.2	31.4	9.8	8.3	10.5	10.4	9.5	21.3	23.3	13.4	20.9	14.6	11.1	16.1	19.2	13.1	20.6	23.5	17.8	17.2	16.3	11.5	10.5	11.8	10.8	27.0	11.5	20.5	12.7	9.2	10.2	19.1	6.5	9.2	9.5	7.0	7.4	12.7	10.7	15.8	5.8
ARFIP1	HSU52521	ENSG00000164144	"ADP ribosylation factor interacting protein 1"	P53367	4	152779937-152918463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005080, HPA037375, HPA063759"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB005080: AB_2058797, HPA037375: AB_2675440, HPA063759: AB_2685114"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.49e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-2)"	"prognostic favorable (2.83e-10)"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.22e-3)"	17.8	15.6	12.2	22.6	13.2	2.8	22.3	15.7	12.3	22.8	25.3	17.5	25.6	20.9	21.1	23.8	23.4	17.6	20.8	11.9	12.6	13.2	23.6	15.3	20.3	14.9	16.1	9.5	22.9	18.8	20.4	22.5	29.0	13.5	23.8	26.4	19.1	19.6	23.9	12.7	19.1	29.9	18.5	18.3	18.5	20.2	12.7	13.9	14.7	23.9	10.2	17.9	24.3	20.4	8.4	10.9	35.7	13.8	12.3	7.6	7.7	13.2	9.9	13.8	13.5	21.8	22.3	17.1	15.9	22.5	16.1	15.4	11.5	27.8	10.6	5.3	22.1	12.4	9.5	14.3	16.1	20.1	8.9	8.9	10.5	10.1	11.4	15.4	19.7	22.2	15.7	17.9	13.7	13.6	17.5	14.8	6.2	12.3	23.0	22.5	15.4	11.0	11.0	11.6	16.6	10.1	6.4	7.8	9.8	29.1	17.8	17.5	14.4	12.0	22.7	15.8	14.1	20.3	10.6	9.1	15.6	11.1	15.1	11.2	25.3	20.8	14.5	19.8	19.8	21.5	12.1	12.0	17.9	6.7	13.8	6.7	8.4	5.3	5.5	10.9	7.7	4.1	5.5	35.7	12.3	12.6	1.3	7.6	7.7	12.2	13.2	15.7	12.3	12.6	13.2	16.1	9.5	13.5	13.9	6.0	25.6	10.4	15.8	26.3	17.3	8.1	28.1	25.4	21.6	36.6	0.0	24.5	23.2	23.7	30.8	19.9	26.4	0.0	15.9	21.2	22.4	21.3	22.0	17.8	19.1	17.5	37.3	19.0	22.2	19.7	20.8	18.5	20.3	5.4	34.5	32.0	19.3	24.6	20.5	24.5	23.6	32.3	18.9	25.5	31.9	29.6	36.7	11.4	29.7	29.4
ARHGAP30	FLJ00267	ENSG00000186517	"Rho GTPase activating protein 30"	Q7Z6I6	1	161046946-161069970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;lymphoid tissue: 45.9"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 64.9;Hofbauer cells: 51.2;Kupffer cells: 65.0;Macrophages: 65.9;monocytes: 85.6;T-cells: 106.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.5;HL-60: 24.3;HMC-1: 34.3;Karpas-707: 25.5;MOLT-4: 19.7;THP-1: 24.2;U-266/70: 38.3;U-266/84: 25.3;U-698: 26.9;U-937: 19.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036300	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA036300: AB_10601117"	"unprognostic (7.31e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.77e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.68e-3)"	"unprognostic (3.05e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.65e-2)"	6.1	3.0	2.6	23.3	3.9	20.4	3.1	0.6	2.4	2.2	3.9	3.5	1.4	3.5	2.0	3.7	8.0	3.3	5.9	4.1	1.9	1.7	3.0	3.3	11.3	27.9	4.3	0.7	1.8	1.8	0.3	1.5	2.5	3.4	2.3	3.2	2.6	6.1	1.8	0.9	11.2	13.7	2.9	4.3	45.9	4.1	1.4	4.5	38.1	2.0	2.4	33.2	5.6	3.8	8.3	12.3	27.1	24.0	10.2	19.7	14.7	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	31.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	14.6	0.0	10.5	0.0	0.0	0.0	24.3	34.3	0.0	0.3	0.0	0.0	0.0	0.0	15.3	0.1	25.5	0.0	0.2	19.7	5.6	0.0	0.2	0.0	12.4	0.1	0.4	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	24.2	0.2	0.0	0.1	0.0	0.1	38.3	25.3	26.9	0.1	19.5	0.0	3.3	15.5	17.6	19.7	18.3	15.1	7.1	13.2	16.1	12.3	8.3	11.0	14.7	27.1	10.2	24.0	8.4	13.2	14.7	2.6	3.9	0.6	2.4	1.9	1.7	4.3	0.7	3.4	4.5	3.0	25.1	39.8	2.9	4.9	0.2	1.2	5.1	9.4	11.4	0.0	3.9	0.5	0.0	2.2	2.1	2.1	0.0	0.0	5.3	1.2	0.9	3.8	64.9	1.5	51.2	0.0	0.0	7.4	65.0	0.4	0.3	65.9	5.0	85.6	0.3	0.2	7.6	0.0	0.0	0.5	3.0	0.0	1.4	0.0	0.1	21.5	3.8	106.6	0.3	13.6
ARL14EP	"ARF7EP, C11orf46, FLJ38968"	ENSG00000152219	"ADP ribosylation factor like GTPase 14 effector protein"	Q8N8R7	11	30323051-30338227	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039634, HPA048127"	Approved		Supported	"Nucleoplasm,Vesicles,Focal adhesion sites,Cytosol"		NA	NA			"Vesicles, Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA039634: AB_2676606, HPA048127: AB_2680277"	"prognostic favorable (2.50e-5)"	"unprognostic (8.93e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (2.50e-2)"	"unprognostic (6.50e-3)"	"unprognostic (5.76e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (7.49e-4)"	13.9	21.5	24.5	12.9	29.1	6.3	18.7	22.7	23.4	17.0	14.5	8.0	22.4	8.7	18.1	22.7	11.1	15.8	12.4	20.5	17.7	15.5	16.5	17.6	10.3	23.5	15.5	20.5	20.1	15.0	33.4	28.6	10.6	15.1	19.0	10.3	9.0	17.0	19.9	28.0	11.6	12.5	18.3	16.0	18.2	14.4	14.5	15.0	11.6	23.3	13.9	19.1	16.1	15.1	17.6	12.7	5.5	9.6	24.4	28.7	11.2	5.8	8.5	9.5	8.3	15.6	17.0	4.8	11.5	14.5	10.4	11.6	4.7	2.2	23.8	7.9	8.2	11.6	9.9	13.8	9.7	14.8	18.9	17.1	7.2	6.7	8.2	24.6	12.8	8.3	17.6	19.6	4.9	18.7	15.2	11.4	9.9	11.3	13.0	18.1	5.6	11.6	10.6	11.0	13.1	11.9	10.2	23.2	9.7	13.9	8.1	10.9	11.6	8.9	12.0	14.1	8.9	12.7	7.3	10.0	12.0	6.4	23.5	10.9	20.4	11.6	15.5	11.4	8.0	11.4	5.5	9.6	3.0	12.1	9.4	28.7	17.6	14.8	13.4	12.7	14.0	13.7	13.1	1.7	24.4	7.0	9.1	9.5	11.2	24.5	29.1	22.7	23.4	17.7	15.5	15.5	20.5	15.1	15.0	26.8	28.1	30.5	38.1	11.0	32.2	57.0	17.8	34.8	20.5	24.4	13.7	14.7	64.6	23.3	99.1	24.8	6.3	0.0	19.6	10.7	22.3	27.7	26.6	24.2	22.8	30.2	13.9	12.9	24.3	44.0	25.3	30.9	25.3	43.3	10.0	34.4	19.0	9.7	23.7	27.2	28.6	12.9	24.1	60.6	33.2	9.7	9.3	28.9	10.4	24.4
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394814	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 213.6"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 816.2;Hofbauer cells: 990.8;Kupffer cells: 840.4;monocytes: 924.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 112.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Enhanced		Supported	Vesicles,Cytosol		NA	NA		53000000	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	31.8	17.8	8.7	50.7	14.4	56.4	35.4	1.9	7.7	17.9	30.7	8.4	18.1	32.6	17.4	21.8	16.0	18.3	23.4	24.4	5.7	7.0	27.9	34.8	40.0	92.8	10.7	3.7	11.6	13.0	3.8	13.1	36.2	9.4	15.6	10.5	20.6	18.3	15.1	10.6	10.0	42.3	12.1	10.2	81.8	16.3	10.8	9.3	31.0	23.0	13.7	37.2	19.0	21.1	53.5	133.7	127.2	154.4	38.9	83.4	213.6	16.0	29.2	2.2	6.4	8.5	30.7	22.4	22.3	22.5	9.0	8.0	19.0	62.6	27.9	41.8	24.3	19.7	12.1	2.8	19.7	3.7	22.7	10.5	20.3	8.5	13.1	24.5	20.3	69.1	17.1	10.2	12.7	12.6	18.1	23.7	14.9	22.5	67.3	13.1	74.1	22.4	44.5	8.0	19.0	63.6	18.1	2.0	68.3	18.6	7.9	1.8	5.9	15.2	67.1	112.2	7.6	15.8	41.4	34.6	25.7	21.3	45.3	28.1	12.5	24.9	34.1	25.6	53.0	46.0	53.7	153.2	121.6	53.8	154.4	50.2	53.5	62.8	59.6	133.7	42.8	37.0	49.3	127.2	38.9	142.0	77.9	83.4	213.6	8.7	14.4	1.9	7.7	5.7	7.0	10.7	3.7	9.4	9.3	38.7	80.0	287.6	95.5	53.8	9.2	5.6	119.8	56.2	54.6	123.9	7.9	492.8	21.6	353.0	2.6	242.9	360.5	0.0	368.7	816.2	113.0	95.0	189.2	37.0	990.8	1.6	108.2	201.3	840.4	4.0	34.5	558.1	170.4	924.3	71.7	20.6	324.8	290.8	17.0	73.6	15.8	90.5	96.8	2.1	14.7	32.4	253.6	319.0	152.9	154.0
ARRDC4	FLJ36045	ENSG00000140450	"Arrestin domain containing 4"	Q8NCT1	15	97960698-97973838	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 67.3"	"Cell type enhanced"	"Detected in many"	4	"Paneth cells: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 19.1;BJ: 39.3;HSkMC: 22.2;hTCEpi: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039934, HPA042109"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA039934: , HPA042109: AB_10795606"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.60e-3)"	"unprognostic (4.49e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.77e-2)"	9.2	9.3	11.4	11.5	18.4	6.7	14.8	3.3	16.3	9.4	27.4	67.3	11.6	11.2	10.7	11.9	11.8	10.8	14.7	9.7	18.7	9.2	14.1	21.8	14.1	6.4	18.1	15.2	7.4	25.0	3.7	6.5	13.0	29.4	8.3	17.0	4.6	6.5	13.5	10.1	25.3	15.3	14.0	48.7	5.9	18.1	10.2	41.9	1.9	14.9	4.5	3.5	11.7	12.4	0.5	2.4	3.1	5.1	0.1	0.1	0.8	2.1	0.0	0.3	5.8	2.6	19.1	0.0	39.3	17.6	5.2	2.3	2.3	1.4	0.0	5.5	1.8	0.5	2.3	1.4	13.7	8.5	0.0	3.6	3.7	0.7	1.5	1.0	2.5	5.9	22.2	33.9	6.0	7.0	7.4	0.2	1.1	5.3	0.0	1.8	7.1	0.4	2.1	1.1	6.5	0.8	0.0	0.3	0.0	10.2	4.8	1.9	3.4	5.9	2.2	10.6	1.2	0.8	3.9	0.0	1.6	1.1	8.2	1.8	0.0	0.0	0.0	3.4	0.4	4.0	2.3	5.1	3.1	0.1	3.6	0.0	0.5	0.0	0.0	2.4	0.4	0.1	0.0	3.0	0.1	0.6	0.6	0.0	0.8	11.4	18.4	3.3	16.3	18.7	9.2	18.1	15.2	29.4	41.9	3.0	7.2	3.2	2.6	22.6	1.6	12.6	15.3	9.4	3.4	21.0	5.9	0.2	6.6	2.4	3.3	5.0	36.0	0.0	7.2	0.1	13.0	10.0	23.1	14.1	18.0	0.0	36.8	6.2	31.5	6.7	4.6	17.3	23.6	0.0	21.7	0.5	8.8	45.6	7.8	1.3	3.1	0.0	16.4	1.4	5.9	27.1	0.6	1.3	20.3	5.9
ASAP3	"CENTB6, DDEFL1, FLJ20199, UPLC1"	ENSG00000088280	"ArfGAP with SH3 domain, ankyrin repeat and PH domain 3"	Q8TDY4	1	23428563-23484568	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.6;ASC TERT1: 18.6;HSkMC: 23.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020537, HPA020546"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA020537: AB_2670467, HPA020546: AB_2670470"	"unprognostic (2.51e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.35e-3)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (3.87e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.19e-3)"	"prognostic favorable (2.80e-4)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (8.30e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.18e-1)"	"prognostic favorable (5.12e-5)"	"unprognostic (3.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.27e-2)"	10.6	15.5	8.7	5.9	9.9	0.7	15.2	2.6	8.3	11.0	8.9	6.6	13.5	2.4	7.9	7.7	12.9	8.7	7.8	20.7	6.9	5.1	10.7	7.4	7.9	2.3	9.2	6.1	29.6	13.7	13.7	7.4	12.4	16.3	12.0	6.8	8.2	14.6	25.5	24.2	32.5	3.7	9.9	15.4	1.9	8.9	9.4	6.7	0.2	12.0	12.0	6.2	7.0	17.7	0.1	0.0	0.0	1.6	0.0	0.4	0.4	1.0	1.0	10.6	6.9	19.6	18.6	13.1	1.9	2.3	3.0	3.8	0.7	0.0	5.4	2.2	3.7	1.7	5.0	7.3	1.7	1.7	0.2	0.9	0.3	2.8	6.8	10.6	0.0	0.5	23.7	2.7	4.7	4.3	8.9	2.3	0.8	3.6	0.0	1.8	2.2	0.7	0.0	1.8	2.9	2.5	2.8	1.1	0.0	2.0	2.1	0.4	3.6	8.3	2.1	2.1	5.5	7.9	0.0	0.8	1.2	3.2	3.6	0.1	2.3	2.3	0.6	0.5	0.0	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.4	8.7	9.9	2.6	8.3	6.9	5.1	9.2	6.1	16.3	6.7	8.9	7.0	0.0	1.7	1.8	1.0	11.6	0.0	2.7	2.3	3.5	0.0	1.6	3.3	4.0	3.5	3.1	2.1	0.0	5.2	32.0	6.7	3.3	1.1	3.4	1.6	0.0	1.2	3.7	0.0	5.6	11.5	0.4	0.0	0.0	7.0	7.5	4.0	0.0	12.7	4.9	0.5	0.0	1.9	6.0	8.1	3.8	1.1	0.0	3.7	1.1
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 171.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1020.7"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 13.7;monocytes: 39.1"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 104.5"	"Region enriched"	"Detected in many"	9	"cerebellum: 49.4"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Intracellular and membrane"	NA	NA			Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171.0	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0.0	0.1	2.0	0.9	0.0	0.0	0.1	0.1	0.2	0.2	0.3	3.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.3	104.5	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.1	1.8	1.6	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0.0	0.0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2	0.0	6.6	13.0	1.0	2.9	31.7	1.2	73.9	1.4	2.3	3.5	151.2	3.2	3.3	0.8	212.5	12.7	0.3	23.3	0.2	3.6	2.0	0.8	0.0	1020.7	41.3	14.3	15.0	23.9	110.6	80.2	2.3	18.3	0.0	0.0	0.7	2.6	0.4	0.6	1.1	1.6	39.8	0.0	0.4	4.5	7.8	4.3	10.4	0.7	1.0	2.4
ASIP	"AGTIL, ASP"	ENSG00000101440	"Agouti signaling protein"	P42127	20	34194569-34269344	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.7;epididymis: 18.4;ovary: 24.8"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 25.4;Hofbauer cells: 12.3;Leydig cells: 11.5;Peritubular cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 5.4"	"Cell type enriched"	"Detected in single"	321	"plasmacytoid DC: 43.7"	"Lineage enriched"	"Detected in single"	321	"dendritic cells: 43.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.6;HSkMC: 5.4;SK-MEL-30: 3.9;U-698: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048636	Uncertain		Supported	Vesicles	"Secreted to blood"	NA	NA			Vesicles		"HPA048636: AB_2680471"	"unprognostic (4.81e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.97e-3)"	"unprognostic (3.26e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.02e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-1)"	0.5	0.1	0.3	0.3	0.3	0.2	1.9	0.3	0.8	2.0	1.0	0.3	0.3	0.0	2.0	18.4	0.3	2.1	0.3	10.3	5.4	0.0	0.3	0.5	0.3	0.4	0.3	0.3	24.8	0.3	0.0	0.3	0.3	0.7	2.5	0.0	0.3	0.3	0.3	0.3	5.4	0.3	0.3	1.3	0.3	0.1	7.1	0.3	0.3	0.3	0.3	0.8	0.5	0.4	0.1	43.7	0.0	0.0	0.0	0.0	0.2	0.1	2.4	0.9	0.8	0.5	1.6	0.2	0.2	0.0	0.0	0.0	6.6	0.1	2.4	0.5	0.7	0.0	0.4	0.0	0.0	0.0	0.2	1.6	3.4	0.7	1.1	0.0	0.0	0.9	5.4	0.0	0.0	0.0	0.3	0.0	1.6	1.2	2.0	0.0	0.7	0.5	3.5	0.0	0.3	1.4	0.7	0.6	3.0	0.0	0.2	0.6	0.6	0.0	0.4	3.9	1.1	0.7	0.4	0.8	1.2	1.2	0.2	0.6	0.8	0.8	4.0	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	43.7	0.0	0.2	0.3	0.3	0.3	0.8	5.4	0.0	0.3	0.3	0.7	0.3	0.0	1.1	0.0	0.0	2.3	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	1.0	1.3	0.0	0.0	0.0	0.1	2.3	0.0	0.0	4.0	12.3	0.0	0.0	4.3	0.3	0.2	11.5	1.7	1.7	0.0	0.0	0.0	0.1	0.0	9.9	4.4	0.0	6.5	1.0	1.6	1.3	2.8	0.7	0.0	0.0	0.0
ASPSCR1	"ASPL, ASPS, TUG, UBXD9, UBXN9"	ENSG00000169696	"ASPSCR1, UBX domain containing tether for SLC2A4"	Q9BZE9	17	81976807-82017406	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"Hep G2: 82.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026749	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA026749: AB_1845114"	"unprognostic (5.01e-2)"	"unprognostic (1.19e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.71e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.01e-2)"	10.3	12.6	14.3	12.6	14.5	16.8	10.6	16.5	20.8	9.9	12.9	16.7	11.8	17.5	10.1	15.8	11.9	9.3	15.1	11.5	13.1	12.6	15.8	31.9	14.1	14.8	18.9	12.9	8.8	17.8	17.0	19.7	21.8	14.8	13.2	7.1	14.4	22.6	9.9	25.1	15.5	14.4	9.1	12.6	13.2	13.0	16.9	14.6	9.8	16.4	12.9	13.0	9.7	8.3	8.1	14.6	15.7	11.3	7.2	10.5	5.2	5.1	9.0	3.5	5.1	2.2	2.8	15.3	4.9	3.7	5.9	5.8	5.2	5.9	5.2	5.0	3.5	4.5	2.5	3.8	3.7	1.8	3.6	11.5	5.8	7.3	82.6	7.3	5.1	8.5	3.2	4.0	2.9	2.1	3.1	5.6	4.4	5.8	7.5	3.3	17.3	4.7	11.1	4.4	9.5	6.6	5.2	5.1	10.6	5.7	4.7	9.4	9.6	3.9	12.6	9.0	4.2	7.5	12.2	4.6	10.1	7.0	7.4	6.1	5.4	3.2	5.8	5.4	5.2	6.0	15.7	11.3	8.0	6.7	7.6	4.0	7.9	10.5	9.0	14.6	8.1	8.0	6.0	2.9	7.2	9.3	9.1	4.9	5.2	14.3	14.5	16.5	20.8	13.1	12.6	18.9	12.9	14.8	14.6	8.9	46.0	18.6	20.7	11.8	21.4	11.4	17.8	10.7	9.1	14.0	39.3	64.7	33.2	21.2	40.2	16.0	26.7	0.0	22.9	151.3	16.6	19.3	20.8	45.6	39.1	47.7	24.0	15.4	16.6	63.2	10.9	17.1	18.6	18.0	24.4	56.7	16.2	20.1	16.6	44.0	32.8	12.9	15.3	43.6	48.7	12.5	49.7	23.6	23.8	19.7
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917248	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	8.4	8.3	6.0	8.4	10.4	63.7	7.1	12.2	14.3	7.2	9.2	11.6	8.2	10.0	9.5	5.5	6.1	7.7	8.9	6.4	7.0	6.4	9.0	33.2	9.3	7.7	7.5	7.5	11.8	11.7	7.6	8.7	8.9	9.0	8.5	4.3	12.1	9.3	8.4	12.4	15.9	11.4	9.7	6.7	11.1	9.2	8.0	8.2	13.2	8.4	7.8	9.4	7.9	6.2	1.0	2.3	16.5	2.0	1.5	2.6	0.9	9.9	9.7	3.6	9.6	4.7	3.3	9.5	5.5	8.3	7.6	5.6	8.6	7.9	7.2	11.7	4.8	9.8	8.6	3.6	6.6	2.0	6.7	12.4	6.4	14.5	7.7	6.7	5.0	14.9	9.1	5.8	9.6	5.1	4.4	6.3	7.3	12.1	5.9	3.3	16.2	6.0	17.0	4.1	2.8	10.8	6.7	5.6	10.4	4.1	8.6	13.1	5.1	8.1	11.8	10.2	2.8	11.4	6.4	8.0	7.2	7.1	14.2	4.2	11.5	4.0	5.1	10.6	4.0	4.5	2.8	2.0	2.0	2.6	1.9	2.2	0.8	1.7	2.2	1.3	1.0	1.4	2.5	16.5	1.5	1.5	2.3	0.9	0.9	6.0	10.4	12.2	14.3	7.0	6.4	7.5	7.5	9.0	8.2	8.9	14.4	11.8	7.7	25.6	17.0	5.6	2.5	10.7	10.3	8.7	31.4	11.2	1.7	8.3	1.7	9.0	26.4	0.0	8.9	4.7	14.6	10.6	9.2	17.5	9.7	12.7	34.4	8.6	14.6	2.5	11.8	16.9	28.7	10.8	12.8	10.3	12.5	16.1	9.6	5.2	25.4	12.9	10.7	6.2	5.5	33.5	56.0	39.2	15.6	13.5
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.5;Late spermatids: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059551	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA059551: AB_2684060"	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	13.9	14.3	15.2	9.0	26.1	23.3	13.2	26.7	37.9	12.2	15.0	23.8	10.0	17.1	14.9	9.4	17.6	10.4	13.3	23.4	14.2	13.2	12.6	21.0	13.6	10.2	18.5	14.0	12.9	16.7	27.0	10.8	20.3	20.6	12.8	14.3	12.5	14.0	14.9	61.3	17.5	19.8	18.0	14.3	13.0	13.0	47.0	16.3	7.8	13.1	16.6	12.6	14.7	12.3	5.0	6.6	8.8	16.8	8.4	7.6	8.5	9.6	12.7	9.9	22.9	20.5	21.6	12.8	18.0	21.3	25.3	23.1	19.2	13.5	2.4	14.5	29.5	20.3	21.5	16.2	20.7	19.3	7.8	24.6	19.4	32.8	22.0	20.4	5.2	14.9	21.6	34.4	26.3	24.7	23.1	25.9	6.3	26.4	9.9	17.5	12.6	4.2	10.8	6.9	9.6	10.1	5.7	13.2	9.8	14.8	14.3	15.3	8.9	18.2	16.9	15.9	21.1	6.2	12.5	17.5	25.2	11.7	10.2	16.2	5.3	5.0	4.0	20.5	12.1	13.6	4.8	9.4	4.3	6.2	14.4	6.6	5.0	4.9	7.6	6.6	3.4	4.7	5.5	8.8	8.4	16.8	2.9	5.6	8.5	15.2	26.1	26.7	37.9	14.2	13.2	18.5	14.0	20.6	16.3	0.0	5.0	9.9	6.8	6.9	16.0	30.7	20.4	1.4	3.4	0.0	13.7	21.5	0.0	0.1	59.5	11.7	32.9	23.3	0.4	19.3	9.8	12.3	10.3	30.8	9.9	20.6	13.3	16.0	11.2	76.7	13.0	2.2	10.1	0.0	15.5	20.3	0.2	23.0	8.1	0.1	13.0	12.9	6.6	21.6	12.5	9.7	29.1	10.2	15.3	5.9
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.7	3.9	7.7	4.1	10.0	14.6	2.0	6.1	6.8	3.5	5.9	4.8	6.5	9.6	9.1	4.9	5.6	4.1	5.8	5.1	5.5	7.7	3.4	8.7	4.8	4.8	5.3	10.5	9.4	9.4	3.2	5.4	10.4	7.7	7.4	8.2	8.4	6.6	6.9	2.0	7.1	9.7	6.3	4.1	3.9	5.6	5.3	15.1	4.0	5.5	5.2	6.4	7.1	3.3	10.5	7.1	5.0	5.9	11.5	8.8	4.9	5.0	5.7	4.4	4.6	48.5	5.8	11.5	9.8	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9	35.7	21.0	122.7	17.4	11.2	101.7	35.4	10.2	13.4	19.4	21.0	198.3	14.8	5.0	7.7	12.8	18.8	4.9	0.0	10.6	10.5	26.4	9.5	12.7	21.2	26.0	57.2	19.5	36.8	82.2	2.7	36.5	48.1	25.3	9.0	15.9	35.9	7.6	10.5	26.2	10.3	196.6	25.8	17.3	18.7	33.6	10.8	3.5	111.7	11.7	9.9
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA		21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.6	13.8	8.5	15.2	14.2	12.4	4.9	4.7	8.8	10.1	13.3	8.8	15.0	1.2	8.7	9.7	13.9	14.5	13.0	8.0	11.8	10.3	13.6	10.7	10.4	6.9	8.8	4.6	19.6	9.1	11.6	16.2	6.9	12.6	7.1	5.0	38.9	42.3	15.0	5.7	1.8	4.1	5.4	8.8	0.1	0.1	8.8	18.6	11.7	5.3	23.4	12.4	7.3	6.7	14.0	11.5	16.3	7.0	4.2	8.6	0.3	12.6	5.6	17.2	23.4	2.5	11.5	0.1	10.0	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1	17.9	46.6	27.3	45.1	17.5	158.7	19.5	30.6	6.7	14.8	14.0	276.9	26.4	10.0	14.7	2.4	19.2	44.6	46.7	15.8	13.4	33.9	38.7	23.1	33.6	46.0	90.6	81.5	19.6	33.1	3.1	16.1	25.8	38.8	3.6	23.1	51.9	17.6	38.6	22.3	28.4	349.7	6.5	48.9	38.7	18.5	17.7	83.5	4.4	19.5	10.7
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197367-20226819	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 116.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 69.7;eosinophil: 47.6;intermediate monocyte: 62.5;myeloid DC: 34.5;neutrophil: 116.0;non-classical monocyte: 54.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 34.5;granulocytes: 116.0;monocytes: 69.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles		NA	NA		240000	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.90e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.25e-2)"	17.1	29.9	31.7	25.8	45.0	14.4	13.2	39.2	72.9	12.2	13.9	15.9	5.5	16.2	10.6	12.2	15.3	10.3	14.8	13.9	33.8	47.8	53.9	18.0	22.8	17.5	46.9	47.1	10.9	12.2	18.8	23.6	18.5	64.2	11.0	16.5	17.3	12.8	10.9	18.2	18.2	21.1	15.0	19.2	20.9	10.7	24.0	12.7	10.3	12.7	9.3	17.5	14.3	12.4	4.9	34.5	116.0	69.7	4.8	7.1	51.1	10.8	18.2	22.7	7.4	31.0	19.2	20.4	24.5	15.7	31.6	32.7	20.5	6.4	19.3	10.0	23.3	32.2	9.3	17.9	16.3	33.7	8.1	12.0	13.4	8.2	15.7	36.4	9.5	28.0	17.1	14.9	19.6	18.1	34.9	19.7	25.8	19.9	18.7	33.7	6.1	27.8	11.3	16.8	16.0	8.0	11.5	29.2	10.0	29.2	17.2	17.6	25.4	11.8	16.0	77.9	19.6	20.9	17.5	20.8	15.9	12.2	26.2	19.5	7.6	10.2	22.7	22.0	22.8	40.3	15.9	69.7	47.6	5.7	62.5	6.2	4.9	5.9	6.1	34.5	4.3	6.1	6.0	116.0	4.8	54.1	8.4	7.1	51.1	31.7	45.0	39.2	69.0	33.8	47.8	46.9	47.1	64.2	12.7	23.8	20.2	30.3	24.8	51.5	100.1	14.0	12.7	12.0	11.4	27.9	96.2	100.2	68.0	38.5	22.5	24.8	23.6	46.7	33.2	46.1	30.0	15.5	21.9	30.6	167.3	179.6	71.4	28.3	171.7	15.9	18.1	165.7	99.5	87.4	19.6	39.2	37.2	20.4	26.5	193.9	117.5	12.9	37.6	83.9	46.7	62.6	104.2	27.7	20.0	18.2
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA		20000	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.3	17.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	28.1	8.0	0.1	0.0	1.4	4.0	0.0	0.0	4.4	2.8	9.9	1.0	0.4	0.0	2.4	0.2	0.3	0.0	0.0	0.0	0.3	0.1	6.3	0.0	3.2	0.0	1.2	3.5	0.8	1.3	1.1	0.3	9.7	0.0	3.1	6.1	0.3	3.1	9.3	0.2	5.9	0.0	0.7	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.7	0.4	3.4	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9	26.8	61.4	5.1	1.7	1.3	17.7	12.8	0.0	0.0	9.1	5.2	76.6	0.0	3.3	0.0	3.0	9.3	46.1	0.0	2.2	0.1	2.2	16.2	8.1	1.1	1.5	58.8	81.2	17.8	7.5	2.3	3.1	3.8	3.3	1.8	23.3	1.0	0.8	7.0	1.8	1.4	41.3	0.0	0.3	1.1	4.1	1.3	0.0	21.8	23.1	2.4
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	10.8	8.3	13.7	18.9	17.1	28.1	21.0	26.4	13.6	10.4	15.8	12.7	9.4	17.3	12.6	8.5	14.1	10.7	12.7	11.0	11.5	7.7	9.8	9.6	13.6	13.4	15.6	10.6	13.3	17.7	11.1	11.9	8.4	13.9	11.4	10.2	9.6	13.9	9.5	17.7	16.9	17.6	18.9	9.6	15.1	15.2	9.6	14.6	17.5	12.7	7.5	14.5	11.9	22.9	1.8	1.4	5.5	1.1	3.6	10.4	2.4	9.6	14.0	7.5	13.2	5.6	5.2	15.8	6.5	6.0	9.1	7.8	20.6	11.3	15.0	10.1	6.7	10.9	13.9	11.7	10.2	4.1	14.7	19.2	9.7	11.8	14.9	9.6	11.1	10.8	5.1	17.8	9.3	11.5	8.0	6.0	11.0	24.1	8.3	4.1	25.8	12.0	7.7	17.1	11.7	8.6	22.7	6.8	20.8	6.8	5.7	17.1	10.5	12.4	13.9	20.5	5.9	9.2	14.2	6.7	9.0	9.7	10.3	9.4	9.6	9.3	18.3	4.3	7.4	8.8	1.4	1.1	5.5	10.4	0.9	9.5	1.8	3.0	7.0	0.8	1.6	3.2	4.3	3.2	3.6	0.7	1.4	3.0	2.4	13.7	17.1	26.4	13.6	11.5	7.7	15.6	10.6	13.9	14.6	3.0	11.3	5.2	5.3	16.4	4.9	5.0	5.1	6.7	6.8	3.5	0.0	3.1	0.0	6.1	1.0	6.7	18.6	0.0	6.1	20.3	5.9	9.4	10.4	4.7	6.5	4.8	10.4	4.3	7.5	1.3	4.9	5.9	10.1	3.6	14.5	3.7	8.8	11.9	4.6	2.1	5.4	12.9	5.3	4.4	7.6	13.2	3.1	7.7	11.8	8.7
B4GALNT3	"B4GalNac-T3, FLJ16224, FLJ40362"	ENSG00000139044	"Beta-1,4-N-acetyl-galactosaminyltransferase 3"	Q6L9W6	12	460364-563509	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 43.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 46.6;Late spermatids: 64.3;Paneth cells: 36.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 26.2;HDLM-2: 9.2;HEK 293: 9.2;NTERA-2: 11.6;U-937: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA011404	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	Vesicles	"HPA011404: AB_1845242"	"unprognostic (2.38e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.69e-10)"	"unprognostic (4.22e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.46e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.98e-1)"	0.3	5.7	1.4	2.1	3.8	1.5	1.1	0.3	8.2	6.1	12.8	0.6	0.4	0.8	8.5	2.9	6.0	3.4	9.6	16.8	5.6	0.9	4.1	0.3	6.2	0.2	0.9	1.7	2.1	7.9	2.5	14.7	0.1	2.0	1.6	9.8	1.5	3.8	1.1	2.7	11.0	1.7	1.9	0.5	0.4	43.1	8.0	0.1	1.0	2.1	9.1	4.1	1.8	4.0	0.0	0.0	0.7	0.1	0.0	1.4	0.0	0.0	0.0	0.2	0.9	0.0	0.0	26.2	0.0	0.0	0.0	0.0	6.5	5.0	0.0	0.7	0.0	0.5	2.9	6.5	0.7	0.0	9.2	9.2	0.0	0.0	1.3	0.0	0.1	3.9	0.0	4.6	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	11.6	7.9	0.5	0.4	3.6	0.0	6.3	5.5	3.1	2.0	0.6	0.2	0.7	4.2	0.6	2.0	0.0	0.0	2.0	0.2	0.6	0.0	0.1	0.1	0.0	11.3	4.4	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	3.8	0.3	8.2	5.6	0.9	0.9	1.7	2.0	0.1	0.0	6.5	0.0	4.8	6.6	0.0	11.8	2.5	6.7	5.7	8.7	0.0	0.0	0.0	8.9	25.7	0.0	46.6	0.0	4.2	0.1	0.6	8.9	0.0	0.0	0.6	0.0	9.9	0.0	0.0	64.3	0.0	0.0	0.0	1.0	18.8	0.0	12.7	36.2	0.0	0.0	0.0	0.0	0.9	1.9	1.4	15.2	0.0	1.7	20.2	13.6
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 180.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"	Approved		Supported	"Golgi apparatus,Vesicles,Mitotic spindle"		Yes	No			"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: AB_2686710"	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	15.0	16.7	10.3	20.7	14.4	18.4	16.1	21.9	13.7	16.2	13.0	15.3	15.6	8.7	17.2	13.9	13.2	13.1	11.7	11.4	9.8	7.3	14.1	14.8	12.5	16.1	13.9	11.8	23.6	24.8	32.5	17.4	14.1	14.8	11.3	13.6	11.5	14.7	17.1	20.9	14.9	16.0	12.5	13.3	16.1	13.9	13.0	14.4	23.1	21.5	9.2	17.2	16.2	12.0	3.8	2.8	10.6	2.4	2.3	3.4	0.7	15.3	12.8	11.9	5.1	9.4	13.4	7.2	6.8	9.6	8.4	8.0	8.8	3.6	16.4	5.4	12.7	9.6	7.1	16.7	10.1	10.4	13.2	7.6	22.3	8.1	7.3	5.2	20.6	7.9	8.9	4.9	13.1	11.7	6.8	12.4	3.7	18.1	7.1	7.7	5.9	10.3	4.8	8.0	5.8	7.6	10.5	19.3	5.6	6.1	15.8	8.9	13.6	13.4	7.0	6.2	9.5	4.6	7.4	19.4	8.8	9.9	5.9	10.4	9.5	13.3	22.0	6.4	10.2	5.7	10.6	1.6	0.9	2.7	1.2	3.4	1.7	2.1	2.3	1.3	3.8	2.3	2.6	2.7	2.3	2.4	2.8	1.6	0.7	10.3	14.4	21.9	13.7	9.8	7.3	13.9	11.8	14.8	14.4	29.8	26.2	37.9	25.6	40.9	59.4	42.2	30.6	10.7	35.2	34.9	180.6	28.6	1.7	22.3	35.8	45.7	44.5	0.0	26.8	18.3	30.5	38.3	29.9	44.3	26.3	65.2	31.2	46.1	58.6	13.7	42.0	32.8	21.9	31.5	36.3	39.9	28.2	25.9	55.5	19.2	89.9	38.8	42.4	52.0	44.5	47.9	31.8	56.8	37.0	38.9
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064414	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB025613, HPA077525"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"CAB025613: , HPA077525: AB_2686843"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	12.2	13.9	10.1	11.0	11.1	4.8	14.1	8.8	8.9	12.0	9.7	9.0	6.4	5.9	14.3	10.5	10.7	9.2	8.2	9.7	7.6	7.0	23.2	14.7	8.0	11.8	10.3	6.0	14.2	8.8	17.2	8.6	9.2	7.4	12.0	7.8	10.6	9.6	13.6	11.3	10.3	10.0	13.4	12.4	12.0	9.2	8.2	9.2	24.1	14.6	7.2	13.8	12.1	10.4	15.7	14.8	16.9	11.2	15.1	15.2	11.4	3.7	3.9	8.7	11.2	9.6	12.0	5.9	4.0	5.6	5.8	5.7	8.1	3.5	12.7	27.4	5.0	6.5	3.4	6.4	3.1	8.2	12.6	6.9	7.6	3.0	14.7	8.6	13.0	8.8	5.3	8.1	5.8	8.7	8.9	10.2	10.4	15.5	2.3	8.1	4.0	15.1	8.6	4.7	8.7	5.6	12.5	10.0	20.0	10.8	3.2	8.2	4.3	4.1	6.2	12.3	16.5	7.8	6.8	4.4	9.1	6.6	5.3	3.4	10.3	20.6	11.5	3.7	10.7	9.3	13.6	9.0	16.9	11.5	11.2	14.8	15.7	14.8	14.6	14.8	14.8	15.2	15.1	2.1	15.1	6.1	6.0	13.0	11.4	10.1	11.1	8.8	8.9	7.6	7.0	10.3	6.0	7.4	9.2	11.9	5.8	5.2	7.4	5.4	6.7	6.3	0.0	9.4	7.9	24.4	2.0	9.5	29.9	8.0	7.3	10.6	4.2	0.0	7.5	8.4	6.9	7.4	16.1	0.0	6.9	6.4	1.7	0.0	0.0	5.7	8.9	8.4	3.3	7.2	7.5	10.9	7.8	2.9	11.7	28.5	8.3	0.0	6.2	6.1	12.8	6.6	6.9	6.1	6.8	5.7
BORCS5	"LOH12CR1, LOH1CR12"	ENSG00000165714	"BLOC-1 related complex subunit 5"	Q969J3	12	12357079-12469694	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039509, HPA043627"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA039509: AB_2676550, HPA043627: AB_2678588"	"unprognostic (1.82e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.47e-4)"	"unprognostic (6.78e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.51e-2)"	8.9	11.9	13.6	8.3	19.4	17.7	13.7	10.8	20.8	9.5	8.6	20.4	4.8	5.9	8.4	19.7	11.1	7.5	8.4	10.9	12.9	14.9	8.6	11.5	9.1	9.4	16.1	18.2	8.1	13.5	14.5	9.9	8.8	16.6	9.1	7.9	10.0	7.7	7.3	10.7	10.7	6.7	10.1	16.0	8.7	8.9	11.3	15.0	9.0	8.5	4.4	12.2	8.8	8.9	8.3	7.8	9.7	10.5	12.9	14.4	6.7	4.2	4.4	3.3	3.3	7.6	10.2	3.9	3.9	4.6	4.7	5.8	11.0	4.4	5.3	2.3	6.1	3.4	3.2	5.6	5.5	5.2	15.2	5.0	3.0	4.4	6.2	7.3	3.0	4.4	5.8	4.0	6.4	7.5	7.5	5.5	7.0	4.1	7.5	6.0	9.0	4.5	3.2	10.1	4.5	2.8	3.8	4.7	5.7	5.9	2.8	4.1	4.7	4.2	3.4	8.3	11.6	2.6	3.5	4.6	3.1	7.3	4.0	3.6	3.8	3.4	12.1	6.7	4.9	5.3	2.5	6.5	9.7	11.3	10.5	13.3	8.3	12.8	12.3	7.8	6.5	8.7	8.8	7.1	12.9	6.7	5.3	14.4	6.7	13.6	19.4	10.8	20.8	12.9	14.9	16.1	18.2	16.6	15.0	8.9	2.9	6.2	10.4	0.0	14.8	0.0	10.2	5.3	4.5	7.0	11.8	7.5	8.3	8.3	4.2	2.9	3.4	0.0	10.9	10.2	3.1	7.6	2.3	4.7	13.1	12.7	4.7	5.5	10.0	3.1	4.9	8.3	0.0	25.2	4.6	14.1	8.2	2.6	6.7	8.6	15.7	25.8	0.0	11.9	5.1	0.0	12.1	12.5	4.7	7.6
BTBD3	"dJ742J24.1, KIAA0952"	ENSG00000132640	"BTB domain containing 3"	Q9Y2F9	20	11890723-11926609	"Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 74.6;Horizontal cells: 62.0;Rod photoreceptor cells: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 6.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 66.5;HeLa: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041424, HPA042048"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA041424: AB_10794667, HPA042048: AB_10796469"	"unprognostic (3.93e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (2.51e-5)"	"prognostic unfavorable (6.94e-4)"	"unprognostic (4.87e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.66e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.37e-2)"	8.9	18.5	32.9	5.5	25.2	8.7	10.4	53.8	40.7	12.2	17.1	32.4	3.8	8.7	15.8	10.1	8.3	12.9	11.1	11.1	56.8	19.8	9.8	6.2	10.0	3.0	25.6	21.2	9.0	10.6	10.5	6.7	33.6	20.9	13.0	14.7	8.4	10.9	9.3	11.5	16.7	8.7	13.8	24.3	6.0	21.2	11.7	22.5	4.1	9.6	5.0	2.5	13.8	7.3	0.3	2.9	0.6	6.3	1.4	0.7	1.1	1.8	5.3	14.5	66.5	3.0	3.2	3.9	5.9	3.8	6.7	4.3	3.0	2.9	0.5	5.0	8.6	2.7	4.9	7.4	4.2	11.0	0.0	6.6	1.9	52.5	6.4	3.1	3.0	1.1	5.7	5.2	6.0	4.9	3.7	3.8	3.3	3.3	5.1	6.7	1.3	3.6	2.8	6.9	7.7	1.5	4.9	2.9	1.8	6.1	9.2	6.3	11.2	16.6	6.8	14.3	8.1	4.0	3.1	2.9	3.7	9.4	3.4	6.5	1.9	2.5	0.0	2.4	0.8	24.0	0.0	2.2	0.2	0.0	3.4	0.0	0.1	0.0	0.0	2.9	0.3	0.7	0.0	0.6	1.4	6.3	2.0	0.0	1.1	32.9	25.2	53.8	40.7	56.8	19.8	25.6	21.2	20.9	22.5	14.9	5.9	2.2	9.5	14.7	12.7	15.9	5.1	26.8	10.3	5.2	74.6	15.7	3.3	8.2	6.5	18.0	15.7	0.0	7.3	3.3	12.0	11.8	2.3	6.6	7.2	62.0	20.1	31.9	4.7	8.8	15.3	5.6	13.5	1.0	9.1	16.3	8.1	21.0	8.1	5.4	54.4	6.5	8.6	6.7	14.0	15.1	18.2	0.0	11.5	8.4
C11orf91		ENSG00000205177	"Chromosome 11 open reading frame 91"	Q3C1V1	11	33698261-33700801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 10.1;Late spermatids: 2.3;Sertoli cells: 6.5;Spermatocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 15.2;hTERT-HME1: 9.8;HUVEC TERT2: 7.8;TIME: 11.9;U-2197: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047064, HPA050487"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA047064: AB_2679920, HPA050487: AB_2681142"	"unprognostic (9.22e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.68e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	7.2	0.2	1.2	2.1	3.0	0.9	2.1	0.3	1.3	0.3	0.3	0.3	0.3	0.0	0.4	0.9	4.3	0.3	7.2	0.7	0.4	0.6	0.9	0.9	1.4	0.3	0.7	0.3	0.6	1.9	0.0	0.3	1.0	1.3	0.3	0.0	0.3	0.9	0.3	0.4	1.3	0.3	0.8	0.8	0.3	2.7	16.6	0.3	0.6	0.3	0.3	0.3	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	1.4	0.0	0.0	0.0	1.7	0.0	0.8	0.4	0.2	0.6	0.0	0.1	1.8	0.2	0.6	0.5	15.2	1.2	0.4	0.0	0.0	2.9	0.8	0.3	0.0	0.0	0.0	0.1	1.2	9.8	0.5	7.8	0.2	0.0	2.4	3.7	0.0	0.0	0.3	0.0	0.1	4.8	0.0	0.0	0.0	1.1	2.0	0.0	0.3	0.0	1.5	0.1	0.5	0.0	0.0	11.9	1.1	0.3	9.8	0.3	0.7	0.5	0.0	2.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.0	0.3	1.3	0.4	0.6	0.7	0.3	1.3	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.2	5.4	0.2	0.0	0.1	0.0	0.0	1.1
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 131.1;Kupffer cells: 223.6;Macrophages: 162.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 75.8"	"Group enriched"	"Detected in many"	42	"granulocytes: 75.8;monocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 6.0;HMC-1: 7.5;U-87 MG: 9.0;U-937: 9.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	33.7	8.0	1.9	34.9	7.0	46.2	8.7	0.7	3.0	5.6	6.0	3.7	1.6	1.0	4.1	4.9	3.5	14.3	16.5	11.7	7.6	3.2	5.3	9.1	38.1	26.9	3.8	1.2	7.6	3.6	1.3	27.9	12.8	10.9	4.2	1.9	7.8	2.9	1.1	7.0	1.1	3.0	11.4	11.2	48.8	4.2	6.3	1.3	2.3	2.5	1.7	3.4	12.2	2.7	0.1	1.1	75.8	20.5	0.1	0.1	2.6	1.4	5.4	0.3	0.5	1.0	0.4	1.1	1.0	0.6	0.3	0.1	0.2	6.0	0.5	1.1	1.2	0.7	2.0	0.7	0.8	0.2	1.0	0.7	0.2	5.0	0.8	0.7	2.7	7.5	0.8	3.0	0.6	0.9	0.9	0.0	0.3	0.3	2.6	0.2	1.5	0.3	3.4	1.9	0.3	0.9	0.3	0.2	0.4	1.8	1.3	0.0	0.1	0.5	0.6	0.8	0.9	0.4	3.1	0.0	0.1	3.2	0.4	0.3	0.4	0.4	0.3	9.0	9.1	0.3	7.0	8.9	6.9	0.1	15.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	75.8	0.1	20.5	0.2	0.0	2.6	1.9	7.0	0.7	3.0	7.6	3.2	3.8	1.2	10.9	1.3	3.0	33.4	11.3	0.6	4.5	0.8	2.0	2.5	52.2	26.1	1.8	2.0	0.8	3.3	0.0	0.6	1.7	1.1	0.0	0.0	0.9	2.6	0.5	23.3	3.4	131.1	0.0	0.0	3.1	223.6	0.0	0.6	162.7	5.0	14.4	0.7	0.4	0.1	0.0	0.0	1.1	4.2	12.9	1.7	0.5	1.1	2.6	1.3	0.0	0.9	0.3
C9orf72	"DENNL72, MGC23980"	ENSG00000147894	"Chromosome 9 open reading frame 72"	Q96LT7	9	27546545-27573866	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	Autophagy	"Guanine-nucleotide releasing factor"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 77.6;Kupffer cells: 86.3;Macrophages: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 8.0;classical monocyte: 15.5;intermediate monocyte: 21.8;myeloid DC: 11.7;neutrophil: 15.6;non-classical monocyte: 16.5"	"Group enriched"	"Detected in all"	5	"dendritic cells: 11.7;granulocytes: 15.6;monocytes: 21.8"	"Cell line enhanced"	"Detected in many"		"AF22: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023873	Uncertain		Supported	"Vesicles,Midbody ring,Cytosol"	"Secreted - unknown location"	NA	NA			"Vesicles, Cytosol"	"Midbody ring"	"HPA023873: AB_1845834"	"unprognostic (1.78e-2)"	"unprognostic (5.01e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.99e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.89e-2)"	"unprognostic (9.13e-2)"	10.0	11.2	9.7	14.2	17.6	19.1	8.0	31.2	21.3	7.4	6.0	10.9	6.7	5.8	10.7	10.6	5.8	14.6	8.9	7.4	9.4	14.6	4.2	14.0	13.0	10.7	11.0	10.7	19.5	8.4	6.7	15.3	10.3	20.0	13.3	7.1	9.4	5.3	5.9	11.0	6.2	6.1	7.6	11.5	13.7	6.5	14.8	6.7	8.0	11.0	3.2	7.3	9.7	6.3	1.7	11.7	15.6	21.8	2.9	2.5	4.4	2.8	2.5	21.1	3.2	4.3	5.3	3.2	4.1	3.5	2.6	1.3	0.3	1.0	7.2	2.7	3.6	5.4	2.2	6.0	5.2	1.9	13.1	2.5	3.4	7.5	2.1	6.6	2.3	3.7	5.6	6.4	0.6	11.9	2.5	5.5	7.4	6.5	13.1	3.1	0.5	4.4	3.5	10.2	4.7	11.6	1.7	6.3	3.2	2.0	2.5	7.2	17.7	2.7	3.1	2.6	8.3	2.6	2.0	4.7	0.0	10.6	6.2	2.7	3.4	10.2	4.7	8.0	7.6	2.6	8.0	15.5	1.0	0.9	21.8	1.7	1.7	1.4	1.2	11.7	1.2	2.5	1.5	15.6	2.9	16.5	1.8	1.8	4.4	9.7	17.6	31.2	21.3	9.4	14.6	11.0	10.7	20.0	6.7	14.9	17.1	6.9	37.1	31.9	22.0	12.8	5.1	77.6	12.5	7.0	19.6	18.4	1.7	6.9	1.7	10.8	3.9	0.0	8.3	6.2	12.4	25.8	16.1	7.8	23.9	11.1	10.9	6.7	86.3	3.3	5.8	73.0	18.6	19.8	9.9	46.1	6.4	8.6	3.5	4.1	28.5	0.0	20.6	30.7	19.3	25.5	28.9	10.9	5.2	35.5
CADPS2	CAPS2	ENSG00000081803	"Calcium dependent secretion activator 2"	Q86UW7	7	122318425-122886759	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 105.4"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 31.6;Collecting duct cells: 38.4;Muller glia cells: 28.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 105.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 20.3;Karpas-707: 26.5;OE19: 29.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 325.7"	HPA056398			Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA056398: AB_2683117"	"unprognostic (1.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.67e-3)"	"unprognostic (8.69e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.01e-7)"	"unprognostic (9.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-2)"	5.1	11.2	5.1	1.9	7.1	0.0	9.5	105.4	21.1	16.5	5.3	1.4	13.3	6.1	16.3	16.4	5.7	5.7	8.0	4.6	6.8	8.8	20.3	6.2	9.0	1.3	14.0	9.3	5.2	13.2	15.4	17.7	2.7	7.0	10.4	5.4	4.7	23.0	11.5	2.6	2.4	4.7	11.2	4.1	3.3	9.8	1.9	1.4	0.4	9.4	2.4	1.6	4.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	2.4	2.5	0.1	0.2	6.3	1.4	6.4	0.0	5.9	0.0	0.0	2.9	0.2	0.0	0.2	0.8	0.6	0.0	5.2	2.0	0.0	11.4	8.2	0.0	0.1	2.6	1.1	1.0	0.8	5.7	20.3	0.0	0.0	26.5	0.1	13.9	0.0	0.0	5.9	29.0	10.0	0.0	0.0	10.5	0.3	6.6	10.3	0.0	0.2	11.5	0.5	1.6	4.4	0.0	5.8	2.2	1.5	0.0	4.1	7.9	0.3	0.0	8.7	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	105.4	21.1	6.8	8.8	14.0	9.3	7.0	1.4	8.9	31.6	0.0	7.7	1.9	0.0	10.1	5.1	8.1	17.0	38.4	0.0	0.2	14.9	4.7	5.5	19.6	4.5	0.0	9.4	0.3	3.8	16.7	1.1	10.2	0.3	3.2	4.6	16.0	2.7	5.3	8.9	1.1	3.3	0.0	11.6	28.4	6.6	2.9	9.6	6.9	1.3	0.0	5.1	0.5	2.5	1.3	0.2	0.0	7.6	7.4
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 276.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	115.3	88.2	42.5	44.9	37.2	67.4	106.3	13.7	33.1	80.6	84.7	34.4	71.5	39.9	99.7	177.9	70.9	60.4	102.7	154.4	36.9	39.0	106.6	92.5	109.6	113.8	49.8	27.2	93.8	187.1	33.3	49.3	176.9	50.8	82.9	81.8	102.1	105.0	83.7	92.7	38.5	72.4	88.2	43.6	107.7	74.8	52.1	30.5	17.6	108.1	50.7	47.4	96.3	82.2	9.6	40.3	147.4	50.8	58.4	29.8	56.6	22.2	38.8	21.3	20.7	276.2	173.2	28.1	90.7	166.3	53.7	58.5	43.3	44.9	6.4	28.9	134.9	38.3	20.7	15.4	37.5	69.1	18.1	14.5	35.0	30.3	23.9	109.9	15.5	83.4	127.4	37.4	59.6	54.7	111.7	59.1	3.2	19.7	44.8	170.8	35.6	3.1	21.1	19.4	49.2	45.2	7.0	46.8	16.0	90.8	75.9	8.3	21.3	24.8	18.8	162.9	32.5	26.5	51.9	43.9	34.8	25.4	47.9	30.3	18.4	11.3	4.4	99.6	10.0	63.4	89.6	50.8	147.4	29.8	38.5	21.8	9.6	11.9	23.7	40.3	6.5	5.3	18.1	55.7	58.4	26.1	27.0	10.0	56.6	42.5	37.2	13.7	33.1	36.9	39.0	49.8	27.2	50.8	30.5	476.4	590.3	176.4	1219.6	503.8	174.4	555.7	917.2	377.4	564.1	830.5	143.3	558.0	197.3	2170.1	13.3	768.7	766.8	0.0	3001.1	2390.1	1497.1	1539.2	986.0	374.3	3024.5	31.8	557.9	750.1	794.3	26.6	1599.3	1215.7	1891.2	756.6	1108.9	851.5	2709.4	1083.7	1087.6	631.9	181.5	1235.3	1556.4	33.0	71.8	350.0	2264.8	339.0	575.6	1313.8
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579467-7582113	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 179.1;lymphoid tissue: 139.1"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 1656.8;Kupffer cells: 486.8;Macrophages: 440.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 68.4;monocytes: 179.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 74.5;U-87 MG: 117.4"	"Low region specificity"	"Detected in all"							"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	118.4	28.5	12.5	46.8	21.6	46.8	40.9	2.9	11.2	27.1	38.1	15.5	2.1	57.0	9.6	24.1	26.9	17.3	33.7	39.0	10.1	6.9	20.9	43.1	84.4	102.5	21.1	4.4	15.8	7.5	2.1	8.5	34.7	15.7	12.1	18.5	12.8	22.2	4.4	16.1	9.4	58.3	15.6	26.0	139.1	17.6	9.4	16.3	13.3	8.8	12.3	21.1	31.4	19.1	3.7	68.4	11.0	179.1	0.9	0.5	125.6	35.7	7.3	0.4	0.5	74.5	28.4	0.3	11.4	31.2	15.2	17.7	1.5	10.8	0.4	13.0	33.1	27.0	1.6	0.1	7.2	10.3	0.3	1.3	5.7	1.8	8.6	6.3	2.8	32.2	9.0	1.5	31.7	23.4	25.1	3.9	0.6	2.2	3.7	14.6	0.2	0.2	2.5	0.4	9.3	5.3	0.4	0.6	21.1	3.1	1.6	0.2	0.4	9.5	4.8	11.1	0.3	0.2	21.9	12.4	19.3	1.2	19.3	14.9	0.2	0.3	0.2	117.4	7.0	9.7	10.1	155.1	0.9	0.4	179.1	0.5	3.7	0.2	0.3	40.9	2.0	0.3	0.2	11.0	0.9	170.1	68.4	0.3	125.6	12.5	21.6	2.9	11.2	10.1	6.9	21.1	4.4	15.7	16.3	0.0	22.4	23.8	26.4	14.0	0.0	0.0	7.6	9.4	13.6	5.2	0.0	7.2	5.0	60.6	0.6	16.8	36.0	0.0	137.4	51.8	33.7	27.3	40.6	16.3	1656.8	0.0	4.7	13.5	486.8	1.1	6.1	440.3	37.1	60.5	7.1	0.2	92.4	25.9	1.8	31.1	1.2	25.8	13.3	0.3	0.2	12.5	27.9	12.5	10.2	68.9
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923080-92935293	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 577.6"	"Cell type enriched"	"Detected in many"	49	"Intestinal endocrine cells: 6314.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 97.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	134	"SCLC-21H: 44.3;SH-SY5Y: 120.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA	295000000	78000000	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698"	"prognostic favorable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavorable (3.99e-4)"	2.0	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4.0	0.0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14.0	1.3	1.2	1.4	1.2	8.0	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2.0	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0.0	5.9	0.0	1.2	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	44.3	120.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.6	18.7	0.5	97.9	11.2	14.0	8.0	36.1	17.1	0.7	0.0	0.0	0.0	0.2	0.8	10.3	2.2	0.0	0.0	0.0	0.0	27.5	0.3	0.0	0.0	1.0	0.1	14.4	0.0	0.3	0.1	0.2	4.0	0.0	0.0	1.2	15.9	6314.9	0.0	0.0	3.6	36.8	0.0	6.8	3.6	28.7	3.2	76.4	23.0	129.0	0.0	11.3	0.0	0.3	4.9	2.2	0.0	0.2	0.0	9.0	0.1
CHPT1	CPT1	ENSG00000111666	"Choline phosphotransferase 1"	Q8WUD6	12	101696947-101744140	"Enzymes, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 497.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 19.4;eosinophil: 9.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 19.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067643	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA067643: "	"unprognostic (1.59e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.72e-1)"	"prognostic favorable (7.41e-4)"	"unprognostic (1.79e-1)"	18.0	21.6	19.3	14.3	20.4	21.4	76.7	12.8	16.7	22.2	40.0	11.0	15.8	36.5	9.3	25.0	10.9	14.7	17.1	71.4	18.5	14.5	30.6	64.6	20.2	30.5	17.8	14.5	11.3	14.2	12.6	7.6	9.6	12.8	16.3	21.0	14.0	53.1	22.8	18.5	13.5	42.9	16.7	17.4	13.0	23.1	28.3	12.6	3.3	26.0	7.4	8.7	17.7	38.7	3.0	2.5	19.4	1.5	3.3	0.8	0.4	3.5	16.5	4.4	9.5	35.8	12.0	12.8	12.9	14.9	13.0	8.4	6.1	2.4	5.4	7.3	17.5	17.9	5.4	27.1	4.5	12.4	8.1	22.9	22.0	8.9	35.7	20.0	10.8	4.4	11.3	1.3	5.8	10.7	19.5	6.4	11.7	31.8	14.0	12.8	8.7	6.4	37.5	11.9	17.1	21.9	5.0	8.8	3.9	5.9	14.0	4.4	3.4	11.9	17.2	32.0	7.3	17.5	7.5	4.7	11.9	6.2	9.3	12.5	8.0	2.4	6.6	9.4	12.6	17.3	19.4	1.5	9.7	0.4	1.2	0.4	3.0	0.8	0.7	2.0	2.0	0.3	0.4	2.2	3.3	1.4	2.5	0.4	0.4	19.3	20.4	12.8	16.7	18.5	14.5	17.8	14.5	12.8	12.6	44.7	22.2	63.5	276.5	33.3	14.2	43.5	114.7	4.0	12.5	61.1	27.5	102.9	59.7	7.2	284.8	18.8	76.4	0.0	11.8	43.5	56.0	122.8	10.4	175.9	50.0	33.4	20.3	18.4	79.5	497.4	79.1	37.8	138.3	1.0	51.0	47.9	10.2	114.8	83.8	145.6	15.2	19.4	33.5	169.9	29.8	37.8	50.5	22.4	79.9	235.4
CLCN3	"ClC-3, CLC3"	ENSG00000109572	"Chloride voltage-gated channel 3"	P51790	4	169612633-169723673	"Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044723	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA044723: AB_10959733"	"unprognostic (1.92e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (2.49e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.38e-3)"	11.6	21.1	27.6	10.9	29.9	5.9	18.4	24.9	37.7	15.0	26.7	32.4	15.5	17.1	11.1	17.7	26.6	15.6	22.0	19.6	29.3	29.7	22.2	14.7	11.9	9.0	32.7	22.7	14.0	23.4	29.4	38.7	14.5	36.1	19.5	30.8	20.6	48.5	13.5	14.6	18.0	16.5	10.4	46.1	9.0	23.2	18.4	25.4	10.8	21.7	18.4	13.5	20.5	16.7	8.6	11.9	6.2	8.1	6.9	11.5	7.9	11.4	11.9	17.8	22.6	36.3	30.5	8.7	15.4	19.3	10.4	12.7	8.4	26.0	14.1	9.6	12.8	12.0	9.8	22.1	9.5	17.5	12.5	8.6	11.9	19.3	9.6	24.7	14.2	19.9	21.2	21.9	18.5	18.3	43.3	18.7	19.7	29.3	32.5	18.4	4.1	19.4	3.3	7.3	19.8	8.1	8.7	7.9	11.0	21.7	23.7	19.3	19.0	13.7	15.0	24.1	15.3	10.2	6.7	15.8	8.4	9.4	13.4	11.9	14.4	21.7	12.6	25.1	5.4	22.0	6.2	6.5	4.7	9.0	8.1	11.5	8.6	6.7	8.2	9.5	7.4	10.4	9.2	5.3	6.9	6.5	11.9	8.1	7.9	27.6	29.9	24.9	36.8	29.3	29.7	32.7	22.7	36.1	25.4	29.8	22.1	14.3	22.7	10.1	84.1	61.8	45.9	71.0	13.6	59.3	123.7	19.6	6.6	32.1	76.3	24.8	82.7	23.3	38.3	14.8	13.8	65.9	112.9	33.3	15.9	57.2	64.2	33.7	32.6	56.4	22.7	13.3	30.4	7.2	61.7	156.2	31.4	48.2	19.8	15.9	109.5	6.5	19.6	16.9	16.4	22.8	59.5	16.0	47.2	30.6
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859175	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 260.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 95.0;eosinophil: 27.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 95.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		340000	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	22.0	23.3	12.6	27.1	18.8	38.1	18.8	13.6	14.7	22.0	27.9	10.0	43.8	28.8	19.1	30.3	56.4	17.1	40.3	23.4	14.0	12.7	40.8	48.6	22.3	19.2	11.7	11.7	20.1	25.3	47.9	25.9	30.1	14.3	21.5	23.7	11.3	39.9	47.1	38.7	26.0	34.6	30.9	13.0	19.0	29.4	12.1	13.0	23.6	30.3	23.3	32.8	37.1	33.8	7.8	9.9	95.0	7.8	8.8	12.7	7.5	22.7	33.0	23.5	21.8	32.8	27.7	33.8	32.2	33.4	31.9	45.0	46.0	36.1	43.0	36.9	30.6	41.3	34.5	31.9	37.2	45.5	20.3	25.7	28.6	29.7	22.9	33.5	39.1	38.9	20.5	28.0	35.7	40.3	19.9	29.7	25.3	24.5	24.0	25.5	20.1	30.7	21.8	24.6	22.4	34.2	27.6	35.3	36.3	31.9	41.1	20.7	22.6	23.2	40.3	31.7	31.1	27.7	27.7	29.9	27.9	20.7	25.3	31.5	28.0	26.6	55.2	22.5	44.8	24.4	95.0	7.4	27.6	7.4	7.8	12.7	7.8	7.1	7.3	9.9	7.0	6.2	6.6	2.8	8.8	7.8	7.8	10.1	7.5	12.6	18.8	13.6	14.7	14.0	12.7	11.7	11.7	14.3	13.0	56.6	99.2	47.4	59.4	50.7	20.8	83.7	107.0	167.3	144.5	64.6	7.9	38.0	81.2	70.0	3.2	43.5	56.7	46.7	56.4	59.6	50.0	79.2	80.0	72.7	26.7	11.1	52.4	21.5	38.0	2.9	43.7	46.0	33.7	103.6	70.8	23.6	54.4	66.6	26.9	71.1	17.5	38.8	32.4	38.1	40.0	68.4	57.1	39.6	82.7	260.7
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392455-176416569	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Pancreatic endocrine cells: 1144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 105.2;MCF7: 93.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		350000	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	20.4	24.1	29.7	18.7	26.7	13.5	16.0	27.5	47.9	27.7	34.7	14.2	11.4	35.4	15.0	15.7	94.2	12.7	28.4	65.7	26.4	26.9	20.3	15.0	15.6	12.2	25.9	22.7	24.3	19.7	17.9	19.8	61.2	28.7	16.8	18.1	19.4	22.2	19.3	93.7	81.8	41.1	27.1	15.4	14.2	39.6	9.9	10.1	14.3	17.2	55.4	31.2	26.1	45.3	4.3	9.9	28.0	9.9	7.4	11.6	3.6	33.3	16.0	4.5	19.4	10.2	7.7	37.4	43.0	16.8	27.3	19.6	20.7	15.6	7.3	25.4	19.3	11.0	31.9	7.7	105.2	10.7	49.9	14.3	4.9	23.8	12.7	16.1	7.8	13.1	8.2	36.7	14.9	17.7	5.5	12.8	5.9	9.3	18.7	15.0	93.6	12.2	11.8	3.7	28.0	23.9	13.3	8.1	24.0	14.4	13.6	19.6	6.7	20.5	22.5	14.6	5.5	9.2	15.0	27.6	9.9	14.8	17.9	24.3	14.9	10.3	9.8	7.9	16.6	11.2	2.8	9.9	28.0	7.2	7.5	3.7	3.1	6.4	7.0	9.9	4.3	5.2	5.5	18.7	7.4	9.7	8.0	11.6	3.6	29.7	26.7	27.5	47.9	26.4	26.9	25.9	22.7	28.7	10.1	53.6	23.2	58.1	196.8	563.1	275.7	186.4	73.9	9.4	29.6	78.5	60.9	109.8	114.4	340.2	7.2	90.2	537.2	23.3	397.9	474.5	139.4	165.3	48.4	90.4	99.6	317.8	145.7	58.9	80.5	11.0	113.1	120.4	209.2	73.9	265.3	88.8	1144.6	526.1	122.0	193.6	54.8	77.6	222.4	15.8	14.4	701.9	323.2	77.3	199.5	331.8
CLUH	"CLU1, KIAA0664"	ENSG00000132361	"Clustered mitochondria homolog"	O75153	17	2689386-2712663	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.2"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CACO-2: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031505, HPA044346"	Uncertain		Supported	"Nuclear bodies,Vesicles"		NA	NA			Vesicles	"Nuclear bodies"	"HPA031505: AB_2673912, HPA044346: AB_10962153"	"unprognostic (3.48e-2)"	"unprognostic (3.97e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.64e-2)"	"unprognostic (5.11e-2)"	"prognostic favorable (1.92e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.26e-2)"	14.1	21.0	9.6	10.4	12.4	7.8	10.2	16.0	20.9	7.6	17.5	10.6	7.4	29.4	8.4	6.9	28.7	7.6	11.2	31.8	8.5	6.9	28.6	75.2	7.4	8.2	7.0	9.7	8.3	20.3	7.0	8.2	6.2	12.5	9.4	8.1	9.9	18.9	8.4	65.6	20.0	20.9	9.9	6.5	9.9	13.6	11.4	7.5	6.8	10.1	22.1	15.9	12.4	10.0	4.5	5.0	0.4	5.9	1.1	4.7	1.5	18.8	33.6	2.4	8.5	5.0	3.7	28.1	10.1	3.6	11.0	7.9	67.8	7.7	34.5	12.2	4.8	6.7	34.5	11.2	13.2	3.6	12.3	24.9	18.9	26.1	23.4	4.7	15.0	12.3	6.1	7.9	12.3	6.4	2.4	5.5	11.4	23.1	10.4	3.2	20.3	16.8	14.6	7.6	8.8	19.4	27.4	10.5	18.2	6.8	29.2	11.4	9.0	11.5	31.8	11.8	1.7	19.1	7.8	10.6	9.1	12.5	24.8	22.1	5.3	5.9	13.0	9.4	20.0	10.7	0.0	4.3	0.0	3.4	5.9	2.6	4.1	2.0	1.8	4.4	4.5	4.7	4.1	0.4	1.1	3.6	5.0	2.6	1.5	9.6	12.4	16.0	20.9	8.5	6.9	7.0	9.7	12.5	7.5	6.0	18.1	8.5	8.5	27.1	17.5	35.8	43.3	8.1	15.9	17.4	21.6	8.2	10.0	15.3	1.5	8.3	36.2	23.3	15.5	6.0	8.2	12.0	1.1	92.0	11.5	7.9	24.8	9.8	7.8	2.5	4.6	6.3	20.3	6.4	32.3	6.2	17.5	10.5	5.6	26.8	15.7	6.5	11.0	5.0	16.6	31.0	6.9	5.7	49.3	18.7
CMTM6	"CKLFSF6, FLJ20396"	ENSG00000091317	"CKLF like MARVEL transmembrane domain containing 6"	Q9NX76	3	32481312-32503408	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 55.5"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 520.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026980, HPA063491"	Enhanced		Supported	Vesicles		NA	NA		390000	Vesicles		"HPA026980: AB_10602801, HPA063491: "	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.23e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.55e-3)"	5.5	6.4	2.8	8.2	2.6	10.4	6.7	1.4	1.4	6.6	5.5			2.5	6.7	4.9	9.8	24.4	6.1	4.2	2.4	2.4	5.1	21.6	9.0	5.6	2.8		4.1	6.0	4.0	3.0	8.6		6.0	7.3		9.0	5.0	0.7	12.6	5.9	4.7	3.9	10.5	6.3	5.7			7.7		9.5	9.3	6.1	10.0	12.8	55.5	35.4	11.2	8.1	16.3	22.9	7.4	14.8	11.1	25.7	25.6	65.6	17.0	24.4	17.9	20.7	7.9	38.4	13.7	19.4	22.7	12.1	14.9	10.3	28.2	24.5	61.1	12.6	17.3	5.4	11.7	18.3	28.8	34.5	25.3	18.2	20.6	15.5	28.9	28.7	13.4	8.4	25.8	22.8	7.1	17.3	15.0	13.2	19.2	11.0	14.7	11.6	10.6	24.8	32.2	3.4	10.0	15.5	8.8	16.3	15.7	12.9	28.9	25.7	19.9	13.2	19.4	20.3	13.4	13.3	12.8	13.9	25.3	24.8	24.6	15.1	35.2	5.6	23.3	6.2	10.0	7.5	5.3	12.8	7.1	4.4	4.9	55.5	11.2	35.4	6.9	8.1	16.3											32.8	47.1	95.1	72.5	85.3	9.9	5.1	81.5	112.4	53.4	90.7	11.8	219.6	28.2	87.5	4.6	59.7	40.2	0.0	72.9	81.3	109.6	119.8	124.6	218.5	140.7	47.7	126.8	122.2	288.9	5.4	36.5	262.8	77.6	520.2	93.6	137.9	99.4	49.1	40.3	54.3	17.2	38.8	75.2	34.5	20.2	110.7	218.9	111.7	53.2	91.4
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel beta 1"	Q14028	16	57882340-57971116	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 79.8"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 312.2;Rod photoreceptor cells: 1014.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;RPMI-8226: 3.4;SCLC-21H: 9.6;SiHa: 5.6;SK-BR-3: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA			Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.2	7.2	13.1	3.0	3.0	0.7	0.2	0.2	6.3	0.2	1.7	0.0	0.0	0.5	0.2	0.5	0.2	0.4	0.8	0.2	7.1	11.0	0.2	0.2	0.4	0.7	1.3	4.0	0.1	1.5	0.0	0.5	1.2	4.2	0.2	1.2	79.8	0.3	0.4	0.1	0.5	1.8	0.2	0.7	0.2	0.2	1.3	0.0	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	2.6	0.3	0.3	0.4	0.0	0.6	1.2	0.0	0.2	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	3.0	0.0	1.0	0.0	0.0	2.5	0.0	0.2	0.0	0.6	1.8	1.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.6	0.1	0.2	0.0	0.2	0.1	0.0	3.4	0.0	1.2	9.6	0.1	5.6	2.8	0.0	0.2	0.1	0.1	0.7	0.3	0.5	0.4	0.1	0.2	0.6	0.1	0.1	0.3	0.1	0.6	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.4	0.2	2.6	0.3	0.3	0.3	0.0	0.0	13.1	3.0	0.2	6.3	7.1	11.0	1.3	4.0	4.2	0.0	0.0	0.0	0.0	0.5	0.0	44.0	0.8	0.0	0.0	0.0	0.0	312.2	4.7	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.4	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.3	0.0	0.0	0.0	1014.1	0.0	0.0	0.4	0.6	0.0	1.1	0.0	0.0	0.1
CNST	"C1orf71, FLJ32001, PPP1R64"	ENSG00000162852	"Consortin, connexin sorting protein"	Q6PJW8	1	246566444-246668584	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007225, HPA007226"	Approved		Supported	Vesicles		NA	NA		4600000	Vesicles		"HPA007225: AB_1848869, HPA007226: AB_2667782"	"unprognostic (1.55e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.33e-2)"	"unprognostic (9.76e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.77e-3)"	"unprognostic (2.26e-1)"	15.5	21.7	10.2	13.7	22.3	21.8	12.8	25.1	22.4	10.6	14.6	8.1	10.2	11.0	14.7	9.4	18.6	10.0	9.7	11.1	9.5	17.6	9.9	25.1	12.4	16.4	11.2	14.1	12.1	11.0	15.2	17.4	11.9	13.7	9.7	13.4	11.6	9.4	9.6	35.5	11.6	15.5	18.4	7.6	12.3	9.6	17.2	9.3	24.6	15.4	10.2	18.6	14.9	11.0	21.1	6.6	21.6	11.1	7.8	19.3	9.0	4.3	5.7	4.2	3.7	6.9	8.1	8.5	14.1	13.9	14.3	10.9	5.5	5.7	12.6	6.3	13.9	4.2	4.5	6.5	4.8	19.5	7.0	2.2	14.8	5.2	4.1	10.1	7.3	28.7	7.6	4.6	13.8	14.8	7.1	4.4	6.8	18.7	5.6	8.0	3.1	8.0	3.4	13.8	6.0	5.0	7.9	7.6	10.3	5.4	12.6	9.7	11.6	6.0	3.5	17.4	5.1	6.5	6.5	6.2	17.8	4.3	7.3	9.5	17.1	21.7	12.8	4.4	11.0	17.1	21.6	4.7	12.9	8.8	5.0	9.6	19.4	15.0	8.1	4.6	21.1	19.3	10.3	6.2	7.8	11.1	6.6	18.1	9.0	10.2	22.3	25.1	22.4	9.5	17.6	11.2	14.1	13.7	9.3	11.9	15.0	6.5	13.5	22.0	28.1	10.4	7.6	32.1	25.0	3.5	13.7	3.1	6.6	5.9	36.0	31.6	39.9	0.0	5.2	5.0	12.2	17.4	38.3	18.1	8.5	15.9	14.5	28.3	13.3	30.0	8.9	11.1	13.5	7.2	16.1	12.2	7.1	17.5	7.4	4.1	21.8	12.9	18.4	12.1	11.9	23.5	7.8	18.4	10.1	17.0
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell type enhanced"	"Detected in many"	12	"Exocrine glandular cells: 52.5;Horizontal cells: 79.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.6;Hep G2: 20.0;K-562: 39.4;NB-4: 32.7;SCLC-21H: 36.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		88000	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.2	1.0	0.0	0.2	0.0	7.0	0.0	0.0	2.1	5.6	6.6	0.4	0.1	0.5	0.0	0.4	0.0	7.1	0.0	3.5	0.0	30.6	5.6	2.6	20.0	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.0	0.1	12.7	39.4	1.6	0.5	0.2	2.8	32.7	3.8	0.0	1.2	8.3	0.0	0.2	0.3	1.0	36.3	9.8	0.8	0.1	0.0	4.1	0.0	15.3	0.2	0.0	0.0	0.1	0.0	1.8	4.8	3.5	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9	0.0	0.3	11.3	1.6	16.9	1.9	0.4	2.5	0.0	1.2	0.0	3.9	3.9	1.7	0.4	1.3	2.1	0.2	0.0	52.5	9.8	3.8	3.0	1.1	3.9	3.1	79.4	16.4	4.3	8.6	1.3	1.4	1.5	18.6	4.6	0.0	14.5	5.7	0.0	5.6	7.9	3.9	0.0	15.6	3.9	6.6	11.8	5.5	2.9	0.4	1.0
COL22A1		ENSG00000169436	"Collagen type XXII alpha 1 chain"	Q8NFW1	8	138588235-138914006	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 46.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 30.8;Late spermatids: 25.2;Muller glia cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.9;RT4: 10.2;SCLC-21H: 6.9;U-2 OS: 5.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024830	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA024830: AB_1847102"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.19e-6)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (1.05e-2)"	"unprognostic (5.57e-3)"	"prognostic unfavorable (2.13e-6)"	"unprognostic (2.01e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.74e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.66e-15)"	"unprognostic (2.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.09e-1)"	0.1	12.0	0.2	1.3	1.1	0.0	0.1	6.8	1.1	1.3	0.7	1.4	10.8	0.3	2.4	1.9	0.2	0.5	0.4	0.2	0.3	0.8	2.8	0.1	0.1	0.5	0.3	0.0	0.3	0.2	1.7	46.5	0.0	1.9	4.7	0.1	1.6	0.8	5.1	0.5	0.1	0.4	2.2	1.8	0.3	3.7	0.8	0.1	1.4	0.3	0.7	1.7	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.2	6.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	6.8	0.3	0.3	0.8	0.3	0.0	1.9	0.1	0.0	0.0	0.0	2.8	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	30.8	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	26.2	2.1	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.8	0.0	0.0	0.0	0.0	1.3
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513027	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 125.7"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 463.3;Peritubular cells: 165.5;Sertoli cells: 368.7;Smooth muscle cells: 174.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 145.1;WM-115: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010751, HPA029118, HPA069337"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		1900000	Vesicles		"CAB010751: AB_476828, HPA029118: , HPA069337: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (9.25e-4)"	87.2	9.5	4.6	26.1	3.3	0.1	50.1	2.0	3.0	37.2	53.1	1.9	30.3	7.6	48.4	25.5	23.0	26.3	52.4	26.6	3.6	1.4	18.4	5.7	35.9	17.5	3.8	1.7	25.7	8.3	7.3	3.8	125.7	5.0	26.9	5.5	12.2	7.6	29.3	26.3	9.2	16.9	84.1	2.8	58.5	23.4	11.0	1.9	4.2	16.0	8.0	5.7	65.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.6	6.6	30.1	0.0	39.2	16.3	47.4	40.8	14.8	24.3	11.4	0.7	0.0	0.0	145.1	9.5	10.7	11.4	0.0	12.2	4.7	1.5	6.3	0.0	11.2	0.3	28.9	0.0	0.1	7.3	0.7	17.0	11.7	31.1	25.4	0.0	0.0	0.1	4.0	0.2	0.0	1.0	4.7	0.2	2.3	0.0	12.4	0.0	26.8	0.2	0.9	4.9	0.0	0.1	12.8	13.5	0.0	0.5	43.7	13.4	34.1	0.3	22.1	0.0	0.2	0.6	0.3	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	3.3	2.0	3.0	3.6	1.4	3.8	1.7	5.0	1.9	77.4	8.0	1.4	6.5	8.5	2.0	27.9	25.5	2.7	2.3	50.6	0.0	67.8	1.7	25.5	1.6	98.7	13.4	0.0	3.7	463.3	94.4	2.1	1.1	1.6	26.8	0.0	0.0	139.3	5.4	1.5	56.1	5.8	37.1	3.6	5.1	9.5	2.8	0.0	165.5	16.1	0.2	368.7	174.9	0.2	8.1	6.0	56.2	0.0	3.7	1.2
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 1: 229.3;Ito cells: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.3;fHDF/TERT166: 149.2;hTERT-RPE1: 63.4;LHCN-M2: 43.8;TIME: 64.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA053107: AB_2682046"	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavorable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.3	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.2	0.2	0.0	0.0	11.6	23.4	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	63.4	17.4	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	64.9	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.2	0.0	32.0	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6	229.3	23.2	0.0	0.4	0.7	0.4	4.2	0.0	1.4	6.8	8.7	0.0	0.1	0.0	0.2	0.7	1.5	0.0	0.0	0.0	0.2	2.4	0.1	4.7	0.8	0.1	0.0	0.0	85.3	1.9	0.4	2.0	0.9	1.7	0.0	0.0	0.5	0.1	0.0	8.9	0.8	0.5	0.0	8.3	0.3	0.2	0.5	0.3	1.0	0.0	0.2
COPB1	COPB	ENSG00000129083	"Coatomer protein complex subunit beta 1"	P53618	11	14443440-14500027	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		400000	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	30.9	33.0	18.4	23.5	20.8	31.2	55.4	23.7	23.6	32.5	26.6	15.5	42.0	25.9	32.2	33.0	32.2	28.3	25.1	34.8	18.9	16.8	37.6	56.6	38.4	53.9	22.6	15.5	31.3	52.2	40.1	43.5	52.3	22.2	31.9	31.3	17.2	43.4	41.7	21.9	24.7	33.1	39.7	26.1	29.8	30.2	21.7	20.6	46.0	37.7	26.7	28.0	28.2	27.3	26.7	33.9	27.9	30.4	28.0	39.6	24.8	31.6	27.2	29.1	21.8	48.6	56.4	23.5	48.0	50.4	42.8	50.4	21.0	49.3	30.8	21.6	60.6	40.7	34.9	32.7	32.2	53.0	28.8	27.2	32.7	19.5	31.9	43.2	30.0	33.3	39.3	42.5	28.6	54.3	39.4	44.7	17.3	24.2	25.3	53.9	23.8	27.2	18.5	15.1	38.7	29.5	22.3	40.1	20.9	38.6	29.3	18.7	20.0	37.2	30.1	24.6	35.1	27.3	26.2	45.4	41.2	21.3	44.4	26.1	13.6	22.9	33.9	31.1	18.8	38.4	27.3	24.9	27.9	32.2	30.4	39.6	26.7	27.5	32.9	33.9	22.6	27.6	28.6	20.5	28.0	30.3	20.4	29.3	24.8	18.4	20.8	23.7	23.6	18.9	16.8	22.6	15.5	22.2	20.6	101.3	47.9	37.9	48.3	34.6	27.2	25.8	35.7	141.8	100.1	41.8	25.5	57.0	34.9	66.2	10.9	46.0	51.5	46.7	71.3	60.9	51.3	55.0	62.5	55.0	54.4	17.5	42.1	54.6	45.5	9.5	47.2	47.5	20.3	64.9	78.6	33.3	79.8	38.6	51.9	43.9	26.9	51.8	41.8	89.3	61.5	31.2	97.8	51.7	43.2	51.2
COPS2	"ALIEN, CSN2, TRIP15"	ENSG00000166200	"COP9 signalosome subunit 2"	P61201	15	49106068-49155661	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016867, HPA018271, HPA061071"	Approved		Supported	"Vesicles,Cytokinetic bridge"		Yes	No		190000	Vesicles	"Cytokinetic bridge"	"HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424"	"unprognostic (3.47e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.10e-3)"	36.6	26.7	23.3	15.6	34.3	48.9	30.1	29.7	35.7	35.1	27.9	10.6	26.4	19.2	26.8	21.5	34.1	20.3	24.3	27.0	21.4	21.6	27.8	33.0	25.7	18.3	28.7	20.4	36.4	25.4	26.6	30.4	25.6	41.4	30.1	19.2	8.1	19.1	22.6	59.8	20.6	27.9	34.8	37.5	22.5	21.7	26.6	27.3	22.1	33.4	27.8	20.9	56.8	33.6	11.7	15.7	8.9	17.8	11.6	20.8	11.5	22.5	13.3	28.6	24.0	35.2	50.3	19.7	39.6	38.0	34.9	32.1	28.1	12.4	37.4	27.2	38.0	28.1	33.3	40.6	32.9	38.5	25.3	16.3	34.8	28.8	22.6	27.0	32.8	18.2	42.3	26.9	28.3	50.2	38.7	36.5	20.8	44.6	20.1	37.9	12.1	17.5	16.4	18.5	31.8	17.5	19.2	27.0	55.9	36.9	34.1	27.9	20.3	22.8	24.6	31.6	34.9	24.3	33.1	23.4	34.3	18.4	64.0	41.5	18.3	46.6	47.2	32.0	53.4	27.7	8.0	13.8	8.9	10.6	17.8	19.5	11.7	16.1	15.3	15.7	10.1	20.8	13.1	5.6	11.6	15.7	10.2	20.8	11.5	23.3	34.3	29.7	35.7	21.4	21.6	28.7	20.4	41.4	27.3	71.5	47.1	37.1	50.1	77.3	21.4	91.1	22.9	53.5	67.1	22.7	9.8	49.0	46.4	34.4	15.4	48.4	19.7	23.3	25.8	59.2	57.0	36.3	50.8	30.6	39.1	31.8	20.0	34.4	36.5	15.2	51.2	40.0	33.7	39.7	22.4	24.9	31.1	21.0	50.2	58.5	18.0	19.4	54.7	53.9	45.4	86.4	110.3	37.4	31.0	49.0
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.0;ASC TERT1: 42.5;hTERT-RPE1: 34.7;Karpas-707: 30.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		51000000	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favorable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.0	42.5	0.5	11.3	17.1	4.0	8.4	1.3	0.7	1.0	9.2	17.8	5.8	0.6	0.7	0.8	3.9	10.2	1.5	9.6	1.8	5.6	8.2	2.3	12.5	22.2	2.0	4.6	1.1	34.7	1.8	0.6	9.3	30.9	9.1	0.6	0.3	4.7	1.2	0.8	1.9	2.1	0.3	0.5	8.3	4.3	1.2	0.8	4.0	0.4	8.7	10.1	4.3	9.3	8.1	17.7	2.1	0.8	4.2	3.1	0.7	0.4	11.2	7.7	11.7	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5	11.9	12.2	10.4	23.2	17.2	13.3	24.2	48.4	5.3	9.1	45.4	27.5	10.3	14.9	15.7	4.0	23.3	10.7	0.0	9.4	1.2	64.4	11.1	36.9	37.7	48.7	9.5	13.3	50.3	56.8	5.7	67.0	38.8	74.2	14.4	6.1	41.4	11.7	8.6	68.6	42.8	14.9	51.8	32.1	4.7	3.6	11.4	5.0	17.9	10.9	12.0
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"liver: 1139.7"	"Cell type enriched"	"Detected in some"	14	"Hepatocytes: 2991.5"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	NA	NA	2920000000	5400000000	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	17.2	0.1	0.1	0.0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	7.8	0.0	0.3	0.0	0.0	0.0	0.3	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.1	0.9	0.0	13.1	2.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	55.9	0.0	0.0	0.0	0.0	109.5	0.0	0.0	0.0	0.0	0.0	0.0	220.4	1.2	0.0	0.0	23.3	52.3	0.0	0.0	0.0	0.0	2991.5	0.1	0.0	0.0	82.9	72.1	0.0	0.0	0.0	0.0	17.2	0.0	0.0	97.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Kupffer cells: 3433.6;Macrophages: 4110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 269.6;monocytes: 211.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 163.2;ASC TERT1: 111.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1040000000	4100000000	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (8.77e-4)"	95.8	72.6	229.0	37.9	254.7	22.2	68.6	61.4	196.7	76.6	78.2	75.4	39.5	59.4	47.6	143.6	73.8	64.9	89.4	79.7	157.4	96.2	35.9	67.3	58.0	91.2	148.3	90.6	51.4	142.1	34.5	45.6	25.8	69.9	55.2	66.1	195.0	338.2	74.2	44.2	44.9	77.9	57.3	73.3	85.5	105.5	57.4	68.4	40.7	43.2	40.1	31.9	49.4	50.2	0.6	269.6	27.4	211.0	6.4	2.4	106.7	12.9	29.3	6.9	15.8	163.2	111.7	12.8	22.5	31.4	15.5	12.6	55.8	20.0	0.0	21.2	30.7	20.1	43.9	6.3	45.0	4.8	0.0	21.7	13.3	5.8	94.7	58.4	0.6	22.3	86.4	37.9	20.8	22.3	32.8	24.2	1.6	12.1	0.3	21.5	20.6	0.1	14.0	9.2	41.0	64.4	0.5	8.4	17.8	63.6	29.3	7.5	8.6	16.4	4.9	28.0	10.4	13.9	48.7	60.9	14.7	10.6	20.5	8.4	13.9	0.5	0.1	12.5	29.1	16.5	1.4	163.9	1.0	2.4	211.0	0.9	0.6	0.6	1.6	269.6	0.5	0.6	1.2	27.4	6.4	135.1	153.5	0.4	106.7	229.0	254.7	61.4	196.7	157.4	96.2	148.3	90.6	69.9	68.4	107.2	165.4	122.1	459.0	837.5	35.4	213.0	1645.8	65.6	135.4	608.9	27.5	429.7	351.5	407.3	34.7	720.9	2161.2	23.3	692.7	269.5	1051.9	864.5	358.3	2073.4	1660.2	46.1	847.5	528.5	3433.6	95.9	1974.8	4110.2	1482.9	256.1	1276.0	130.5	997.4	2367.2	1683.0	939.5	34.6	2160.2	727.9	82.7	461.4	718.5	392.2	90.0	866.3	802.3
CTNS	"CTNS-LSB, PQLC4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636468-3661542	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	9.6	19.0	8.5	8.2	11.9	8.3	12.1	5.0	9.9	18.8	8.2	16.1	34.8	10.8	10.3	7.2	7.3	8.3	10.6	9.3	7.7	5.9	23.9	16.4	11.4	9.1	12.1	5.6	12.6	32.7	11.3	14.5	13.2	8.5	10.2	6.4	11.4	10.5	46.2	22.6	18.0	9.2	7.9	10.2	12.2	12.9	27.0	13.0	11.7	9.0	6.5	9.0	10.1	9.1	3.5	19.6	13.7	5.6	2.5	3.3	3.7	6.2	14.0	8.2	7.0	13.3	6.8	5.1	6.0	10.2	7.0	8.8	7.8	6.1	3.7	6.4	4.1	19.2	16.0	7.2	4.1	5.4	46.5	12.7	4.2	10.5	6.3	18.0	2.8	29.1	8.4	5.3	7.3	6.0	10.9	7.7	6.0	4.3	5.9	6.5	5.7	2.8	2.7	3.6	4.3	6.1	6.2	3.3	8.8	6.2	6.3	1.6	6.0	7.1	9.5	7.1	7.3	6.7	2.8	9.0	6.9	4.3	15.5	4.9	4.7	6.1	1.8	10.6	3.1	4.7	13.7	5.6	12.1	1.9	3.7	2.7	3.5	2.3	3.3	5.4	3.1	2.9	3.1	2.0	2.5	3.8	19.6	2.6	3.7	8.5	11.9	5.0	9.9	7.7	5.9	12.1	5.6	8.5	13.0	3.0	2.1	0.0	3.2	1.4	1.4	3.6	7.6	2.7	1.2	12.2	9.8	5.1	0.0	5.4	33.5	6.0	2.8	0.0	5.5	5.9	4.8	5.5	8.1	5.8	20.7	4.8	2.4	13.5	7.1	23.4	8.9	8.3	5.0	12.6	2.5	6.6	5.8	2.0	12.0	7.9	3.6	6.5	2.8	11.4	8.5	2.0	7.1	4.3	1.8	2.6
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell type enhanced"	"Detected in all"	11	"Hofbauer cells: 2617.6;Kupffer cells: 1392.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 239.8;fHDF/TERT166: 139.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"	NA	NA		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favorable (5.76e-4)"	"prognostic unfavorable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.5	3.8	16.2	66.6	74.9	11.8	122.8	239.8	43.0	51.0	14.0	38.4	0.1	17.8	139.3	57.7	35.8	5.2	33.9	27.2	3.2	5.0	9.5	3.4	34.5	67.8	2.1	7.1	82.1	46.2	38.9	34.8	74.9	84.1	2.8	7.9	21.7	35.7	5.2	0.8	3.5	3.2	75.8	9.9	3.4	3.8	16.6	13.1	10.2	1.6	9.6	14.2	7.7	64.0	11.7	12.5	6.4	116.4	73.1	24.8	23.4	22.8	21.6	15.7	0.6	83.9	8.2	34.2	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4	101.3	205.9	73.7	364.9	48.5	44.4	251.7	175.8	137.9	227.5	108.2	39.3	224.9	23.2	276.8	13.3	119.6	152.5	210.2	211.7	280.5	149.9	239.1	169.3	203.7	2617.6	55.6	148.7	214.9	1392.4	12.2	70.8	859.7	153.5	399.5	80.9	115.8	264.9	108.7	87.4	331.7	35.7	38.8	121.0	4.8	18.5	35.4	543.3	50.7	114.7	284.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88293592-88337787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 218.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 362.7;Hofbauer cells: 897.2;Macrophages: 364.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 111.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	No	No		19000000	Vesicles		"CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989"	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavorable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	40.7	20.5	6.7	44.5	10.6	12.0	35.3	1.5	5.6	14.0	25.3	7.1	6.2	20.4	16.1	24.0	21.8	16.7	36.6	53.3	6.8	6.5	62.7	18.1	110.1	218.6	12.5	3.6	11.0	24.8	3.8	17.3	43.4	9.4	13.8	33.1	27.0	35.1	5.8	10.0	11.7	28.5	14.2	14.6	86.6	13.5	10.8	9.2	19.5	17.7	25.3	30.0	30.2	16.9	8.5	75.9	52.5	92.6	34.7	42.4	31.2	11.1	11.5	4.5	9.4	12.1	32.9	30.1	76.8	111.7	43.9	31.7	31.1	51.7	17.4	40.9	41.7	10.1	18.1	7.0	32.5	35.0	30.7	12.7	22.7	31.8	35.0	16.2	28.9	15.4	45.8	23.0	33.8	69.4	37.0	43.1	16.9	20.6	21.1	5.3	2.1	13.0	39.9	23.5	75.5	35.6	17.0	4.7	30.9	56.4	18.8	1.2	9.4	12.9	17.1	10.0	27.9	3.8	19.8	20.9	3.0	27.2	20.9	48.8	8.9	12.8	17.7	7.9	60.9	16.6	12.5	32.5	52.5	42.4	69.3	36.5	8.5	19.5	37.8	35.1	4.6	9.9	23.8	37.2	34.7	92.6	75.9	28.4	31.2	6.7	10.6	1.5	5.6	6.8	6.5	12.5	3.6	9.4	9.2	20.8	83.9	64.9	5.0	26.8	1.0	2.5	56.0	80.3	93.3	38.4	0.0	362.7	24.9	14.0	1.2	41.8	29.0	0.0	79.6	130.7	85.3	3.1	72.8	14.0	897.2	0.0	10.9	24.5	290.2	4.0	183.8	364.2	45.5	139.7	15.7	0.6	35.1	69.1	24.1	150.6	0.6	58.2	183.3	3.0	11.5	23.7	190.1	167.5	36.3	14.2
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563463-66568841	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 256.1;Muller glia cells: 186.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 7.5;T-cells: 9.7"	"Cell line enhanced"	"Detected in many"		"HSkMC: 28.4;SK-MEL-30: 52.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431"	Approved		Uncertain	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3600000	Cytosol	"Vesicles, Plasma membrane"	"CAB002141: AB_563471, HPA031431: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favorable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	28.1	29.4	24.7	8.0	29.0	1.8	31.1	38.4	47.1	37.3	23.8	32.6	25.2	5.8	38.1	29.8	12.9	34.3	37.3	34.5	25.3	20.5	29.8	45.4	17.3	8.5	28.0	26.0	68.2	23.1	42.6	15.9	20.2	25.4	32.3	8.1	35.0	35.5	37.8	35.8	19.7	9.4	34.6	22.4	10.4	17.8	37.1	30.1	0.8	18.6	14.2	6.3	22.2	21.5	2.1	1.1	0.5	0.7	7.5	9.7	2.4	0.1	9.3	5.0	13.0	21.5	8.7	3.6	6.6	16.7	6.8	4.8	0.0	8.3	0.0	11.1	14.4	0.3	0.9	8.6	2.8	3.6	2.2	0.0	0.3	3.8	0.0	12.0	0.1	5.1	28.4	9.7	1.5	1.1	20.3	4.3	2.7	2.9	1.5	8.5	1.9	0.1	1.1	0.6	5.0	3.4	0.0	1.9	1.6	6.1	0.2	6.0	6.5	17.5	2.0	52.8	0.5	13.3	0.8	2.8	2.8	2.7	3.2	0.7	8.9	0.1	0.0	6.6	0.1	4.1	0.0	0.7	0.4	6.5	0.7	7.0	2.0	5.6	7.3	0.8	2.1	9.7	5.5	0.5	7.5	0.3	1.1	1.7	2.4	24.7	29.0	38.4	47.1	25.3	20.5	28.0	26.0	25.4	30.1	11.9	14.1	3.4	58.6	35.3	99.1	43.9	35.7	2.7	5.7	34.9	39.3	22.1	13.3	8.5	123.6	24.1	0.0	0.0	6.6	8.1	75.7	48.4	9.2	51.3	13.1	127.1	11.5	49.7	15.8	256.1	134.9	9.9	148.5	2.8	3.1	186.2	8.9	1.9	114.5	30.7	63.2	77.6	43.8	164.4	36.6	22.1	19.8	19.2	3.0	26.5
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 82.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 1152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 42.8"	"Group enriched"	"Detected in all"	5	"B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.1;HaCaT: 31.5;OE19: 31.0;RT4: 119.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"	NA	NA		10000000	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	16.7	10.6	9.5	24.2	7.0	5.4	23.9	4.5	9.8	25.1	11.4	17.7	14.7	10.6	10.3	17.1	7.8	13.1	29.2	16.5	14.8	6.7	66.7	18.7	82.6	65.4	12.1	11.6	14.6	25.8	12.3	6.5	7.7	9.4	18.6	6.6	6.7	15.4	15.9	7.0	13.5	16.6	9.8	10.8	20.3	15.6	6.7	15.7	6.6	8.5	4.8	34.8	39.6	13.5	20.6	41.2	1.4	42.8	1.3	7.6	27.3	16.2	1.1	0.4	4.8	1.1	0.0	5.3	1.6	0.6	2.8	1.5	7.1	43.1	5.7	1.8	0.1	3.1	31.5	2.0	7.8	2.3	24.0	0.1	0.1	0.2	16.5	1.7	0.0	1.1	0.8	2.2	0.0	0.0	11.8	0.2	0.7	11.6	0.0	3.9	1.7	3.7	10.0	1.2	31.0	0.3	0.0	0.3	0.9	9.9	119.7	0.5	1.2	7.0	3.9	9.7	2.3	1.6	5.4	2.2	0.0	1.0	0.0	0.7	0.1	12.4	3.1	0.0	10.5	1.7	0.0	42.8	0.4	1.4	28.3	7.6	20.6	4.1	2.1	41.2	12.0	0.4	0.7	1.4	1.3	17.0	4.2	3.1	27.3	9.5	7.0	4.5	9.8	14.8	6.7	12.1	11.6	9.4	15.7	220.3	1152.3	144.6	210.0	21.5	0.8	25.2	351.6	270.4	197.9	349.0	3.9	16.6	71.3	153.3	17.1	109.7	15.8	0.0	128.8	33.6	30.0	89.1	30.2	82.9	261.0	0.0	8.7	15.4	160.1	15.9	67.6	392.5	75.9	476.1	19.5	21.1	69.6	11.5	5.6	352.9	5.6	19.4	17.8	5.0	52.9	16.3	19.6	25.4	37.0	308.4
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Cell type enhanced"	"Detected in many"	11	"Basal keratinocytes: 61.1;Leydig cells: 110.1;Melanocytes: 92.8;Peritubular cells: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Group enriched"	"Detected in some"	8	"ASC diff: 205.0;ASC TERT1: 75.1;BJ hTERT+: 165.6"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA050346: AB_2681101"	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavorable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.4	0.3	205.0	75.1	0.2	5.8	165.6	0.4	0.9	0.0	0.1	0.1	0.2	11.4	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.1	0.1	0.4	14.9	0.5	4.6	0.1	13.1	0.6	0.1	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.7	0.3	0.0	3.1	0.9	0.2	0.2	0.4	0.2	0.1	0.2	0.3	0.7	0.5	1.1	17.4	0.0	1.0	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9	3.0	5.8	0.0	0.5	61.1	8.4	1.2	2.5	2.7	5.7	3.5	3.9	1.0	0.0	1.1	0.8	5.2	1.1	0.0	0.2	1.9	31.5	0.9	0.0	0.0	19.2	3.2	1.2	9.8	3.7	1.7	110.1	6.6	92.8	2.8	1.9	2.4	1.3	0.6	140.7	0.0	7.8	12.9	47.6	1.4	0.7	51.7	0.8	0.0	0.9	0.5
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87725519-87731393	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 237.0"	"Cell type enhanced"	"Detected in all"	8	"Cytotrophoblasts: 935.7;Extravillous trophoblasts: 843.2;Hofbauer cells: 1004.8;Ito cells: 672.8;Syncytiotrophoblasts: 1290.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 31.0;non-classical monocyte: 44.3"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.3"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 201.6;HSkMC: 93.2"									"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		17000000	"Golgi apparatus, Vesicles"		"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	60.3	21.5	10.4	27.2	24.6	18.4	23.3	6.9	12.3	14.8	23.2	14.1	13.7	9.0	24.1	22.3	11.4	25.7	20.7	37.7	10.7	11.4	65.4	98.0	53.1	80.5	18.9	7.7	25.0	14.3	18.8	18.0	237.0	18.4	19.4	13.0	23.2	22.0	23.5	29.3	9.1	12.0	36.6	16.1	108.1	17.5	14.1	15.7	6.8	19.2	9.4	10.1	41.3	26.5	0.0	1.7	0.1	44.3	0.0	4.3	2.4	6.4	37.4	2.6	4.4	47.1	201.6	15.7	20.8	60.7	17.9	22.4	3.6	5.9	0.0	9.8	26.9	56.7	5.5	3.4	6.8	14.8	0.1	3.3	1.1	10.6	8.7	30.5	0.0	4.5	93.2	11.4	29.2	11.4	15.6	14.1	0.0	12.1	0.0	25.7	10.8	0.0	0.7	4.9	10.1	7.1	1.5	1.5	0.0	12.5	3.4	3.7	4.6	4.3	9.8	23.9	15.6	1.1	7.4	22.0	16.0	8.7	58.4	8.8	1.6	6.0	0.0	58.7	0.0	5.2	0.1	3.5	0.1	0.0	31.0	0.0	0.0	1.8	0.0	1.7	0.0	4.3	0.3	0.1	0.0	44.3	0.1	0.3	2.4	10.4	24.6	6.9	11.7	10.7	11.4	18.9	7.7	18.4	15.7	38.7	60.6	38.5	79.1	33.5	37.4	87.3	84.1	56.2	38.7	71.5	17.7	935.7	23.2	77.5	3.5	75.9	8.6	46.7	82.1	843.2	226.1	43.7	27.8	100.7	1004.8	12.7	11.1	672.8	182.1	10.4	145.3	481.4	60.8	19.8	7.7	78.6	55.2	2.9	176.0	107.8	35.6	90.5	103.2	144.4	46.2	29.6	1290.9	15.3	8.8	43.0
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58995185-59007247	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 945.4;Macrophages: 462.5;monocytes: 1072.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 119.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		85000000	Vesicles		"CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172"	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	70.7	27.9	12.4	40.8	20.4	20.7	51.2	14.6	13.5	25.4	52.8	16.0	19.9	40.8	20.6	25.5	20.1	20.7	22.3	50.1	9.8	13.3	34.9	83.7	54.3	61.2	18.8	10.5	29.7	29.0	30.6	27.6	38.6	19.2	28.8	37.8	31.5	40.3	17.7	20.7	12.9	63.6	26.4	22.1	56.5	19.2	13.8	14.9	18.4	42.4	17.5	35.8	29.8	21.5	1.9	3.9	3.5	3.2	0.3	0.6	0.8	27.6	21.5	0.0	0.0	25.4	29.2	15.2	45.5	50.4	34.9	31.2	41.5	46.5	15.2	30.2	119.6	0.0	22.1	13.7	43.1	23.9	48.6	1.8	13.9	34.8	0.0	26.6	1.6	48.4	24.8	26.0	15.2	18.2	11.6	55.2	0.0	10.0	7.7	23.3	0.0	0.1	15.0	1.7	12.1	21.5	0.3	0.1	18.2	25.5	6.5	0.4	0.3	35.4	41.0	0.1	14.2	18.9	23.6	60.6	0.0	23.6	30.7	0.2	36.7	22.3	2.9	0.4	33.5	0.0	0.0	3.2	0.3	0.6	2.7	0.0	1.0	0.4	0.1	3.9	1.9	0.4	0.1	3.5	0.3	2.9	2.2	0.2	0.8	12.4	20.4	14.6	13.5	9.8	13.3	18.8	10.5	19.2	14.9	14.9	4.0	130.0	51.2	44.8	4.6	17.5	53.5	8.1	5.7	68.0	0.0	34.5	19.9	168.0	2.8	62.8	285.7	23.3	37.2	91.0	58.0	41.9	10.4	307.7	945.4	11.1	26.0	44.2	260.7	3.3	12.0	462.5	96.2	1072.2	50.0	45.9	72.3	98.2	13.1	68.2	4.9	45.3	59.0	1.7	4.5	36.3	34.6	29.9	76.8	46.2
CYP4B1		ENSG00000142973	"Cytochrome P450 family 4 subfamily B member 1"	P13584	1	46757838-46819413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 92.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 56.9"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Cell type enriched"	"Detected in single"	11	"memory CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.1"	"Cell line enriched"	"Detected in some"	8	"RT4: 81.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004331	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA004331: AB_1078616"	"unprognostic (2.29e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (7.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.12e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.69e-3)"	41.6	2.2	0.0	0.6	0.1	0.3	45.5	0.1	0.3	9.5	6.7	0.1	7.2	0.7	2.1	2.8	17.9	18.5	0.8	13.5	0.0	0.0	1.4	0.2	92.0	1.5	1.7	0.1	3.3	0.9	0.5	4.8	0.9	0.8	15.4	0.5	2.8	5.0	6.9	14.4	10.4	3.4	6.8	3.5	0.5	3.0	1.7	0.1	0.7	12.7	4.5	5.7	36.5	18.9	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	1.7	0.1	0.8	0.1	1140.4	70.0	0.0	114.6	0.5	0.0	4.8	0.0	602.3	304.8	0.0	0.0	0.9	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.2	4.7	3.9	5.8	0.0	0.6	0.0	0.0	2.5	0.0	0.8	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	3.6	0.7	0.0	0.0	142.5
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		70000000	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	19.2	17.4	16.5	10.1	21.1	2.8	16.2	17.3	27.1	17.3	23.9	24.1	13.1	14.1	23.4	14.3	19.1	19.6	19.7	40.9	19.9	10.3	22.7	31.7	18.9	6.3	16.7	15.7	22.6	35.0	32.7	15.8	45.6	18.1	18.6	18.9	22.2	19.9	24.3	57.3	18.7	17.5	27.9	14.0	7.3	22.2	29.4	16.3	6.0	15.3	24.0	14.3	20.4	15.0	3.2	3.6	1.8	6.1	1.9	3.7	3.3	19.5	19.5	13.6	33.6	18.2	8.9	62.0	13.8	20.5	23.7	15.3	16.0	20.8	2.7	14.1	22.5	20.1	36.7	11.8	17.9	14.7	2.6	3.9	1.8	19.6	18.2	8.1	2.4	3.9	7.8	16.2	22.5	7.5	21.7	21.2	3.3	2.8	2.1	6.4	15.7	2.0	1.6	14.6	24.1	6.5	1.2	13.2	4.6	18.6	27.5	4.8	9.9	16.6	45.8	22.4	41.3	38.6	4.8	11.1	9.0	14.3	16.7	19.7	2.4	4.9	1.7	10.9	2.6	54.3	1.8	2.8	1.1	3.3	3.5	3.7	3.2	2.8	2.5	1.8	2.6	3.0	2.4	0.6	1.9	6.1	3.6	1.9	3.3	16.5	21.1	17.3	27.1	19.9	10.3	16.7	15.7	18.1	16.3	50.6	13.6	9.0	8.0	12.7	7.8	50.0	30.6	10.7	11.4	33.2	3.9	95.1	1.7	26.2	25.8	16.8	20.6	0.0	69.3	96.3	24.2	13.2	6.9	48.8	18.3	3.2	31.7	17.8	7.2	13.6	19.8	4.0	32.1	5.4	27.5	30.3	50.2	25.1	34.6	6.8	8.7	45.3	23.7	7.0	18.6	14.9	80.2	5.0	26.4	9.0
DAPK2	"DRP-1, MGC119312"	ENSG00000035664	"Death associated protein kinase 2"	Q9UIK4	15	63907036-64072033	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.8;skeletal muscle: 46.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 80.4;Enterocytes: 44.6;Late spermatids: 59.2"	"Cancer enriched"	"Detected in many"	15	"thyroid cancer: 30.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"basophil: 19.1;eosinophil: 51.8;neutrophil: 16.4"	"Lineage enriched"	"Detected in many"	23	"granulocytes: 51.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 10.1;HaCaT: 8.4;HMC-1: 17.2;MCF7: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA071581			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA071581: AB_2686421"	"unprognostic (3.20e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (1.04e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.51e-2)"	"unprognostic (4.77e-7)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.07e-2)"	8.2	1.6	2.6	6.8	5.0	10.3	5.2	1.4	3.9	3.6	16.6	12.0	8.3	14.2	1.7	1.5	2.1	1.2	1.7	17.6	3.6	2.0	2.2	1.4	14.0	2.5	6.8	3.0	0.7	1.7	1.1	1.1	0.3	4.7	3.1	4.7	1.9	4.8	4.8	46.1	4.6	25.8	1.2	3.4	4.7	6.9	2.0	6.5	1.1	22.3	8.7	3.3	2.1	9.6	0.3	2.2	51.8	0.0	0.7	0.6	0.3	2.8	2.0	5.7	1.4	10.1	0.4	0.1	1.9	6.1	1.0	1.1	0.9	1.4	0.2	0.6	6.1	3.4	8.4	3.5	0.1	0.6	0.2	0.1	1.1	3.9	0.1	0.1	0.1	17.2	1.1	7.3	0.4	0.2	6.6	0.6	0.1	0.4	0.1	0.7	8.7	0.0	0.3	0.6	2.8	2.0	2.6	0.0	0.3	0.0	2.8	0.4	0.3	0.4	1.1	0.0	1.4	4.8	0.4	0.4	0.8	1.0	1.3	1.6	0.6	0.2	0.0	0.0	2.7	0.2	19.1	0.0	51.8	0.6	0.0	0.2	0.3	0.1	0.5	0.0	0.1	0.0	0.4	16.4	0.7	0.0	2.2	0.0	0.3	2.6	5.0	1.4	3.9	3.6	2.0	6.8	3.0	4.7	6.5	80.4	21.1	2.7	6.6	10.3	0.0	34.6	2.5	2.7	19.4	0.0	0.0	0.1	1.7	7.8	19.1	2.8	44.6	0.0	30.2	0.1	3.1	14.5	15.0	0.8	0.4	4.8	8.1	8.6	1.2	59.2	2.8	1.4	0.0	0.0	13.0	1.6	13.0	28.8	5.3	0.3	0.1	12.9	2.1	0.9	3.4	3.6	0.1	14.9	16.9	10.7
DCT	TYRP2	ENSG00000080166	"Dopachrome tautomerase"	P40126	13	94436808-94479682	"Enzymes, Predicted membrane proteins"	"Melanin biosynthesis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	58	"retina: 151.5;skin 1: 54.2"	"Cell type enriched"	"Detected in some"	25	"Melanocytes: 3369.1"	"Cancer enriched"	"Detected in some"	215	"melanoma: 155.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	259	"SK-MEL-30: 76.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010742, HPA010743, HPA010800, CAB017634"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.18e-5)"	"unprognostic (6.97e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.42e-1)"	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0.0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0.0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0.0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4	0.0	0.0	0.0	0.1	135.3	0.7	0.8	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	12.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.9	0.0	3369.1	0.0	0.0	2.4	0.0	0.0	0.7	0.0	0.2	0.0	0.9	0.5	0.2	29.2	0.0	0.0	0.0	0.0
DCUN1D4	KIAA0276	ENSG00000109184	"Defective in cullin neddylation 1 domain containing 4"	Q92564	4	51843000-51916837	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036483, HPA036484"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036483: AB_10670719, HPA036484: AB_10671843"	"unprognostic (3.16e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.93e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.40e-1)"	16.9	22.9	15.9	9.9	26.1	3.5	13.5	15.4	24.8	15.9	14.3	12.8	15.5	7.6	17.8	17.3	13.4	13.6	14.2	14.9	29.8	22.3	19.4	36.5	10.4	10.7	17.7	22.0	20.8	9.8	9.9	19.8	9.3	24.6	16.6	12.0	9.4	15.9	22.9	14.3	10.2	9.8	31.4	24.0	11.4	14.6	20.4	13.4	3.9	16.8	8.6	8.2	20.3	13.7	4.6	2.9	10.2	4.2	4.4	10.7	5.3	5.7	10.3	13.9	20.1	14.3	14.3	5.3	17.9	13.3	10.2	9.2	6.6	6.2	4.3	11.6	20.1	13.5	5.8	17.7	11.2	14.1	2.7	5.2	7.6	8.0	15.9	30.2	10.5	10.3	14.8	13.2	11.7	10.2	13.6	10.2	4.1	8.4	3.2	17.6	8.4	12.9	7.4	8.2	11.6	8.5	6.2	7.2	2.4	13.3	6.8	8.2	8.9	7.7	9.6	14.8	8.2	9.8	6.7	16.6	13.6	11.1	10.9	14.2	5.8	8.3	4.0	9.5	10.1	7.7	5.5	4.2	10.2	7.2	3.7	10.7	4.6	8.1	8.0	2.9	3.3	7.8	8.5	1.7	4.4	2.6	1.9	3.7	5.3	15.9	26.1	15.4	24.8	29.8	22.3	17.7	22.0	24.6	13.4	6.0	13.1	10.4	16.2	33.1	22.1	33.1	20.4	16.0	12.5	15.7	15.7	4.6	11.6	9.4	58.2	21.5	8.7	0.0	10.5	7.4	21.0	13.4	12.7	32.7	7.2	28.6	6.4	18.4	6.3	89.6	13.8	10.8	30.4	3.6	6.9	14.1	10.8	10.5	24.4	19.5	15.9	0.0	18.6	22.8	27.9	29.1	2.9	10.1	8.1	13.7
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"	Nucleoplasm	"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favorable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	11.4	12.2	17.4	13.9	19.8	32.5	10.0	18.6	21.2	10.9	14.8	12.8	10.3	15.8	13.3	9.0	11.3	13.0	10.5	10.3	15.9	12.8	16.4	14.5	9.4	11.6	11.8	14.9	12.0	8.9	20.1	19.0	23.9	13.9	11.0	14.1	14.5	8.5	11.8	11.0	9.3	17.2	14.4	10.1	20.2	9.9	12.1	13.2	10.6	15.5	5.6	9.5	10.6	17.4	1.5	8.4	11.2	15.2	0.5	1.3	3.2	14.8	8.8	7.9	14.9	5.4	8.5	36.8	14.4	21.8	12.3	10.7	12.0	6.6	11.9	3.0	11.6	16.3	8.4	6.7	10.5	12.0	5.0	5.1	5.6	21.3	8.8	7.2	6.7	3.8	7.8	9.5	10.2	17.5	4.3	10.9	11.6	15.4	9.2	9.9	8.5	8.0	9.7	15.7	17.2	13.4	12.5	7.7	10.1	6.1	5.3	16.8	13.7	11.6	7.7	9.0	5.4	10.5	17.0	5.1	13.3	5.1	15.5	7.5	14.0	10.9	8.2	11.2	13.4	8.8	11.2	15.2	2.8	1.3	10.1	0.7	1.1	0.9	0.6	8.4	1.5	0.6	0.7	9.3	0.5	8.2	1.3	0.4	3.2	17.4	19.8	18.6	21.2	15.9	12.8	11.8	14.9	13.9	13.2	0.0	1.0	7.3	2.3	4.5	15.9	7.7	7.6	1.4	1.2	15.7	15.7	8.6	5.0	4.0	28.4	10.1	17.6	0.0	4.4	27.4	5.2	4.7	4.6	12.1	14.5	30.2	11.5	7.4	15.9	67.9	13.6	10.8	3.3	2.8	6.6	13.5	5.2	10.7	10.6	11.5	12.3	0.0	5.2	3.4	1.1	2.5	7.3	3.8	6.7	3.1
DENND4C	"bA513M16.3, C9orf55, C9orf55B, FLJ20686, RAB10GEF"	ENSG00000137145	"DENN domain containing 4C"	Q5VZ89	9	19230435-19373545	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014917, HPA015096"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles, Cytosol"		"HPA014917: AB_2261659, HPA015096: AB_1845831"	"unprognostic (4.57e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (3.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	31.5	14.0	7.4	11.2	9.4	5.8	17.8	17.7	10.4	18.8	17.9	7.3	17.5	17.4	15.0	12.7	15.8	12.5	9.9	13.7	8.0	5.7	10.2	10.1	16.3	7.2	9.1	6.7	16.3	16.0	16.9	18.2	14.6	8.4	14.9	14.5	10.4	16.9	12.2	11.5	20.5	18.4	19.1	8.9	9.8	13.8	9.0	9.6	14.3	12.9	8.3	11.0	22.3	17.7	3.0	4.0	8.5	2.1	8.1	10.2	3.4	11.7	11.1	8.0	10.4	17.6	21.3	14.6	6.7	10.2	7.2	9.6	5.5	7.8	5.0	5.7	8.9	8.3	6.3	9.3	5.6	8.8	32.9	5.3	22.9	12.8	6.4	8.7	5.3	13.1	8.3	12.9	6.3	10.8	14.6	13.4	6.6	6.1	5.8	9.2	4.5	9.3	11.8	6.0	15.5	5.5	8.4	4.6	7.2	18.9	22.7	8.1	5.9	6.0	13.7	4.8	7.6	8.4	7.2	12.5	6.4	3.6	6.9	7.0	3.9	9.5	2.7	5.3	5.2	3.5	8.5	2.1	2.5	7.8	1.1	10.2	2.5	6.7	7.8	4.0	3.0	6.1	7.3	1.1	8.1	1.1	4.0	4.8	3.4	7.4	9.4	17.7	10.4	8.0	5.7	9.1	6.7	8.4	9.6	8.9	8.6	1.4	14.5	45.4	21.5	10.4	15.3	14.7	15.9	15.7	56.9	22.1	1.7	8.0	6.3	18.3	23.8	0.0	10.6	11.1	15.5	14.1	25.5	9.6	17.4	22.3	19.0	46.1	20.6	4.0	17.3	19.5	20.3	3.6	23.6	16.7	9.8	17.3	19.1	3.7	17.8	0.0	11.1	2.4	6.4	43.2	13.5	12.2	23.9	17.1
DENND6A	"AFI1A, FAM116A, FLJ34969"	ENSG00000174839	"DENN domain containing 6A"	Q8IWF6	3	57625457-57693089	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 13.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062618, HPA069725, HPA071711"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435"	"unprognostic (6.20e-2)"	"unprognostic (3.86e-2)"	"prognostic favorable (9.21e-4)"	"unprognostic (1.76e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.36e-4)"	"unprognostic (7.16e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.28e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.77e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.61e-3)"	"unprognostic (2.94e-1)"	18.6	12.0	8.6	16.7	12.4	15.0	18.1	18.6	12.8	19.8	16.9	15.3	15.3	9.7	23.7	16.8	16.1	16.3	13.7	11.4	9.3	9.7	14.6	10.5	15.1	20.9	10.7	10.6	29.8	10.5	16.1	17.2	16.0	12.1	15.3	13.0	21.4	14.8	17.2	22.0	14.2	16.9	22.3	12.2	21.8	13.8	11.3	9.6	23.0	19.6	11.3	19.8	18.2	17.4	1.7	1.5	13.5	1.6	2.4	4.4	1.0	12.1	9.9	13.4	8.2	7.2	8.1	7.7	6.3	8.1	7.9	6.2	6.4	13.6	14.4	2.7	6.5	7.0	6.4	10.6	13.4	6.7	3.6	9.6	11.3	10.8	4.9	6.9	8.6	6.7	8.7	9.7	5.4	14.2	8.0	11.2	15.6	7.6	15.8	5.6	5.3	18.5	10.7	7.6	7.7	6.9	7.8	8.0	10.5	9.7	20.5	4.7	16.6	12.5	10.4	9.0	6.1	6.8	10.6	12.2	9.7	5.2	10.2	16.4	11.8	15.1	15.0	11.2	14.5	14.0	13.5	1.2	1.6	3.2	1.3	3.6	1.1	2.9	3.0	1.5	1.7	4.4	3.2	2.0	2.4	1.6	1.2	1.5	1.0	8.6	12.4	18.6	12.8	9.3	9.7	10.7	10.6	12.1	9.6	17.9	10.9	6.5	10.0	11.4	16.2	21.9	20.4	4.0	9.1	5.2	7.9	5.3	3.3	6.8	21.3	11.3	4.1	0.0	9.3	3.8	10.2	5.5	2.3	7.8	9.4	9.5	2.9	21.5	26.7	10.5	10.9	10.0	3.3	10.0	4.5	9.4	14.2	2.9	13.4	7.9	14.6	6.5	11.8	11.6	4.1	9.4	1.9	16.0	4.7	11.6
DEPP1	"C10orf10, DEPP, FIG, Fseg"	ENSG00000165507	"DEPP1, autophagy regulator"	Q9NTK1	10	44970981-44978810	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 204.9;breast: 227.9"	"Cell type enhanced"	"Detected in some"	17	"Ductal cells: 96.0;Exocrine glandular cells: 99.5;Pancreatic endocrine cells: 71.2;Syncytiotrophoblasts: 251.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.2;HDLM-2: 24.4;HHSteC: 63.6;HSkMC: 49.5;HUVEC TERT2: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013687, HPA037818, HPA037819"	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria	Vesicles	"CAB013687: , HPA037818: , HPA037819: AB_2675685"	"unprognostic (3.99e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.89e-2)"	"prognostic unfavorable (2.29e-6)"	"unprognostic (2.30e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.74e-1)"	204.9	14.6	8.7	14.1	16.8	2.4	227.9	10.8	19.7	14.1	36.5	2.9	10.0	7.4	25.0	14.9	23.5	25.5	28.0	37.0	8.5	6.0	13.0	48.2	70.7	20.6	9.4	3.3	51.2	107.1	4.7	12.2	33.4	21.6	25.8	5.7	12.1	16.2	13.0	81.0	19.6	9.9	30.2	39.0	9.5	12.7	31.9	11.0	0.8	33.3	13.4	19.1	52.1	27.6	0.0	3.7	1.2	0.3	0.0	0.7	1.4	6.9	0.0	0.1	0.0	35.2	17.2	1.7	0.0	2.4	0.1	0.4	0.2	2.6	0.0	0.4	3.1	1.7	0.3	0.3	2.1	0.1	24.4	0.9	0.0	0.0	2.5	63.6	0.0	0.0	49.5	0.1	0.0	0.3	6.0	39.2	0.0	0.0	15.1	0.1	0.0	0.0	0.3	0.0	0.1	0.2	1.1	0.4	5.8	0.1	2.5	1.3	0.0	0.0	0.3	1.3	4.2	0.0	1.6	0.3	1.9	1.3	0.1	1.6	0.4	0.6	0.0	10.7	0.6	1.0	0.0	0.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.5	0.0	0.1	3.7	0.0	1.4	8.7	16.8	10.8	19.7	8.5	6.0	9.4	3.3	21.6	11.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	10.7	11.4	29.6	0.0	39.6	31.5	96.0	0.0	0.0	0.0	0.0	99.5	11.6	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	71.2	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	251.0	0.0	0.0	0.0
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 117.7;Syncytiotrophoblasts: 99.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: AB_2665693, CAB068184: AB_2665694, HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.1	18.5	0.0	7.0	7.4	3.8	8.0	3.3	7.6	11.3	5.6	6.0	7.2	0.0	10.4	1.1	4.9	0.3	5.9	0.0	4.9	3.6	9.3	14.6	5.2	9.3	3.7	5.0	15.8	5.1	7.3	8.5	0.0	9.4	7.0	3.2	5.5	6.0	15.4	0.0	5.9	0.0	10.5	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.6	12.5	1.7	8.0	9.1	8.1	3.7	6.7	4.5	0.1	0.0	9.5	6.8	14.9	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1	29.8	42.7	10.6	4.8	9.6	5.7	19.0	7.6	42.8	18.2	19.2	0.0	41.5	6.6	16.9	60.0	25.2	23.6	0.0	20.1	14.6	25.5	6.7	7.0	23.1	17.8	0.0	23.6	8.0	30.6	117.7	41.7	21.4	8.5	6.4	27.6	12.5	26.4	35.1	19.1	6.1	14.0	25.8	18.6	4.9	12.2	15.9	99.0	12.5	28.1	4.8
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101561351-101563452	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 40.9;placenta: 17.6"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 8.0;Leydig cells: 10.0;Muller glia cells: 6.6;Peritubular cells: 7.1;Syncytiotrophoblasts: 23.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"AF22: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073684			Supported	Vesicles		NA	NA			Vesicles		"HPA073684: "	"unprognostic (4.52e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-5)"	"unprognostic (4.82e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.11e-4)"	"unprognostic (9.80e-3)"	4.5	0.2	0.2	1.7	1.8	0.0	3.5	0.1	0.8	40.9	1.6	0.1	1.0	0.0	3.4	2.2	1.9	3.5	2.9	1.6	0.7	0.0	0.9	2.7	1.4	7.1	0.1	0.1	9.2	4.1	0.0	0.6	17.6	0.3	1.6	0.4	12.6	0.8	2.5	2.2	1.9	0.7	0.9	0.1	2.5	0.7	1.0	0.1	0.1	3.6	1.1	0.4	6.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.1	0.6	0.7	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.1	0.0	0.9	0.0	0.0	2.1	8.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.0	0.0	6.6	0.6	0.0	7.1	0.0	0.1	0.0	1.2	0.0	0.0	0.1	23.7	0.0	0.0	0.1
DIRC2	"FLJ14784, RCC4"	ENSG00000138463	"Disrupted in renal carcinoma 2"	Q96SL1	3	122794795-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Syncytiotrophoblasts: 189.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	7.6	7.8	6.5	4.0	7.7	7.9	6.8	5.2	8.8	5.0	6.2	10.0	4.4	3.0	4.2	6.1	8.8	5.0	5.9	9.9	6.4	6.3	7.5	9.2	8.0	6.9	7.5	4.5	4.9	12.9	18.4	7.6	34.8	6.7	7.8	6.9	11.9	7.7	6.0	27.0	9.7	6.1	6.7	7.8	5.8	5.9	4.2	3.8	3.1	8.0	11.2	7.4	7.4	5.4	0.6	0.3	4.2	0.8	0.0	0.5	0.1	5.6	4.7	4.7	2.6	6.1	5.0	15.7	2.4	5.3	3.9	4.0	11.1	6.4	0.8	3.1	2.7	8.8	8.3	3.4	4.4	3.8	1.2	2.5	0.9	2.6	4.7	4.5	0.5	0.6	4.1	12.0	2.8	4.8	6.1	4.4	1.6	0.5	1.0	5.0	2.5	0.7	0.6	4.2	1.9	7.8	1.5	10.6	1.2	5.6	6.6	4.9	3.8	7.1	3.3	6.3	3.1	3.8	1.2	6.2	6.1	2.3	3.7	2.0	1.1	0.9	0.3	3.1	1.0	3.3	0.0	0.7	0.1	0.5	0.8	0.0	0.1	0.0	0.0	0.3	0.6	0.5	0.3	4.2	0.0	0.7	0.0	0.1	0.1	6.5	7.7	5.2	8.8	6.4	6.3	7.5	4.5	6.7	3.8	11.9	5.9	2.7	17.9	9.4	4.8	11.8	7.6	6.7	7.9	14.0	3.9	38.7	1.7	19.4	2.9	3.9	4.4	0.0	22.2	50.7	5.1	13.3	2.3	3.9	11.3	1.6	14.3	4.3	12.7	1.0	3.1	12.2	8.5	21.6	5.6	20.3	18.6	6.8	4.2	5.7	5.4	6.5	3.8	4.7	4.1	10.2	189.5	1.8	4.7	14.5
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 489.8;Muller glia cells: 1823.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"BJ: 60.1;BJ hTERT+: 93.0;fHDF/TERT166: 87.0;hTERT-RPE1: 54.3;TIME: 49.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.1	93.0	26.6	30.3	1.3	0.4	0.0	6.6	87.0	14.2	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	17.0	0.0	0.0	6.7	8.7	9.0	22.3	54.3	28.2	0.0	0.0	0.0	36.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	9.2	0.0	0.0	7.8	0.2	0.0	0.0	7.3	0.0	0.0	49.9	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5	3.0	4.8	0.0	55.5	40.5	22.0	489.8	0.0	4.0	20.5	0.0	11.8	0.4	0.0	0.6	98.7	37.6	0.0	0.0	0.2	0.6	30.9	9.6	1.1	0.0	15.3	12.7	1.7	47.3	1.0	66.1	19.0	2.3	60.8	0.0	0.0	1823.0	1.0	0.0	54.1	0.0	52.9	187.5	74.5	0.5	1.3	12.9	0.7	4.9	0.1	2.6
DMPK	"DM, DM1, DM1PK, DMK, MDPK, MT-PK"	ENSG00000104936	"DM1 protein kinase"	Q09013	19	45769717-45782552	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.6"	"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RH-30: 44.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007164, HPA008905"	Enhanced		Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA007164: AB_1078687, HPA008905: AB_1078685"	"unprognostic (7.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.29e-1)"	"unprognostic (5.46e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (9.39e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.24e-3)"	9.0	18.7	5.1	9.7	6.3	1.7	4.9	8.8	6.2	16.5	23.4	4.4	15.6	8.7	21.2	15.0	31.2	13.7	20.3	56.7	5.0	5.3	4.9	2.2	6.5	4.1	4.8	6.5	8.4	33.3	3.1	10.7	6.8	5.6	16.3	3.8	22.0	6.1	19.7	79.6	5.1	11.3	65.1	4.2	5.3	12.0	5.9	4.0	1.1	6.1	36.6	5.0	44.9	8.2	1.5	0.0	0.0	0.8	0.3	2.2	0.0	7.2	10.2	12.1	7.5	8.2	11.5	7.3	16.4	12.1	6.6	6.4	1.2	3.9	2.3	2.5	18.7	5.3	10.7	3.5	1.6	2.5	11.4	10.7	0.9	12.7	1.7	8.0	0.1	4.1	16.6	5.7	5.7	2.8	16.3	3.0	1.2	7.2	5.9	9.5	8.1	1.1	2.8	7.2	3.2	2.2	3.7	44.7	3.8	3.5	8.4	6.5	10.5	8.9	18.8	5.3	6.9	15.4	3.6	9.2	7.7	7.6	7.2	12.0	11.4	9.7	2.3	7.0	1.0	10.7	0.0	0.0	0.0	2.2	0.8	0.5	0.3	0.7	0.2	0.0	1.5	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	5.1	6.3	8.8	6.2	5.0	5.3	4.8	6.5	5.6	4.0	0.0	2.1	0.9	7.0	7.1	4.9	3.1	2.5	0.0	2.3	3.5	7.9	2.3	1.7	2.4	1.4	6.0	3.6	0.0	15.0	1.5	12.7	3.3	0.0	0.9	0.7	4.8	9.7	10.4	1.2	1.4	6.6	0.5	6.8	0.0	5.5	2.2	5.0	3.5	21.9	22.0	7.6	58.2	23.7	6.3	6.0	5.9	1.4	5.0	3.6	3.7
DNAJC13	"KIAA0678, RME8"	ENSG00000138246	"DnaJ heat shock protein family (Hsp40) member C13"	O75165	3	132417526-132539032	"Predicted membrane proteins"	"Protein transport, Transport"	Chaperone	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036923, HPA036924"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA036923: AB_10672480, HPA036924: AB_2675386"	"unprognostic (3.35e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (3.68e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (8.36e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.81e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.22e-1)"	23.3	17.8	20.4	15.1	14.4	20.5	16.2	18.0	19.9	20.8	23.1	8.1	23.3	14.5	25.0	18.7	22.3	16.8	13.1	20.5	19.9	11.0	23.6	12.1	17.7	14.9	11.5	17.8	20.1	12.2	21.1	12.3	22.9	17.3	17.8	18.8	10.2	16.1	24.6	20.0	13.7	20.1	26.3	12.5	19.4	16.0	10.3	16.4	13.0	20.6	13.8	13.6	24.5	32.4	2.2	5.7	3.4	7.0	1.7	2.1	1.6	14.8	8.5	11.7	5.9	27.2	24.2	7.1	16.2	30.3	15.7	17.4	9.5	9.5	7.8	10.3	21.9	21.1	12.2	10.8	11.7	22.0	8.9	3.0	9.6	8.6	6.3	14.4	9.6	9.5	17.6	8.6	14.2	17.7	12.0	22.0	12.8	5.4	13.0	22.2	11.4	7.9	4.6	6.8	12.9	7.7	7.7	8.3	6.2	14.2	15.7	4.2	6.9	15.4	8.1	17.5	10.4	12.7	9.1	20.4	17.8	9.2	17.3	6.9	7.4	7.2	10.6	18.6	6.8	13.0	3.4	5.2	0.7	1.9	4.3	1.8	2.2	2.0	1.7	5.7	1.4	1.5	2.1	1.2	1.7	7.0	2.7	1.1	1.6	20.4	14.4	18.0	19.9	19.9	11.0	11.5	17.8	17.3	16.4	11.9	18.7	7.5	6.2	6.0	10.4	41.1	10.2	14.7	11.4	12.2	31.4	6.7	1.7	7.9	1.3	15.5	16.5	0.0	7.9	6.5	10.3	11.3	11.5	7.8	17.4	63.5	13.8	16.5	39.6	1.9	14.1	18.3	27.0	9.0	13.3	13.4	10.9	11.5	20.1	15.8	11.0	6.5	10.3	3.4	12.3	6.6	4.2	6.1	12.1	10.5
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Actin-binding, Endonuclease, Hydrolase, Nuclease"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 26.7"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	Vesicles		"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.14e-4)"	1.5	1.4	1.5	2.6	1.6	1.7	1.5	3.8	2.5	2.2	12.2	1.8	1.5	14.9	1.5	2.2	3.4	1.2	2.5	1.5	1.5	1.2	11.4	1.5	1.5	4.4	1.5	1.5	2.0	13.7	1.6	12.2	1.9	3.1	5.1	2.1	1.5	3.3	1.5	1.5	3.9	26.7	1.5	1.5	2.3	6.0	2.7	1.5	1.5	1.6	2.6	3.8	1.9	2.3	4.5	2.2	9.2	2.0	1.9	3.4	1.0	2.5	5.8	10.2	5.3	3.0	2.6	4.8	4.0	0.7	3.3	4.8	6.9	6.1	10.7	3.3	0.6	7.0	4.2	3.6	1.1	3.5	4.6	5.6	3.7	8.6	4.5	1.5	2.6	8.7	2.1	4.3	4.4	1.1	5.2	2.2	9.0	9.3	4.7	2.8	10.4	5.3	11.5	6.2	7.4	3.1	12.6	4.6	5.2	2.8	2.2	7.2	6.7	3.0	9.2	1.7	5.3	9.1	6.6	3.0	6.1	4.5	3.8	2.3	4.3	6.1	18.5	1.7	4.9	5.8	4.3	2.0	5.3	3.0	1.3	1.9	2.5	2.3	2.4	1.0	4.5	2.7	3.4	9.2	1.9	1.2	2.2	2.4	1.0	1.5	1.6	3.8	2.5	1.5	1.2	1.5	1.5	3.1	1.5	8.9	10.1	2.4	8.5	2.4	27.4	4.8	5.1	9.4	11.4	15.7	21.6	6.6	48.0	4.5	16.1	4.5	12.7	0.0	9.7	3.3	5.1	9.8	2.3	1.5	3.2	23.8	13.7	4.9	2.7	34.9	7.8	3.8	1.7	11.8	11.3	12.8	4.3	11.2	7.4	1.4	18.3	0.0	4.2	15.1	17.5	3.3	5.1	10.5	15.3	5.3
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	21.3	21.4	22.4	23.0	18.2	18.6	43.4	24.1	18.5	22.8	21.1	29.9	16.4	28.8	16.9	21.7	23.3	19.3	23.6	27.7	27.4	15.2	19.2	32.8	20.6	16.5	15.0	23.2	17.3	16.8	14.1	24.0	24.8	21.9	27.5	15.0	23.6	12.5	26.0	8.3	9.2	19.5	47.3	13.6	10.5	15.7	42.2	19.7	19.2	29.5	19.6	20.1	25.6	17.6	18.7	52.0	20.2	15.9	24.8	19.4	19.6	45.5	22.3	8.8	23.7	30.0	18.9	15.6	14.7	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9	35.7	38.5	29.4	27.6	26.7	71.7	69.9	20.4	26.8	40.9	24.4	123.7	25.6	26.6	27.7	51.2	34.9	15.4	0.0	21.8	50.9	25.9	26.7	49.7	14.8	27.0	119.2	29.3	25.2	33.3	58.7	24.7	32.4	13.5	44.1	18.9	66.0	35.1	14.0	28.7	19.5	150.0	19.4	37.0	66.2	50.8	24.1	30.1	27.7	23.8	31.5
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427355-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 229.6;Late spermatids: 321.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 56.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	15.6	11.5	13.9	12.2	20.0	55.7	11.4	18.1	19.1	9.8	11.7	13.3	11.5	12.7	10.1	9.9	13.1	9.4	12.9	7.6	14.3	18.1	13.7	22.2	12.0	12.4	14.7	13.0	8.0	11.8	13.0	17.6	18.9	18.6	12.7	12.4	9.6	9.5	15.4	8.6	15.9	12.5	10.4	13.7	15.1	13.7	9.7	10.1	14.0	13.0	9.1	12.9	11.9	9.0	5.1	9.9	7.1	7.4	8.1	15.4	4.3	4.0	6.6	7.0	7.1	4.1	3.5	56.2	5.9	4.2	6.8	6.7	9.0	4.5	11.3	3.8	4.3	4.5	3.4	9.0	5.2	7.9	9.2	6.5	9.7	6.0	8.1	9.2	9.1	7.9	4.6	9.3	9.9	6.7	5.2	6.8	9.3	10.3	8.3	5.6	8.3	9.0	5.1	12.4	7.6	6.8	8.3	5.8	6.2	5.9	7.1	7.2	12.6	7.2	6.8	6.9	9.4	10.1	7.3	6.6	7.2	5.3	6.3	8.5	11.0	22.1	11.9	7.0	10.9	8.5	7.1	7.4	4.5	12.0	5.4	15.4	5.1	10.1	9.3	4.3	3.8	6.0	9.8	6.7	8.1	6.5	9.9	10.5	4.3	13.9	20.0	18.1	19.1	14.3	18.1	14.7	13.0	18.6	10.1	8.9	12.9	2.9	7.7	41.7	6.8	4.5	7.6	6.7	10.3	12.2	5.9	7.2	8.3	7.8	229.6	11.7	13.6	0.0	7.0	11.7	16.0	15.1	10.3	27.0	14.1	20.6	33.0	11.6	21.8	321.2	10.6	14.6	21.9	5.4	11.2	4.8	11.8	10.5	11.3	18.9	6.0	25.8	11.3	18.6	11.5	47.4	30.0	20.4	10.9	14.5
EEA1	ZFYVE2	ENSG00000102189	"Early endosome antigen 1"	Q15075	12	92770637-92929331	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 173.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005861, CAB018782, HPA038158, HPA038159"	Supported		Supported	Vesicles		NA	NA			Vesicles		"CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356"	"unprognostic (5.38e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.75e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.65e-1)"	26.4	11.1	10.9	14.9	13.5	5.3	13.7	20.5	12.4	18.4	12.2	7.7	8.3	10.2	14.4	9.5	20.9	11.0	11.4	13.4	12.0	9.8	10.6	14.7	12.9	8.0	12.5	11.8	17.6	9.3	16.9	14.3	23.6	16.7	14.2	11.0	7.3	13.7	12.3	23.1	16.7	10.3	15.7	14.3	15.3	10.7	7.8	12.5	6.9	12.6	15.2	8.2	19.2	17.9	2.2	2.0	2.2	3.3	0.7	3.4	0.9	9.0	3.0	4.5	3.2	19.4	19.6	10.4	17.8	10.3	9.5	6.7	10.4	2.4	9.2	3.3	12.5	13.5	11.0	10.0	5.0	14.7	6.2	4.9	9.8	3.5	9.5	10.8	6.9	4.6	12.7	7.4	10.1	15.3	10.6	16.6	2.6	7.3	3.1	9.8	4.1	5.0	4.7	4.5	3.6	6.8	5.6	11.5	6.2	4.9	12.4	3.8	2.9	13.0	8.6	7.9	6.5	11.4	6.2	21.2	13.4	5.1	10.6	6.8	3.5	5.9	6.4	4.9	6.2	7.2	0.1	2.5	0.7	1.7	1.8	1.8	2.2	2.0	1.8	2.0	2.0	3.4	2.4	2.2	0.7	3.3	2.0	0.7	0.9	10.9	13.5	20.5	12.4	12.0	9.8	12.5	11.8	16.7	12.5	92.3	47.3	15.2	33.3	33.7	48.6	77.2	12.7	24.1	33.0	24.4	35.3	52.4	36.5	50.3	10.8	44.9	26.8	0.0	30.1	43.2	56.1	38.3	31.3	32.1	32.0	173.2	16.1	25.2	34.6	5.9	57.2	41.1	45.5	36.9	22.8	50.8	33.3	34.5	64.0	25.1	70.2	45.3	42.2	91.9	7.9	44.0	95.0	20.2	27.0	48.2
EIF2B3	"EIF-2B, EIF2Bgamma"	ENSG00000070785	"Eukaryotic translation initiation factor 2B subunit gamma"	Q9NR50	1	44850522-44986722	"Disease related genes, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024213, HPA024218, HPA024219"	Supported		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069"	"unprognostic (2.12e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.45e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.98e-2)"	"unprognostic (7.80e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.73e-2)"	16.5	18.3	12.9	9.2	14.6	7.1	16.1	22.2	16.5	11.6	10.1	13.1	11.2	6.6	13.1	10.1	11.8	9.6	7.5	22.5	10.7	11.1	11.9	20.7	8.8	9.9	13.7	11.1	12.3	18.5	23.3	26.7	7.3	16.0	10.6	10.6	12.3	17.9	11.9	52.1	10.5	6.6	14.8	12.1	9.8	9.1	13.7	12.3	11.1	9.8	13.7	12.4	12.2	10.9	11.3	21.9	2.3	21.4	14.1	15.4	12.5	14.0	11.5	12.7	10.8	15.6	18.7	15.2	22.8	17.4	23.4	22.2	16.6	8.4	36.8	16.8	17.1	18.7	8.3	26.8	19.3	28.7	12.7	24.6	18.2	12.7	15.9	19.8	27.9	10.4	12.9	10.5	25.6	29.2	11.1	21.5	12.3	41.8	12.8	25.3	9.7	26.8	12.2	17.7	16.0	22.9	21.7	21.3	26.2	12.0	6.6	23.0	8.4	23.0	26.5	14.5	17.5	10.3	13.0	11.5	15.2	18.2	22.3	29.5	13.3	15.0	27.5	11.8	23.5	18.1	1.0	14.3	2.3	12.2	21.4	14.4	9.5	12.0	13.5	21.9	11.3	15.2	15.4	1.2	14.1	18.5	15.4	9.9	12.5	12.9	14.6	22.2	16.5	10.7	11.1	13.7	11.1	16.0	12.3	6.0	19.5	8.2	17.8	12.2	13.2	75.1	12.7	46.8	21.6	5.2	19.6	21.5	24.9	16.9	18.8	15.6	5.1	0.0	13.7	17.9	16.5	14.5	24.4	19.1	22.1	20.6	3.5	3.7	11.6	7.7	24.5	15.7	16.9	41.5	6.1	17.0	12.9	5.8	23.7	17.7	20.5	25.8	39.1	38.7	23.0	13.0	12.5	10.0	7.9	13.1
EIF5A2		ENSG00000163577	"Eukaryotic translation initiation factor 5A2"	Q9GZV4	3	170888415-170908693	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 309.4;Late spermatids: 705.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029090	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA029090: AB_10671359"	"unprognostic (2.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.05e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (1.11e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.29e-3)"	5.6	3.9	3.6	4.1	8.4	4.9	4.2	1.9	14.4	4.4	4.6	4.3	2.0	2.5	6.2	2.0	4.1	3.6	4.9	5.4	4.3	5.8	6.8	3.4	3.2	3.6	6.7	6.2	6.4	4.5	2.2	5.2	2.5	21.6	4.8	3.8	3.4	2.7	4.2	1.9	3.0	2.6	9.6	5.1	3.0	11.0	31.2	2.5	6.1	3.1	2.6	4.2	6.3	6.2	2.6	0.9	10.2	1.3	6.9	11.2	4.3	11.6	6.1	2.2	3.1	12.0	7.9	5.3	8.8	11.5	9.4	13.2	12.4	7.7	7.4	16.6	12.3	21.1	3.9	7.1	3.2	12.0	8.1	3.1	3.4	2.5	3.9	8.1	9.1	10.7	8.6	4.7	14.1	11.7	13.1	4.6	1.9	2.8	0.0	15.3	3.7	4.1	4.1	4.2	9.1	3.9	0.0	6.5	0.0	3.9	2.1	1.8	3.4	9.4	2.4	7.4	3.7	5.4	6.2	6.4	11.6	8.2	23.8	20.2	11.6	0.1	16.8	3.9	3.2	8.2	10.2	1.2	1.2	11.2	1.3	7.7	2.0	7.7	10.6	0.9	2.6	4.6	7.6	0.6	6.9	1.2	0.8	9.2	4.3	3.6	8.4	1.9	14.4	4.3	5.8	6.7	6.2	21.6	2.5	0.0	0.3	3.2	5.2	15.1	2.8	8.1	0.0	4.0	1.2	1.8	0.0	0.8	1.7	6.4	309.4	7.1	1.0	0.0	6.6	1.7	11.3	4.4	2.3	2.4	7.4	0.0	4.7	2.5	4.1	705.4	11.8	4.9	10.1	11.8	1.1	7.5	12.5	4.2	10.6	18.0	2.6	45.3	14.5	25.1	9.3	18.9	0.6	16.6	1.6	5.0
EPN2	"EHB21, KIAA1065"	ENSG00000072134	"Epsin 2"	O95208	17	19215615-19336715	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 19.9"	"Cell line enhanced"	"Detected in many"		"SuSa: 53.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049809, HPA053360"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049809: AB_2680893, HPA053360: AB_2682126"	"unprognostic (1.38e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (8.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (9.13e-5)"	"unprognostic (1.32e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (8.15e-5)"	6.5	5.1	16.3	6.2	11.8	3.4	4.4	9.9	34.8	7.0	5.2	4.3	3.6	2.9	9.9	7.0	13.9	7.7	4.8	10.7	16.7	10.5	4.5	3.6	6.1	3.6	14.9	13.1	7.2	4.3	8.4	3.6	7.7	8.5	7.3	3.0	5.6	5.0	9.2	9.8	18.4	3.6	8.7	14.7	4.5	3.2	6.7	10.6	3.6	4.4	8.1	3.6	5.4	6.9	2.9	0.7	19.9	1.1	0.6	1.5	0.4	11.8	11.9	17.4	7.6	9.2	14.8	13.7	11.4	7.4	7.1	6.2	7.7	3.6	1.8	11.2	11.3	6.6	11.2	7.7	8.5	8.7	8.8	8.6	1.2	7.5	3.8	9.6	0.5	5.2	8.3	7.7	11.2	9.1	9.4	15.1	2.6	3.3	1.6	6.2	8.6	0.5	0.8	4.5	15.8	7.8	2.7	7.4	3.1	8.3	3.3	5.1	11.6	8.1	5.4	5.9	53.3	8.2	1.5	13.8	7.9	9.1	12.3	4.9	2.6	1.6	1.5	21.5	0.2	12.1	7.1	1.1	19.9	1.5	0.7	1.0	2.3	1.1	1.2	0.5	2.9	1.3	1.2	7.3	0.6	0.8	0.7	0.9	0.4	16.3	11.8	9.9	34.8	16.7	10.5	14.9	13.1	8.5	10.6	50.6	24.8	8.0	24.9	21.4	65.7	28.8	28.1	48.2	27.3	36.6	45.2	23.3	23.2	18.4	30.4	27.0	5.3	0.0	7.3	34.8	19.7	26.8	13.9	7.3	7.0	33.4	5.8	14.7	4.7	54.7	43.1	5.7	5.0	1.0	14.8	42.7	16.8	14.0	37.1	7.8	80.3	25.8	29.9	37.7	38.9	42.8	18.3	5.0	8.3	28.7
EPN3	"FLJ20778, MGC129899"	ENSG00000049283	"Epsin 3"	Q9H201	17	50532543-50543750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 17.4;Cytotrophoblasts: 52.4;Mucus-secreting cells: 17.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 6.8;pons and medulla: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.0;HBEC3-KT: 16.6;MCF7: 26.7;OE19: 25.1;RT4: 20.9;SK-BR-3: 10.8;T-47d: 24.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebellum: 4.7;midbrain: 7.9;pons and medulla: 7.5;thalamus: 10.2"	"HPA055546, HPA063224"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA055546: AB_2682844, HPA063224: AB_2684964"	"unprognostic (1.91e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.70e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (1.53e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (3.52e-3)"	0.4	7.7	0.5	1.9	0.7	0.4	1.9	1.1	6.8	5.3	7.8	1.5	24.0	5.1	0.7	3.8	26.2	6.0	12.6	6.6	0.5	0.7	10.9	0.4	0.7	0.0	2.0	1.4	10.3	18.3	9.6	0.9	8.4	17.8	9.3	3.4	0.3	16.7	18.7	0.4	19.7	5.1	0.5	0.6	0.3	23.8	2.2	0.0	3.4	1.2	15.9	21.9	8.2	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	6.1	5.2	0.0	0.1	0.0	0.0	12.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	9.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.1	0.0	0.0	25.1	0.2	0.0	0.0	0.0	0.1	20.9	0.2	0.0	0.0	10.8	0.0	0.1	24.1	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.1	6.8	0.5	0.7	2.0	1.4	17.8	0.0	0.0	0.0	0.0	3.4	2.1	0.3	4.8	7.6	0.0	0.0	17.4	0.0	52.4	5.0	5.6	0.4	0.1	9.3	0.0	10.0	5.6	0.3	4.4	0.0	0.0	5.1	0.0	3.5	0.0	0.0	1.8	2.6	0.0	0.0	1.0	17.7	0.5	5.2	10.5	0.0	0.0	0.3	0.0	0.3	0.0	0.4	4.8	8.9	0.0	16.6	5.8
ERC1	"CAST2, ELKS, KIAA1081, MGC12974, RAB6IP2"	ENSG00000082805	"ELKS/RAB6-interacting/CAST family member 1"	Q8IUD2	12	990509-1495933	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 174.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019513, HPA019523, HPA024130"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA019513: AB_1856012, HPA019523: AB_1856013, HPA024130: AB_1856014"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.37e-2)"	"prognostic unfavorable (7.01e-4)"	12.6	11.4	10.3	12.5	14.7	7.4	15.1	41.7	10.4	11.2	11.9	8.5	9.2	4.3	17.1	11.0	13.7	9.8	9.9	14.7	10.0	11.2	11.2	8.0	8.8	5.4	9.0	6.4	12.5	8.6	24.3	19.4	13.2	10.7	11.4	7.5	10.1	9.3	14.4	9.2	9.9	6.4	22.1	8.5	7.3	8.6	11.0	9.9	9.8	15.3	7.2	8.6	15.7	15.3	8.6	2.9	2.1	3.8	1.1	3.5	0.5	2.9	7.3	3.9	2.6	10.4	8.8	5.4	9.2	7.4	6.3	5.8	6.4	3.6	4.5	1.3	11.9	6.3	4.9	8.3	7.1	8.8	9.5	4.2	11.1	7.3	3.2	7.9	5.7	2.6	7.1	6.2	11.1	20.8	7.6	8.1	2.9	3.3	8.9	4.7	3.2	1.8	1.2	6.2	2.8	3.5	3.6	14.8	1.4	6.2	5.3	2.3	4.6	14.4	3.3	5.2	14.7	3.4	2.4	15.0	10.9	11.1	8.0	8.6	2.4	4.5	6.7	7.1	3.4	4.8	1.4	2.8	2.1	1.6	1.0	2.2	8.6	2.4	2.4	2.4	5.6	3.5	2.6	2.1	1.1	3.8	2.9	2.2	0.5	10.3	14.7	41.7	10.4	10.0	11.2	9.0	6.4	10.7	9.9	23.8	21.4	15.2	22.2	18.7	34.0	51.9	15.3	14.7	23.9	19.2	45.2	25.8	1.7	17.5	29.4	26.3	7.0	0.0	11.7	14.8	17.3	21.4	13.9	15.3	10.8	174.8	28.8	24.5	10.7	24.2	23.0	11.3	13.5	16.2	8.4	47.3	15.2	9.0	29.0	3.3	34.7	19.4	16.5	15.6	28.4	24.0	65.8	7.4	7.6	29.2
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 351.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli rim,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	"Nucleoli rim"	"HPA049695: AB_2680855"	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavorable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favorable (8.18e-4)"	"prognostic unfavorable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	26.6	21.0	24.4	21.9	32.8	5.5	29.9	28.1	36.1	25.4	22.7	14.6	25.8	21.2	23.1	33.1	32.5	16.6	21.2	33.7	25.3	22.6	27.7	36.2	18.6	18.9	29.8	24.2	24.9	32.6	27.3	40.1	40.9	31.2	29.5	21.4	12.1	28.8	23.8	29.2	15.6	24.3	31.4	31.0	25.6	21.1	32.8	30.7	25.7	28.6	21.6	25.8	33.4	20.6	27.0	39.0	59.2	30.1	22.1	40.8	27.5	24.5	22.5	18.5	12.4	26.8	31.5	45.1	40.0	33.7	25.1	27.1	29.7	41.4	13.5	39.8	31.7	45.3	25.7	17.6	26.4	40.1	28.9	18.9	22.0	32.3	17.2	15.7	30.5	18.6	22.2	21.3	31.6	32.0	46.6	19.4	18.5	17.9	38.5	33.3	13.2	15.2	33.1	26.1	26.1	63.8	14.1	51.0	27.4	21.2	35.9	7.1	11.6	20.3	23.1	23.6	41.1	44.7	25.1	21.4	34.1	29.1	45.1	43.0	28.3	35.8	27.0	28.5	22.9	27.6	24.2	17.0	22.1	29.7	25.3	35.8	27.0	38.1	34.8	17.8	22.3	38.4	32.3	59.2	22.1	30.1	39.0	40.8	27.5	24.4	32.8	28.1	36.1	25.3	22.6	29.8	24.2	31.2	30.7	26.8	22.9	45.6	61.3	51.4	54.1	50.9	35.7	38.8	36.4	50.6	51.1	98.6	41.4	61.1	351.1	42.1	17.7	46.7	54.6	97.9	61.2	75.0	54.3	44.3	50.6	46.1	40.1	33.7	17.2	29.1	48.6	35.9	59.1	46.9	30.8	66.0	56.1	21.0	56.3	38.6	50.8	32.3	70.7	51.7	35.3	58.1	130.7	44.8	32.4	68.7
ESPL1	"ESP1, KIAA0165, SEPA"	ENSG00000135476	"Extra spindle pole bodies like 1, separase"	Q14674	12	53268299-53293643	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Chromosome partition"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.9;lymphoid tissue: 30.3"	"Cell type enhanced"	"Detected in some"	6	"Enterocytes: 4.1;Hepatocytes: 4.9;Proximal tubular cells: 5.6;Spermatocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB012185, HPA073188"	Approved		Supported	Nucleoplasm,Vesicles		NA	Yes			Nucleoplasm	Vesicles	"CAB012185: AB_304056, HPA073188: "	"unprognostic (1.57e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (5.32e-5)"	"unprognostic (2.91e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.01e-5)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.42e-13)"	"prognostic favorable (7.10e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.42e-1)"	0.7	0.4	0.2	7.1	0.4	7.2	0.3	0.2	0.5	3.9	2.3	0.4	0.8	4.2	0.6	0.7	17.9	0.2	0.5	1.0	1.1	0.1	1.0	0.9	0.7	4.1	0.2	0.2	0.3	0.2	0.0	0.2	3.0	0.6	0.4	1.5	0.6	2.6	0.2	0.2	2.7	4.4	0.5	0.2	3.0	0.8	10.9	0.3	30.3	0.3	2.5	7.8	0.7	6.2	0.0	0.0	0.4	0.1	0.0	1.8	0.0	12.6	12.9	13.8	11.3	0.3	1.2	8.5	8.3	4.2	14.3	9.1	7.0	11.1	22.8	4.6	3.4	8.4	10.5	16.0	4.9	7.5	7.1	16.2	15.3	11.7	5.3	0.0	9.6	12.7	0.4	0.3	8.3	4.1	1.4	7.3	11.3	20.5	20.6	4.2	13.1	15.0	8.2	11.2	7.5	7.0	14.1	14.8	9.5	2.0	5.3	10.0	7.7	7.0	10.3	5.4	6.8	17.0	6.4	3.3	7.2	14.0	6.0	11.4	15.3	14.2	15.4	4.1	9.1	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.8	0.0	0.2	0.4	0.2	0.5	1.1	0.1	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.2	0.6	0.4	4.1	0.0	0.0	1.9	1.0	0.3	0.0	4.9	2.1	0.0	3.4	1.3	0.6	1.1	0.0	1.3	0.0	0.0	1.2	0.0	1.0	0.2	0.4	5.6	0.0	0.0	0.4	6.5	2.7	0.5	0.2	0.0	3.1	0.5
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.2;U-138 MG: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.4	9.9	0.1	0.4	0.0	2.0	27.2	17.8	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.4	0.7	0.0	0.0	5.0	2.7	23.9	11.0	19.5	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	0.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.6	0.7	0.0	0.1	9.8	36.5	15.3	0.6	22.6	0.2	0.0	0.0	20.7	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3	38.7	30.7	2.7	9.2	2.5	0.8	0.2	0.0	1.4	36.4	10.4	0.0	33.7	23.2	27.0	11.0	1.3	0.0	0.0	14.2	17.5	2.1	5.2	0.0	71.0	3.2	0.0	1.7	3.7	0.6	8.2	0.3	0.8	27.0	0.0	0.0	0.0	15.1	0.0	0.7	53.7	0.0	0.0	1.0	1.7	0.4	0.6	104.4	0.0	0.0	10.0
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92834713-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Rod photoreceptor cells: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	9.7	19.4	15.3	8.5	16.9	11.6	9.4	18.9	16.2	7.4	9.6	4.5	5.1	8.3	7.3	7.5	4.9	6.3	10.3	7.0	15.5	8.6	7.0	10.8	12.0	16.7	6.1	12.8	5.4	12.5	8.2	17.8	34.6	8.1	9.4	10.8	3.5	7.2	5.0	29.3	6.2	9.8	12.8	6.7	12.6	7.6	10.0	8.1	13.5	29.1	10.2	8.2	9.5	8.2	4.9	7.6	21.2	3.4	1.8	2.5	1.7	8.5	10.7	11.4	7.5	0.6	0.7	4.1	3.9	10.9	3.6	4.4	4.0	7.3	9.7	8.3	1.9	2.9	5.4	9.2	2.5	4.6	8.6	9.3	14.1	3.8	5.0	4.4	15.2	12.6	1.0	1.3	3.2	2.2	6.6	46.7	6.4	11.9	6.5	1.7	4.6	6.4	9.9	1.5	17.4	3.1	9.7	4.9	5.0	7.8	5.8	3.8	5.4	4.1	4.1	5.1	3.0	8.1	8.0	9.5	0.2	3.7	3.4	6.4	4.9	5.2	7.9	1.2	17.2	4.0	3.7	3.4	10.1	2.2	2.7	2.2	4.7	2.5	2.1	3.4	4.9	2.1	2.4	21.2	1.8	2.6	7.6	2.3	1.7	15.3	16.9	18.9	16.2	15.5	8.6	6.1	12.8	8.1	8.1	14.9	14.7	15.9	8.5	3.0	36.3	10.8	22.9	12.0	13.6	15.7	37.3	18.0	5.0	22.6	4.1	34.6	10.2	70.0	13.2	6.2	3.6	13.6	10.4	13.4	17.9	22.3	24.5	55.9	20.6	10.9	4.0	14.9	5.0	4.6	14.7	20.2	13.2	8.5	13.8	7.1	133.9	12.9	3.3	15.7	22.4	4.3	17.2	12.8	10.0	15.7
FAM192A	"C16orf94, NIP30"	ENSG00000172775	"Family with sequence similarity 192 member A"	Q9GZU8	16	57152466-57186116	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 195.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054382, HPA059652"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA054382: AB_2682469, HPA059652: AB_2684095"	"unprognostic (1.69e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.20e-3)"	"unprognostic (4.69e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.19e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-3)"	21.2	23.1	39.3	31.3	42.5	60.4	31.0	38.0	45.6	22.4	33.4	41.8	19.1	30.3	25.2	31.0	28.0	25.4	21.9	25.8	37.2	36.3	26.9	27.0	25.3	39.6	44.8	32.5	26.1	33.9	52.1	31.1	28.4	36.7	28.1	41.1	24.7	24.8	24.6	31.8	40.7	32.4	25.4	40.8	42.0	27.5	41.4	40.0	47.2	33.2	21.9	42.6	23.1	23.9	26.6	30.4	48.5	38.1	17.9	22.2	20.8	31.4	40.3	45.0	30.2	19.8	24.5	42.4	37.2	27.9	46.1	29.9	38.1	33.4	47.7	41.9	28.4	23.4	42.3	31.2	37.3	46.8	21.2	25.1	33.2	36.1	39.4	28.6	40.6	47.4	24.5	37.3	43.7	35.5	28.3	32.9	36.4	44.4	15.4	30.3	23.4	44.2	37.9	29.0	23.5	30.4	54.4	65.6	46.2	31.1	26.0	32.4	37.2	68.0	29.0	25.0	32.8	24.0	28.2	32.5	34.2	28.7	24.9	27.7	37.0	28.9	61.3	35.0	29.5	32.6	48.5	26.6	40.1	17.3	30.6	16.8	26.6	16.7	16.0	30.4	23.9	17.4	18.0	36.8	17.9	38.1	21.0	22.2	20.8	39.3	42.5	38.0	45.6	37.2	36.3	44.8	32.5	36.7	40.0	50.6	43.5	36.6	26.3	15.5	24.2	69.4	25.5	62.9	44.3	33.2	11.8	50.4	131.0	53.3	180.9	38.6	42.8	0.0	51.0	50.0	31.3	28.4	54.4	28.0	56.7	35.0	27.6	31.9	55.1	195.2	31.4	62.2	40.5	77.5	31.3	41.0	53.0	34.5	23.3	51.5	20.1	38.8	24.7	107.5	36.5	19.2	44.4	26.2	29.8	26.9
FAM198A	"C3orf41, DKFZP434B172"	ENSG00000144649	"Family with sequence similarity 198 member A"	Q9UFP1	3	42979267-43060211	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Hepatocytes: 11.9;Leydig cells: 9.2;Muller glia cells: 17.2;Peritubular cells: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.9;RPMI-8226: 6.2;SK-BR-3: 4.2;T-47d: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047726	Approved		Supported	Vesicles	"Secreted - unknown location"	NA	NA		440000	Vesicles		"HPA047726: AB_10960554"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.93e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.57e-4)"	"unprognostic (4.45e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.81e-1)"	8.9	3.5	6.2	3.7	8.3	0.1	5.4	4.1	6.8	10.8	3.5	6.1	2.4	1.3	11.7	9.4	4.0	13.8	13.0	2.0	7.2	2.6	1.3	12.1	3.8	1.1	5.1	5.5	9.4	3.0	0.3	2.6	3.2	11.2	2.7	1.8	4.0	4.1	3.8	1.4	1.8	2.5	9.2	5.2	1.2	4.3	3.1	6.8	0.0	2.0	1.1	0.6	3.8	4.2	0.0	1.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	5.9	0.2	0.0	1.7	0.3	0.6	0.0	0.0	0.2	1.8	0.0	1.8	0.0	2.8	0.0	0.7	0.0	0.0	0.0	2.5	0.9	0.0	0.0	1.3	0.5	2.1	1.2	0.0	0.6	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	3.4	0.0	0.0	0.0	0.0	6.2	0.0	0.8	0.1	0.4	0.0	4.2	0.0	0.3	11.9	1.4	0.0	0.8	1.2	2.4	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	0.0	6.2	8.3	4.1	6.8	7.2	2.6	5.1	5.5	11.2	6.8	0.0	0.0	0.0	0.1	0.1	1.2	0.6	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.1	0.6	0.3	0.0	0.0	0.2	1.9	3.1	0.2	0.0	11.9	3.1	3.2	0.0	1.8	0.3	0.0	9.2	0.0	0.0	1.0	0.0	17.2	0.3	0.0	18.7	0.3	1.6	6.5	1.4	0.9	0.9	0.5	2.3	0.0	0.0	0.0
FBXW7	"AGO, CDC4, FBW7, FBX30, FBXW6, FLJ11071, SEL-10, SEL10"	ENSG00000109670	"F-box and WD repeat domain containing 7"	Q969H0	4	152320544-152536063	"Cancer-related genes, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 60.1;skin 1: 45.0"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 179.3;Suprabasal keratinocytes: 152.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 38.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013793, CAB029987"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB013793: AB_2533451, CAB029987: AB_2246842"	"unprognostic (3.32e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.29e-1)"	"unprognostic (5.32e-3)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.17e-3)"	9.2	6.8	27.0	8.9	27.9	11.1	9.8	27.2	60.1	5.5	6.1	3.6	3.8	4.9	6.0	18.3	9.8	10.6	6.3	10.9	21.4	10.1	4.1	7.3	6.9	9.8	9.1	40.5	6.4	8.0	6.4	7.3	6.2	37.2	5.1	6.9	2.8	7.6	5.3	15.8	45.0	6.5	6.1	6.4	10.1	8.0	13.7	5.7	6.5	6.8	10.6	12.3	7.9	6.5	2.9	2.2	16.6	3.4	7.8	5.0	1.3	4.9	4.0	10.3	7.5	7.2	5.2	8.6	7.2	6.6	4.5	4.2	8.0	6.4	12.9	2.0	6.9	3.4	3.0	8.9	16.2	6.3	7.3	4.2	6.0	4.9	5.7	7.3	14.6	5.5	8.2	25.8	7.7	13.1	4.7	7.8	10.5	9.4	13.8	5.6	7.0	16.8	5.8	5.0	4.2	3.2	16.9	4.4	2.5	5.5	8.6	6.6	5.7	4.6	6.3	3.9	12.2	3.4	6.9	8.2	6.1	6.9	3.1	4.0	38.0	21.7	12.6	4.9	4.8	4.3	16.6	3.1	1.7	5.0	3.4	3.3	2.9	3.7	3.2	1.8	2.4	3.9	3.2	5.5	7.8	2.5	2.2	3.3	1.3	27.0	27.9	27.2	60.1	21.4	10.1	9.1	40.5	37.2	5.7	8.9	18.5	27.6	32.1	179.3	67.8	54.1	7.6	8.1	13.6	8.7	29.5	9.7	3.3	11.6	13.1	26.4	13.5	0.0	11.7	33.1	24.6	28.4	15.1	15.6	9.4	11.1	13.9	17.8	16.2	7.4	14.1	20.2	27.0	16.2	11.7	30.1	15.8	15.8	10.6	6.0	40.5	12.9	25.6	57.9	80.3	152.9	26.1	34.6	11.3	48.9
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026897	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 51.1"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 29.6;Muller glia cells: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.5;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	21.8	22.9	16.0	6.1	20.5	5.8	21.5	13.8	20.6	8.1	6.6	9.1	5.3	6.6	6.6	5.0	4.7	19.7	9.8	12.2	16.6	3.6	11.5	25.1	6.4	4.0	8.8	8.4	14.0	51.1	12.6	9.0	3.1	17.0	7.6	4.8	12.7	29.3	3.1	9.6	3.7	6.0	4.1	14.0	5.3	15.0	3.2	11.1	1.0	33.8	3.9	3.6	6.2	11.5	0.4	0.3	1.2	3.6	0.1	1.2	0.4	8.5	11.6	4.2	12.8	4.5	4.7	1.1	15.2	2.3	4.9	3.2	8.4	17.7	0.9	19.8	23.2	22.0	2.2	8.1	5.1	4.5	3.2	7.9	0.1	15.2	22.1	9.2	4.9	2.1	9.9	4.4	8.4	3.6	18.3	4.6	3.4	9.3	3.3	2.9	11.1	5.7	13.5	5.3	14.4	31.6	9.4	6.2	6.0	8.5	1.3	0.4	0.8	14.1	0.3	5.6	5.3	8.4	4.3	9.9	26.2	10.7	13.2	36.8	3.6	4.8	1.3	6.9	5.7	8.4	1.2	0.1	0.0	0.7	3.5	0.1	0.4	1.2	0.2	0.3	0.1	0.2	0.5	0.0	0.1	3.6	0.3	0.1	0.4	16.0	20.5	13.8	20.6	16.6	3.6	8.8	8.4	17.0	11.1	3.0	5.5	0.5	2.9	5.8	4.7	7.5	7.6	9.4	4.5	7.0	0.0	1.2	0.0	8.0	0.2	2.2	3.2	0.0	8.9	16.2	4.6	8.6	1.1	29.6	2.6	0.0	1.7	4.9	2.1	1.0	4.0	2.9	6.8	1.0	8.1	87.5	15.6	3.5	3.2	6.2	5.1	0.0	4.2	0.2	2.2	4.1	1.3	2.5	3.2	5.1
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109691312-109825428	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	11.0	13.5	14.5	12.2	30.3	14.0	14.4	13.5	35.3	12.4	13.2	11.0	5.0	8.3	11.3	17.0	11.7	10.5	13.4	10.1	14.5	18.5	13.2	8.7	19.2	16.6	17.6	17.7	12.2	9.9	25.4	15.4	12.6	19.0	11.6	14.6	9.7	17.0	12.0	12.1	9.2	10.7	14.7	16.0	17.3	11.4	12.6	12.9	18.1	12.6	8.5	15.0	12.5	10.5	15.5	15.9	12.8	20.0	8.0	7.7	9.8	6.2	6.5	9.8	11.7	10.4	14.4	6.2	8.1	11.7	6.7	18.0	4.8	6.6	16.8	5.2	13.1	12.4	4.7	9.6	6.4	15.6	10.2	11.7	9.4	6.5	4.8	9.6	8.8	8.4	7.4	8.4	11.4	7.9	17.2	13.6	11.1	5.5	7.2	9.4	5.8	9.0	7.6	5.1	9.3	3.2	6.3	4.5	5.8	11.3	15.5	10.9	10.2	5.3	7.8	16.4	12.5	5.6	14.7	9.5	4.2	3.6	6.1	6.9	3.4	2.4	8.1	22.3	6.3	3.8	11.5	20.0	12.8	7.7	19.7	6.0	14.6	5.7	7.3	15.9	15.5	7.0	6.8	8.7	8.0	13.5	6.9	6.6	9.8	14.5	30.3	13.5	35.3	14.5	18.5	17.6	17.7	19.0	12.9	14.9	7.0	5.9	6.5	4.0	6.1	5.1	5.1	9.4	4.5	8.7	2.0	11.5	5.0	8.9	13.3	5.0	5.3	0.0	9.9	5.8	4.4	4.5	8.1	3.8	20.0	1.6	9.8	6.2	20.5	13.8	3.1	13.5	8.5	9.0	8.8	7.5	6.8	6.8	6.3	6.3	6.0	0.0	6.6	4.9	11.7	3.9	10.3	10.7	6.1	7.6
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742733	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 54.3;hTERT-RPE1: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		1500000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	25.7	43.8	32.1	22.6	26.1	22.4	45.9	27.8	37.4	32.9	23.3	14.3	18.8	16.7	19.3	16.7	15.8	27.6	18.8	46.4	29.5	25.7	26.6	26.0	22.9	34.1	29.2	31.9	16.5	24.7	28.7	17.9	25.9	27.2	23.1	18.4	13.0	25.5	32.9	46.1	8.2	16.7	29.0	30.4	22.8	16.7	11.7	18.7	7.8	28.7	13.8	17.1	21.3	36.9	2.9	6.0	29.1	7.3	7.2	3.5	4.7	5.1	2.1	5.0	5.8	5.1	7.9	2.6	5.2	7.2	9.3	8.3	2.7	2.5	3.5	5.7	11.9	54.3	3.8	4.9	2.0	5.7	10.7	4.7	4.5	2.0	2.7	12.2	0.8	5.9	8.5	3.0	5.5	10.7	33.1	6.4	2.8	3.2	5.6	9.7	1.7	2.9	1.2	1.6	3.3	5.9	3.8	5.6	4.8	3.6	1.5	4.7	4.5	3.9	2.8	19.7	5.7	4.5	0.9	4.3	17.8	5.8	3.1	14.7	3.8	3.7	3.5	2.4	3.7	11.2	12.8	7.3	12.2	3.5	3.4	2.3	2.9	2.2	2.9	5.5	2.2	2.5	2.9	29.1	7.2	2.2	6.0	0.3	4.7	32.1	26.1	27.8	37.4	29.5	25.7	29.2	31.9	27.2	18.7	83.4	85.1	32.7	93.5	25.4	14.4	80.8	56.0	88.3	63.7	80.3	5.9	67.0	104.5	62.0	46.3	117.8	81.2	23.3	74.8	57.5	67.5	53.3	140.8	42.9	116.2	19.1	66.0	127.7	63.0	109.6	57.2	92.7	67.4	121.8	59.2	44.6	72.3	101.7	35.7	125.1	17.0	51.8	58.7	108.0	26.7	23.5	51.5	43.6	72.5	97.7
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897679	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		1900000	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	26.1	19.5	21.5	28.3	21.9	47.8	21.1	17.3	35.9	17.3	20.7	14.4	13.7	11.1	15.7	14.3	25.9	21.0	15.0	24.5	17.3	18.7	36.4	52.5	24.7	40.1	15.3	17.8	19.8	18.5	18.8	9.1	30.4	31.9	27.6	14.8	20.9	24.3	29.5	21.1	17.7	19.2	25.5	12.8	49.6	17.5	8.4	12.3	17.4	21.8	14.5	33.1	36.7	34.4	25.7	29.4	84.8	21.3	14.8	21.4	24.1	15.0	25.6	19.9	17.0	10.1	12.9	21.5	11.7	16.1	17.3	20.4	26.4	12.9	20.9	22.7	13.0	11.8	17.8	21.5	19.4	7.5	66.3	25.3	25.4	24.0	19.0	13.5	20.6	4.3	15.6	15.0	14.3	19.2	18.3	27.3	6.2	23.8	18.4	8.0	22.7	5.7	15.6	17.5	13.7	6.8	8.8	20.0	51.2	30.5	47.0	17.6	29.5	27.4	19.6	21.2	19.9	20.4	37.1	22.2	6.2	11.1	9.9	17.7	10.4	18.0	10.7	17.3	19.9	11.5	28.0	21.3	41.2	21.4	19.5	15.8	21.4	16.4	18.1	29.4	25.7	12.3	15.2	84.8	14.8	20.8	8.0	19.3	24.1	21.5	21.9	17.3	35.9	17.3	18.7	15.3	17.8	31.9	12.3	20.8	25.3	27.9	21.2	11.2	6.9	30.3	20.4	13.4	17.0	19.2	9.8	82.0	13.3	34.2	11.7	29.2	15.6	0.0	27.1	58.0	13.4	18.0	5.8	38.9	38.5	4.8	24.8	39.9	41.6	28.5	10.0	26.9	8.5	90.2	24.2	9.1	25.0	10.5	8.1	23.7	11.1	19.4	9.2	1.7	7.1	8.2	31.0	21.7	26.0	23.5
FZD7	FzE3	ENSG00000155760	"Frizzled class receptor 7"	O75084	2	202034587-202038445	"G-protein coupled receptors, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 17.3;Fibroblasts: 22.1;Smooth muscle cells: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 25.5;CAPAN-2: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059979, HPA069165, HPA076183"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA059979: , HPA069165: AB_2686096, HPA076183: "	"unprognostic (3.44e-2)"	"unprognostic (6.89e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.44e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.71e-5)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	"unprognostic (8.22e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.87e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.05e-3)"	4.8	1.6	3.2	4.7	6.5	0.0	9.9	23.3	4.5	8.5	17.8	2.0	3.3	3.9	9.7	9.4	9.1	8.6	3.7	8.7	10.8	0.7	4.1	0.8	3.0	4.0	0.8	6.2	17.4	0.8	0.0	4.9	3.2	3.8	12.4	3.4	6.1	13.4	16.2	13.5	5.3	5.6	17.3	3.0	2.0	3.1	3.2	3.0	0.8	2.6	4.3	3.2	13.1	8.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.6	2.6	17.3	5.5	5.8	4.3	7.4	19.8	25.5	6.4	7.4	16.3	31.8	0.0	11.8	13.6	4.1	5.1	3.1	0.7	7.4	2.3	4.1	0.5	1.1	1.3	3.9	0.9	1.0	4.1	0.5	3.4	2.0	5.1	0.0	0.3	1.3	1.3	5.1	2.1	0.0	2.8	18.1	1.0	1.7	1.9	3.2	0.5	1.0	3.1	2.8	6.2	2.6	0.2	3.2	14.9	1.8	1.2	0.0	12.4	4.4	7.5	2.5	1.2	0.9	0.0	2.5	0.2	8.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	6.5	23.3	4.5	10.8	0.7	0.8	6.2	3.8	3.0	0.0	7.2	0.0	7.2	9.2	0.0	17.3	2.5	1.4	0.0	1.8	0.0	0.4	1.7	0.8	0.1	0.6	7.8	0.0	0.2	0.7	22.1	3.8	1.1	0.0	1.2	0.0	1.2	1.3	0.6	0.0	4.9	1.4	3.3	0.0	6.4	6.1	0.4	2.3	4.6	0.0	0.4	6.5	12.6	1.1	0.5	8.5	0.7	0.0	3.8	1.6
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell type enhanced"	"Detected in many"	10	"Ductal cells: 39.1;Exocrine glandular cells: 43.2;Extravillous trophoblasts: 33.3;Glandular cells: 54.2;Pancreatic endocrine cells: 30.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 48.0;HEK 293: 22.4;K-562: 24.8;NB-4: 88.7;SH-SY5Y: 35.8"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in many"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	60000		"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: AB_2680922"	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	4.5	6.8	0.0	0.1	0.0	48.0	1.8	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.4	1.1	14.4	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	0.0	1.1	0.0	24.8	0.0	0.0	13.6	0.0	88.7	11.4	0.5	4.3	0.0	0.0	9.1	0.1	0.0	9.4	35.8	4.7	0.2	0.0	5.3	0.2	10.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4	0.0	0.0	0.0	15.3	1.8	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	39.1	0.0	0.2	0.0	0.0	43.2	33.3	2.4	54.2	4.6	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	1.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.0	13.7	0.4	11.4	3.0	1.6	0.0	0.6	11.9
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"		No	No		2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavorable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	188.4	332.6	95.9	149.5	93.6	154.4	209.1	143.2	204.0	209.6	218.8	234.7	129.4	220.4	28.3	168.8	159.1	107.3	89.1	332.2	145.5	193.2	96.8	121.9	208.7	199.3	126.2	197.0	98.1	129.1	108.5	206.0	232.8	501.3	230.7	161.2	65.4	46.4	238.1	376.0	224.4	103.7	354.5	226.1	110.8	182.6	170.9	104.9	238.5	230.6	68.0	109.1	126.4	329.8	190.3	285.1	51.5	139.2	143.9	163.6	197.8	84.4	247.4	105.5	76.7	284.0	346.8	124.9	256.0	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9	220.3	245.0	821.1	1485.4	1615.7	992.1	33.2	1355.4	275.7	444.7	970.1	392.7	4082.4	2934.5	4447.1	583.7	1564.4	2836.9	443.9	3299.5	7140.5	1484.6	1124.2	551.6	1346.2	3470.6	2218.3	1273.2	1144.2	2599.6	1556.8	823.5	2367.4	4003.5	3613.2	2061.2	5234.8	4742.6	2687.7	965.3	5345.0	1026.0	1131.8	2133.1	429.6	390.5	1399.2	3925.6	1271.1	3009.6	2464.1
GDF6	"BMP13, KFS, KFS1, SGM1"	ENSG00000156466	"Growth differentiation factor 6"	Q6KF10	8	96142330-96160792	"Disease related genes, Predicted secreted proteins"	Apoptosis	"Cytokine, Developmental protein, Growth factor"	"Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 11.8;placenta: 16.9"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 2.0;Distal tubular cells: 1.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.2"	"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	HPA045206	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"	"Secreted to blood"	NA	NA			Vesicles	"Nucleoplasm, Nuclear membrane"	"HPA045206: AB_10962508"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.66e-9)"	"unprognostic (6.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.13e-3)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (5.88e-4)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.71e-1)"	2.5	0.2	1.4	1.5	0.9	0.0	0.8	0.1	1.7	0.3	1.4	0.3	1.5	0.6	3.0	0.7	0.8	1.0	6.6	11.8	0.9	1.0	0.4	0.7	0.4	1.9	0.9	0.1	2.2	1.3	0.1	0.3	16.9	1.1	0.6	0.5	2.9	0.1	2.7	0.8	0.0	1.6	1.8	0.2	0.1	1.4	1.1	1.1	0.1	1.4	0.1	0.1	3.2	2.1	0.1	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.4	2.9	1.9	0.0	1.7	1.5	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	2.4	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.2	0.0	15.4	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.6	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.4	0.9	0.1	1.7	0.9	1.0	0.9	0.1	1.1	1.1	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.2	0.0	0.0	0.0
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608475-37633564	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.8"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 173.5;Spermatocytes: 198.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: AB_2680338, HPA051016: AB_2681312"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	10.7	15.8	13.5	12.2	14.0	17.3	10.8	21.8	18.4	11.6	10.6	19.3	14.5	13.1	12.9	14.1	13.3	13.8	11.8	10.2	12.5	10.6	12.0	14.1	10.9	14.0	17.7	13.2	18.1	13.9	20.6	19.4	12.5	13.5	12.0	9.6	17.7	16.7	16.7	17.1	17.1	12.0	9.3	14.2	15.8	12.8	83.8	16.6	12.1	15.4	9.9	14.2	10.6	11.0	6.4	5.0	4.9	7.7	7.6	18.0	7.6	18.4	12.9	16.2	15.7	14.2	11.7	17.8	15.2	12.3	13.5	15.0	11.5	10.5	28.3	10.4	10.9	8.3	17.2	14.3	17.0	12.4	24.2	23.8	11.2	23.2	12.3	13.9	27.5	21.9	14.2	15.2	19.1	12.1	22.1	12.6	14.4	22.6	18.4	13.8	17.6	12.2	29.5	12.7	18.6	13.3	13.6	13.0	12.1	13.9	15.0	14.9	26.5	9.7	20.4	23.6	16.1	21.3	20.0	15.1	18.4	18.0	16.5	12.1	39.7	15.9	29.3	20.6	16.7	16.1	4.9	7.7	4.3	14.0	7.6	17.3	6.4	5.6	18.0	5.0	4.1	4.2	13.0	3.3	7.6	5.5	4.3	5.8	7.6	13.5	14.0	21.8	18.4	12.5	10.6	17.7	13.2	13.5	16.6	23.8	36.3	43.5	27.8	21.5	53.9	15.9	15.3	34.8	22.7	41.8	78.5	30.7	5.0	30.2	118.6	26.2	53.9	0.0	17.7	31.6	17.1	20.5	48.5	18.1	69.1	23.8	31.2	32.5	44.8	173.5	24.5	44.5	15.1	46.9	35.7	41.0	27.7	42.1	21.2	10.3	73.2	25.8	21.2	198.9	40.2	25.0	47.5	91.4	34.6	30.1
GIMAP7	"IAN7, MGC27027"	ENSG00000179144	"GTPase, IMAP family member 7"	Q8NHV1	7	150514830-150521073	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 155.1"	"Group enriched"	"Detected in many"	7	"Endothelial cells: 154.6;Ito cells: 251.0;Kupffer cells: 150.3;T-cells: 350.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"monocytes: 41.1;NK-cells: 65.0;T-cells: 155.1"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 39.9;MOLT-4: 32.4"					"Low region specificity"	"Detected in some"			"HPA020266, HPA020268"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA020266: AB_1849680, HPA020268: AB_1849682"	"unprognostic (4.85e-3)"	"unprognostic (1.65e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (7.43e-4)"	"prognostic favorable (8.98e-5)"	"unprognostic (6.49e-3)"	"unprognostic (5.24e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.86e-2)"	32.2	7.3	6.2	30.1	9.8	1.9	19.7	4.3	8.0	19.9	9.5	2.1	5.3	7.6	13.4	11.9	12.2	10.2	9.4	14.6	9.3	6.4	20.1	10.5	22.8	54.7	10.0	3.3	7.0	4.7	3.3	4.9	12.5	7.2	13.5	8.8	6.2	10.7	4.6	17.0	4.6	20.5	12.4	8.1	51.5	7.7	6.7	8.2	18.7	16.7	11.3	34.9	13.4	11.0	0.4	18.0	3.4	41.1	65.0	155.1	131.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	4.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	41.1	0.5	79.6	36.9	77.6	0.4	118.6	95.4	18.0	0.3	155.1	108.0	3.4	65.0	38.6	1.0	64.7	131.0	6.2	9.8	4.3	8.0	9.3	6.4	10.0	3.3	7.2	8.2	0.0	19.9	6.5	0.2	2.2	0.0	8.9	7.6	1.4	1.2	1.8	0.0	0.1	0.0	0.0	1.3	154.6	0.0	0.0	0.6	0.0	2.3	0.2	12.8	2.6	14.9	0.0	0.0	251.0	150.3	0.7	2.3	34.3	1.7	12.6	0.0	0.3	0.7	0.2	0.4	1.6	0.2	0.0	1.4	0.0	0.5	2.9	0.3	350.3	0.0	0.0
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 139.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: AB_2677039, HPA069503: AB_2686142"	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.8	10.0	6.5	7.7	39.9	20.7	139.7	9.3	25.2	12.0	15.4	14.2	13.8	2.8	8.3	19.0	8.9	5.6	6.1	11.9	8.9	16.3	5.1	11.2	6.0	7.3	20.5	7.7	11.4	23.9	11.4	10.8	6.4	23.6	18.4	3.9	10.1	10.9	13.1	6.8	4.6	5.1	4.4	12.2	4.4	4.0	4.3	13.2	12.9	8.5	2.0	6.8	12.0	19.4	11.7	12.0	12.9	20.4	10.7	7.7	5.4	10.5	7.9	8.6	13.7	0.9	16.2	11.2	5.8	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0	17.9	22.3	15.9	10.2	5.4	11.3	7.1	35.7	14.7	17.0	26.2	5.9	80.5	23.2	42.1	22.3	10.5	31.5	0.0	31.3	47.6	24.4	11.4	26.5	36.5	70.6	4.8	16.3	18.4	38.2	3.1	14.1	38.3	13.5	81.2	22.4	20.0	27.0	39.5	19.8	24.2	15.0	12.9	10.8	1.1	7.2	3.0	41.1	20.0	28.4	8.4
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 108.7"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 163.9;Hofbauer cells: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.5;HBEC3-KT: 61.5;hTCEpi: 61.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced		Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		23000000	"Vesicles, Cytosol"		"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	55.8	16.1	17.8	15.5	18.8	9.6	15.2	8.1	15.2	20.5	10.3	31.7	6.4	8.4	9.5	17.3	39.5	8.8	12.6	13.8	18.0	12.6	7.5	13.2	24.8	30.2	22.4	13.0	12.2	9.3	11.7	5.6	108.7	18.9	11.9	14.5	14.1	13.3	10.4	3.9	42.8	11.2	10.9	35.9	28.5	8.2	8.9	15.3	21.9	7.1	25.9	39.7	21.0	32.0	15.9	19.0	4.2	19.4	1.9	3.3	8.0	4.6	3.0	3.2	15.3	21.3	10.6	44.5	7.3	15.8	4.0	5.5	6.3	5.4	15.0	7.7	5.6	11.0	12.7	3.5	61.5	5.8	8.4	2.2	2.4	3.8	7.7	5.2	3.9	25.2	14.2	61.3	5.2	3.5	5.6	5.8	19.1	2.3	6.5	6.3	1.9	8.2	3.7	2.2	2.3	6.9	3.7	1.5	9.4	3.9	9.1	0.8	2.9	6.0	28.4	12.0	11.7	6.5	4.6	5.1	10.0	3.9	8.2	2.2	16.2	19.3	41.1	11.4	6.2	4.1	3.5	19.4	1.1	1.9	6.5	1.4	14.9	2.3	2.0	19.0	15.9	3.3	2.5	4.2	1.9	1.4	13.7	2.4	8.0	17.8	18.8	8.1	13.9	18.0	12.6	22.4	13.0	18.9	15.3	14.9	23.1	14.7	13.3	13.3	4.5	26.2	0.0	13.4	12.5	17.4	2.0	45.1	1.7	5.8	0.4	6.3	4.6	0.0	6.9	163.9	8.0	7.4	66.0	16.3	98.1	6.4	3.5	7.4	38.4	1.1	7.5	34.4	8.5	55.1	5.0	8.0	5.4	3.5	13.1	4.5	3.1	0.0	5.7	1.4	4.9	20.8	43.8	3.8	5.6	32.5
GNL1	HSR1	ENSG00000204590	"G protein nucleolar 1 (putative)"	P36915	6	30541377-30557174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033575, HPA043338, HPA050455"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132"	"unprognostic (2.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.78e-1)"	14.2	9.2	15.6	12.9	18.6	7.7	13.4	18.8	29.2	13.3	7.9	12.1	7.6	4.3	15.2	15.1	8.4	17.4	10.6	6.9	14.6	14.1	13.5	9.3	12.8	9.7	13.1	17.3	25.9	13.0	40.3	11.6	11.1	14.3	9.0	13.2	9.3	10.1	15.3	8.0	13.8	7.8	16.9	13.9	8.8	8.8	31.7	12.5	12.8	13.5	7.6	16.7	11.1	10.6	1.4	0.3	0.8	0.7	1.2	3.6	1.7	7.4	1.5	4.3	12.4	8.2	9.7	0.3	2.3	4.6	1.9	3.0	10.7	4.6	3.4	4.4	7.4	19.0	5.0	11.1	9.1	3.2	1.2	6.5	5.5	5.3	1.0	0.0	1.0	3.6	8.3	7.3	14.9	5.0	0.0	0.8	13.4	9.6	0.4	4.7	1.7	2.6	0.2	2.4	5.9	1.2	5.7	2.7	3.7	6.4	3.2	3.7	3.6	3.0	2.2	1.3	1.5	2.1	3.4	4.4	7.8	2.2	1.4	2.6	5.8	6.3	6.8	0.2	4.7	9.4	0.8	0.5	0.7	2.7	0.7	3.6	1.4	2.9	3.4	0.3	1.2	0.6	1.1	0.7	1.2	0.7	0.3	1.7	1.7	15.6	18.6	18.8	29.2	14.6	14.1	13.1	17.3	14.3	12.5	41.7	42.8	28.9	84.1	52.7	40.0	11.2	33.1	8.1	21.6	24.4	39.3	59.0	19.9	34.2	92.0	43.0	23.2	23.3	30.7	56.3	42.9	42.6	31.1	14.1	25.3	15.9	44.2	40.5	18.7	144.9	33.6	17.8	27.0	12.6	21.6	29.3	24.9	22.6	30.1	23.0	31.9	38.8	46.4	86.6	45.5	35.5	133.9	30.5	23.4	49.4
GOLPH3	"GOPP1, GPP34, MIDAS, Vps74"	ENSG00000113384	"Golgi phosphoprotein 3"	Q9H4A6	5	32124704-32174350	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044564, HPA055841"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA044564: AB_10795169, HPA055841: AB_2682940"	"unprognostic (1.64e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.95e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-2)"	26.7	22.0	17.9	21.8	17.4	7.9	24.9	19.9	20.6	27.9	40.5	22.1	25.0	20.9	24.3	28.3	24.6	19.4	36.0	23.1	17.7	17.8	30.7	75.0	24.3	22.6	20.9	12.6	26.6	37.2	27.2	22.9	35.6	19.0	36.0	28.2	22.3	35.8	24.9	20.6	19.0	34.0	33.0	19.6	21.3	28.1	16.0	19.1	26.4	30.0	19.3	26.0	25.4	27.9	11.9	9.5	18.9	11.1	8.7	13.2	4.2	15.8	10.6	17.2	18.7	32.8	31.5	49.6	21.9	29.3	20.7	19.7	14.4	28.7	14.3	21.8	29.6	20.1	14.9	21.3	15.5	26.2	18.6	12.7	15.7	36.5	27.4	26.4	24.3	18.5	24.0	22.3	20.2	23.3	19.1	16.4	9.5	16.4	34.9	22.9	15.9	15.5	31.7	14.8	21.7	11.0	14.5	24.9	14.8	25.7	20.2	13.2	14.8	51.0	53.6	21.5	22.9	21.8	27.0	15.9	18.3	17.1	14.3	15.4	39.4	48.2	17.4	16.4	35.0	21.7	7.3	8.4	18.9	8.9	11.1	7.8	10.8	9.7	11.5	9.5	11.9	11.1	8.4	8.6	8.7	10.8	7.3	13.2	4.2	17.9	17.4	19.9	20.6	17.7	17.8	20.9	12.6	19.0	19.1	56.6	35.6	54.1	38.2	62.2	11.8	27.3	71.4	34.8	39.8	41.8	9.8	51.1	44.7	41.5	4.5	43.3	53.1	0.0	38.3	98.3	44.9	87.1	13.9	137.0	45.9	12.7	50.0	54.0	50.9	9.6	46.9	29.0	42.2	27.9	72.7	18.8	48.3	24.6	53.7	49.6	9.8	38.8	52.8	14.4	26.0	64.4	92.0	35.7	44.8	65.7
GOLT1B	"CGI-141, GOT1, YMR292W"	ENSG00000111711	"Golgi transport 1B"	Q9Y3E0	12	21501781-21518408	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055909, HPA066383"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA055909: AB_2682967, HPA066383: AB_2685667"	"unprognostic (1.22e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.37e-3)"	"prognostic unfavorable (1.99e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.32e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.83e-10)"	"unprognostic (3.13e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.04e-1)"	21.1	26.0	18.3	18.2	24.4	23.4	20.4	31.9	30.4	22.3	14.7	18.9	13.8	12.0	16.9	18.9	15.3	14.6	16.4	17.0	19.1	22.4	23.2	40.1	19.9	16.0	20.1	16.2	14.1	30.9	11.3	34.9	31.1	23.8	19.0	16.8	16.1	17.4	15.3	15.9	14.5	13.0	19.6	22.2	17.8	15.3	11.6	17.5	13.5	19.1	11.6	15.6	22.5	14.2	17.7	22.2	26.7	22.9	14.8	21.1	19.4	11.4	12.1	10.0	12.9	20.2	31.5	17.0	45.1	17.2	14.3	23.4	15.8	17.0	6.9	11.6	23.4	26.6	11.1	8.3	9.3	25.1	10.1	7.9	10.1	7.9	11.0	22.5	13.0	13.0	15.9	18.2	17.1	31.5	24.6	12.9	8.6	6.3	7.7	21.9	10.7	5.8	21.6	27.6	9.9	8.7	5.0	24.4	14.5	11.8	7.0	2.7	8.4	18.4	7.2	24.6	33.8	10.0	14.7	14.4	16.9	18.4	20.8	24.5	7.5	16.3	18.3	23.1	12.5	22.7	26.7	20.6	14.8	17.9	22.9	21.1	17.7	21.1	19.5	20.2	16.5	19.3	19.2	5.6	14.8	20.9	22.2	20.4	19.4	18.3	24.4	31.9	30.4	19.1	22.4	20.1	16.2	23.8	17.5	8.9	14.1	38.8	20.4	41.4	28.9	15.5	15.3	8.1	25.0	15.7	9.8	25.0	23.2	28.8	2.7	27.1	10.5	0.0	29.2	54.0	45.6	35.7	20.8	21.7	37.8	17.5	12.6	17.8	21.3	3.6	16.1	35.7	50.6	22.6	22.7	17.8	30.7	14.4	18.7	17.4	6.7	12.9	30.7	22.9	31.0	55.8	53.5	33.1	13.2	20.5
GPRC5B	RAIG-2	ENSG00000167191	"G protein-coupled receptor class C group 5 member B"	Q9NZH0	16	19856691-19886167	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 108.0"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 172.9;Late spermatids: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive CD4 T-cell: 6.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.2;HHSteC: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015247	Enhanced		Supported	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Vesicles	"Nucleoplasm, Nucleoli"	"HPA015247: AB_1849323"	"unprognostic (1.26e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.60e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.30e-4)"	"unprognostic (4.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.42e-3)"	"unprognostic (6.78e-3)"	12.6	4.4	45.2	3.2	55.9	1.0	7.3	22.8	108.0	5.4	2.9	95.1	4.9	4.0	7.1	9.3	5.5	12.7	9.2	22.3	47.8	28.7	12.1	2.7	3.9	4.6	63.1	34.9	13.7	12.7	9.5	3.8	9.3	38.6	6.3	2.3	3.8	20.8	11.5	35.1	2.5	3.3	5.1	61.6	2.2	22.7	19.6	63.1	0.0	7.2	2.6	2.7	6.2	3.0	0.0	0.0	0.0	1.5	0.0	6.5	1.3	0.4	12.6	12.5	2.2	12.9	0.9	2.3	0.1	3.1	1.2	0.8	11.5	0.4	0.0	39.2	0.4	8.2	0.6	9.2	0.0	0.7	0.0	3.3	0.0	0.0	0.0	26.8	0.0	0.0	1.1	0.0	2.1	0.0	3.3	6.1	0.3	2.6	0.2	2.8	0.6	0.0	0.0	13.7	0.0	6.0	3.6	0.0	0.0	0.4	5.8	9.7	0.8	1.4	0.8	11.3	4.1	0.0	0.2	1.2	0.0	1.5	6.1	0.3	0.1	0.0	0.0	0.6	0.1	0.7	0.0	0.1	0.0	0.0	1.5	0.0	0.0	1.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.3	0.0	0.0	1.3	45.2	55.9	22.8	40.5	47.8	28.7	63.1	34.9	38.6	63.1	0.0	4.0	0.9	4.6	1.1	30.1	13.4	35.7	5.3	7.9	29.6	0.0	3.9	1.7	47.7	172.9	30.1	0.0	0.0	56.2	1.2	9.7	4.3	0.0	0.0	3.3	0.0	0.0	6.2	1.0	145.0	22.2	1.1	15.1	1.8	0.0	20.5	53.7	0.0	25.1	0.1	5.7	12.9	9.2	2.8	1.5	1.5	2.1	0.0	0.0	1.7
GRB10		ENSG00000106070	"Growth factor receptor bound protein 10"	Q13322	7	50590063-50793462	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 65.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 82.5;Early spermatids: 134.4;Late spermatids: 152.5;Rod photoreceptor cells: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"basophil: 11.4;eosinophil: 3.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 11.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019423, HPA027502, HPA031818"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057"	"unprognostic (2.82e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.31e-3)"	"unprognostic (4.44e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.73e-3)"	"unprognostic (8.16e-3)"	"unprognostic (2.63e-2)"	"unprognostic (8.50e-2)"	14.3	14.6	14.7	4.9	26.7	6.5	18.8	22.0	20.9	9.7	10.5	14.6	2.0	12.3	8.9	8.0	7.3	9.0	15.6	19.1	13.8	14.8	19.8	15.6	8.3	4.3	19.8	10.7	6.5	65.8	6.0	21.5	10.6	20.9	10.6	5.1	16.5	7.0	11.7	35.7	3.7	8.4	13.0	9.9	15.9	7.2	11.4	16.9	0.4	18.3	4.2	3.2	12.7	17.3	0.0	0.1	11.4	0.2	0.0	0.4	0.1	0.1	10.6	17.6	7.1	8.2	6.3	9.3	4.3	3.7	8.4	10.1	6.4	0.1	0.2	7.7	5.4	24.3	1.0	18.1	4.6	4.1	0.1	7.3	18.4	10.9	4.6	17.5	11.5	28.6	16.5	7.2	12.9	12.8	8.3	21.4	1.3	34.8	0.2	6.3	1.2	2.0	15.5	19.1	8.9	18.6	5.4	0.0	0.1	5.6	4.2	7.7	0.0	0.5	2.7	22.9	11.9	9.3	23.4	26.1	7.4	10.2	15.2	16.4	0.7	0.2	0.1	23.6	10.5	25.1	11.4	0.1	3.5	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.1	14.7	26.7	22.0	20.9	13.8	14.8	19.8	10.7	20.9	16.9	6.0	8.8	0.9	5.6	6.6	11.0	12.2	58.6	1.4	3.4	5.2	82.5	3.7	1.7	16.5	134.4	28.6	8.6	23.3	21.0	11.9	11.5	17.1	0.0	22.5	1.4	4.8	0.0	52.2	11.4	152.5	1.7	2.3	6.8	1.0	2.2	18.0	30.3	2.9	0.4	14.7	83.0	0.0	12.7	1.4	19.2	3.8	2.2	0.9	3.3	5.6
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982314	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 56.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		48000	Vesicles		"HPA036322: AB_10670796, HPA036323: AB_2675059"	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	23.5	12.0	3.7	7.9	5.5	20.7	25.4	5.7	4.4	10.4	14.6	7.7	22.0	10.0	10.4	12.2	9.3	7.6	11.1	8.0	3.7	2.9	11.8	50.4	15.3	12.3	6.3	3.1	8.6	17.1	9.0	7.3	30.0	4.5	12.1	11.4	9.9	17.2	11.8	5.9	10.0	16.1	8.3	3.9	17.5	11.0	7.9	5.8	14.7	17.7	5.9	13.0	9.2	7.4	9.7	27.7	22.1	36.0	15.2	11.5	15.8	17.0	6.6	6.5	14.5	22.1	13.2	9.4	5.4	15.1	11.9	11.0	9.5	17.6	7.8	8.5	6.9	6.2	6.9	4.2	6.5	7.1	7.3	8.5	10.6	10.0	6.4	10.8	22.7	17.7	9.1	7.0	6.9	9.0	14.2	10.4	4.5	16.1	56.5	7.7	12.4	8.3	24.4	4.3	26.0	5.5	8.6	15.0	44.2	7.5	10.3	9.5	8.4	14.5	33.9	18.9	7.6	18.9	22.6	7.3	14.6	13.2	5.5	13.5	32.1	38.5	13.1	10.9	30.2	17.7	7.4	28.1	22.1	11.5	36.0	10.3	9.7	9.0	10.2	27.7	7.8	6.2	7.3	4.5	15.2	30.0	11.3	11.3	15.8	3.7	5.5	5.7	4.4	3.7	2.9	6.3	3.1	4.5	5.8	47.6	56.2	18.6	26.4	16.0	13.7	8.3	25.5	48.2	37.5	27.9	7.9	72.3	5.0	32.4	47.6	31.3	41.1	23.3	26.7	48.8	48.3	25.5	35.8	64.7	114.3	15.9	41.2	39.9	74.2	36.8	40.0	72.1	37.1	43.3	42.3	27.3	25.9	48.9	26.9	19.2	17.7	25.8	22.6	41.3	28.8	12.9	56.0	34.6	40.6	25.3
HACL1	"2-HPCL, HPCL, PHYH2"	ENSG00000131373	"2-hydroxyacyl-CoA lyase 1"	Q9UJ83	3	15560704-15601852	"Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 34.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035496, HPA035497, HPA073760"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA035496: AB_10601328, HPA035497: AB_2674653, HPA073760: AB_2686633"	"unprognostic (6.64e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (5.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.62e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.07e-2)"	12.9	12.1	9.1	7.3	12.5	7.6	11.6	20.7	14.1	9.0	22.4	13.5	5.8	39.6	13.1	13.2	6.7	7.9	6.6	7.9	6.7	6.0	18.8	38.1	7.5	9.0	9.1	8.3	7.9	14.3	12.9	16.8	6.4	10.1	8.2	9.0	10.9	8.5	6.9	15.7	9.9	31.6	7.2	8.2	11.0	11.5	18.4	10.3	16.6	15.1	6.1	10.7	8.2	6.5	8.5	6.5	34.1	9.1	9.1	9.3	5.0	6.0	12.5	4.0	13.9	7.0	5.6	39.4	5.9	9.6	12.7	12.5	12.9	6.0	6.2	4.3	8.0	5.0	4.5	9.2	11.4	11.3	5.2	17.5	12.2	9.5	12.5	10.5	13.3	10.7	6.4	8.4	18.0	7.5	3.8	15.9	8.3	10.0	10.4	10.8	13.3	6.4	6.3	9.1	9.6	14.6	6.0	9.8	8.2	13.6	9.5	4.2	5.5	8.8	9.7	11.6	6.6	3.1	12.5	9.7	6.9	6.8	8.5	10.8	12.8	21.6	12.2	12.9	12.1	7.8	34.1	6.5	7.0	6.0	8.2	9.3	6.4	6.5	7.5	6.5	8.5	6.4	7.1	1.4	9.1	9.1	4.0	7.8	5.0	9.1	12.5	20.7	14.1	6.7	6.0	9.1	8.3	10.1	10.3	8.9	15.9	11.9	9.6	9.2	18.3	4.9	12.7	37.5	15.9	10.4	27.5	24.4	11.6	10.9	53.9	11.1	8.8	0.0	22.1	15.1	8.6	8.1	12.7	26.4	11.8	12.7	8.7	8.6	9.1	43.3	21.6	8.7	11.8	24.4	5.8	22.5	12.7	10.5	14.5	27.1	32.9	6.5	9.0	49.7	22.6	6.1	15.8	18.7	8.6	5.8
HAO2	"GIG16, HAOX2"	ENSG00000116882	"Hydroxyacid oxidase 2"	Q9NYQ3	1	119368779-119394130	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 65.1;liver: 90.2"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 210.7;Proximal tubular cells: 261.6"	"Group enriched"	"Detected in some"	26	"liver cancer: 25.6;renal cancer: 11.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;BJ hTERT+: 1.2;HL-60: 2.0;SiHa: 1.5;U-698: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050355			Approved	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA050355: "	"unprognostic (1.13e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.22e-2)"	"unprognostic (5.33e-3)"	"unprognostic (2.80e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (4.92e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-2)"	"unprognostic (5.14e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	65.1	90.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.3	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.7	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.3	0.5	0.0	0.6	0.8	2.0	0.4	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.8	0.2	1.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	2.5	0.0	0.0	10.4	0.0	0.0	41.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	210.7	0.1	0.0	0.0	3.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HAPLN1	CRTL1	ENSG00000145681	"Hyaluronan and proteoglycan link protein 1"	P10915	5	83637805-83721613	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 41.8"	"Cell type enhanced"	"Detected in some"	20	"Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019105, HPA019482, HPA025238"	Enhanced	Approved	Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles		"HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: "	"unprognostic (5.74e-4)"	"unprognostic (2.94e-2)"	"unprognostic (6.58e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.76e-3)"	"unprognostic (6.01e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (4.81e-9)"	"unprognostic (6.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.62e-2)"	"unprognostic (3.91e-2)"	0.1	0.0	5.4	1.5	3.9	0.0	0.1	0.6	4.7	0.1	4.7	0.1	0.1	3.8	0.5	0.1	1.2	0.0	0.5	1.8	3.4	1.3	0.4	0.1	0.9	0.1	1.7	0.7	0.2	0.2	0.0	0.1	41.8	1.5	4.9	5.8	1.5	0.9	0.1	0.1	0.5	9.3	0.3	0.6	0.1	2.4	0.1	0.1	0.1	0.3	0.5	0.3	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.1	0.0	0.0	28.3	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	3.9	0.6	4.4	3.4	1.3	1.7	0.7	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	4.4	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0
HCK	JTK9	ENSG00000101336	"HCK proto-oncogene, Src family tyrosine kinase"	P08631	20	32052188-32101856	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 107.1;lymphoid tissue: 72.6"	"Group enriched"	"Detected in many"	8	"Hofbauer cells: 131.2;Kupffer cells: 133.2;Macrophages: 170.5;monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1"	"Group enriched"	"Detected in many"	15	"dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1"	"Group enriched"	"Detected in some"	8	"THP-1: 23.1;U-937: 66.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005195, HPA063768"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"CAB005195: AB_631619, HPA063768: AB_2685118"	"unprognostic (6.22e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"unprognostic (7.98e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (4.92e-2)"	"unprognostic (4.42e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.12e-1)"	12.3	5.8	5.9	40.8	13.1	20.8	4.0	1.8	5.3	3.0	5.8	6.1	0.9	5.9	2.5	5.7	3.1	5.9	6.5	8.8	6.0	3.7	4.0	7.9	20.9	50.3	11.2	1.2	3.4	2.8	0.7	2.9	8.8	8.0	3.8	5.9	3.1	4.1	1.9	3.1	2.8	7.8	10.2	9.1	72.6	3.7	2.6	8.2	5.8	3.3	1.2	16.4	9.4	3.5	4.7	31.6	73.0	107.1	1.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	23.1	0.0	0.0	0.1	0.0	0.0	0.7	0.1	3.4	0.0	66.3	0.0	0.5	50.8	62.5	0.1	96.5	0.1	4.7	0.1	0.1	31.6	3.7	0.1	0.0	73.0	1.1	107.1	2.8	0.1	40.2	5.9	13.1	1.8	5.3	6.0	3.7	11.2	1.2	8.0	8.2	6.0	21.8	10.3	3.5	2.7	0.0	1.7	2.5	2.7	6.8	7.0	0.0	0.8	1.7	0.0	0.2	1.4	0.0	0.0	0.5	0.7	1.3	0.0	5.8	0.8	131.2	0.0	1.7	1.8	133.2	0.0	0.0	170.5	1.7	221.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	1.0	1.4	0.5	0.0	4.6
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 207.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA018082, HPA054583"	Supported		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		20000000	Vesicles	Cytosol	"HPA018082: , HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favorable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.5	12.8	5.5	10.6	45.5	51.9	7.9	10.6	53.8	23.0	36.8	6.7	55.4	6.3	10.2	21.3	12.0	15.1	14.6	6.7	14.6	5.1	5.8	7.9	12.7	11.6	35.2	18.9	22.7	44.1	20.2	10.0	17.9	42.2	21.0	9.4	12.2	39.2	30.6	6.5	4.1	9.5	3.1	24.7	0.1	4.2	12.0	14.2	25.7	11.9	4.8	5.3	26.5	25.1	59.9	11.7	4.6	23.9	10.6	34.5	14.4	31.7	11.2	20.9	28.2	6.5	12.5	25.3	16.7	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9	59.6	55.5	41.1	30.3	19.7	40.2	22.6	35.7	17.4	28.4	62.8	100.1	116.3	51.4	65.3	16.3	43.0	46.2	0.0	33.3	55.3	62.5	30.5	29.9	37.8	207.1	25.4	45.3	44.2	76.0	10.5	68.7	108.5	89.4	50.5	39.4	48.4	43.8	84.5	42.1	55.5	56.1	45.3	20.6	20.4	28.2	13.7	131.8	47.5	44.4	25.0
HFM1	"FLJ36760, FLJ39011, MER3, SEC63D1"	ENSG00000162669	"HFM1, ATP dependent DNA helicase homolog"	A2PYH4	1	91260766-91404869	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	Meiosis	"Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;testis: 19.9"	"Cell type enhanced"	"Detected in some"	22	"Early spermatids: 10.1;Spermatocytes: 40.0;Spermatogonia: 7.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 4.9;K-562: 5.0;SCLC-21H: 3.1;SH-SY5Y: 3.8;U-266/70: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035036, HPA035557"			Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA035036: AB_2797224, HPA035557: AB_10696507"	"unprognostic (1.35e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.76e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.89e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.77e-4)"	"unprognostic (9.59e-2)"	0.8	0.7	2.6	0.3	4.1	0.4	0.8	11.3	4.4	1.7	0.9	1.5	2.7	0.6	3.7	2.5	0.4	1.2	0.6	1.0	2.3	0.9	1.3	0.4	0.5	1.6	0.7	1.4	6.4	1.2	0.1	7.8	0.9	3.9	1.1	0.7	2.7	1.0	2.0	2.3	0.4	0.5	1.7	4.7	0.7	0.6	19.9	1.5	0.0	2.7	0.5	0.4	0.7	2.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	9.3	4.9	0.0	0.2	0.1	0.5	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	1.9	1.0	0.0	0.1	0.2	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.6	0.2	2.4	0.0	0.0	0.3	1.4	0.1	0.0	0.0	3.1	3.8	0.0	0.0	1.3	2.6	0.0	0.8	0.1	0.0	1.0	0.9	0.1	4.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.6	4.1	11.3	4.4	2.3	0.9	0.7	1.4	3.9	1.5	0.0	0.6	0.0	0.0	0.0	3.7	2.6	0.0	0.0	0.0	0.0	5.9	0.4	0.0	0.2	10.1	0.3	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	3.7	0.0	0.0	0.0	0.0	3.1	0.1	0.0	2.1	0.0	6.4	0.0	0.3	40.0	7.8	0.0	0.0	0.0	0.0	0.0
HIP1	ILWEQ	ENSG00000127946	"Huntingtin interacting protein 1"	O00291	7	75533300-75738962	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation"	"Actin-binding, Activator"	"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1171.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013606, CAB015334, CAB016402, HPA017964"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719"	"unprognostic (8.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.70e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.09e-1)"	16.5	8.7	14.6	7.2	25.9	5.1	13.5	13.2	20.8	13.2	5.3	34.4	4.9	2.9	13.4	10.1	5.7	13.8	8.7	9.2	17.5	11.9	14.6	9.6	17.7	4.6	27.2	11.8	8.1	4.0	4.9	3.6	20.0	16.1	6.8	4.5	9.9	4.0	12.4	3.9	10.8	4.6	12.6	24.8	10.8	4.6	18.5	29.7	1.6	15.8	5.7	4.6	9.7	8.8	0.5	4.0	8.8	1.1	3.3	1.5	0.3	2.5	27.3	18.6	17.5	7.9	10.7	5.6	4.8	3.1	3.1	2.3	1.5	2.4	1.8	5.6	11.8	10.9	3.1	18.8	3.9	4.2	1.5	3.5	1.4	3.2	2.5	7.8	0.4	7.4	8.2	2.4	10.2	2.1	5.8	13.0	2.0	1.9	1.8	5.0	10.4	1.2	10.6	20.2	0.2	3.3	2.1	7.8	0.1	2.4	9.7	0.9	8.2	4.4	2.8	6.3	17.3	17.2	6.7	4.6	9.2	7.1	3.1	6.6	2.0	0.2	4.4	9.2	3.9	6.2	8.8	1.1	7.6	1.1	1.1	1.0	0.4	0.2	0.9	1.6	0.5	0.1	0.7	7.7	3.3	0.8	4.0	1.5	0.3	14.6	25.9	13.2	16.9	17.5	11.9	27.2	11.8	16.1	29.7	56.6	35.7	6.0	6.3	15.7	7.1	12.5	5.1	0.0	17.0	26.2	11.8	1.3	11.6	10.2	240.8	40.7	0.7	0.0	5.3	7.5	15.4	4.0	13.9	20.2	11.7	22.3	4.6	30.1	15.1	1171.7	20.8	22.9	10.1	1.0	1.4	18.6	2.6	8.5	23.3	2.2	8.2	84.1	37.2	9.3	4.1	8.0	0.7	17.0	2.6	3.1
HIP1R	"FLJ14000, HIP12, HIP3, ILWEQ, KIAA0655"	ENSG00000130787	"Huntingtin interacting protein 1 related"	O75146	12	122834453-122862960	"Cancer-related genes, Predicted intracellular proteins"	Endocytosis	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 57.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 9.5;naive B-cell: 12.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017187, HPA038135, HPA038136"	Enhanced		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"CAB017187: , HPA038135: AB_2675851, HPA038136: AB_2675852"	"unprognostic (4.52e-1)"	"unprognostic (6.39e-2)"	"unprognostic (7.07e-2)"	"unprognostic (6.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.11e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.72e-2)"	"prognostic favorable (6.50e-7)"	"unprognostic (2.18e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.54e-3)"	"prognostic favorable (7.26e-4)"	9.8	14.5	24.6	13.2	26.5	11.6	8.0	11.5	31.6	4.6	11.6	40.5	19.7	29.2	4.0	9.1	7.0	4.0	7.8	10.8	29.5	21.7	16.2	9.0	6.3	15.3	31.4	20.6	3.2	27.7	7.4	15.6	5.2	18.0	8.6	5.4	2.9	52.0	24.1	5.7	26.5	21.3	3.0	27.4	11.1	30.4	4.0	30.6	8.1	8.1	5.9	12.6	7.4	6.5	12.3	0.0	2.7	0.0	0.6	3.2	1.6	17.5	5.1	3.8	15.8	1.1	3.0	18.9	2.8	4.5	2.8	2.2	7.8	5.3	16.7	9.3	2.0	4.3	15.2	4.6	10.1	0.2	2.6	6.7	0.4	5.8	8.2	3.5	1.3	11.9	1.9	7.2	3.8	6.5	3.9	19.5	7.9	4.3	0.9	1.6	25.2	7.9	4.1	3.5	15.2	6.1	4.1	4.9	5.8	9.5	21.3	3.9	8.7	3.3	8.6	4.5	2.2	17.6	0.7	15.4	1.8	13.6	5.6	2.6	12.0	6.4	9.9	2.9	2.8	1.5	0.0	0.0	2.7	2.9	0.0	1.7	9.5	1.8	2.2	0.0	12.3	3.2	2.0	0.2	0.6	0.0	0.0	0.4	1.6	24.6	26.5	11.5	19.8	29.5	21.7	31.4	20.6	18.0	30.6	0.0	12.0	32.0	12.8	11.7	8.4	4.1	50.9	8.1	7.9	57.6	27.5	3.0	0.0	34.4	2.3	11.7	36.4	0.0	24.6	10.4	2.1	17.0	5.7	20.8	0.6	17.5	7.5	18.4	1.2	2.2	1.4	0.4	10.1	0.0	24.4	12.3	20.4	22.6	1.1	12.5	17.4	0.0	1.9	4.7	9.8	18.3	1.6	6.7	18.0	25.8
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941070	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"B-cells: 222.5;Hofbauer cells: 281.2;Kupffer cells: 131.2;Macrophages: 353.4;monocytes: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9"	"Group enriched"	"Detected in some"	13	"CAPAN-2: 7.3;Daudi: 10.3;EFO-21: 4.9;U-266/70: 3.9;U-698: 12.6"									"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	12.0	13.0	5.9	20.2	7.5	4.3	7.9	0.4	4.9	8.1	9.7	8.8	2.1	1.2	6.2	10.2	3.3	12.6	6.0	8.0	5.7	4.2	13.1	5.4	20.8	24.0	10.2	2.3	7.4	5.0	1.2	3.2	6.2	8.1	6.3	10.5	6.3	7.8	3.2	2.9	4.5	31.8	1.9	14.5	35.6	6.1	2.1	7.3	10.5	33.7	3.8	34.5	10.6	3.2	19.9	11.5	2.2	11.9	2.2	1.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	10.3	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.3	12.6	0.0	0.0	0.0	0.0	11.9	2.2	0.3	10.1	0.4	15.1	0.2	0.5	11.1	19.9	0.1	0.5	0.5	2.2	3.5	11.5	1.0	10.3	5.9	7.5	0.4	4.9	5.7	4.2	10.2	2.3	8.1	7.3	8.9	53.6	222.5	0.9	10.6	0.1	2.2	7.6	10.7	6.8	15.7	0.0	1.4	10.0	10.4	0.5	31.8	3.1	0.0	4.0	1.2	4.7	1.4	14.0	0.6	281.2	0.0	4.1	3.7	131.2	0.7	3.1	353.4	15.1	112.8	1.5	0.5	3.9	0.9	1.8	6.0	1.2	6.5	4.1	0.4	0.5	9.5	2.3	15.0	1.7	2.4
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 59.5"	"Cell type enhanced"	"Detected in many"	18	"B-cells: 1100.8;Hofbauer cells: 1218.6;Kupffer cells: 965.1;Macrophages: 2476.0;monocytes: 4193.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1"	"Group enriched"	"Detected in all"	8	"B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.8;HDLM-2: 48.6;REH: 12.4;U-698: 11.4"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		92000	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	25.2	12.8	3.3	13.3	3.6	4.7	16.3	3.5	3.3	11.8	6.8	3.1	4.3	8.6	8.5	15.9	8.5	5.7	14.7	11.1	4.2	6.2	12.4	9.7	35.9	20.2	6.2	3.8	3.8	5.4	3.8	5.2	6.5	4.8	7.4	7.3	7.5	7.4	15.7	4.1	5.8	14.7	6.4	20.4	37.6	5.6	8.6	4.1	10.9	14.2	9.5	21.5	8.5	17.8	30.0	59.5	1.3	37.8	4.0	5.6	20.3	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.2	0.1	0.2	0.0	0.0	2.1	15.8	2.2	0.3	3.1	0.0	0.0	0.0	0.0	48.6	1.0	2.6	0.0	0.0	0.0	0.0	5.1	0.7	0.0	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	1.1	3.5	0.0	0.0	0.0	2.4	0.3	11.4	5.5	0.1	1.9	0.3	16.3	1.3	4.6	37.8	1.2	30.0	2.1	5.0	59.5	26.7	0.7	3.4	0.6	4.0	23.2	17.1	5.6	20.3	3.3	3.6	3.5	3.3	4.2	6.2	6.2	3.8	4.8	4.1	77.4	317.2	1100.8	5.1	183.6	2.5	10.5	76.5	80.3	113.7	22.7	0.0	4.2	8.3	15.4	2.1	188.1	6.1	0.0	15.8	5.3	55.4	10.4	62.4	4.5	1218.6	4.8	9.8	60.2	965.1	4.3	16.7	2476.0	286.8	4193.1	9.2	4.8	4.8	4.5	25.8	32.7	3.1	51.8	21.8	0.9	2.9	153.2	5.7	100.5	4.1	8.9
HOOK2	HK2	ENSG00000095066	"Hook microtubule tethering protein 2"	Q96ED9	19	12763003-12872740	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 35.2;RT4: 40.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043519, HPA050351"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA043519: AB_2678525, HPA050351: AB_2681102"	"unprognostic (4.26e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.25e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (7.59e-5)"	"prognostic favorable (3.28e-4)"	"unprognostic (3.27e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-2)"	18.6	6.6	14.9	5.7	13.5	1.9	15.5	21.9	17.5	8.5	14.5	4.2	32.7	25.5	8.0	24.9	18.5	8.9	16.8	15.5	12.2	6.9	16.0	15.0	8.1	4.1	10.2	8.4	8.7	31.9	28.4	49.1	11.3	12.9	17.3	12.2	6.6	22.9	35.9	29.8	26.4	27.1	5.3	10.8	6.0	18.1	7.4	12.1	3.5	33.5	15.8	11.4	10.1	12.0	3.9	3.7	2.2	2.7	2.6	6.8	2.4	15.6	3.9	4.8	3.2	5.1	4.9	17.0	4.7	2.2	2.6	3.5	13.1	18.7	2.9	8.9	4.7	2.3	20.9	4.9	14.3	2.7	9.0	3.5	3.1	7.2	4.4	2.9	1.6	4.9	5.9	13.7	3.7	5.6	6.2	1.6	6.5	5.1	2.5	5.4	35.2	1.6	3.0	2.2	10.3	4.1	5.2	2.9	7.1	5.6	40.6	12.7	6.1	3.4	10.6	3.2	4.9	15.4	4.1	3.1	6.1	3.6	9.0	1.8	9.9	9.7	1.9	5.7	5.9	4.0	0.8	1.6	0.0	3.4	2.7	2.1	3.9	4.0	1.5	3.7	3.1	6.8	4.4	2.2	2.6	1.6	1.3	1.0	2.4	14.9	13.5	21.9	17.5	12.2	6.9	10.2	8.4	12.9	12.1	17.9	33.1	12.3	94.0	44.9	115.7	31.9	63.7	16.0	21.6	78.5	94.2	60.9	36.5	60.8	8.0	14.2	163.1	0.0	39.8	32.1	17.4	85.4	11.6	20.7	14.2	60.4	60.5	17.8	8.3	6.3	25.0	14.2	27.0	27.9	58.2	33.8	44.8	101.7	25.1	32.2	86.7	12.9	16.7	69.8	14.5	57.2	107.1	16.0	69.7	77.7
HPSE	"HPA, HPSE1, HSE1"	ENSG00000173083	Heparanase	Q9Y251	4	83292461-83335153	"Enzymes, Predicted secreted proteins"	"Cell adhesion"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 15.9;Kupffer cells: 27.7;Macrophages: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.8;neutrophil: 12.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.8;monocytes: 17.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.3;OE19: 20.5"	"Region enhanced"	"Detected in some"		"olfactory region: 4.5"	"Low region specificity"	"Detected in all"			"CAB009813, HPA055344"			Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"	No	No		9700000	Nucleoplasm	Vesicles	"CAB009813: AB_2120854, HPA055344: "	"unprognostic (6.57e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.13e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.62e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.70e-3)"	4.9	5.1	3.0	6.8	3.5	2.2	1.2	0.8	2.4	3.6	6.2	7.1	0.0	2.3	2.9	2.8	14.5	5.7	3.0	5.8	3.2	1.5	3.0	5.6	8.2	16.1	7.1	1.4	7.5	1.1	15.5	2.3	11.3	3.4	1.1	7.0	0.7	12.5	2.1	0.7	6.9	3.6	2.1	7.0	19.0	2.4	6.0	2.8	1.6	1.4	16.9	9.7	2.4	4.9	0.3	1.9	12.8	17.8	1.4	3.4	4.8	7.6	0.3	0.0	1.0	1.8	0.5	0.0	0.9	4.2	1.9	8.1	0.2	5.7	0.2	1.4	2.1	13.0	7.4	9.7	1.3	3.4	0.7	0.9	2.0	5.5	0.1	1.0	1.3	4.6	0.8	2.9	1.3	9.2	0.8	10.2	1.3	0.0	23.3	0.8	1.6	0.1	0.1	0.4	20.5	1.4	0.0	0.3	0.3	5.3	0.2	5.5	0.0	10.6	5.9	0.8	1.5	0.8	1.8	11.8	0.8	2.7	0.8	0.9	0.3	3.6	0.1	6.1	6.2	1.4	0.2	17.8	0.0	1.0	6.7	0.7	0.2	1.9	0.7	1.9	0.3	1.4	1.2	12.8	1.4	0.9	0.1	3.4	4.8	3.0	3.5	0.8	2.4	3.2	1.5	7.1	1.4	3.4	2.8	6.0	4.1	0.0	2.6	3.1	0.0	0.4	0.0	2.7	3.4	1.8	0.0	0.5	0.0	1.3	0.6	0.6	5.1	0.0	1.2	2.3	0.6	1.5	0.0	0.2	15.9	0.0	6.3	3.1	27.7	0.0	0.6	10.2	0.0	0.0	2.9	0.0	0.8	8.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	3.1	1.3	3.2	4.6	3.7
HSD11B1L	"SCDR10, SDR26C2"	ENSG00000167733	"Hydroxysteroid 11-beta dehydrogenase 1 like"	Q7Z5J1	19	5680604-5688523	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"brain: 34.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 17.2"					"Low region specificity"	"Detected in all"			HPA049078			Supported	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"HPA049078: AB_2680622"	"unprognostic (2.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.73e-3)"	"unprognostic (5.26e-2)"	"unprognostic (9.37e-2)"	"prognostic favorable (4.38e-4)"	"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.52e-1)"	"unprognostic (1.73e-2)"	3.9	8.8	34.4	2.1	19.2	4.7	5.0	10.3	29.7	3.9	2.9	5.4	3.7	2.6	3.6	8.5	2.2	7.6	4.8	3.8	25.4	16.1	6.7	3.5	4.4	2.3	11.7	20.4	6.1	6.2	5.8	8.5	2.5	10.7	4.0	1.9	3.2	9.1	6.9	15.0	6.9	2.9	2.7	6.0	2.6	3.3	4.3	7.5	0.0	6.6	1.3	1.8	2.5	2.2	2.5	4.8	2.5	5.8	1.4	4.5	1.7	2.9	2.8	10.4	1.9	4.9	5.3	2.1	2.2	4.5	1.0	4.5	1.3	2.9	0.7	4.9	1.9	0.8	1.5	1.2	1.6	1.0	2.4	3.1	1.9	2.5	1.8	3.4	0.7	7.1	5.2	3.5	1.6	1.5	9.6	1.6	4.4	1.9	2.8	4.2	0.4	1.8	2.0	2.8	12.5	3.3	3.3	0.4	2.5	8.7	0.7	2.8	17.2	0.5	1.5	11.0	3.8	2.4	0.6	2.8	2.6	4.6	4.4	1.8	6.9	2.3	0.8	7.2	1.1	2.0	1.7	2.5	0.2	1.2	5.8	1.6	1.2	3.2	3.6	2.3	2.5	4.5	3.9	2.5	1.4	2.9	4.8	0.9	1.7	34.4	19.2	10.3	29.7	25.4	16.1	11.7	20.4	10.7	7.5	0.0	1.6	0.8	7.6	7.2	11.2	2.0	5.1	13.4	4.5	22.7	13.7	4.0	13.3	8.9	6.8	3.8	3.8	0.0	4.1	3.9	8.9	8.0	10.3	3.2	4.2	7.9	24.6	8.0	2.8	9.6	6.6	3.6	5.0	2.8	4.3	17.0	4.8	2.8	12.0	23.7	11.7	0.0	9.9	10.3	10.6	8.9	2.4	3.3	3.5	7.5
ICA1	"ICA69, ICAp69"	ENSG00000003147	"Islet cell autoantigen 1"	Q05084	7	8113184-8262687	"Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 58.6"	"Group enriched"	"Detected in many"	8	"Early spermatids: 546.5;Late spermatids: 690.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"T-reg: 20.8"	"Lineage enriched"	"Detected in many"	8	"T-cells: 20.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 16.3;MCF7: 15.3;OE19: 17.5;RT4: 17.9;SCLC-21H: 25.1;SH-SY5Y: 41.4;SK-BR-3: 19.6;T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017646, HPA061452"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA017646: AB_1851382, HPA061452: AB_2684525"	"unprognostic (1.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.83e-3)"	"unprognostic (9.49e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.62e-1)"	"prognostic favorable (4.23e-8)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.08e-2)"	8.9	6.1	12.6	4.2	15.3	11.7	13.0	19.4	24.2	10.7	13.2	2.5	8.7	7.7	5.5	8.5	5.8	8.1	10.4	25.7	7.7	7.8	9.1	5.3	9.2	6.9	4.8	12.4	1.6	58.6	13.2	13.5	4.6	10.5	13.7	14.3	2.5	21.2	8.3	2.8	7.0	10.4	3.7	2.8	7.6	17.9	16.0	3.2	0.8	8.1	4.1	5.5	9.6	4.1	0.3	1.7	2.4	1.6	0.7	20.8	1.1	0.0	0.3	0.6	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.3	16.3	0.1	1.6	0.0	0.3	0.0	0.3	0.7	0.0	0.0	2.5	3.4	0.3	0.0	0.1	2.8	0.5	0.0	1.1	0.0	0.0	0.1	11.9	3.2	9.6	0.0	0.0	15.3	0.1	0.0	3.7	17.5	0.1	0.0	0.0	7.1	7.0	17.9	25.1	41.4	0.0	19.6	0.2	4.4	15.9	5.2	7.0	0.0	0.3	0.0	0.3	5.2	2.4	0.0	0.0	2.2	3.4	0.5	1.6	0.1	0.2	0.5	0.4	0.2	3.9	0.3	1.7	0.3	0.2	0.1	2.4	0.7	0.2	0.4	20.8	1.1	12.6	15.3	19.4	24.2	7.7	7.8	4.8	12.4	10.5	3.2	26.8	16.6	0.8	11.9	18.2	10.0	32.3	20.4	14.7	17.0	21.0	5.9	2.2	36.5	31.7	546.5	36.1	22.9	0.0	65.8	0.7	3.3	58.9	8.1	0.8	19.0	0.0	74.0	36.2	8.3	690.2	6.9	5.8	13.5	9.0	64.9	0.8	53.9	47.2	2.8	7.3	1.6	6.5	4.7	7.5	6.4	7.9	1.8	8.9	33.8	34.2
IDUA	MPS1	ENSG00000127415	"Iduronidase, alpha-L-"	P35475	4	986997-1004506	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		130000	Vesicles		"CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429"	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favorable (8.04e-5)"	11.0	15.0	14.7	12.0	15.3	10.8	12.9	36.5	15.7	12.4	9.2	10.9	16.9	17.1	13.0	13.4	7.7	12.1	15.9	8.9	13.4	6.5	13.4	10.7	12.8	11.2	11.6	10.0	14.6	22.6	13.0	15.2	4.0	12.8	14.5	6.0	14.1	20.2	15.8	6.2	16.8	11.8	7.3	9.0	15.3	21.3	4.7	12.6	7.6	14.0	3.4	10.0	10.4	11.2	0.8	4.1	0.0	3.8	3.1	4.5	1.1	3.1	5.8	0.0	2.4	13.4	4.8	8.8	8.4	7.4	2.9	1.7	2.0	9.9	1.3	9.5	5.7	2.9	1.9	0.3	1.1	0.6	8.4	0.4	5.0	6.0	0.7	5.6	4.0	13.5	9.2	4.2	2.3	0.0	4.2	2.0	3.2	2.5	0.1	2.8	3.4	2.8	4.2	1.9	9.7	5.5	7.6	0.0	1.4	4.7	6.2	0.1	3.8	0.9	0.0	4.8	1.3	6.8	3.4	8.8	15.7	1.7	8.8	2.3	32.6	3.7	1.6	7.6	5.5	3.8	0.0	3.5	0.0	3.3	2.7	4.5	0.6	2.7	2.6	4.1	0.8	3.4	2.0	0.0	3.1	3.8	2.5	1.3	1.1	14.7	15.3	36.5	15.7	13.4	6.5	11.6	10.0	12.8	12.6	6.0	5.3	0.5	8.6	3.2	1.9	2.4	0.0	0.0	1.2	7.0	3.9	0.4	0.0	1.6	0.7	3.7	4.2	0.0	2.1	1.4	5.1	7.4	2.3	2.4	5.8	0.0	10.3	6.2	4.6	0.2	18.1	3.5	5.0	0.0	3.6	1.9	1.6	6.0	9.9	1.3	2.2	0.0	3.9	1.4	1.5	1.6	0.3	5.0	3.5	5.8
IFI30	"GILT, IFI-30, IP-30, IP30, MGC32056"	ENSG00000216490	"IFI30, lysosomal thiol reductase"	P13284	19	18173162-18178117	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 348.5"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 159.4;Kupffer cells: 201.6;Macrophages: 219.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 348.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 145.5;granulocytes: 95.4;monocytes: 348.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 76.0;RPMI-8226: 82.4;SK-BR-3: 55.7;U-266/84: 91.1"					"Low region specificity"	"Detected in many"			HPA026650	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		89000	"Vesicles, Cytosol"		"HPA026650: AB_10602237"	"unprognostic (4.66e-2)"	"unprognostic (1.25e-4)"	"unprognostic (2.35e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (9.19e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.29e-11)"	"unprognostic (3.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.59e-3)"	104.2	31.0	5.8	85.5	10.8	28.3	13.9	1.2	5.2	5.3	17.4	6.5	3.2	23.3	5.0	13.7	9.3	15.9	13.1	16.2	5.0	4.0	37.5	60.4	109.7	139.5	12.0	0.8	15.0	14.6	2.0	7.6	123.2	11.0	8.6	18.2	9.2	18.7	4.3	7.2	10.1	28.5	18.9	13.3	140.6	19.4	5.7	7.9	20.6	15.6	9.6	41.2	24.5	8.2	24.3	145.5	95.4	348.5	1.7	1.0	213.4	12.8	6.8	0.0	4.5	1.3	1.8	12.2	1.4	1.9	3.9	10.2	15.3	23.0	76.0	11.7	4.4	20.2	10.1	8.1	3.0	0.4	20.2	5.8	0.9	12.6	21.7	13.0	2.2	5.9	7.9	6.9	6.4	2.3	0.5	0.2	2.3	10.7	47.8	1.9	25.2	1.0	0.2	2.5	44.2	6.8	7.4	0.5	82.4	11.7	0.4	0.6	0.8	23.6	55.7	1.3	0.9	3.8	0.9	0.3	6.8	4.1	13.9	1.4	1.6	91.1	43.3	18.8	15.0	1.0	2.0	228.9	95.4	1.0	348.5	1.0	24.3	0.7	0.8	145.5	16.8	0.5	0.6	52.5	1.7	230.0	4.3	1.0	213.4	5.8	10.8	1.2	5.2	5.0	4.0	12.0	0.8	11.0	7.9	8.9	51.2	68.0	1.9	3.2	0.1	0.6	7.6	13.4	31.8	12.2	0.0	4.4	1.7	1.2	0.2	2.2	3.8	0.0	1.0	12.3	1.9	3.5	12.8	1.5	159.4	0.0	0.0	4.9	201.6	0.0	0.3	219.1	5.0	58.7	4.6	0.6	1.7	2.5	0.0	4.8	0.4	0.0	0.9	0.0	0.7	2.9	10.1	3.8	5.1	1.3
IGSF8	"CD316, CD81P3, EWI2, PGRL"	ENSG00000162729	"Immunoglobulin superfamily member 8"	Q969P0	1	160091340-160098943	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.2"	"Cell type enhanced"	"Detected in many"	7	"Extravillous trophoblasts: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011917, HPA075970"	Approved		Supported	Vesicles		NA	NA		190000	Vesicles		"HPA011917: AB_1851536, HPA075970: "	"unprognostic (4.08e-1)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.75e-3)"	9.9	10.4	25.2	9.0	30.3	2.4	11.1	40.9	54.2	9.6	11.8	53.5	6.4	18.2	8.6	16.6	7.0	13.9	8.5	11.6	32.4	24.1	10.4	19.3	10.1	10.3	32.2	29.9	15.1	19.1	9.0	8.7	7.8	25.9	13.8	7.4	11.2	21.0	14.0	6.0	34.0	14.4	5.1	42.6	10.6	9.8	11.5	25.3	6.2	10.0	5.9	6.2	6.0	6.9	14.3	5.6	1.2	4.0	4.7	15.6	6.4	8.9	5.4	7.0	17.9	4.1	2.6	14.8	4.4	5.8	9.5	8.9	6.1	6.2	13.2	16.6	6.4	8.2	17.3	2.8	6.5	1.3	15.7	5.1	1.7	6.0	10.4	6.9	4.5	14.7	3.2	13.2	6.1	2.0	6.7	1.9	14.6	2.3	7.6	2.2	8.5	11.2	10.5	14.8	18.8	8.6	6.4	3.6	9.5	8.6	9.3	2.9	12.8	5.0	16.5	58.9	6.4	11.7	5.8	1.9	4.2	9.1	7.5	3.5	21.0	23.2	5.9	14.8	1.8	10.9	0.0	2.9	1.2	13.3	4.0	11.7	12.2	11.0	15.4	3.3	14.3	14.8	15.6	0.8	4.7	2.4	5.6	14.9	6.4	25.2	30.3	40.9	54.2	32.4	24.1	32.2	29.9	25.9	25.3	8.9	3.5	22.5	26.4	38.8	54.6	3.2	12.7	0.0	1.2	36.6	9.8	28.1	5.0	30.1	3.1	7.9	34.9	0.0	10.8	187.6	24.7	18.9	10.3	26.8	13.7	62.0	19.1	9.8	3.2	0.5	15.5	8.0	40.5	85.6	23.2	90.2	17.8	37.4	14.9	13.3	11.7	6.5	16.3	1.7	5.8	54.5	58.0	14.4	27.4	24.0
IL33	"C9orf26, DKFZp586H0523, DVS27, IL1F11, NF-HEV"	ENSG00000137033	"Interleukin 33"	O95760	9	6215786-6257983	"Predicted intracellular proteins, Predicted secreted proteins"	Transcription	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Ciliated cells: 112.4;Club cells: 135.4;Endothelial cells: 153.6;Ito cells: 400.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 19.9;U-2197: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007057, HPA022899, HPA024426"	Supported		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA			Nucleoplasm	Vesicles	"CAB007057: , HPA022899: , HPA024426: AB_1845820"	"prognostic favorable (4.42e-4)"	"unprognostic (8.36e-2)"	"unprognostic (5.67e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.66e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.70e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.85e-3)"	19.7	8.6	13.7	17.7	13.2	0.0	14.8	7.4	6.7	33.0	16.7	4.6	9.1	3.4	29.2	14.8	32.3	13.5	13.8	29.6	12.7	5.6	3.9	22.3	22.0	57.7	5.8	7.9	18.6	2.5	1.9	6.0	25.2	5.9	39.8	8.3	16.6	9.5	13.9	6.6	18.1	9.6	42.0	6.3	7.9	21.6	9.2	6.0	1.3	13.9	11.6	17.4	53.2	15.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.1	0.1	19.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	13.2	7.4	6.7	12.7	5.6	5.8	7.9	5.9	6.0	6.0	11.1	0.0	10.2	21.5	0.0	5.6	7.6	112.4	135.4	0.0	0.0	0.0	0.0	2.2	0.6	153.6	0.0	23.3	6.7	0.0	9.7	1.7	1.1	2.6	0.1	0.0	10.3	400.8	26.5	0.7	19.0	1.5	1.7	0.0	0.0	9.6	7.1	0.0	11.7	0.0	0.0	0.0	12.4	0.0	0.4	42.3	0.1	1.5	0.1	1.7
IL37	"FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H4, IL-1RP1, IL1F7"	ENSG00000125571	"Interleukin 37"	Q9NZH6	2	112912971-112918882	"Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 55.0"	"Cell type enhanced"	"Detected in single"	22	"Suprabasal keratinocytes: 2.5"	"Cancer enriched"	"Detected in some"	6	"lung cancer: 6.5"					"Cell type enriched"	"Detected in single"	28	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	28	"NK-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.9;PC-3: 10.6;RT4: 5.7"									"HPA054371, HPA057950"	Uncertain		Supported	Nucleoplasm,Vesicles	"Secreted to blood"	NA	NA	76700		"Nucleoplasm, Vesicles"		"HPA054371: AB_2682465, HPA057950: AB_2683561"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.71e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-2)"		"unprognostic (1.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.26e-3)"			"unprognostic (3.95e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.35e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.4		0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.0	0.6			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.9	0.0	0.8	0.1	0.0	0.0	0.2	0.4	4.9	0.3	0.5	0.5	0.6	0.0	0.5	0.3	0.5	0.1	0.2	0.8	1.5	0.3	0.0	1.8	0.2	0.8	0.0	0.0	0.3	0.0	0.0	0.5	1.2	0.4	0.0	0.1	0.0	0.1	1.1	0.0	0.0	1.4	0.5	0.4	10.6	0.1	0.0	0.0	0.0	5.7	0.4	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	2.5	0.0	0.0	0.0	0.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin beta E subunit"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 127.6"	"Cell type enriched"	"Detected in single"	51	"Hepatocytes: 32.6"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HHSteC: 15.2;Karpas-707: 22.8;RH-30: 10.7;U-266/70: 76.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"	NA	NA		1400000	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	127.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	1.0	0.9	3.1	0.6	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.8	2.2	0.0	2.7	0.1	0.0	1.1	0.5	0.2	0.0	0.1	0.5	0.0	0.3	5.1	0.0	0.0	0.0	3.3	15.2	0.6	0.7	1.4	1.5	0.3	3.3	0.1	0.0	0.5	1.3	22.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	2.3	0.0	0.0	5.7	0.2	0.0	0.0	2.1	0.1	0.1	2.4	0.0	0.0	1.2	0.0	0.1	76.9	2.4	1.0	0.4	0.1	0.1	1.9	0.5	0.5	0.3	0.4	0.4	0.9	0.1	0.2	0.1	1.0	0.2	0.5	3.1	0.6	0.6	0.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
INPP5F	"hSac2, KIAA0966, SAC2"	ENSG00000198825	"Inositol polyphosphate-5-phosphatase F"	Q9Y2H2	10	119726097-119829278	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 30.5;SH-SY5Y: 24.2;SK-MEL-30: 46.0;SuSa: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042605			Supported	Vesicles		NA	NA			Vesicles		"HPA042605: AB_10793886"	"unprognostic (2.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.21e-2)"	4.6	12.3	17.5	5.9	50.4	3.2	5.7	37.0	52.9	10.9	5.0	5.5	2.2	3.1	11.8	18.0	4.5	4.2	5.5	4.1	24.6	53.1	7.3	2.0	4.2	7.6	23.7	29.1	9.8	4.6	8.9	34.0	8.2	69.7	8.3	6.1	3.4	7.1	8.4	7.5	10.4	3.8	10.8	19.2	4.1	3.8	10.1	7.3	1.4	8.4	1.4	9.3	5.3	4.5	12.2	7.4	1.5	4.5	3.8	6.7	2.2	3.9	2.7	30.5	4.4	3.3	3.4	2.7	5.5	3.0	2.6	2.6	4.0	5.0	2.5	2.1	6.9	3.6	4.4	3.3	3.2	4.0	1.6	3.0	1.7	1.4	4.1	4.6	1.1	5.6	4.1	3.0	5.2	5.2	5.4	8.8	2.0	1.5	4.1	6.2	2.2	1.5	4.6	2.9	3.6	3.5	2.1	5.4	0.6	4.4	2.0	2.2	24.2	6.1	1.9	46.0	63.8	1.3	1.2	5.8	2.6	3.4	3.4	5.3	4.6	2.0	1.1	3.3	3.9	10.7	1.1	4.0	1.5	1.3	3.5	1.6	8.1	2.8	1.9	7.4	12.2	3.2	1.4	1.0	3.8	4.5	1.8	6.7	2.2	17.5	50.4	37.0	50.5	24.6	53.1	23.7	29.1	69.7	7.3	6.0	4.5	10.0	9.8	8.0	24.8	5.3	0.0	2.7	5.7	12.2	15.7	7.7	10.0	3.1	28.7	7.4	6.4	0.0	3.9	7.2	6.7	8.4	2.3	2.8	8.6	39.7	1.2	4.9	5.7	18.7	4.9	11.5	18.6	21.6	5.8	18.8	5.5	5.5	3.5	16.7	21.0	6.5	7.5	10.3	40.3	9.2	11.1	4.3	6.0	10.2
IST1	KIAA0174	ENSG00000182149	"IST1, ESCRT-III associated factor"	P53990	16	71845996-71931199	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041802, HPA054532"	Approved		Supported	Vesicles		NA	NA		45000	Vesicles		"HPA041802: AB_10794491, HPA054532: AB_2682517"	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (4.55e-4)"	"unprognostic (1.64e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.43e-3)"	"prognostic favorable (8.88e-4)"	43.9	41.2	40.4	36.4	48.5	54.9	43.2	42.4	50.8	41.5	51.7	63.2	36.6	39.9	48.1	35.4	44.9	49.6	37.1	40.0	39.9	38.6	54.9	36.4	43.9	45.4	53.4	36.8	49.6	49.8	91.6	55.5	52.1	41.7	40.2	50.0	45.1	39.2	38.4	64.6	45.7	46.5	48.4	56.4	55.8	40.5	45.9	48.9	50.6	47.3	32.8	60.6	44.6	42.6	52.4	52.1	87.3	56.5	52.7	67.6	71.8	16.9	25.0	35.3	22.7	35.5	25.1	29.9	21.2	26.9	29.8	31.3	27.1	23.7	24.2	26.5	24.6	21.3	25.7	34.4	22.6	38.1	16.0	16.7	20.3	15.0	43.6	26.9	19.8	28.9	29.6	31.6	26.7	25.8	29.9	37.2	22.9	27.8	8.9	30.6	28.3	25.6	16.6	40.3	27.8	15.6	40.6	19.3	29.5	24.9	24.8	26.6	19.9	23.6	12.5	19.3	45.3	22.8	24.7	18.5	22.6	22.4	13.8	16.8	23.5	41.6	66.5	19.2	17.8	27.1	55.5	56.5	67.7	49.0	53.0	53.0	52.4	47.0	51.2	52.1	51.8	50.7	47.4	87.3	52.7	49.6	36.2	67.6	71.8	40.4	48.5	42.4	50.8	39.9	38.6	53.4	36.8	41.7	48.9	44.7	53.3	37.3	35.4	62.3	26.4	36.4	68.8	52.2	44.3	43.6	23.6	49.1	29.9	40.1	13.5	48.8	83.5	0.0	36.6	37.1	53.1	37.5	59.0	37.7	46.2	20.6	72.4	50.3	73.9	15.0	38.0	52.9	40.5	66.7	69.5	21.7	47.6	73.7	44.9	42.6	29.3	58.2	42.6	47.8	54.0	61.2	54.9	56.4	51.0	50.3
JAG2		ENSG00000184916	"Jagged 2"	Q9Y219	14	105140981-105168824	"Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.0"	"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 20.7;Cone photoreceptor cells: 23.6;Endothelial cells: 17.9;Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.7;CAPAN-2: 10.7;HaCaT: 33.0;HBEC3-KT: 11.1;SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025481, HPA030636, HPA050567"	Approved		Supported	Vesicles,Cytosol		NA	NA		120000	Vesicles	Cytosol	"CAB025481: , HPA030636: AB_10602607, HPA050567: AB_2681178"	"unprognostic (6.74e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.28e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.17e-1)"	11.5	2.5	5.4	3.5	6.3	1.3	11.4	6.4	8.4	4.2	3.0	3.5	5.2	3.2	7.5	8.4	8.1	5.0	4.4	9.5	5.6	6.4	3.0	1.5	6.6	2.4	4.5	5.3	2.7	5.8	4.3	15.9	6.8	8.7	7.1	1.7	5.9	12.2	6.9	16.8	36.0	4.3	3.2	2.9	3.7	3.8	4.2	3.0	2.7	4.2	11.0	4.1	5.2	5.6	0.0	0.0	0.0	0.0	0.5	0.3	0.0	8.5	3.5	0.2	0.9	0.0	0.0	10.7	0.1	0.1	0.0	0.0	2.9	10.7	0.0	7.4	0.0	0.0	33.0	2.1	11.1	0.0	1.1	5.1	0.0	9.5	0.0	0.1	0.0	2.1	0.1	5.4	0.0	1.2	0.1	2.7	0.4	2.1	0.0	0.0	3.9	0.0	0.0	1.1	1.0	1.2	2.7	2.1	3.7	0.1	2.3	16.9	0.5	2.9	0.7	0.1	0.2	8.4	1.3	9.1	0.0	0.9	0.0	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	5.4	6.3	6.4	8.4	5.6	6.4	4.5	5.3	8.7	3.0	6.0	2.7	0.0	7.9	20.7	1.1	5.9	0.0	5.3	7.9	0.0	23.6	1.9	0.0	3.4	0.1	17.9	4.9	0.0	2.2	0.9	1.0	2.7	0.0	0.6	0.6	25.4	0.0	5.5	0.0	0.4	1.4	1.2	6.8	1.8	2.8	0.6	3.6	2.8	0.7	0.1	4.8	0.0	2.1	0.5	13.7	5.9	1.1	2.6	2.9	1.4
KCNH1	"eag, eag1, h-eag, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134180	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 20.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 9.0;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.3;RH-30: 7.2;RPTEC TERT1: 4.2;SH-SY5Y: 9.2;SK-MEL-30: 8.6;T-47d: 6.5"	"Low region specificity"	"Detected in all"							"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.9	2.3	6.3	1.3	13.3	0.7	0.6	19.1	20.2	1.0	1.3	3.3	0.2	1.2	1.5	1.0	0.9	1.2	1.0	0.7	3.8	1.7	1.0	0.7	0.7	0.7	1.1	7.5	0.8	0.9	0.9	0.8	1.1	1.7	1.3	1.3	0.0	0.8	0.9	0.7	0.9	1.0	1.0	2.1	0.6	1.5	2.4	1.5	0.0	0.8	0.0	0.7	0.9	0.7	0.1	0.7	0.7	0.1	0.1	0.3	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.7	0.1	1.5	1.7	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	4.2	0.0	0.3	9.2	1.6	0.1	8.6	1.2	6.5	0.0	0.0	1.1	0.1	1.4	0.8	0.0	0.0	0.0	0.2	0.0	0.6	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.7	0.1	0.0	6.3	13.3	19.1	20.2	3.8	1.7	1.1	7.5	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382570-48391553	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 488.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	46.9	49.3	22.6	23.4	21.5	14.5	60.6	16.1	28.8	51.8	43.3	24.4	64.8	47.7	44.0	45.2	41.3	40.3	56.5	42.8	20.9	20.4	57.3	81.3	38.0	44.6	18.6	20.4	68.9	61.0	63.5	45.7	81.4	20.9	44.8	47.7	39.7	65.8	69.9	31.8	37.4	59.9	39.6	26.0	33.7	42.5	33.2	18.6	26.2	75.5	32.9	42.3	53.2	54.4	10.6	26.5	6.8	23.3	11.6	12.8	9.3	30.2	43.8	25.4	26.9	57.2	67.0	18.6	29.9	52.9	36.5	41.9	28.8	34.6	12.6	19.6	65.3	22.8	27.2	30.6	32.0	34.9	10.2	32.6	10.5	15.6	53.7	49.8	11.7	19.7	63.2	39.5	24.7	26.5	57.6	33.9	10.9	18.2	23.5	48.4	24.4	11.0	120.4	18.4	60.6	17.8	15.8	15.2	19.7	46.3	25.2	25.5	19.9	26.2	23.5	15.6	30.4	18.5	14.5	26.2	25.8	21.4	21.3	25.4	66.6	52.1	8.5	16.4	15.9	26.3	5.9	23.3	6.8	11.2	19.8	12.8	10.6	11.0	12.1	17.7	9.6	9.2	9.9	5.9	11.6	16.5	26.5	11.7	9.3	22.6	21.5	16.1	28.8	20.9	20.4	18.6	20.4	20.9	18.6	32.8	44.6	55.9	109.7	66.9	36.0	25.0	94.3	48.2	69.4	89.0	5.9	200.0	48.0	191.8	3.8	91.1	175.8	46.7	148.2	488.3	138.8	143.5	61.2	66.0	162.8	38.1	139.2	77.3	97.8	10.5	151.3	75.4	87.7	106.4	269.4	89.6	162.2	178.9	124.1	122.0	21.4	84.1	77.3	41.2	38.1	61.4	324.3	45.4	168.0	114.5
KLHL12	C3IP1	ENSG00000117153	"Kelch like family member 12"	Q53G59	1	202891100-202928636	"Predicted intracellular proteins"	"ER-Golgi transport, Transport, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 101.2;Late spermatids: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071324			Supported	"Vesicles,Centriolar satellite"		NA	NA		9600000	"Vesicles, Centriolar satellite"		"HPA071324: AB_2686389"	"unprognostic (1.69e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.11e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.22e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.87e-2)"	14.1	18.3	19.3	17.1	20.2	16.1	20.1	18.6	35.5	14.1	18.4	14.2	13.5	13.9	14.7	23.2	17.2	18.5	12.6	25.2	19.2	25.6	21.5	17.1	20.4	29.6	19.6	20.1	18.1	25.6	17.9	19.0	15.0	24.7	19.6	23.2	12.7	13.8	16.6	14.6	13.5	14.3	19.7	25.2	19.4	15.4	41.3	14.6	15.9	19.6	10.1	20.6	16.1	16.2	9.5	12.7	18.4	14.9	10.2	13.3	9.9	10.1	12.1	15.5	17.4	24.0	18.2	18.1	12.2	14.2	15.4	14.1	11.4	16.6	28.2	9.5	13.8	15.6	12.9	20.7	17.1	16.9	14.7	8.7	9.9	9.5	11.4	17.4	20.6	16.5	17.3	21.8	13.3	29.3	12.1	13.7	28.8	24.6	18.7	20.9	13.6	17.1	10.0	22.0	12.7	9.2	18.2	27.1	18.0	13.3	12.5	11.5	13.1	15.2	13.9	16.4	29.4	25.3	14.5	11.1	15.1	10.6	3.6	10.8	13.5	10.8	23.8	14.7	14.8	14.3	9.2	12.0	18.4	9.1	14.9	13.2	9.5	9.1	10.8	12.7	9.3	9.6	10.3	12.4	10.2	14.7	7.6	13.3	9.9	19.3	20.2	18.6	35.5	19.2	25.6	19.6	20.1	24.7	14.6	6.0	8.6	6.9	9.0	4.7	9.9	14.6	7.6	2.7	4.5	15.7	11.8	9.8	19.9	10.1	101.2	6.4	11.1	0.0	7.9	10.1	6.7	8.5	3.5	5.9	14.9	4.8	10.4	11.1	12.3	66.5	7.8	9.8	5.0	15.4	14.3	10.8	10.2	10.5	7.8	12.3	9.0	6.5	6.2	16.9	45.6	5.8	9.3	11.4	12.1	6.4
KLHL22	"FLJ14360, KELCHL"	ENSG00000099910	"Kelch like family member 22"	Q53GT1	22	20441519-20495883	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040766			Supported	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	No			"Vesicles, Microtubules, Cytokinetic bridge, Mitotic spindle"		"HPA040766: AB_2732488"	"unprognostic (4.15e-1)"	"unprognostic (9.34e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (4.88e-6)"	"unprognostic (1.17e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.99e-2)"	"prognostic favorable (3.85e-6)"	"unprognostic (3.94e-2)"	"prognostic favorable (1.34e-8)"	"unprognostic (3.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.08e-2)"	10.8	12.4	15.2	11.2	17.8	8.6	9.6	26.9	24.0	15.4	10.7	11.8	13.1	6.5	17.8	15.7	8.5	15.1	15.9	11.2	14.2	14.9	13.7	9.0	11.1	13.1	11.5	16.3	19.8	16.3	20.7	14.7	13.2	10.9	16.6	9.2	17.0	11.3	16.2	16.3	9.9	8.0	19.0	7.8	12.5	9.9	8.3	9.6	5.0	18.5	6.8	17.1	11.1	12.3	7.1	12.9	15.1	6.6	13.7	16.0	5.1	9.0	8.9	20.1	16.7	17.2	19.8	5.0	11.6	19.2	11.9	13.1	4.6	3.4	6.0	3.9	20.4	9.2	11.6	13.9	5.2	10.6	12.3	7.5	5.7	8.7	4.5	15.8	1.4	6.7	15.3	7.9	10.3	7.3	14.7	16.5	4.9	16.7	6.4	11.5	14.2	1.2	8.5	3.5	7.1	6.4	12.5	7.4	0.3	6.9	11.0	10.9	11.3	12.0	9.3	8.4	7.3	8.2	5.0	7.3	14.4	6.9	9.7	4.8	3.6	3.7	4.5	7.6	5.6	9.3	5.4	3.6	15.1	7.3	5.1	5.7	7.1	9.3	6.6	12.9	6.1	7.3	7.3	8.7	13.7	6.6	4.9	16.0	5.1	15.2	17.8	26.9	24.0	14.2	14.9	11.5	16.3	10.9	9.6	0.0	3.0	3.7	2.7	1.4	10.8	4.1	10.2	4.0	3.4	8.7	3.9	13.9	3.3	7.6	0.2	3.0	2.1	0.0	2.2	5.8	5.5	3.4	4.7	5.0	6.9	12.7	2.9	4.3	4.3	1.3	11.2	3.4	1.7	1.8	4.8	12.8	5.3	3.2	18.7	7.3	5.9	6.5	4.7	6.2	7.7	1.3	11.2	6.9	3.5	1.3
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120427827-120469365	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 112.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 112.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100, HPA029101"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		820000000	"Vesicles, Plasma membrane"		"CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: "	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	21.8	33.6	39.9	16.1	87.9	22.6	27.1	16.2	55.5	33.0	18.3	88.7	27.9	25.1	20.8	37.5	34.6	22.4	43.3	20.9	52.5	30.3	55.0	83.7	25.3	14.3	131.0	36.9	22.7	27.4	28.8	20.2	35.4	58.6	37.3	19.7	17.2	47.8	32.9	32.4	26.9	20.5	21.1	84.3	17.9	23.6	11.9	116.9	21.2	33.7	14.3	15.4	21.1	27.0	3.7	11.6	112.9	21.7	5.4	5.8	10.5	11.7	11.6	8.6	10.9	112.3	38.3	23.6	20.3	35.4	19.7	37.0	9.6	21.0	8.3	17.9	35.2	63.0	19.7	12.4	15.3	32.2	9.3	8.8	6.5	12.9	12.9	37.4	28.7	18.2	41.5	30.9	26.3	17.4	52.1	26.9	5.9	7.5	29.7	31.9	21.6	8.0	14.7	6.6	16.8	10.2	6.2	14.5	14.8	28.9	8.7	2.9	4.5	21.7	22.1	43.3	15.8	13.1	32.1	27.8	28.4	13.8	36.5	54.7	14.9	14.2	5.4	27.1	34.7	67.9	4.9	21.7	41.3	5.0	18.7	4.0	3.1	4.8	4.7	11.6	3.7	4.3	4.1	112.9	5.4	17.3	6.3	5.8	10.5	39.9	87.9	16.2	55.5	52.5	30.3	131.0	36.9	58.6	116.9	68.5	48.0	23.8	73.6	89.6	15.0	29.0	186.0	44.2	52.4	62.8	13.7	140.2	33.2	170.8	2.3	65.2	53.1	0.0	62.0	111.7	86.5	124.2	16.3	167.8	191.1	17.5	35.2	100.7	120.2	4.2	105.3	97.6	124.9	124.4	31.2	128.8	66.8	43.5	103.3	128.2	9.3	38.8	61.8	5.6	13.2	119.1	336.5	30.5	31.0	76.1
LAMTOR1	"C11orf59, FLJ20625, p18, p27RF-Rho, Pdro, Ragulator1"	ENSG00000149357	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 1"	Q6IAA8	11	72085895-72103387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002997	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		270000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"HPA002997: AB_1845531"	"unprognostic (7.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.78e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	47.3	55.3	51.3	33.3	55.6	49.7	69.1	23.1	51.1	43.3	40.4	44.1	39.4	35.1	36.0	48.1	42.2	40.7	44.0	59.9	45.4	41.4	58.0	60.5	44.3	71.5	52.5	29.9	38.0	45.0	33.3	37.6	41.6	38.1	39.8	40.2	40.4	45.0	45.5	57.6	33.2	41.8	38.8	49.0	52.9	35.6	22.6	31.9	28.2	61.3	39.4	40.0	32.7	35.0	25.7	57.7	44.9	68.7	19.7	16.4	55.4	17.7	35.1	19.0	23.1	41.8	29.0	19.1	24.7	35.2	38.1	29.0	44.4	24.4	17.9	32.0	38.8	41.8	25.8	29.7	49.6	27.5	22.4	19.7	46.8	22.6	29.7	59.6	18.1	27.9	50.1	36.3	40.3	38.5	22.0	30.5	20.3	19.6	16.6	37.4	56.1	14.0	28.2	17.9	52.5	38.5	12.3	32.9	14.4	47.6	37.6	11.6	19.8	25.0	23.5	62.8	19.9	34.6	16.1	24.5	26.2	19.3	61.8	17.1	22.3	25.3	13.7	15.3	14.5	19.8	17.7	68.7	44.9	15.0	38.6	14.4	23.8	14.2	14.9	57.7	25.7	12.0	14.6	40.5	19.7	29.3	34.3	16.4	55.4	51.3	55.6	23.1	51.1	45.4	41.4	52.5	29.9	38.1	31.9	41.7	67.1	112.5	126.6	49.5	55.8	59.6	117.2	40.2	38.7	122.1	11.8	215.3	250.4	239.8	8.2	119.1	202.2	23.3	296.4	256.0	106.0	156.2	96.8	74.4	406.3	73.1	111.8	121.5	233.5	14.8	99.8	203.7	108.0	462.5	116.1	147.8	252.3	157.8	96.5	288.8	41.4	109.9	92.7	47.9	102.2	48.4	235.8	114.6	149.4	137.5
LAMTOR4	C7orf59	ENSG00000188186	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4"	Q0VGL1	7	100148907-100155944	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 206.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020998	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA020998: AB_1845762"	"prognostic favorable (2.48e-4)"	"prognostic favorable (6.08e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.68e-2)"	31.0	30.7	43.8	36.0	40.2	54.7	43.2	20.9	70.6	28.5	41.8	27.9	26.5	28.6	25.0	35.3	32.9	35.9	36.0	42.2	39.5	35.1	36.3	24.9	32.0	44.7	49.5	30.7	30.0	36.9	19.3	28.5	26.8	38.7	30.8	34.5	31.2	35.4	27.5	44.4	84.7	27.2	31.3	47.8	41.5	29.7	21.3	35.2	15.7	37.3	33.1	26.6	31.3	39.6	31.4	35.1	206.0	53.2	17.6	26.5	46.2	19.2	46.9	24.8	31.3	26.4	30.5	20.2	11.6	28.6	21.6	26.8	21.6	31.1	31.1	39.3	17.5	39.5	20.4	23.5	29.9	9.3	31.4	66.4	24.8	44.4	37.2	24.9	19.2	35.9	36.5	29.6	22.6	28.0	24.2	33.0	29.2	23.3	50.2	29.4	91.9	18.6	77.5	26.3	53.5	37.7	19.6	20.4	55.4	24.5	23.6	17.5	32.4	21.4	50.4	38.4	19.8	20.2	38.2	22.0	20.7	30.8	42.6	18.6	30.5	40.6	57.6	33.0	54.0	29.3	52.0	53.2	183.0	19.6	46.9	16.3	31.4	24.8	20.2	35.1	27.7	25.5	20.5	206.0	17.6	43.4	29.7	26.5	46.2	43.8	40.2	20.9	70.6	39.5	35.1	49.5	30.7	38.7	35.2	86.4	157.1	194.3	153.1	244.3	54.7	157.4	145.2	139.2	85.3	207.6	11.8	217.7	452.6	149.0	26.3	183.1	559.6	0.0	283.4	159.4	191.6	159.9	180.0	212.1	461.4	55.6	287.5	220.4	484.9	36.2	135.4	342.4	411.7	182.1	346.6	148.8	173.2	634.8	113.1	406.9	51.3	142.3	219.3	71.5	128.6	579.4	168.4	176.8	418.7	161.9
LDLRAD4	C18orf1	ENSG00000168675	"Low density lipoprotein receptor class A domain containing 4"	O15165	18	13217498-13652755	"Predicted intracellular proteins, Predicted membrane proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.4;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 112.3;Late spermatids: 181.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.6;JURKAT: 15.5;MOLT-4: 47.7;REH: 14.4;U-698: 12.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047633, HPA065246"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA047633: , HPA065246: AB_2685444"	"unprognostic (2.52e-1)"	"unprognostic (4.31e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.94e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (2.51e-2)"	"unprognostic (4.38e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.18e-2)"	8.3	6.6	9.6	11.5	22.0	11.9	7.5	10.3	22.9	8.6	6.1	45.4	4.3	9.8	12.9	5.2	5.6	11.0	7.8	17.8	14.6	10.7	3.9	10.4	5.9	11.6	19.9	12.5	3.6	6.2	4.6	8.3	8.0	23.5	10.4	3.3	3.7	4.8	8.3	19.0	4.8	10.9	7.5	30.7	8.9	7.6	8.9	21.2	49.2	5.2	2.5	8.5	7.9	6.7	8.2	8.2	17.2	11.0	12.5	14.5	6.2	0.1	0.2	0.9	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.5	0.4	0.2	0.0	0.0	0.0	7.8	0.8	15.6	3.2	0.2	0.0	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	15.5	0.2	0.6	0.0	1.2	47.7	0.6	1.2	0.2	5.5	14.4	0.1	0.6	0.0	0.8	1.1	1.6	0.2	1.1	0.0	0.7	2.1	4.8	1.4	0.8	5.6	0.1	1.0	2.2	0.2	12.0	0.0	3.5	3.2	12.7	10.3	3.4	10.2	10.3	8.9	7.2	9.7	8.8	5.1	8.2	14.5	12.6	17.2	12.5	11.0	8.2	5.2	6.2	9.6	22.0	10.3	20.6	14.6	10.7	19.9	12.5	23.5	21.2	3.0	6.6	34.6	2.1	9.3	4.2	15.4	0.0	6.7	7.9	1.8	66.8	0.6	1.7	5.0	112.3	18.0	7.1	0.0	3.3	0.4	27.0	21.2	23.1	21.7	18.5	0.0	56.4	18.4	18.9	181.4	10.3	35.0	13.5	6.4	7.9	4.3	0.5	3.5	23.0	2.1	17.0	6.5	9.2	2.3	5.3	6.8	1.4	16.6	6.7	3.0
LIPA	"CESD, LAL"	ENSG00000107798	"Lipase A, lysosomal acid type"	P38571	10	89213569-89414557	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 139.0"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 503.3;Kupffer cells: 514.1;Macrophages: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 31.8;intermediate monocyte: 68.4;myeloid DC: 23.3;non-classical monocyte: 35.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.3;monocytes: 68.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 61.6;ASC TERT1: 77.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034892, HPA057052"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		150000	"Vesicles, Cytosol"	"Nucleoplasm, Nucleoli fibrillar center"	"CAB034892: AB_784329, HPA057052: AB_2683322"	"unprognostic (1.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.71e-2)"	139.0	16.3	15.8	14.4	22.7	7.8	19.9	8.8	21.4	13.4	28.1	61.3	3.4	37.4	10.2	5.2	9.5	9.0	19.4	8.7	22.5	13.8	10.8	49.3	38.5	45.7	41.6	13.4	10.4	9.5	17.5	6.3	17.8	28.4	7.4	16.7	5.7	11.0	8.8	4.1	6.8	65.8	11.3	55.1	87.3	7.9	3.1	37.2	7.0	8.3	4.7	10.0	15.1	8.6	7.0	23.3	3.2	68.4	5.5	8.3	25.5	55.0	8.5	5.6	61.6	58.1	77.3	1.6	29.2	34.2	12.2	21.9	3.2	29.7	10.2	5.7	45.7	13.1	55.2	2.4	15.8	9.1	14.3	5.7	4.2	3.6	13.1	15.3	8.1	8.4	34.3	11.4	13.0	7.0	14.8	2.4	7.7	0.0	19.0	9.5	4.6	7.0	5.5	3.6	9.8	9.6	4.6	6.6	9.4	11.3	8.7	1.9	3.9	7.1	9.2	21.5	3.9	10.5	10.5	4.4	10.4	2.7	22.2	7.1	9.9	10.5	4.2	12.4	18.0	13.0	0.8	31.8	3.2	8.2	68.4	8.2	6.5	7.3	7.8	23.3	7.0	7.7	8.3	1.4	5.5	35.6	4.7	7.1	25.5	15.8	22.7	8.8	21.4	22.5	13.8	41.6	13.4	28.4	37.2	38.7	42.2	50.6	22.0	15.8	5.2	8.5	45.9	14.7	13.6	31.4	0.0	28.4	18.3	29.7	4.4	53.1	3.9	23.3	31.7	28.0	34.8	15.2	27.7	46.5	503.3	15.9	20.9	52.8	514.1	1.8	10.6	167.0	45.5	27.9	9.4	29.4	17.5	5.9	20.5	14.6	1.3	6.5	21.8	4.8	10.9	10.9	16.7	33.0	8.7	20.1
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	DNA-binding	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 202.5"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 551.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 202.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 202.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	55.0	14.1	18.0	49.2	42.4	53.3	65.7	5.0	18.5	50.4	36.4	45.2	20.2	13.9	42.7	28.8	19.6	34.0	35.3	31.5	20.7	15.7	48.9	66.3	73.0	80.6	28.6	13.2	43.1	26.3	15.9	17.1	46.2	42.8	36.2	36.7	26.0	57.3	32.2	18.6	28.5	24.1	41.6	52.1	57.9	26.3	11.0	19.0	18.7	53.3	18.8	36.4	47.4	41.6	14.1	16.9	202.5	10.3	20.2	37.6	35.6	13.9	26.1	16.5	7.9	2.5	1.9	16.7	18.2	56.1	17.4	25.9	10.8	37.7	7.0	23.3	15.3	20.2	17.3	6.9	30.5	16.6	53.6	7.2	0.5	22.7	54.7	38.7	2.1	2.4	5.8	59.3	14.2	38.9	15.6	0.0	0.4	4.3	27.3	0.2	13.3	0.3	32.3	26.8	18.6	0.1	2.1	3.6	40.3	14.5	19.8	4.1	12.4	31.5	40.3	32.4	26.6	22.5	11.9	0.1	7.2	12.2	4.2	4.2	10.7	23.5	18.0	8.3	17.1	41.3	32.2	10.3	20.8	37.6	9.8	22.8	14.1	23.5	33.5	13.6	13.9	26.8	31.7	202.5	20.2	5.7	16.9	26.2	35.6	18.0	42.4	5.0	18.5	20.7	15.7	28.6	13.2	42.8	19.0	41.7	81.4	104.3	281.2	139.8	1.8	51.2	129.9	133.8	114.9	155.3	0.0	57.9	411.1	191.6	1.7	48.8	46.4	0.0	64.4	335.4	125.8	223.3	202.9	35.5	219.5	0.0	16.8	61.4	140.8	7.9	52.0	294.8	148.5	551.0	130.0	207.3	91.3	203.2	64.3	66.5	3.5	51.8	174.1	0.0	4.7	115.6	31.0	220.6	89.7	303.0
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69675802-69797111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	21.3	44.1	34.1	14.2	32.5	5.4	29.1	32.9	34.1	23.7	20.9	38.1	20.0	23.1	18.4	32.1	20.6	25.5	23.9	19.8	35.8	32.7	53.1	38.9	24.7	21.9	37.9	22.8	29.0	36.8	58.9	23.6	25.0	32.5	19.0	21.8	26.5	22.4	24.6	17.9	18.6	30.2	17.2	57.8	19.9	19.9	11.9	30.6	17.8	41.8	13.2	18.7	22.7	19.4	24.4	9.9	37.8	18.5	7.8	14.4	11.5	6.7	3.2	7.6	10.3	22.9	24.5	11.4	5.4	19.8	4.5	9.5	5.3	14.0	9.0	15.4	14.2	7.0	10.8	8.4	8.0	8.1	17.6	10.8	8.7	6.3	7.7	14.0	5.3	11.8	17.3	17.0	5.2	7.3	21.7	8.0	7.3	15.9	13.5	14.4	4.6	3.6	5.6	3.9	12.7	3.4	4.1	18.7	25.3	31.0	11.2	4.9	8.1	6.8	9.3	9.9	6.1	9.9	19.0	12.2	6.3	4.0	5.9	5.4	8.1	7.0	3.4	7.8	8.6	11.9	25.2	10.6	19.0	8.4	13.2	8.6	24.4	11.2	9.5	9.9	21.7	12.8	9.0	37.8	7.8	18.5	9.6	14.4	11.5	34.1	32.5	32.9	34.1	35.8	32.7	37.9	22.8	32.5	30.6	59.6	34.7	34.6	36.9	25.8	68.6	35.2	45.9	52.2	50.0	55.8	104.1	65.0	16.6	37.2	15.4	36.2	60.6	23.3	43.3	52.5	48.2	25.5	39.3	51.4	37.9	52.4	18.0	36.8	63.3	3.2	32.8	46.1	30.4	39.7	38.1	48.7	36.8	42.1	31.8	49.4	81.3	25.8	22.8	17.0	15.9	33.2	64.8	31.0	27.5	33.1
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell type enhanced"	"Detected in many"	20	"Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Cell line enriched"	"Detected in some"	5	"AF22: 91.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		880000	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	91.4	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	14.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4	11.9	93.6	0.0	0.1	1.3	1.0	482.3	0.0	5.3	1.2	0.0	2.0	0.3	13.3	0.0	0.6	5.4	0.0	0.0	0.0	0.6	3.1	0.3	5.8	0.0	114.1	195.5	0.0	4.3	13.4	1.0	1.1	23.8	13.5	2.8	0.0	1.7	0.0	0.0	0.0	0.0	2.2	232.8	19.1	0.3	0.2	0.5	0.3	0.0	0.0	0.1
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391586-40587465	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 21.7"	"Cell type enriched"	"Detected in some"	5	"Cone photoreceptor cells: 58.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.8;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;T-cells: 1.8"	"Group enriched"	"Detected in some"	5	"REH: 3.5;SH-SY5Y: 10.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076660	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA076660: AB_2686812"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.5	1.4	5.9	0.5	7.6	1.3	0.6	4.5	21.7	0.5	0.8	0.0	0.0	0.5	0.6	0.4	1.8	0.6	0.6	0.4	5.0	5.2	0.5	0.4	0.4	0.5	2.3	7.4	2.1	0.7	0.4	0.6	0.5	0.9	0.5	0.7	2.7	0.4	0.4	0.4	0.5	0.5	0.5	0.8	3.1	0.7	2.5	0.5	0.0	0.7	0.0	0.6	0.5	0.2	0.0	1.3	0.0	0.0	0.3	1.8	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	3.5	0.0	0.0	0.0	0.3	1.4	10.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.4	0.0	0.3	0.0	1.3	0.0	0.2	5.9	7.6	4.5	21.7	5.0	5.2	2.3	7.4	0.9	0.5	0.0	0.0	0.0	0.0	0.0	11.6	0.6	0.0	0.0	0.0	0.0	58.9	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0
LRRK2	"DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2"	ENSG00000188906	"Leucine rich repeat kinase 2"	Q5S007	12	40196744-40369285	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Differentiation"	"GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 40.4;lung: 50.4"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 391.0"	"Group enriched"	"Detected in many"	7	"lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 40.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 40.4"	"Cell line enhanced"	"Detected in some"		"A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014293, CAB037160"	Approved		Supported	Vesicles		NA	NA			Vesicles		"CAB037160: AB_1840989, HPA014293: AB_1853353"	"unprognostic (2.67e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (6.10e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.02e-6)"	"unprognostic (2.55e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.01e-3)"	"unprognostic (5.21e-3)"	3.7	3.4	2.3	7.0	3.9	8.6	3.0	1.7	5.0	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4.0	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1.0	1.9	3.6	1.6	3.3	4.2	2.0	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0.0	0.0	0.8	0.0	9.9	0.1	0.0	3.9	10.2	0.1	2.1	5.7	0.4	0.3	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.3	0.0	0.4	0.0	0.8	0.3	0.2	0.0	0.7	0.5	0.1	2.5	0.7	0.0	0.2	3.8	0.6	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.2	0.0	0.1	0.0	0.0	0.0	10.9	0.0	0.1	0.6	0.0	0.2	2.8	0.3	2.8	2.2	1.4	1.2	1.1	1.2	0.7	0.0	0.0	0.0	2.4	0.0	0.5	0.0	5.8	1.2	0.0	3.1	0.0	0.9	0.0	0.0	1.5	0.9	0.0	0.0	40.4	0.0	3.0	0.2	0.0	0.8	2.3	3.9	1.7	5.0	1.8	1.4	2.2	3.6	1.9	2.4	29.8	391.0	17.5	1.5	2.2	7.5	6.9	5.1	5.3	30.7	26.2	0.0	0.0	1.7	0.8	0.4	4.5	0.0	0.0	2.3	0.1	9.4	0.6	12.8	7.8	4.6	44.5	0.0	9.2	74.8	0.0	17.5	19.9	11.8	10.8	0.0	11.0	1.1	0.0	11.3	15.2	0.9	0.0	3.9	0.2	0.4	2.8	0.3	0.8	0.0	0.5
LSM14B	"bA11M20.3, C20orf40, FAM61B, FLJ25473, FT005, LSM13, RAP55B"	ENSG00000149657	"LSM family member 14B"	Q9BX40	20	62122461-62135378	"Predicted intracellular proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 205.8;Late spermatids: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 5.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041274, HPA061189"	Approved		Supported	"Nucleoli fibrillar center,Vesicles"		NA	NA			Vesicles	"Nucleoli fibrillar center"	"HPA041274: AB_2677388, HPA061189: AB_2684448"	"unprognostic (2.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (3.61e-5)"	"unprognostic (4.99e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.93e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.98e-1)"	13.6	19.6	21.4	17.3	24.4	20.2	24.0	50.0	38.6	19.5	16.1	15.9	11.9	20.4	21.9	15.6	20.1	16.8	16.1	28.7	20.8	18.9	14.9	15.1	15.3	18.9	17.3	28.2	30.6	26.5	19.4	16.9	13.2	20.4	18.2	13.2	16.8	20.2	16.9	55.5	23.4	19.5	17.9	18.6	18.1	18.3	35.2	12.2	28.8	16.6	20.1	16.7	19.1	17.7	1.4	1.3	5.8	1.1	0.1	1.2	0.2	14.1	13.6	21.6	20.7	9.9	10.4	18.6	15.0	11.3	31.4	13.8	39.8	9.9	15.0	17.5	10.3	22.7	20.6	10.4	13.0	15.6	6.1	7.5	36.1	17.3	23.7	13.7	15.4	21.9	8.9	23.6	13.1	12.1	12.3	8.0	17.7	19.3	10.8	10.9	18.7	25.5	23.2	13.4	22.8	20.1	33.4	42.8	11.8	8.5	16.8	29.8	25.8	27.4	24.4	19.2	13.2	30.3	19.6	10.3	44.8	30.7	23.0	15.2	13.8	16.2	18.5	19.7	10.3	14.2	0.2	1.1	5.8	1.0	1.0	0.4	1.2	0.7	1.2	0.9	1.4	0.8	0.8	1.8	0.1	0.5	1.3	0.5	0.2	21.4	24.4	50.0	38.6	20.8	18.9	17.3	28.2	20.4	12.2	8.9	5.0	4.9	3.2	8.7	15.0	20.1	2.5	16.0	10.3	1.8	7.9	5.4	1.7	4.2	205.8	5.9	8.4	0.0	4.5	5.2	6.2	7.3	4.7	10.2	7.4	7.9	13.4	4.3	11.6	432.7	12.4	8.2	3.3	1.8	14.1	16.0	6.7	7.0	14.9	5.7	19.3	0.0	5.0	11.7	22.2	8.8	4.3	4.4	12.4	2.1
LYN	JTK8	ENSG00000254087	"LYN proto-oncogene, Src family tyrosine kinase"	P07948	8	55879813-56014168	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.9"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 110.4;Kupffer cells: 161.3;Macrophages: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 36.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 57.7;HMC-1: 58.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001231, CAB004492"	Enhanced		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		11000000	"Golgi apparatus, Plasma membrane"	Vesicles	"CAB004492: AB_627897, HPA001231: AB_1079286"	"unprognostic (7.87e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	8.8	6.8	4.5	34.0	6.3	33.6	11.1	9.5	4.1	5.3	10.5	5.8	7.2	15.6	3.4	7.8	7.2	6.7	13.7	8.9	4.8	3.6	6.1	13.8	34.6	70.9	7.7	2.1	5.3	9.8	3.1	4.9	19.1	5.6	5.7	6.6	6.3	14.9	8.5	2.7	3.4	16.2	6.6	8.5	69.4	7.4	3.6	5.1	3.8	9.4	5.3	25.8	10.7	7.5	8.4	9.2	36.8	26.5	1.9	0.9	2.7	12.8	7.7	1.8	0.3	0.1	0.0	13.9	9.8	14.5	6.2	4.4	5.3	4.4	12.4	4.4	3.9	4.8	6.0	7.2	7.3	5.3	20.1	7.2	57.7	2.3	1.9	1.9	5.8	58.6	0.3	2.5	0.1	4.5	3.6	8.3	0.0	30.5	26.9	0.9	0.7	0.0	6.1	11.1	20.2	0.9	0.9	2.8	1.5	4.0	6.1	1.2	22.3	4.9	0.0	2.0	13.8	1.1	13.6	9.7	0.0	2.9	0.0	4.4	9.0	3.3	28.1	0.6	11.5	0.4	2.1	7.2	12.3	0.9	16.8	0.7	8.2	0.2	0.3	6.4	8.4	0.1	0.4	36.8	1.9	26.5	9.2	0.0	2.7	4.5	6.3	9.5	4.1	4.8	3.6	7.7	2.1	5.6	5.1	32.8	35.7	89.3	18.6	4.7	2.1	1.4	17.8	22.7	31.8	8.7	2.0	2.5	0.0	18.6	0.6	18.5	14.9	0.0	44.9	61.3	8.4	36.9	70.5	10.9	110.4	0.0	5.8	25.8	161.3	1.7	3.1	122.4	5.0	73.1	13.5	61.7	37.6	13.5	1.1	1.3	1.5	19.4	4.3	0.2	1.2	5.1	32.4	24.5	12.3	92.1
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Macrophages: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 41.9;monocytes: 42.1"	"Low cell line specificity"	"Detected in all"											"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		3400000	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	25.2	15.6	7.9	26.7	11.0	33.4	24.4	4.4	7.0	10.5	15.0	14.0	8.6	14.2	15.3	16.5	12.2	13.4	16.4	19.4	6.4	4.4	13.6	16.3	30.2	68.6	10.0	4.7	12.2	21.7	9.1	7.2	15.8	8.6	13.7	10.6	12.0	22.0	8.1	7.7	18.0	20.0	10.2	11.7	51.3	19.5	6.3	8.2	22.1	11.3	7.8	30.0	18.7	11.2	7.7	41.9	6.5	42.1	2.7	8.4	26.0	16.5	8.5	8.7	10.2	29.0	19.5	24.6	12.3	26.0	11.0	10.8	6.8	7.0	18.2	15.0	9.7	3.1	13.0	4.4	8.2	5.3	9.0	13.5	6.3	4.2	11.0	14.8	41.5	43.3	23.2	16.2	6.1	7.8	11.9	10.4	6.9	8.0	13.8	5.8	12.9	5.6	23.4	7.2	8.3	10.8	13.0	11.9	9.0	13.0	19.2	2.7	8.5	12.2	10.5	20.0	5.5	16.2	25.7	13.6	15.0	6.2	14.5	11.5	18.4	20.2	9.0	10.1	40.9	16.7	2.2	42.1	6.2	7.5	39.4	8.4	7.7	6.9	6.7	35.2	6.5	3.8	3.8	6.5	2.7	28.4	41.9	6.8	26.0	7.9	11.0	4.4	7.0	6.4	4.4	10.0	4.7	8.6	8.2	6.0	6.9	14.4	1.6	3.2	2.6	0.7	2.5	5.3	1.2	1.8	0.0	2.0	1.7	1.6	2.0	1.0	2.5	23.3	2.0	2.3	2.8	2.2	1.1	0.8	7.9	0.0	1.7	2.5	10.2	8.1	3.4	18.6	1.7	5.4	0.9	1.3	1.0	2.9	4.2	1.1	3.0	12.9	1.2	0.5	1.5	2.9	2.3	5.4	1.7	1.6
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		12000000	Vesicles		"HPA053478: AB_2682165"	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.0	3.9	1.9	1.9	37.5	17.4	4.9	4.9	9.7	2.1	4.2	5.1	8.2	7.6	6.6	6.8	6.8	3.3	5.0	10.8	1.7	5.3	2.1	4.3	4.5	7.8	11.4	8.0	19.6	14.8	18.5	9.1	7.6	27.8	3.9	3.3	7.2	7.8	7.7	3.2	1.9	7.7	2.7	8.7	3.2	3.9	4.5	2.1	6.1	8.3	1.2	0.9	5.8	10.1	7.6	20.0	14.4	5.5	3.0	5.8	2.8	13.0	2.6	4.2	8.7	0.7	10.5	3.6	4.2	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5	29.8	35.2	25.3	8.3	5.3	5.4	10.4	12.7	4.0	12.5	8.7	5.9	32.0	1.7	5.7	1.9	7.2	4.6	0.0	2.4	6.3	10.6	7.4	33.5	15.8	38.4	6.4	1.7	9.2	46.4	1.1	8.3	42.8	0.0	29.7	10.9	4.3	5.7	21.0	18.7	7.6	7.1	0.0	8.3	0.2	1.1	4.0	18.9	10.9	10.5	8.3
MARCH3	"MARCH-III, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030808	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 52.5;Spermatocytes: 61.1;Syncytiotrophoblasts: 82.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 8.8;naive B-cell: 13.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 25.1;HUVEC TERT2: 16.7;TIME: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043406	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	11.3	6.0	5.6	11.0	9.4	6.6	6.2	5.3	4.8	2.0	10.8	8.2	0.5	2.4	3.7	3.6	3.4	3.2	10.4	15.2	7.8	6.8	2.0	1.9	5.2	5.2	9.5	2.3	4.0	5.0	1.7	10.8	4.0	12.3	2.9	11.8	9.7	11.2	1.1	11.9	11.5	5.2	6.5	16.0	3.7	5.5	14.2	7.6	2.1	3.6	3.4	5.8	6.5	6.7	13.1	0.7	2.5	0.4	1.9	2.6	0.7	0.3	1.2	2.4	1.3	2.1	2.1	0.8	8.5	3.6	6.9	10.2	1.1	0.5	2.3	0.8	1.3	1.5	0.7	3.0	1.5	9.8	0.5	2.7	7.2	2.0	1.1	3.5	2.9	1.8	1.5	0.5	25.1	3.0	1.6	16.7	0.3	3.0	0.4	5.7	0.8	0.3	1.3	2.0	1.8	2.8	0.9	9.6	0.6	0.5	1.2	0.7	0.5	2.0	0.3	1.0	1.2	1.7	3.0	20.3	1.3	1.1	7.9	0.9	1.1	1.3	1.3	5.1	2.3	1.2	0.0	0.2	2.5	0.5	0.4	0.1	8.8	0.6	0.3	0.1	13.1	2.4	0.5	0.8	1.9	0.3	0.7	2.6	0.7	5.6	9.4	5.3	4.8	7.8	6.8	9.5	2.3	12.3	7.6	3.0	3.4	18.2	0.0	5.4	18.3	12.9	17.8	1.4	3.4	0.0	2.0	33.6	0.0	0.0	33.1	6.0	15.5	23.3	0.0	3.1	6.7	0.0	24.3	0.8	7.7	35.0	14.3	11.6	3.5	9.8	0.3	2.0	3.3	0.0	23.4	52.5	0.0	44.4	1.8	0.2	25.6	0.0	0.9	61.1	12.7	7.8	82.5	5.1	21.9	0.0
MARF1	"KIAA0430, LKAP, LMKB, Marf1, PPP1R34"	ENSG00000166783	"Meiosis regulator and mRNA stability factor 1"	Q9Y4F3	16	15594386-15643166	"Predicted intracellular proteins"	"Differentiation, Meiosis, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 26.6;Ciliated cells: 32.1;Club cells: 34.2;Collecting duct cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.0"	"Group enriched"	"Detected in many"	4	"B-cells: 6.4;granulocytes: 12.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017992	Uncertain		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA017992: AB_1852921"	"unprognostic (2.33e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-2)"	"unprognostic (7.94e-2)"	12.2	9.1	22.4	12.3	17.7	16.7	11.2	25.9	40.0	16.9	17.2	12.0	7.6	8.9	15.2	7.1	10.7	15.1	11.0	8.8	20.7	15.4	13.0	9.0	10.8	17.2	15.1	18.4	20.8	12.0	18.8	12.0	9.3	16.5	12.8	12.8	9.1	12.4	12.8	20.4	11.9	13.0	15.5	13.6	14.6	12.0	6.8	14.0	11.8	15.5	4.2	26.1	18.8	13.9	6.4	0.8	12.0	1.9	0.8	2.1	0.8	4.3	8.1	10.3	7.5	9.5	13.6	4.3	4.8	6.6	4.5	7.7	1.3	5.9	19.5	9.7	9.6	3.8	3.0	6.1	6.7	8.1	6.6	4.2	8.2	7.3	6.2	7.9	9.2	10.9	8.1	7.4	9.7	11.7	10.2	11.3	11.1	7.1	7.4	8.8	4.0	7.5	4.2	2.8	3.7	4.1	10.4	13.5	4.9	3.9	8.3	5.9	7.6	7.1	4.6	8.8	5.6	4.9	8.1	11.7	6.7	4.3	11.4	3.9	8.5	7.9	11.9	9.0	6.0	8.6	2.4	1.6	4.3	1.4	1.4	0.8	4.2	2.1	1.4	0.7	6.4	1.9	2.0	12.0	0.8	1.9	0.8	1.9	0.8	22.4	17.7	25.9	40.0	20.7	15.4	15.1	18.4	16.5	14.0	20.8	26.6	0.0	0.0	0.0	0.0	0.0	0.0	32.1	34.2	22.7	0.0	4.6	13.3	8.1	0.0	0.0	0.0	0.0	12.1	4.4	0.0	0.0	10.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	12.6	0.0	0.0	12.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
MAST1	"KIAA0973, SAST"	ENSG00000105613	"Microtubule associated serine/threonine kinase 1"	Q9Y2H9	19	12833951-12874951	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 22.6;Cone photoreceptor cells: 41.2;Early spermatids: 13.0;Horizontal cells: 14.3;Rod photoreceptor cells: 18.7"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 3.6;T-reg: 2.0"	"Lineage enriched"	"Detected in single"	8	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.0;SCLC-21H: 26.5;SH-SY5Y: 13.2;U-266/70: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028181, HPA073106"	Enhanced		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA028181: AB_10603872, HPA073106: AB_2732218"	"unprognostic (6.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.83e-5)"	"unprognostic (1.72e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.89e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	1.2	5.2	20.4	1.7	13.6	1.6	1.5	51.0	40.1	1.1	1.5	1.4	0.0	1.7	1.3	1.2	1.3	1.2	1.6	1.3	16.1	16.3	1.2	1.3	1.2	1.3	8.8	19.5	1.5	1.6	1.2	10.4	1.2	19.9	1.2	1.3	1.6	1.3	1.2	1.2	4.1	1.6	1.3	4.2	1.2	1.5	3.9	2.7	0.0	1.2	0.0	1.3	1.2	0.2	0.4	0.0	0.0	0.2	0.0	3.6	0.1	2.2	1.0	1.0	15.0	0.0	0.0	1.2	0.1	0.1	0.2	0.6	0.5	0.9	3.6	1.7	0.0	2.5	0.0	4.4	0.0	0.0	2.5	2.9	0.3	3.6	1.6	0.0	0.8	0.8	0.3	0.0	0.5	0.5	0.8	0.0	9.8	3.1	1.9	0.0	0.5	1.5	0.4	4.5	0.4	4.6	9.9	3.0	5.1	0.2	0.1	26.5	13.2	0.5	0.9	2.7	0.8	2.4	1.3	0.0	1.8	2.8	2.0	0.5	10.8	8.6	2.1	3.3	2.0	0.1	0.0	0.2	0.0	0.0	0.2	3.6	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	2.0	0.1	20.4	13.6	51.0	34.3	16.1	16.3	8.8	19.5	19.9	2.7	0.0	3.7	0.0	1.9	0.8	22.6	0.8	0.0	1.4	0.0	0.0	41.2	0.4	0.0	0.1	13.0	1.0	0.7	0.0	0.4	0.4	0.7	0.9	1.1	0.8	0.2	14.3	0.0	0.6	1.2	6.5	0.6	1.0	5.0	0.0	0.0	3.6	0.3	2.9	1.1	0.1	18.7	0.0	0.8	2.8	4.1	1.3	0.2	1.0	0.4	0.6
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 91.8;Kupffer cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.4	6.6	3.2	11.0	18.9	6.1	9.3	12.0	9.7	14.6	12.6	5.0	5.7	3.6	14.8	8.1	12.9	3.0	5.4	4.1	4.3	7.0	12.0	3.2	6.5	4.0	16.6	3.6	14.2	8.6	9.7	13.9	2.4	4.6	6.1	8.1	5.9	16.1	8.4	2.1	4.9	3.6	7.2	3.4	14.2	6.9	5.4	7.7	5.5	5.6	8.4	10.3	5.1	9.1	15.2	3.7	5.5	6.4	7.6	7.0	4.0	28.1	8.9	12.4	19.0	2.5	11.2	5.1	10.4	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4	3.0	1.6	10.4	6.1	11.8	26.9	2.0	17.8	4.0	1.2	29.6	21.6	10.4	1.7	20.9	4.9	11.9	19.5	46.7	19.9	15.2	17.9	4.5	1.1	12.4	91.8	55.6	16.1	11.1	81.2	10.8	15.3	42.0	20.3	5.4	8.6	23.6	17.7	20.1	14.9	9.2	37.0	6.5	9.2	10.2	11.9	15.2	24.7	10.2	8.6	4.1
MEF2C		ENSG00000081189	"Myocyte enhancer factor 2C"	Q06413	5	88717117-88904257	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.8"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 255.0;Ito cells: 239.4;Sertoli cells: 329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.2;intermediate monocyte: 19.5;memory B-cell: 32.6;myeloid DC: 22.3;naive B-cell: 48.2;non-classical monocyte: 15.9;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	5	"B-cells: 48.2;dendritic cells: 23.8;monocytes: 19.5"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.2;HEL: 53.4;Karpas-707: 29.4;REH: 60.8;U-266/70: 22.3;WM-115: 34.8"	"Group enriched"	"Detected in many"	7	"amygdala: 209.9;basal ganglia: 138.6;cerebral cortex: 403.6;hippocampal formation: 331.6;olfactory region: 196.3"	"Group enriched"	"Detected in all"	4	"amygdala: 103.2;cerebral cortex: 309.8;hippocampal formation: 290.6;olfactory region: 138.8"	"HPA005533, CAB068196, CAB068197"	Enhanced		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB068196: AB_2665646, CAB068197: AB_2665645, HPA005533: AB_1079352"	"unprognostic (2.74e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.78e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (7.18e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-2)"	13.9	10.8	17.0	15.0	26.7	3.8	10.7	4.3	52.8	8.2	6.8	6.1	1.5	2.8	10.9	5.4	5.0	6.4	9.8	11.2	11.1	6.8	4.5	4.0	8.3	19.3	6.6	28.0	12.3	2.9	5.2	6.5	14.8	4.8	7.1	5.7	4.6	6.6	6.6	154.8	3.9	7.4	10.8	8.3	16.0	4.5	3.6	4.4	1.6	9.6	3.5	24.0	8.9	5.8	48.2	23.8	5.8	19.5	4.0	0.1	7.2	0.3	0.0	1.7	0.0	1.9	1.1	0.0	0.5	1.0	0.0	0.2	0.0	0.2	24.2	0.1	2.8	0.6	0.7	2.3	2.1	0.0	7.3	3.0	53.4	3.2	0.0	0.6	2.3	0.1	5.3	0.0	0.0	0.0	0.3	8.4	0.0	2.8	29.4	2.1	0.0	0.0	0.0	0.5	0.0	2.0	60.8	15.3	11.6	0.0	0.3	0.0	2.0	0.0	0.1	7.0	1.0	0.0	13.5	9.6	1.3	0.2	0.1	1.2	22.3	2.5	14.6	0.3	16.5	34.8	0.1	17.2	0.0	0.0	19.5	0.0	32.6	0.0	0.0	22.3	48.2	0.0	0.0	5.8	4.0	15.9	23.8	0.1	7.2	17.0	26.7	4.3	52.8	11.1	6.8	6.6	28.0	4.8	4.4	29.8	48.3	255.0	4.7	9.5	22.0	80.9	12.7	6.7	39.8	1.8	202.2	0.8	23.2	0.8	6.9	155.1	1.6	70.0	11.1	1.1	13.9	1.6	4.7	3.0	134.1	4.8	1.2	239.4	207.6	5.3	27.6	138.9	64.1	28.9	0.3	65.1	0.4	2.9	67.5	0.5	196.7	329.8	171.0	1.2	16.6	7.3	1.4	7.9	1.9	1.6
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917732-127966034	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	8.9	9.6	9.1	11.7	15.4	5.3	13.0	19.6	15.4	12.2	12.1	14.6	9.4	17.1	19.0	11.9	10.3	9.8	9.2	7.5	8.9	10.1	12.6	19.1	9.1	9.7	9.3	11.8	13.2	14.5	16.7	21.5	18.0	15.8	10.2	15.6	14.8	10.9	9.7	7.2	11.0	15.0	12.4	11.8	13.5	12.0	9.4	10.2	12.9	13.6	7.1	15.0	9.9	10.5	7.0	5.8	7.1	8.2	5.4	8.3	4.1	8.3	6.9	7.2	4.0	6.4	5.7	6.2	6.2	8.1	8.2	8.2	4.3	11.9	3.9	12.2	11.2	13.2	6.9	8.4	6.3	11.8	9.1	6.7	4.8	7.8	6.6	7.2	5.0	5.9	6.2	2.1	7.7	5.8	4.1	8.7	6.1	8.1	5.3	11.6	7.7	4.3	1.7	1.4	8.6	4.6	4.6	0.5	4.5	5.8	11.9	7.3	2.6	7.8	8.0	3.3	5.7	4.7	3.4	4.5	2.7	2.8	10.1	5.9	11.5	18.9	8.8	8.7	4.3	7.3	4.6	5.6	7.1	7.1	6.2	6.2	7.0	7.9	6.6	4.5	3.6	8.3	8.3	6.3	5.4	8.2	5.8	8.0	4.1	9.1	15.4	19.6	15.4	8.9	10.1	9.3	11.8	15.8	10.2	11.9	13.1	8.1	4.7	2.9	16.3	2.8	2.5	10.7	13.6	15.7	19.6	9.8	1.7	7.4	9.5	5.6	7.0	0.0	6.1	6.5	5.6	4.3	12.7	9.4	6.6	11.1	4.1	8.0	7.5	10.7	8.6	6.0	3.3	6.4	6.8	11.0	6.3	9.7	8.9	5.7	21.2	6.5	3.8	11.4	4.3	5.0	18.4	14.4	6.8	3.5
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 16.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA			Vesicles	"Endoplasmic reticulum"	"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	18.7	23.1	22.9	24.0	24.3	29.7	19.9	43.1	37.6	16.3	16.6	28.7	16.8	28.9	23.7	13.8	14.7	20.9	20.2	20.7	24.3	18.6	15.9	30.4	21.6	22.2	27.9	21.5	21.3	34.9	19.7	21.5	18.8	18.6	19.0	11.6	20.7	23.8	22.9	29.9	13.5	28.6	20.0	17.2	26.2	25.2	11.5	24.5	12.9	19.7	10.4	11.0	18.7	14.2	1.7	4.1	16.6	3.9	1.4	3.3	2.9	5.3	25.4	13.2	13.4	7.9	7.7	17.9	11.4	8.1	9.6	8.2	16.7	12.8	15.7	14.8	13.8	7.2	8.5	10.4	9.4	2.9	21.8	11.6	8.6	17.7	23.0	14.5	12.4	21.4	14.3	6.1	13.4	5.7	6.9	9.2	10.4	12.5	11.5	6.6	23.3	12.9	16.6	19.4	7.5	11.1	23.7	6.9	21.1	8.5	15.6	21.1	17.5	19.0	20.5	11.4	6.6	12.4	12.3	16.2	18.0	10.0	50.5	9.8	18.3	14.2	10.6	7.6	12.5	12.9	4.5	3.5	3.4	2.7	3.9	2.5	1.4	1.5	2.3	2.3	1.7	3.3	2.0	16.6	1.4	2.4	4.1	1.7	2.9	22.9	24.3	43.1	37.6	24.3	18.6	27.9	21.5	18.6	24.5	23.8	30.6	16.0	25.4	8.1	26.6	8.9	20.4	5.3	6.8	17.4	41.2	19.1	5.0	16.7	16.3	14.6	24.5	0.0	19.7	14.0	16.1	20.3	13.9	27.7	25.8	23.8	35.5	14.1	21.9	20.6	24.7	20.4	20.3	31.5	18.9	21.5	25.2	18.6	23.3	11.0	28.4	0.0	13.7	9.6	11.8	14.3	28.6	21.3	18.7	22.0
MINDY4	"C7orf67, FAM188B, FLJ22374"	ENSG00000106125	"MINDY lysine 48 deubiquitinase 4"	Q4G0A6	7	30771417-30892387	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 8.9;Ciliated cells: 33.5;Collecting duct cells: 12.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.1;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019475, HPA030129, HPA030130"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA019475: AB_1848806, HPA030129: AB_10599621, HPA030130: AB_10601565"	"unprognostic (2.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	9.3	6.7	9.3	2.6	15.2	4.1	7.0	3.4	15.1	10.8	6.6	5.4	16.6	2.9	15.6	16.2	5.7	20.7	10.0	7.5	8.4	5.1	9.4	3.8	14.2	2.4	4.3	9.5	14.8	5.6	9.6	16.1	6.2	9.0	9.4	4.3	7.8	5.3	15.9	3.7	5.1	3.7	10.8	3.6	2.3	5.8	20.1	5.0	1.5	12.5	3.6	2.2	6.4	6.3	0.0	1.1	0.0	0.3	0.0	2.7	0.7	2.1	5.3	2.8	8.5	2.5	9.6	4.1	3.1	5.4	2.4	2.0	0.0	4.0	0.0	3.6	2.0	3.3	2.3	1.9	1.7	2.3	0.0	3.1	1.7	2.8	0.0	3.1	2.3	1.2	4.9	2.8	7.0	1.4	0.2	3.4	1.6	16.4	1.0	2.0	0.0	1.3	0.7	8.0	7.4	1.2	0.4	0.0	0.5	6.4	1.0	5.2	7.1	2.1	11.3	1.2	3.4	5.7	1.7	2.0	0.1	1.3	2.4	1.3	2.3	3.0	0.0	4.5	0.1	10.0	0.0	0.1	0.0	0.6	0.0	2.7	0.0	0.8	0.2	1.1	0.0	0.3	0.5	0.0	0.0	0.3	0.0	0.5	0.7	9.3	15.2	3.4	15.1	8.4	5.1	4.3	9.5	9.0	5.0	8.9	3.8	0.0	0.0	0.0	0.0	0.0	0.0	33.5	3.4	12.2	0.0	2.1	3.3	2.3	0.0	0.0	0.0	0.0	1.2	3.5	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Cell type enhanced"	"Detected in some"	10	"Basal glandular cells: 11.5;Basal keratinocytes: 7.4;Club cells: 11.4;Early spermatids: 14.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BJ: 101.3;BJ hTERT+: 275.6;fHDF/TERT166: 119.3"					"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA	2540000	170000	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	275.6	1.8	0.5	0.0	0.0	0.0	0.0	119.3	6.8	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.8	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2	3.0	0.0	0.0	11.5	7.4	0.0	0.2	5.1	0.0	11.4	0.0	0.0	0.1	0.0	0.7	14.6	0.0	0.0	0.0	1.2	2.2	1.3	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.9	3.0	0.2	0.0	0.1	5.2
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Cell type enhanced"	"Detected in some"	11	"Distal tubular cells: 1.7;Kupffer cells: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Group enriched"	"Detected in some"	93	"HL-60: 218.1;NB-4: 285.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	No	NA	576000000	15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	218.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	285.8	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	1.2	0.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
MPV17L	"FLJ39599, MLPH1, MLPH2, MPV17L1"	ENSG00000156968	"MPV17 mitochondrial inner membrane protein like"	Q2QL34	16	15395754-15413268	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 33.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"HMC-1: 30.3"									HPA041180	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA041180: AB_10794266"	"unprognostic (9.65e-2)"	"unprognostic (8.74e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.38e-3)"	"unprognostic (8.41e-2)"	"unprognostic (8.99e-3)"	"unprognostic (8.70e-2)"	"unprognostic (6.36e-3)"	"prognostic favorable (1.48e-11)"	"unprognostic (2.84e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.61e-3)"	"unprognostic (3.87e-2)"	3.1	4.9	6.2	3.7	8.7	8.3	16.0	6.8	8.0	7.1	4.5	10.5	1.6	7.1	4.5	3.1	2.5	3.3	5.7	3.7	7.4	5.4	8.2	12.2	2.3	4.7	5.8	6.1	4.8	33.1	10.6	11.7	1.4	6.3	3.7	2.9	9.7	10.1	5.0	16.0	9.1	5.6	9.4	7.2	3.7	4.1	2.7	7.0	0.0	5.2	1.3	1.6	4.8	2.4	4.0	2.2	5.7	3.6	3.6	2.5	1.2	0.8	1.6	0.6	0.6	0.1	0.1	1.0	0.4	0.0	0.0	0.0	1.5	2.9	1.2	1.2	0.5	0.4	1.2	2.9	0.0	0.0	0.9	0.8	5.9	3.6	3.0	0.3	2.8	30.3	0.2	0.3	0.1	0.2	0.4	0.0	1.2	1.8	2.7	0.0	1.6	0.9	1.7	1.5	0.2	1.0	1.5	0.5	1.1	0.5	0.6	4.8	1.7	2.5	7.0	0.2	0.7	1.5	2.0	2.0	1.1	0.6	0.9	0.8	1.1	0.4	1.3	0.6	1.3	0.4	3.9	3.6	0.6	2.3	2.7	1.9	2.1	1.5	2.4	1.2	4.0	1.5	2.5	5.7	3.6	1.0	2.2	1.2	1.2	6.2	8.7	6.8	8.0	7.4	5.4	5.8	6.1	6.3	7.0	6.0	9.1	2.9	11.2	7.0	12.3	5.0	10.2	22.7	14.8	0.0	9.8	0.4	13.3	6.8	2.5	4.5	2.6	0.0	11.2	0.4	10.3	5.6	5.8	26.3	0.9	7.9	1.2	5.5	8.3	0.4	6.6	6.9	20.3	0.0	6.2	5.7	8.5	14.8	13.4	14.6	14.8	0.0	11.3	4.1	2.1	10.0	0.5	3.1	10.5	8.4
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 175.7;Alveolar cells type 2: 67.0;Club cells: 66.0;Paneth cells: 190.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 104.2;EFO-21: 16.1;HeLa: 31.8;hTCEpi: 23.1;OE19: 19.3"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		14000000	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favorable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.5	104.2	0.0	16.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.8	1.2	0.9	0.0	0.0	0.0	23.1	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	19.3	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0	175.7	67.0	0.0	1.3	0.2	1.3	1.2	50.9	25.4	66.0	24.4	0.0	0.1	0.0	1.6	1.1	0.0	1.9	0.0	0.7	0.0	0.6	1.2	0.0	0.0	2.9	0.0	2.9	0.0	0.6	4.5	4.4	2.6	1.7	7.2	1.3	0.0	19.2	190.0	0.0	0.0	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.0	2.5	37.2
MSMP	"PC-3, PSMP"	ENSG00000215183	"Microseminoprotein, prostate associated"	Q1L6U9	9	35752990-35756613	"Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.9;pituitary gland: 6.0;placenta: 5.7"	"Group enriched"	"Detected in some"	67	"Early spermatids: 95.5;Late spermatids: 142.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.9"	"Cell type enhanced"	"Detected in some"		"basophil: 3.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 35.1;PC-3: 44.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055174	Uncertain		Supported	Vesicles,Cytosol	"Secreted in male reproductive system"	No	No			Vesicles	Cytosol	"HPA055174: AB_2682726"																		0.5	0.0	1.2	1.1	0.6	0.0	0.8	0.0	0.7	0.2	0.8	0.6	0.0	0.0	0.1	0.0	0.0	0.5	1.9	0.0	0.1	0.1	0.4	0.0	0.4	0.9	3.9	0.0	0.0	0.0	0.0	6.0	5.7	0.8	0.7	0.5	0.0	0.0	0.3	1.3	0.5	1.5	0.3	2.2	0.0	0.1	0.6	0.0	0.0	1.3	0.0	0.2	0.1	0.1	0.0	0.1	3.2	0.3	1.2	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.3	0.2	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.7	1.1	0.0	1.2	0.3	0.1	0.3	0.4	1.2	0.6	0.0	0.6	0.1	0.1	3.9	0.0	0.8	0.0	0.0	0.6	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	95.5	0.3	0.0	0.0	1.8	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	142.6	0.3	0.0	1.7	0.0	0.0	0.8	1.3	0.0	0.7	0.2	0.6	0.0	0.0	0.7	0.4	0.1	0.2	0.0	0.0	1.1
MTMR2	"CMT4B, KIAA1073"	ENSG00000087053	"Myotubularin related protein 2"	Q13614	11	95832882-95925315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049831	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049831: AB_2680904"	"unprognostic (1.71e-2)"	"unprognostic (2.55e-3)"	"unprognostic (7.81e-3)"	"unprognostic (4.16e-1)"	"unprognostic (4.18e-3)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (1.61e-8)"	"unprognostic (3.23e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-3)"	16.4	10.4	14.2	12.1	19.9	5.3	15.4	14.9	23.3	14.1	13.5	22.6	4.9	8.0	14.1	7.5	15.5	13.3	15.4	13.8	18.1	13.9	16.9	4.5	14.3	13.6	27.5	13.6	14.5	11.0	15.9	8.2	25.1	21.3	17.6	14.5	19.6	18.8	12.3	6.8	9.7	9.5	18.2	30.0	10.5	13.6	29.0	21.8	12.2	11.3	7.7	11.7	13.4	14.3	5.4	6.6	9.7	4.9	11.8	14.2	6.6	9.4	10.1	23.3	16.9	8.2	12.7	19.5	17.7	15.8	17.6	15.9	23.9	19.2	6.8	21.2	18.6	14.9	13.1	19.0	19.3	15.9	12.4	9.2	14.1	25.3	13.4	18.8	23.9	11.7	10.6	12.9	23.1	23.2	18.0	26.5	15.3	17.4	6.5	16.5	7.0	11.9	11.1	18.9	22.8	14.3	10.0	13.6	6.4	18.1	50.8	14.9	17.4	17.5	14.8	7.9	15.3	11.7	10.2	27.1	20.6	18.9	15.0	16.3	6.1	16.8	6.2	8.6	6.6	20.8	9.7	3.3	1.4	11.4	3.9	12.3	5.4	7.7	14.2	6.6	4.8	4.1	11.0	0.9	11.8	4.9	3.4	6.9	6.6	14.2	19.9	14.9	23.3	18.1	13.9	27.5	13.6	21.3	21.8	3.0	7.5	5.1	13.3	9.2	0.0	14.0	0.0	9.4	12.5	8.7	0.0	8.0	8.3	15.9	48.9	19.5	7.3	0.0	14.6	26.0	14.0	13.2	18.5	0.9	11.0	0.0	15.5	10.4	9.1	87.8	10.3	7.5	3.3	9.0	9.1	0.0	14.2	2.9	11.3	20.7	0.0	32.3	20.0	34.6	16.4	5.3	7.6	7.9	8.4	13.2
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8"	"Cell type enriched"	"Detected in some"	4	"Cholangiocytes: 591.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"OE19: 41.8;PC-3: 45.1"									"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"	NA	NA		590000	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.1	0.1	0.7	0.1	0.0	0.2	0.1	0.1	67.4	8.4	0.0	0.0	0.0	1.9	0.0	11.6	0.2	301.7	0.1	0.1	0.1	0.1	0.6	2.0	0.0	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.1	4.6	0.0	192.8	0.0	0.7	0.1	0.3	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.1	31.6	155.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	41.8	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	32.8	0.9	0.0	0.0	0.0	10.5	591.1	34.8	46.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.1	0.0	1.2	4.6	0.0	0.2	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	0.0	0.5	48.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	131.5	0.3
MYCBPAP	"AMAP-1, DKFZp434N1415"	ENSG00000136449	"MYCBP associated protein"	Q8TBZ2	17	50508384-50531501	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"testis: 81.2"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 56.2;Early spermatids: 173.4;Late spermatids: 100.2;Spermatocytes: 52.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 7.5;JURKAT: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023257, HPA024405"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA023257: AB_2671126, HPA024405: "	"unprognostic (2.05e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.13e-3)"	"unprognostic (3.98e-5)"	"unprognostic (8.62e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.32e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.02e-2)"	0.5	0.6	1.1	0.4	1.6	0.9	0.4	1.3	1.4	0.9	0.4	1.6	0.8	0.1	1.3	2.2	0.6	3.5	1.0	0.4	1.2	0.8	0.4	0.2	1.1	0.6	0.4	0.9	1.9	0.2	0.4	0.7	0.2	3.5	0.8	0.2	0.6	0.7	1.2	0.6	0.8	0.3	0.7	0.9	0.5	0.3	81.2	0.4	0.3	0.6	0.0	0.4	0.4	0.5	0.3	0.2	2.8	0.4	1.0	1.0	0.3	0.3	1.5	0.8	0.6	1.9	1.2	1.5	0.7	0.4	0.5	0.7	1.3	3.2	0.5	0.2	0.3	1.6	0.8	0.4	2.3	0.3	7.5	0.7	2.6	2.5	0.7	1.7	0.1	0.6	2.7	0.6	1.2	4.0	1.9	1.4	7.1	0.9	0.8	1.5	0.9	0.3	0.7	0.2	0.2	1.1	0.4	0.7	0.4	0.1	0.8	1.5	3.3	0.9	0.5	0.5	1.2	0.7	1.5	4.1	0.9	1.2	0.3	0.2	4.6	1.5	0.4	1.1	0.5	2.3	1.2	0.4	0.7	0.3	0.3	0.4	0.1	0.4	0.3	0.1	0.3	0.9	0.4	2.8	1.0	0.1	0.2	1.0	0.3	1.1	1.6	1.3	1.4	1.2	0.8	0.4	0.9	3.5	0.4	0.0	1.7	0.0	1.4	0.1	3.6	0.5	0.0	56.2	11.4	1.8	0.0	1.4	0.0	0.0	173.4	0.6	0.4	0.0	0.3	0.2	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.6	100.2	6.4	0.6	0.0	0.0	1.5	6.5	0.1	0.0	3.5	0.0	0.4	0.0	0.3	52.0	5.5	0.4	0.1	0.9	0.1	0.9
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482317	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 95.7;Urothelial cells: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 15.9;non-classical monocyte: 18.0"	"Group enriched"	"Detected in many"	65	"dendritic cells: 6.2;monocytes: 18.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 76.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		14000	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	27.5	7.3	2.1	8.9	4.1	0.2	21.7	1.3	2.7	27.0	12.3	5.1	16.0	2.0	27.2	17.7	27.2	16.2	11.4	7.2	3.5	2.1	12.2	1.7	18.7	7.5	5.8	2.5	12.7	3.3	16.1	4.2	31.9	15.0	20.7	12.8	10.1	14.9	17.4	5.7	22.4	6.8	49.0	9.4	10.0	8.8	5.7	4.4	1.5	15.7	14.2	9.4	35.0	20.0	0.0	6.2	0.1	18.0	0.0	0.1	1.1	36.1	34.2	3.7	2.3	25.6	57.0	10.4	31.8	76.2	19.4	19.2	8.2	28.4	0.0	12.7	58.2	19.9	55.3	0.3	32.6	14.3	0.2	0.1	0.0	13.4	0.3	8.9	0.0	0.0	29.9	11.3	13.1	53.6	48.5	50.3	0.0	0.0	0.0	45.7	5.7	0.0	0.1	0.2	10.9	30.5	0.0	2.6	0.0	50.3	45.2	0.0	0.0	21.8	4.6	8.0	14.3	22.6	0.7	62.8	28.6	1.9	18.9	18.5	0.0	0.0	0.0	21.2	0.4	33.7	0.0	4.3	0.0	0.0	15.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	18.0	2.1	0.1	1.1	2.1	4.1	1.3	2.7	3.5	2.1	5.8	2.5	15.0	4.4	56.6	42.0	2.7	42.9	21.1	0.0	7.6	10.2	32.1	66.0	21.0	0.0	48.8	1.7	48.5	0.5	20.4	36.0	0.0	28.8	20.4	33.3	62.3	1.1	0.0	21.2	0.0	1.7	27.0	31.3	0.6	5.5	20.9	8.5	3.6	24.4	0.0	95.7	18.2	8.5	0.5	0.9	6.5	31.9	0.1	0.1	26.8	42.8	0.0	13.3	93.6
NADSYN1	FLJ10631	ENSG00000172890	"NAD synthetase 1"	Q6IA69	11	71453109-71524107	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017798, HPA038523, HPA038524"	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Golgi apparatus, Cytosol"	"CAB017798: , HPA038523: AB_2676060, HPA038524: AB_2676061"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.17e-6)"	"unprognostic (1.19e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (4.12e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.10e-4)"	14.5	16.9	10.8	23.2	21.2	39.6	14.0	12.2	18.5	12.4	30.6	21.9	24.1	26.3	15.0	17.5	29.1	16.4	33.1	10.6	10.4	9.5	16.5	24.8	18.1	20.5	22.7	9.2	15.6	20.6	13.5	20.2	17.1	15.6	23.9	25.3	12.9	18.0	17.2	9.8	15.0	36.8	13.6	14.6	30.7	19.2	17.4	20.0	26.4	17.3	21.7	29.8	26.1	17.1	9.5	22.3	12.8	19.7	11.9	12.6	13.1	6.1	14.9	4.8	8.8	14.6	21.4	13.3	12.0	10.9	6.3	6.9	12.7	10.5	5.4	13.7	14.1	8.4	22.1	6.3	17.2	3.3	10.9	5.1	8.8	10.0	14.1	18.3	17.6	17.0	30.3	27.1	8.1	7.4	14.4	22.1	9.8	4.5	7.6	8.9	19.3	8.6	11.5	2.9	27.5	8.7	10.8	15.3	5.3	15.5	28.6	3.6	5.2	8.6	11.3	22.0	7.6	10.0	9.6	26.6	7.0	6.0	12.7	4.6	9.8	4.2	4.6	12.3	10.1	4.8	4.5	19.7	11.8	11.7	17.4	9.9	9.5	10.5	10.6	22.3	7.4	7.0	8.8	12.8	11.9	15.1	16.7	12.6	13.1	10.8	21.2	12.2	18.5	10.4	9.5	22.7	9.2	15.6	20.0	20.8	35.4	18.2	14.5	5.6	6.5	6.9	15.3	14.7	18.2	10.4	3.9	14.5	3.3	15.1	16.8	15.8	63.6	23.3	14.9	11.8	10.8	15.4	20.9	14.4	17.4	12.7	22.5	9.2	22.1	49.9	8.6	20.8	8.5	20.8	28.6	6.9	16.9	54.7	9.6	13.9	7.7	12.9	7.8	16.4	4.3	11.2	14.4	21.3	38.6	20.2
NBR1	"1A1-3B, CA125, KIAA0049, M17S2"	ENSG00000188554	"NBR1, autophagy cargo receptor"	Q14596	17	43170481-43211689	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 246.4;Late spermatids: 675.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022944, HPA022999, HPA023999"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Nuclear bodies"	"HPA022944: AB_2671001, HPA022999: AB_1859532, HPA023999: AB_1859533"	"unprognostic (1.85e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.54e-2)"	"prognostic favorable (2.00e-5)"	"unprognostic (1.65e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.39e-1)"	26.3	29.5	27.1	17.2	27.3	7.7	28.0	27.3	29.4	25.6	32.9	33.3	29.0	31.0	28.4	25.5	23.1	25.6	20.7	29.8	26.0	22.0	38.3	39.6	21.1	25.4	27.2	21.8	34.1	26.5	55.8	25.0	31.2	22.8	30.1	32.1	20.7	25.5	29.5	62.9	23.9	37.7	24.2	34.2	23.3	23.2	57.0	31.7	29.8	32.1	24.5	19.8	32.5	23.7	9.6	12.6	25.2	21.5	15.5	17.1	14.4	12.6	15.4	13.2	14.0	30.1	31.3	12.7	23.8	47.3	19.8	16.4	8.0	20.1	6.7	24.8	33.1	19.7	13.9	15.0	30.8	28.8	21.0	16.0	8.0	19.6	17.2	28.8	6.7	12.4	35.5	34.9	21.7	42.8	40.4	30.8	15.6	17.1	18.1	26.2	7.1	14.4	4.9	4.2	14.7	10.0	4.8	20.8	22.0	25.1	14.3	8.0	14.2	16.4	8.1	23.8	23.2	22.1	11.1	25.5	29.1	10.9	13.3	9.4	21.7	17.6	8.8	19.7	9.3	20.0	23.5	16.1	25.2	14.2	15.3	14.6	9.6	12.9	13.7	12.6	6.7	12.4	11.9	23.1	15.5	21.5	8.0	17.1	14.4	27.1	27.3	27.3	29.4	26.0	22.0	27.2	21.8	22.8	31.7	38.7	36.1	13.0	29.2	21.2	32.9	75.1	40.8	54.9	43.3	34.9	37.3	22.6	16.6	20.6	246.4	37.9	79.4	0.0	19.1	15.5	24.6	46.9	24.4	55.7	18.8	19.1	38.7	46.1	53.8	675.8	54.4	30.1	25.3	7.2	58.7	45.6	24.4	63.7	41.8	46.8	51.6	38.8	23.9	41.7	27.0	23.8	13.2	29.6	48.7	29.1
NDFIP2	"KIAA1165, N4wbp5a"	ENSG00000102471	"Nedd4 family interacting protein 2"	Q9NV92	13	79481124-79556075	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 304.4;Suprabasal keratinocytes: 321.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 17.3"	"Group enriched"	"Detected in many"	18	"granulocytes: 17.3;T-cells: 5.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009160	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA009160: AB_1079456"	"unprognostic (2.56e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.95e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (5.99e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.63e-2)"	"prognostic favorable (4.18e-5)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.02e-1)"	8.0	13.0	15.3	6.7	28.4	1.2	12.8	8.7	39.6	11.8	24.0	12.0	10.5	27.9	5.8	12.9	36.4	9.4	11.1	13.9	23.6	9.6	25.2	24.7	9.5	6.4	11.6	27.3	4.8	16.9	8.8	7.5	29.7	20.4	12.8	25.8	4.8	15.8	9.3	18.2	39.4	36.1	5.0	12.7	6.1	13.7	9.4	13.8	7.3	10.7	15.7	10.7	16.8	18.8	0.3	0.1	17.3	0.0	0.6	5.0	2.1	36.3	6.2	6.5	8.3	8.0	14.8	12.4	13.4	18.8	14.2	23.8	13.6	40.8	1.5	9.3	17.6	8.1	49.8	5.7	23.6	21.6	18.8	15.9	1.7	20.7	7.4	14.7	28.6	5.0	11.7	31.1	9.5	15.1	15.9	6.7	2.9	7.3	2.8	15.9	5.2	2.3	6.5	4.8	30.0	6.3	0.1	13.0	6.8	34.9	21.3	6.7	9.5	15.2	14.8	10.6	11.2	12.3	24.1	5.7	4.6	5.8	8.8	9.0	10.7	11.7	5.7	18.8	0.1	18.3	9.7	0.0	17.3	2.6	0.0	2.2	0.2	2.4	2.1	0.0	0.3	5.0	2.8	0.1	0.6	0.0	0.1	2.4	2.1	15.3	28.4	8.7	39.6	23.6	9.6	11.6	27.3	20.4	13.8	38.7	28.2	13.7	104.5	304.4	31.6	25.7	66.2	52.2	45.5	45.4	5.9	82.8	19.9	74.5	207.3	20.9	161.3	0.0	62.9	127.6	41.2	71.9	87.6	57.0	12.8	15.9	66.7	22.7	13.6	210.2	16.1	6.1	32.1	4.6	78.3	18.6	82.7	70.2	12.0	89.2	13.9	12.9	22.7	38.1	46.6	321.3	91.8	11.5	62.9	132.4
NDNF	"C4orf31, FLJ23191"	ENSG00000173376	"Neuron derived neurotrophic factor"	Q8TB73	4	121035613-121073021	"Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.6;retina: 41.0"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 229.3;Early spermatids: 225.6;Late spermatids: 164.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 12.6"	"Region enriched"	"Detected in many"	4	"pons and medulla: 7.6"	"Cell type enriched"	"Detected in single"	11	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 23.2;U-266/70: 10.3;U-266/84: 39.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 11.4;olfactory region: 41.7"	"Low region specificity"	"Detected in all"			HPA048881			Supported	Vesicles	"Secreted in other tissues"	NA	NA			Vesicles		"HPA048881: "	"unprognostic (2.84e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.94e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.18e-3)"	"unprognostic (6.27e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (2.38e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.74e-1)"	3.8	1.3	1.2	0.4	1.0	0.0	14.2	0.6	1.5	7.2	3.5	1.2	1.7	1.3	3.1	2.2	5.7	10.0	6.9	4.9	1.2	1.5	12.5	0.5	91.6	0.1	1.8	1.2	21.3	0.6	0.4	8.2	28.0	7.6	26.1	4.0	41.0	2.1	2.2	7.5	1.8	3.9	2.6	5.5	0.4	2.2	8.0	0.8	7.0	1.6	9.0	1.4	8.9	11.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	5.2	0.0	7.0	5.7	0.1	0.1	0.2	0.1	0.2	0.7	0.0	0.0	0.0	23.2	0.4	0.0	0.0	0.0	0.5	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	6.9	0.4	0.0	0.0	0.0	0.4	3.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.3	0.1	0.0	0.0	5.7	0.0	0.1	0.2	10.3	39.6	0.0	1.9	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.0	0.6	1.5	1.2	1.5	1.8	1.2	7.6	0.8	229.3	38.7	0.0	0.0	1.0	69.0	1.6	15.3	22.7	52.4	12.2	17.7	0.2	0.0	0.0	225.6	11.7	0.0	0.0	0.2	0.0	3.1	0.0	2.3	0.0	0.1	1.6	1.7	4.3	0.0	164.5	3.1	0.4	5.0	0.0	0.2	15.1	0.1	0.0	0.7	0.0	18.7	0.0	3.3	7.5	4.7	0.6	0.5	0.0	1.2	0.0
NDP	"EVR2, norrin"	ENSG00000124479	"NDP, norrin cystine knot growth factor"	Q00604	X	43948776-43973504	"Disease related genes, Predicted secreted proteins"	"Sensory transduction, Vision, Wnt signaling pathway"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 40.4"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 100.6"	"Cancer enhanced"	"Detected in many"		"glioma: 25.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	17	"U-87 MG: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	"Secreted to extracellular matrix"	NA	NA			Vesicles	"Nucleoplasm, Nucleoli"	"HPA003095: AB_1079457"	"unprognostic (1.12e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.55e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.51e-1)"		"unprognostic (9.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15.0	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18.0	0.9	1.4	14.0	7.8	0.7	0.5	0.6	0.7	11.0	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0.0	1.2	0.0	0.7	1.0	1.7	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.1	1.1	0.7	0.0	0.0	1.1	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	41.2	0.4	2.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.3	18.6	14.6	15.0	14.0	7.8	11.0	10.9	13.1	12.2	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	12.4	0.0	0.0	0.0	0.0	100.6	0.7	0.0	9.2	0.0	3.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.4	2.4	2.4	5.6	8.2	3.1	4.8	2.2	7.5	6.5	9.6	14.1	2.6	0.8	5.7	2.9	38.4	1.3	5.1	2.0	2.5	2.0	3.4	1.2	1.4	16.5	14.7	1.5	6.9	5.1	3.8	7.9	4.1	3.9	5.8	1.6	2.6	5.8	3.3	4.3	1.2	2.3	1.9	4.3	1.9	1.7	1.3	8.5	10.8	5.2	1.8	1.1	2.4	3.3	5.8	3.2	6.2	7.1	2.4	4.3	2.5	6.0	3.9	7.2	11.5	1.7	3.1	3.9	3.0	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0	23.8	47.7	44.6	42.4	30.5	24.5	18.7	38.2	10.7	17.0	45.4	23.6	52.4	8.3	82.1	0.8	27.6	80.5	0.0	51.5	49.0	63.2	112.7	66.9	21.3	139.8	9.5	108.9	26.4	42.3	0.7	25.6	53.4	67.4	25.2	37.4	48.4	45.4	80.7	21.9	55.3	29.8	25.8	42.2	5.0	7.5	36.4	164.8	28.7	38.6	31.8
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493071	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Intestinal endocrine cells: 162.6;Peritubular cells: 231.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (6.66e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-2)"	"unprognostic (6.56e-3)"	"unprognostic (4.96e-2)"	"unprognostic (8.33e-3)"	"prognostic favorable (1.91e-4)"	"unprognostic (1.40e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.05e-3)"	16.5	24.9	29.7	14.3	36.1	18.1	16.7	84.5	47.5	24.1	16.4	21.4	22.1	12.9	24.4	19.5	14.1	20.9	16.4	14.1	24.7	18.8	14.9	11.8	17.1	15.9	13.2	35.6	30.7	21.8	23.3	55.3	21.0	20.8	29.8	11.4	27.0	26.5	30.2	12.2	42.5	14.8	20.9	13.3	16.8	14.8	27.3	13.9	16.3	17.1	7.8	12.6	21.9	19.5	5.8	6.6	6.5	8.3	6.1	8.1	6.4	7.4	7.9	24.6	20.0	18.4	20.4	20.2	16.2	10.7	13.0	13.3	11.8	11.3	10.5	4.5	22.4	10.7	10.1	13.0	17.6	7.7	10.6	14.0	18.9	27.5	11.4	16.8	11.1	17.0	32.0	14.2	14.0	12.0	27.5	20.9	21.1	10.0	11.7	12.1	10.7	19.8	24.6	15.0	9.6	13.5	11.8	6.7	12.2	14.8	15.0	10.4	18.2	17.5	4.6	11.2	22.4	14.5	18.7	22.8	18.3	17.6	18.5	11.5	19.5	11.1	13.3	12.6	18.1	11.1	6.3	8.3	6.5	6.4	7.6	6.3	4.7	5.4	8.1	4.5	5.8	6.5	6.5	2.9	6.1	1.1	6.6	5.8	6.4	29.7	36.1	84.5	47.5	24.7	18.8	13.2	35.6	20.8	13.9	23.8	28.8	12.0	14.1	24.5	39.6	18.2	7.6	10.7	18.2	14.0	7.9	26.9	8.3	11.4	7.2	20.2	15.8	0.0	8.2	11.6	19.3	13.0	24.3	12.4	25.4	27.0	162.6	52.2	62.2	16.8	81.7	22.2	18.6	5.4	16.3	10.6	9.2	13.9	231.3	11.0	23.3	25.8	23.1	31.1	15.6	19.4	20.3	13.8	15.0	10.8
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586898	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.7;T-cells: 14.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		27000	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	13.4	38.8	17.4	11.2	30.9	26.4	15.8	7.1	25.1	10.1	8.7	65.6	3.4	10.2	11.1	11.7	12.8	8.2	11.2	7.1	23.4	14.3	9.9	10.3	17.8	13.0	46.0	15.4	12.0	7.9	51.8	9.9	18.9	27.7	9.7	8.9	12.0	25.4	10.1	13.7	17.0	12.2	10.9	41.4	11.5	12.0	9.5	38.4	7.0	8.3	5.3	10.7	10.8	10.8	3.6	32.7	3.8	5.8	4.6	14.5	4.1	5.3	10.7	4.6	7.4	15.0	11.6	10.5	9.3	20.2	9.9	21.5	7.1	7.8	4.5	7.2	13.4	33.8	15.0	5.8	16.0	8.8	3.5	4.6	1.6	9.7	16.0	21.4	6.1	7.4	11.1	15.9	20.9	70.4	19.6	9.7	5.2	4.8	12.1	11.1	8.1	2.5	3.6	3.2	6.1	9.6	3.6	7.2	11.2	23.0	13.3	1.9	3.7	11.1	16.2	13.7	7.4	4.0	4.8	12.5	21.0	4.1	8.3	8.0	7.5	23.1	3.1	46.3	5.4	9.4	1.8	4.1	3.8	14.5	3.8	9.8	2.4	5.9	9.9	1.7	3.6	2.7	7.3	3.7	4.6	5.8	32.7	7.7	4.1	17.4	30.9	7.1	25.1	23.4	14.3	46.0	15.4	27.7	38.4	23.8	44.3	6.2	23.3	8.2	5.0	4.4	10.2	0.0	15.9	8.7	17.7	11.6	0.0	9.3	1.1	11.4	11.3	0.0	12.8	6.2	6.5	30.4	10.4	7.9	25.1	3.2	3.5	7.4	9.2	1.4	8.3	17.9	11.8	2.8	4.8	16.2	23.5	14.0	9.9	4.7	12.4	0.0	9.0	12.6	20.4	12.7	19.9	20.3	4.5	51.4
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309598	"Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 23.9;testis: 36.0"	"Cell type enhanced"	"Detected in some"	15	"Intestinal endocrine cells: 5.2;Melanocytes: 1.7;monocytes: 4.6;Pancreatic endocrine cells: 2.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 35.1;RT4: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA			"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.4	23.9	1.0	0.0	0.8	0.0	0.2	0.4	1.1	1.3	0.1	1.7	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.5	0.6	3.5	2.1	0.0	1.6	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.6	0.1	0.7	36.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.1	0.9	0.9	0.5	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.7	1.1	0.0	1.7	4.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"		Vasoactive		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 115.3"	"Cell type enhanced"	"Detected in some"	19	"Club cells: 27.3;Collecting duct cells: 8.7;Ito cells: 11.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 70.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 81.8"	"HPA026664, HPA071012"	Enhanced		Supported	Vesicles	"Secreted to digestive system"	NA	NA		120000	Vesicles		"HPA026664: AB_2671936, HPA071012: "	"unprognostic (3.63e-1)"	"prognostic favorable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavorable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	2.9	0.6	3.9	1.4	3.2	0.1	2.5	0.3	0.4	0.5	5.2	2.5	0.0	2.8	0.2	1.6	2.5	0.5	0.8	0.8	10.3	22.1	0.9	0.7	2.0	15.1	6.3	0.1	0.7	0.4	0.1	15.0	0.3	25.0	0.4	0.7	0.0	1.6	0.5	0.1	0.1	115.3	0.5	2.7	0.2	18.8	0.3	0.4	0.1	0.9	0.8	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	1.3	0.0	0.5	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	70.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.3	0.4	10.3	22.1	6.3	0.1	25.0	0.4	0.0	0.3	0.0	0.4	1.1	0.0	0.3	0.0	5.3	27.3	8.7	0.0	0.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.2	0.2	2.8	0.0	0.0	0.2	0.0	2.4	11.1	0.8	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.5	0.0	1.9	0.1	0.0	0.0	1.1
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	18	"Fibroblasts: 177.9;Ito cells: 73.6;Leydig cells: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"myeloid DC: 5.4"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.8;ASC TERT1: 46.4;BJ hTERT+: 52.9;HSkMC: 84.8;LHCN-M2: 84.6"	"Low region specificity"	"Detected in many"							HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		1500000	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	25.8	11.8	3.9	9.7	6.6	0.0	25.6	1.4	7.9	75.3	22.7	16.2	17.9	3.9	57.7	41.8	13.8	33.9	31.5	20.3	3.0	2.3	9.7	9.4	18.4	5.7	7.1	4.0	52.6	11.7	1.0	6.6	29.1	8.9	33.1	9.6	41.4	6.1	21.9	5.8	13.5	10.8	29.4	5.1	2.5	19.1	13.3	4.6	0.6	7.8	15.0	7.0	28.0	37.6	0.0	5.4	0.0	0.4	0.0	0.0	0.2	0.0	2.7	1.4	0.0	84.8	46.4	0.0	10.8	52.9	3.7	12.3	3.5	0.0	0.0	0.6	31.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	2.6	22.0	0.0	0.0	84.8	0.0	5.3	0.0	1.5	0.3	0.0	0.0	0.0	84.6	0.0	0.0	0.0	6.4	0.0	0.1	0.0	20.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.4	21.4	31.4	0.1	0.2	2.1	4.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	13.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.9	6.6	1.4	7.9	3.0	2.3	7.1	4.0	8.9	4.6	0.0	5.9	0.5	0.1	11.6	0.0	1.4	2.5	0.0	1.2	1.8	0.0	5.6	0.0	0.6	1.5	3.5	0.0	0.0	0.0	5.0	177.9	1.1	1.1	0.2	33.4	0.0	5.8	73.6	5.0	1.1	67.9	3.6	11.8	1.0	0.2	0.0	0.4	0.0	31.1	0.5	0.0	0.0	37.3	0.2	0.4	10.0	10.4	0.7	0.0	0.3
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	35.7	28.8	12.6	19.0	20.7	20.3	27.4	30.3	17.6	29.4	15.4	29.8	20.0	13.1	36.3	29.7	18.8	19.4	15.0	27.2	13.5	16.1	35.4	52.6	25.7	18.2	25.1	14.0	29.4	26.9	43.2	27.6	20.8	22.2	37.1	16.6	29.9	18.2	22.4	55.6	15.2	16.4	25.3	28.2	22.5	22.5	20.0	24.8	19.4	28.2	18.5	24.6	27.7	31.6	23.4	19.9	28.7	13.6	12.8	23.2	12.6	20.5	10.6	21.4	4.7	15.3	7.6	38.5	10.5	17.7	17.1	20.4	15.3	15.4	29.9	18.4	11.6	37.9	9.5	18.1	18.3	24.3	21.3	13.2	23.6	20.6	31.6	14.9	24.3	12.2	15.4	17.7	19.3	12.7	22.5	22.4	16.1	44.7	9.8	9.5	14.6	6.9	26.3	29.2	8.5	4.9	17.6	31.2	31.8	22.8	16.0	10.7	14.1	9.0	24.6	29.2	54.5	11.9	24.5	13.4	4.9	16.4	6.1	18.8	24.0	15.2	34.9	12.0	11.3	7.6	28.7	13.6	25.0	16.1	11.4	23.2	23.4	16.0	16.6	19.9	16.4	17.1	18.1	15.9	12.8	8.6	15.7	15.3	12.6	12.6	20.7	30.3	17.6	13.5	16.1	25.1	14.0	22.2	24.8	74.5	49.1	18.6	29.9	15.8	56.5	40.9	33.1	34.8	64.8	43.6	39.3	73.6	106.1	38.4	33.8	24.8	19.8	23.3	41.8	42.1	39.1	43.6	32.4	52.3	33.4	25.4	28.6	20.3	22.4	30.8	57.8	20.0	62.4	63.1	19.4	41.4	33.7	8.6	47.0	45.4	31.9	45.3	36.4	30.9	17.6	16.6	63.2	23.5	21.4	23.0
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteopetrosis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Melanocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		130000	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.3	21.9	9.0	18.1	13.5	5.5	16.7	13.7	17.2	14.4	17.8	12.8	9.9	8.4	21.8	10.3	14.1	15.0	13.5	23.2	10.4	16.5	22.0	15.9	17.0	17.2	11.0	10.5	15.6	9.7	11.8	26.0	24.7	20.0	15.4	12.4	29.7	10.8	19.0	18.0	10.4	12.9	24.7	13.1	21.7	14.3	11.1	10.7	13.6	12.4	8.1	13.9	21.0	19.4	10.8	12.4	20.9	28.1	14.5	16.4	16.9	2.1	6.4	7.6	11.1	23.0	7.5	10.9	16.0	16.1	11.7	19.5	3.8	3.6	5.0	13.2	11.1	31.6	4.1	7.5	5.4	18.1	11.5	5.9	10.6	4.1	4.7	17.8	11.6	24.7	10.9	13.6	14.4	11.5	10.8	5.9	5.7	8.3	18.5	18.9	3.0	2.5	2.6	3.0	2.6	4.9	4.1	11.1	2.7	8.4	5.8	0.8	4.5	12.9	3.3	28.5	10.6	3.7	16.9	7.2	10.3	3.8	22.7	22.6	7.1	12.1	4.4	30.4	7.9	22.6	16.8	13.9	15.2	15.0	19.9	16.0	10.8	12.8	16.4	12.4	6.2	12.0	15.0	20.9	14.5	28.1	8.9	15.4	16.9	9.0	13.5	13.7	17.2	10.4	16.5	11.0	10.5	20.0	10.7	8.9	21.3	25.4	14.7	41.4	29.2	18.5	12.7	5.3	6.8	12.2	9.8	18.7	1.7	10.8	3.4	18.0	10.3	0.0	19.8	29.3	16.9	16.3	24.2	12.4	46.3	27.0	4.1	28.8	46.6	2.7	13.3	33.0	143.4	10.8	4.2	24.0	15.6	12.9	26.9	21.0	15.7	25.8	33.9	19.8	19.5	27.1	51.1	27.7	2.9	14.0
OTX2		ENSG00000165588	"Orthodenticle homeobox 2"	P32243	14	56799905-56810479	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 27.7;retina: 78.2"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 181.3;Cone photoreceptor cells: 159.0;Rod photoreceptor cells: 203.6"	"Cancer enriched"	"Detected in single"	27	"testis cancer: 11.6"	"Group enriched"	"Detected in many"	5	"cerebellum: 20.4;pons and medulla: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 63.9;NTERA-2: 53.5"	"Low region specificity"	"Detected in many"							"HPA000633, HPA001123"	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA000633: AB_1079538, HPA001123: "					"unprognostic (3.82e-1)"			"unprognostic (2.56e-2)"							"unprognostic (9.28e-2)"			0.2	0.2	0.0	0.2	0.3	0.2	0.2	20.4	0.3	0.2	0.2	3.7	0.0	0.2	0.2	1.0	0.2	0.2	0.2	0.2	1.8	2.7	0.2	0.2	0.2	0.5	4.7	0.0	0.5	0.2	0.2	2.8	0.2	27.7	0.3	0.2	78.2	0.2	1.3	0.2	0.5	0.2	0.2	0.2	0.4	0.2	3.1	2.3	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	20.4	0.3	1.8	2.7	4.7	0.0	27.7	2.3	0.0	0.0	0.0	0.0	0.0	181.3	0.2	0.0	0.0	0.0	0.0	159.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	203.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0
PACSIN2	SDPII	ENSG00000100266	"Protein kinase C and casein kinase substrate in neurons 2"	Q9UNF0	22	42835412-43015145	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 37.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049854, HPA056520"	Enhanced		Supported	"Nuclear speckles,Vesicles,Plasma membrane,Cytosol"		NA	NA		83000	"Nuclear speckles, Vesicles, Cytosol"	"Plasma membrane"	"HPA049854: AB_2680915, HPA056520: AB_2683163"	"unprognostic (5.62e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (7.33e-4)"	"unprognostic (4.48e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.09e-13)"	"unprognostic (2.87e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.95e-1)"	20.1	42.0	19.4	19.4	20.7	14.3	22.9	32.3	21.3	18.7	28.4	17.5	21.1	22.5	20.8	18.9	19.3	17.5	33.3	28.0	17.9	19.5	32.5	20.7	25.8	16.9	20.6	15.7	17.4	77.3	14.3	21.5	33.8	32.4	24.6	23.5	26.6	31.7	16.6	23.9	19.4	25.6	25.1	17.8	22.5	27.8	12.6	19.2	13.1	31.0	15.8	18.4	17.7	17.6	4.7	8.3	37.9	12.6	6.7	4.5	5.0	24.7	26.0	21.9	14.0	11.3	12.1	18.0	22.6	13.7	20.5	17.1	27.0	14.6	11.5	19.2	16.7	14.0	17.6	14.3	24.0	13.5	11.7	14.2	18.6	13.3	38.4	16.1	13.1	40.4	11.6	23.8	26.9	11.8	16.7	16.8	10.7	16.0	8.4	17.6	16.2	13.8	20.6	12.1	36.2	11.0	17.0	32.9	7.7	23.5	14.7	14.3	6.4	27.0	18.7	50.7	14.8	13.5	17.4	24.7	15.3	19.5	16.9	13.3	6.3	8.6	12.6	14.6	11.6	33.2	7.9	7.0	17.4	2.8	12.6	3.0	4.2	3.2	2.4	8.3	4.7	3.2	2.4	37.9	6.7	12.1	3.1	4.5	5.0	19.4	20.7	32.3	21.3	17.9	19.5	20.6	15.7	32.4	19.2	65.5	52.9	11.5	38.7	20.6	14.4	20.9	28.1	28.1	35.2	43.6	37.3	28.5	38.1	63.1	2.7	25.4	95.4	0.0	56.4	21.0	22.1	70.2	69.3	19.8	37.7	6.4	23.7	14.1	37.5	4.3	20.1	36.1	79.2	65.9	46.1	7.8	79.7	43.8	21.9	34.2	23.4	90.5	44.3	22.0	26.4	14.8	40.3	17.5	33.5	27.3
PAIP2	PAIP2A	ENSG00000120727	"Poly(A) binding protein interacting protein 2"	Q9BPZ3	5	139341587-139369720	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 720.9;Late spermatids: 1930.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035945, CAB037212, HPA056766"	Approved		Supported	Vesicles		NA	NA			Vesicles		"CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: AB_2683231"	"unprognostic (1.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.40e-2)"	"unprognostic (3.80e-3)"	"unprognostic (7.70e-3)"	"unprognostic (8.91e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.36e-1)"	"unprognostic (6.92e-2)"	36.2	57.4	50.8	27.0	46.7	36.3	34.4	64.5	59.9	31.0	27.6	32.0	25.7	16.1	36.0	33.3	26.0	35.2	24.9	62.9	49.7	57.8	39.0	41.8	26.8	36.1	58.4	51.7	44.2	23.7	20.5	47.2	34.2	61.8	32.6	20.6	23.0	32.2	33.0	56.1	17.7	18.2	31.3	57.0	32.0	23.0	59.2	41.0	45.8	30.4	27.0	38.2	30.9	28.2	54.9	45.2	122.8	53.3	49.4	65.5	74.8	20.5	23.4	46.1	27.5	34.5	19.7	22.4	18.8	26.2	24.5	38.6	31.2	20.0	36.4	40.4	14.2	28.4	20.5	40.1	25.8	32.6	34.9	31.4	33.5	34.9	27.9	22.3	20.7	24.8	22.3	21.6	18.4	21.1	26.7	25.0	39.9	31.8	32.3	22.1	27.1	56.1	50.6	27.8	29.3	17.0	31.4	58.3	39.5	19.5	36.8	21.4	38.9	27.9	25.8	55.0	60.9	49.9	43.5	15.4	13.2	16.2	14.3	15.2	47.3	57.2	37.9	23.3	36.6	13.5	69.9	45.3	107.8	46.7	48.8	51.0	54.9	52.0	53.3	44.1	48.5	60.9	59.5	122.8	49.4	53.3	45.2	65.5	74.8	50.8	46.7	64.5	59.9	49.7	57.8	58.4	51.7	61.8	41.0	68.5	77.0	138.7	140.5	142.0	96.6	57.4	86.6	155.2	71.7	94.2	55.0	174.3	144.2	98.1	720.9	118.2	51.9	116.8	100.1	119.9	128.8	187.4	106.2	93.6	125.9	92.2	93.1	106.8	139.3	1930.3	149.0	168.1	128.2	247.1	49.3	108.0	109.4	53.2	146.0	189.5	80.1	168.1	120.5	352.6	211.4	182.2	401.2	199.3	51.7	127.6
PARM1	"Cipar1, DKFZP564O0823, WSC4"	ENSG00000169116	"Prostate androgen-regulated mucin-like protein 1"	Q6UWI2	4	74933095-75050115	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 143.3;Mucus-secreting cells: 90.2;Paneth cells: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 10.1;myeloid DC: 4.6;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	15	"B-cells: 10.1;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;Karpas-707: 23.9;U-266/70: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038236	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"HPA038236: AB_10675789"	"unprognostic (2.57e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.26e-3)"	"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.74e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.23e-1)"	23.1	21.5	5.7	25.0	15.2	0.3	16.4	1.3	29.4	18.7	36.0	1.2	28.5	2.8	20.3	18.0	5.8	12.2	11.5	39.8	6.9	13.0	27.5	1.1	15.1	10.2	3.3	10.3	11.9	29.2	23.2	32.1	16.1	4.8	35.0	45.8	70.2	25.6	27.6	7.4	6.2	8.3	29.3	2.4	9.7	5.5	11.2	1.2	6.3	79.8	3.7	8.0	24.9	19.7	10.1	4.6	0.1	0.5	0.0	0.0	0.7	0.5	1.0	0.9	0.0	24.5	0.1	0.1	0.0	0.1	0.0	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.0	8.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	4.1	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.9	0.4	0.2	2.6	0.1	2.3	0.0	1.4	0.0	2.2	6.0	0.1	4.9	1.5	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0	1.4	1.6	0.1	2.1	26.8	2.5	6.8	2.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.0	10.1	0.0	0.0	4.6	6.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.7	5.7	15.2	1.3	29.4	6.9	13.0	3.3	10.3	4.8	1.2	14.9	63.1	13.4	17.1	2.9	7.9	143.3	30.6	1.4	11.4	0.0	0.0	0.3	3.3	0.1	6.8	3.8	80.6	23.3	43.2	0.6	15.4	43.3	1.1	0.0	1.4	0.0	19.1	3.1	0.0	20.6	33.9	7.2	8.5	1.0	90.2	0.0	26.9	120.2	70.0	27.6	1.0	45.3	52.3	1.7	3.3	1.6	0.7	1.5	46.2	8.4
PCDHB3	PCDH-BETA3	ENSG00000113205	"Protocadherin beta 3"	Q9Y5E6	5	141100473-141103827	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 17.3"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 12.4;HAP1: 3.8;SH-SY5Y: 16.5;U-138 MG: 5.8"	"Low region specificity"	"Detected in all"							HPA050296	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA050296: AB_2681078"	"unprognostic (2.72e-2)"	"unprognostic (7.47e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-4)"	"unprognostic (9.34e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.52e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.18e-4)"	5.7	4.6	3.1	2.6	9.3	0.4	5.9	3.8	6.2	4.8	2.5	2.2	1.3	1.4	8.0	3.0	1.3	3.1	3.1	3.6	3.8	3.0	4.9	0.8	3.3	1.0	3.0	3.8	5.6	3.9	4.4	17.3	1.8	4.0	5.4	2.1	3.4	2.4	2.4	1.9	2.0	2.1	3.8	3.0	1.5	1.8	11.6	2.0	0.0	2.1	2.3	0.7	2.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.4	2.1	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	1.8	0.0	3.8	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.6	16.5	0.0	0.2	0.0	0.6	2.1	0.1	0.0	5.8	0.8	0.6	0.3	0.3	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	9.3	3.8	6.2	3.8	3.0	3.0	3.8	4.0	2.0	0.0	0.0	0.0	0.1	0.0	1.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.3	0.7	0.6	0.0	0.0	0.2	0.0	0.5	0.6	0.0	0.0	0.0	7.9	0.0	0.6	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.8	0.5	0.0	0.7	0.0	0.2	0.0	0.5	1.4	0.9	0.3	0.0	0.0	0.0	0.3
PCDHGB2	PCDH-GAMMA-B2	ENSG00000253910	"Protocadherin gamma subfamily B, 2"	Q9Y5G2	5	141360042-141512979	"Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 14.4;ASC TERT1: 10.5;LHCN-M2: 8.5;REH: 7.8"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580, HPA077526"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane, Cytosol"	Nucleoplasm	"HPA008755: AB_1079577, HPA010580: AB_2732401, HPA077526: AB_2732350"	"unprognostic (7.14e-3)"	"unprognostic (8.79e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.46e-3)"	"unprognostic (4.59e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.36e-4)"	4.9	3.6	11.3	2.2	9.7	0.9	3.7	8.7	12.2	7.2	2.4	11.6	0.3	1.2	9.2	3.2	3.2	5.6	6.2	4.6	9.3	7.0	2.7	2.7	5.4	1.4	7.0	8.6	9.0	2.6	7.5	3.0	3.9	7.3	4.4	2.8	3.1	2.4	4.4	1.9	2.9	2.1	5.0	7.0	2.2	2.0	1.8	7.8	0.1	2.6	1.3	1.4	2.8	3.3	0.9	0.9	0.5	0.0	0.0	0.7	0.0	0.1	0.3	2.1	0.2	14.4	10.5	0.1	2.2	3.0	0.6	3.4	0.0	0.3	3.8	1.0	1.7	7.5	0.5	0.5	0.3	1.0	0.0	0.2	0.0	0.3	0.4	0.6	0.2	0.2	2.7	0.5	0.2	0.1	4.9	1.7	0.1	0.2	1.2	8.5	0.4	2.9	0.6	0.1	0.9	0.9	7.8	2.7	0.2	0.2	0.3	1.6	1.7	0.2	0.4	0.4	1.6	3.1	0.2	6.0	3.0	0.7	4.6	3.9	0.2	2.2	0.7	3.3	1.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.4	0.0	0.0	0.4	0.0	0.6	0.5	0.0	0.0	0.9	0.0	0.0	11.3	9.7	8.7	10.6	9.3	7.0	7.0	8.6	7.3	7.8	0.0	0.3	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"Sertoli cells: 1267.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	8	"monocytes: 4.1;T-cells: 2.9"	"Group enriched"	"Detected in some"	4	"ASC diff: 173.0;ASC TERT1: 59.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		35000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavorable (8.11e-4)"	61.8	10.4	8.3	11.0	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17.0	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5.0	19.6	9.2	21.5	6.7	1.4	21.4	16.0	7.3	23.6	35.1	0.4	0.1	0.0	4.1	0.0	2.9	0.6	0.0	0.0	1.0	0.0	173.0	59.9	0.4	6.0	25.1	4.2	7.1	0.6	0.0	0.0	0.8	17.3	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.4	24.5	0.0	0.0	27.0	0.0	5.8	0.0	13.5	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.8	2.2	2.9	0.3	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	2.9	0.6	0.0	0.4	0.1	0.8	0.1	0.1	0.0	1.3	0.0	0.0	4.1	0.0	0.0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7	0.0	0.6	0.0	0.5	21.3	5.0	13.4	0.0	1.4	0.0	1.8	3.9	0.6	0.0	0.0	0.8	16.2	0.0	0.0	0.0	1.0	68.8	0.6	0.0	1.5	1.4	0.0	0.0	6.7	0.0	4.7	153.1	2.2	23.6	1.0	0.0	74.9	0.1	0.0	191.6	0.0	1.1	1267.6	273.4	1.1	1.5	13.4	0.7	1.0	0.4	0.9
PEF1	PEF1A	ENSG00000162517	"Penta-EF-hand domain containing 1"	Q9UBV8	1	31629862-31644896	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061608			Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		660000	"Nucleoplasm, Cytosol"	Vesicles	"HPA061608: AB_2684567"	"unprognostic (2.92e-2)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (2.88e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.89e-3)"	34.0	27.0	26.9	15.3	28.7	17.0	27.1	22.5	40.8	26.6	23.4	25.9	21.1	16.2	27.1	46.5	29.7	29.0	26.1	26.4	24.3	23.8	28.3	38.7	24.9	20.8	25.0	17.3	31.1	20.8	31.6	21.6	44.2	28.6	29.8	24.2	25.7	24.8	33.4	25.5	32.5	20.7	31.9	22.4	23.6	20.5	17.8	16.5	27.4	85.9	20.3	30.7	23.7	21.9	39.1	40.4	60.9	39.5	42.0	49.2	48.7	17.7	20.8	17.4	13.4	20.6	21.6	16.7	16.9	29.1	41.0	36.2	12.2	26.9	19.0	23.7	37.7	21.1	18.7	33.6	43.2	33.3	23.8	36.4	15.7	16.8	24.6	36.3	15.3	14.9	22.2	50.0	40.0	37.6	26.2	39.6	23.5	16.2	19.7	29.3	20.9	23.3	14.9	24.1	22.0	23.7	22.7	16.9	20.7	32.0	19.3	24.9	14.4	19.3	18.2	25.2	28.6	16.2	11.2	20.9	17.8	15.3	30.2	22.3	12.7	12.8	20.4	22.4	22.6	21.3	60.9	39.5	46.2	49.2	35.3	47.5	37.8	42.1	44.6	40.4	39.1	39.9	40.0	40.1	42.0	32.7	37.4	41.9	48.7	26.9	28.7	22.5	40.8	24.3	23.8	25.0	17.3	28.6	16.5	38.7	33.6	34.3	57.8	32.2	37.2	14.6	20.4	20.1	21.6	66.3	11.8	131.6	96.2	58.8	67.1	60.4	35.8	0.0	54.4	80.4	36.6	45.7	71.5	20.5	54.6	50.9	42.5	31.9	17.0	60.2	41.7	26.1	47.2	124.4	29.6	55.3	47.2	34.8	55.2	41.2	20.3	19.4	42.2	34.5	41.5	44.9	152.9	34.6	33.2	48.8
PEX11B		ENSG00000131779	"Peroxisomal biogenesis factor 11 beta"	O96011	1	145911350-145918837	"Disease related genes, Predicted membrane proteins"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA017150, HPA050104"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA017150: , HPA050104: AB_2681017"	"unprognostic (4.59e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.67e-4)"	"prognostic favorable (6.85e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.48e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.62e-3)"	"unprognostic (4.28e-1)"	12.0	17.3	25.9	13.3	29.5	8.5	24.4	25.1	39.6	19.9	18.2	17.3	21.3	18.4	16.2	27.2	21.6	20.1	14.7	17.9	25.8	28.1	25.4	19.8	14.9	18.4	24.0	20.3	19.7	23.2	20.4	16.4	17.3	26.9	18.2	21.7	15.7	19.0	20.9	23.7	20.6	17.2	16.1	14.7	18.7	18.4	18.0	14.8	21.4	20.3	17.2	25.3	16.7	13.9	42.5	42.8	32.0	29.6	29.5	37.0	34.1	11.2	10.3	9.2	9.1	21.5	16.9	9.5	11.4	15.2	15.0	11.6	4.7	13.2	10.6	12.4	16.2	7.3	13.8	8.0	17.0	10.5	11.8	6.0	6.5	6.8	12.2	30.4	19.4	12.0	22.2	21.3	10.1	10.0	19.3	19.0	14.9	11.8	17.6	23.6	17.9	14.9	18.5	3.3	24.1	12.8	13.8	13.8	23.1	25.7	8.0	6.4	10.5	8.6	16.6	10.4	9.6	23.0	30.3	16.9	10.1	8.1	13.2	8.3	19.0	21.9	15.0	17.1	11.0	6.9	32.0	29.6	20.6	28.7	26.3	31.2	42.5	32.9	31.0	32.0	37.2	37.0	33.5	14.7	29.5	25.8	42.8	34.8	34.1	25.9	29.5	25.1	39.6	25.8	28.1	24.0	20.3	26.9	14.8	14.9	10.1	11.9	7.5	17.2	7.2	11.8	17.8	12.0	6.8	38.4	0.0	31.7	38.1	11.9	9.5	11.7	16.7	0.0	12.2	11.2	11.8	8.1	3.5	27.2	19.8	4.8	12.2	12.9	18.1	15.7	13.0	11.3	20.3	31.5	18.1	12.6	12.4	14.0	18.7	27.8	4.5	6.5	6.2	34.7	19.1	19.3	16.7	11.8	14.5	8.6
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	21.3	30.9	25.4	17.9	23.8	17.3	30.7	20.7	24.6	24.3	23.8	24.1	65.7	22.5	25.7	24.3	21.6	24.1	18.0	22.1	26.9	20.7	31.3	25.3	20.4	27.8	29.8	18.3	20.5	26.4	21.2	32.6	17.4	25.9	25.8	22.9	24.9	28.7	63.6	32.4	17.4	27.2	25.7	30.5	23.1	27.0	14.7	30.9	32.2	34.4	19.0	23.4	24.2	23.5	17.3	17.1	52.4	22.9	28.3	22.3	24.2	27.3	9.3	15.1	15.2	16.1	20.3	7.9	20.6	23.5	15.9	17.6	5.8	24.6	15.6	30.7	18.4	13.0	10.6	10.3	15.6	19.4	28.8	8.5	19.0	8.6	8.9	10.9	15.7	15.1	22.8	13.3	12.0	14.4	25.0	17.3	25.3	10.4	15.0	16.6	8.2	27.6	9.4	8.9	39.2	8.4	5.1	12.0	12.9	18.4	19.4	5.3	14.0	13.2	60.2	11.2	13.5	18.8	11.4	17.2	14.6	19.2	18.8	10.2	27.9	16.1	27.2	18.6	8.4	16.1	52.4	20.3	35.8	22.3	20.8	19.9	17.3	15.6	17.9	16.9	17.2	20.6	19.6	14.1	28.3	22.9	17.1	17.4	24.2	25.4	23.8	20.7	24.6	26.9	20.7	29.8	18.3	25.9	30.9	44.7	18.5	25.9	28.0	16.1	26.4	23.8	28.1	24.1	19.4	26.2	11.8	35.4	112.7	45.9	2.4	15.7	28.0	0.0	43.3	19.6	25.8	30.4	17.4	29.7	24.1	12.7	27.7	17.2	35.1	5.9	27.3	21.5	27.0	32.5	33.2	49.5	36.5	29.1	33.6	53.7	29.7	6.5	24.8	13.5	17.6	18.3	29.1	41.1	26.4	33.0
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963870-42979220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 73.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	13.0	14.9	12.1	11.5	18.9	9.0	11.5	21.7	19.0	14.7	16.9	14.6	15.3	9.8	11.9	8.8	18.2	23.4	13.0	10.4	12.9	12.1	11.3	18.8	7.4	17.6	17.3	9.1	20.0	73.2	21.3	18.2	10.6	16.0	17.8	8.5	10.8	15.0	12.8	15.2	14.2	24.6	10.5	9.9	12.8	10.6	10.6	17.2	22.3	21.5	6.9	10.9	11.2	12.4	4.3	4.3	4.8	3.2	4.0	6.1	2.5	15.9	7.7	3.9	14.5	14.5	14.0	4.0	2.8	4.4	2.3	4.8	4.8	4.7	6.5	3.9	6.7	9.8	15.1	13.5	14.6	2.4	12.6	7.2	2.1	10.9	2.8	9.8	2.2	4.5	17.4	16.9	9.5	2.6	18.8	11.7	8.9	11.3	6.7	5.0	1.8	5.7	7.2	4.8	36.3	6.7	12.3	6.8	2.6	5.9	4.6	12.2	5.3	2.6	10.4	14.7	6.6	20.5	9.8	6.5	7.4	1.4	3.6	6.4	10.1	8.8	8.9	2.5	11.3	5.9	2.1	3.2	4.8	3.0	2.4	5.4	2.6	4.4	6.1	4.3	4.3	5.5	5.1	2.0	4.0	1.5	2.5	2.1	2.5	12.1	18.9	21.7	19.0	12.9	12.1	17.3	9.1	16.0	17.2	6.0	1.6	2.7	8.8	4.4	14.5	4.5	5.1	5.3	3.4	7.0	2.0	7.7	11.6	2.4	2.2	4.0	12.4	0.0	1.3	5.7	6.4	6.2	0.0	10.5	4.9	20.6	5.2	9.8	6.7	2.2	13.6	2.8	8.5	1.0	7.4	10.6	1.7	7.0	8.9	9.8	6.4	0.0	5.2	7.7	2.8	4.8	6.2	4.4	8.0	5.5
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913937	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.5	17.8	8.1	7.0	8.9	4.0	13.5	7.0	10.7	8.7	8.5	7.9	14.0	6.1	5.5	18.9	9.1	8.9	17.0	14.5	7.2	6.7	16.3	10.0	9.2	4.7	8.9	9.5	6.1	43.6	15.5	10.2	6.7	6.9	11.7	9.2	13.6	15.4	18.9	11.7	12.0	6.6	7.5	9.6	4.7	14.5	19.4	5.4	5.9	11.5	7.5	6.8	6.9	7.0	4.6	5.4	4.3	5.3	2.9	6.9	1.8	4.7	4.6	4.6	6.5	6.0	8.9	2.5	6.6	8.3	7.1	7.5	5.7	5.6	1.7	12.6	7.1	8.6	6.1	3.3	12.3	8.8	4.9	8.0	6.4	4.6	0.8	14.4	8.0	3.7	8.5	13.1	5.1	10.2	8.1	5.3	11.7	11.9	5.1	9.7	11.3	3.5	9.9	4.7	12.6	7.9	4.7	4.7	5.0	15.4	6.4	8.8	12.6	6.1	8.8	8.5	5.4	5.7	10.1	4.0	4.7	2.2	7.3	5.1	7.2	4.7	0.0	3.7	7.3	5.6	0.2	3.0	4.3	2.6	2.5	2.0	4.6	3.4	4.2	5.3	2.9	6.9	4.1	0.5	2.9	5.3	5.4	6.4	1.8	8.1	8.9	7.0	10.7	7.2	6.7	8.9	9.5	6.9	5.4	3.0	6.5	1.5	10.9	10.8	8.2	14.1	5.1	8.1	7.9	10.4	7.9	16.2	51.4	13.6	8.7	5.3	10.7	0.0	19.9	17.5	7.5	13.8	13.9	5.7	10.8	0.0	9.9	6.2	5.4	7.3	8.3	7.2	13.5	15.4	17.9	14.0	15.4	14.0	9.2	27.9	8.5	6.5	9.4	34.9	17.6	15.8	14.3	4.3	17.8	15.3
PIK3C2A	PI3K-C2alpha	ENSG00000011405	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	O00443	11	17077730-17207983	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Exocytosis"	"Kinase, Transferase"	"Cataract, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037641, HPA037642"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA037641: AB_10671878, HPA037642: AB_10697081"	"unprognostic (2.35e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-1)"	22.3	16.8	17.6	17.2	26.3	9.2	20.0	22.6	17.2	22.1	17.2	13.9	22.2	15.6	20.3	19.2	16.8	18.2	20.2	16.3	14.5	11.6	25.7	16.3	22.2	11.3	17.6	16.1	17.6	14.2	62.9	23.0	23.5	28.5	18.7	14.3	15.2	15.6	27.5	15.4	13.1	17.9	19.5	31.8	17.5	18.3	19.4	18.0	11.4	32.2	9.3	11.5	23.1	20.5	4.4	5.2	6.0	7.2	4.2	4.8	1.6	23.1	10.6	17.8	11.1	12.9	13.2	16.0	14.7	15.9	10.8	15.1	25.8	2.6	6.8	7.3	12.6	17.7	15.4	14.2	11.2	19.2	5.8	12.3	4.2	12.9	10.1	14.1	5.2	6.7	10.2	7.9	10.6	20.9	10.1	25.6	4.3	9.9	6.6	8.3	7.1	2.8	3.3	10.1	13.0	8.2	2.9	18.5	4.7	13.4	20.6	10.5	9.3	22.3	9.6	10.3	15.6	5.7	5.3	31.9	8.7	12.6	22.5	8.9	2.7	5.9	5.6	10.4	4.9	10.0	4.1	4.1	2.9	4.6	2.5	3.0	3.6	3.7	3.6	5.2	4.4	4.8	2.8	6.0	4.2	7.2	3.7	2.3	1.6	17.6	26.3	22.6	17.2	14.5	11.6	17.6	16.1	28.5	18.0	71.5	56.0	17.6	19.9	31.4	47.8	22.4	22.9	29.4	39.8	34.9	66.8	25.6	16.6	15.8	21.3	80.2	17.1	0.0	21.6	14.0	19.7	34.1	30.2	28.6	16.4	33.4	27.5	108.1	38.5	12.0	23.9	23.8	18.6	11.8	20.1	82.7	22.6	11.5	29.4	17.0	41.1	38.8	29.8	36.4	15.5	29.6	120.0	19.2	17.2	27.3
PIKFYVE	"FAB1, KIAA0981, MGC40423, p235, PIKfyve, PIP5K, PIP5K3, ZFYVE29"	ENSG00000115020	"Phosphoinositide kinase, FYVE-type zinc finger containing"	Q9Y2I7	2	208266267-208358751	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042558, HPA042604"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA042558: , HPA042604: AB_10796580"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.04e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (6.82e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	15.9	13.5	17.7	21.1	21.9	36.1	24.9	25.6	23.1	14.8	12.1	14.0	16.6	9.1	14.7	18.3	11.2	12.6	11.1	12.5	19.4	14.3	16.2	15.2	16.5	23.1	14.4	15.3	15.6	31.5	21.5	17.0	14.1	20.6	17.7	11.5	13.8	13.7	19.7	13.6	12.9	15.3	13.5	24.4	21.7	12.1	19.3	15.8	23.5	18.2	7.8	22.6	12.4	14.0	7.5	2.1	1.4	1.2	5.6	2.6	0.5	4.9	5.0	12.0	9.3	12.1	14.5	5.6	6.2	12.6	7.3	10.0	7.2	4.2	5.8	6.5	10.5	14.3	5.2	10.4	6.9	12.4	4.9	6.6	20.7	9.8	6.4	9.2	18.3	18.7	10.7	7.6	8.5	15.9	12.2	11.8	15.5	14.0	10.5	9.1	2.1	16.5	13.8	9.9	3.8	3.8	6.2	9.3	7.9	9.3	7.3	3.8	9.1	6.8	4.4	12.3	14.7	2.8	19.8	13.5	9.2	6.1	6.1	5.7	7.3	8.7	12.4	7.3	16.0	9.0	1.4	1.0	0.7	1.7	0.8	1.1	7.5	2.3	2.6	0.9	5.4	1.8	2.1	1.4	5.6	1.2	2.1	1.5	0.5	17.7	21.9	25.6	23.1	19.4	14.3	14.4	15.3	20.6	15.8	23.8	14.4	13.7	6.0	13.6	20.7	14.4	12.7	8.1	10.3	10.4	15.7	6.1	5.0	4.6	5.2	14.8	9.3	0.0	3.7	4.4	12.2	15.4	34.7	16.6	12.2	9.5	17.9	18.4	27.6	5.9	17.3	20.4	10.1	2.8	8.9	14.8	7.1	6.2	12.7	8.1	19.0	12.9	12.2	27.2	22.8	13.4	6.1	10.2	7.8	7.0
PITPNM1	"DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1"	ENSG00000110697	"Phosphatidylinositol transfer protein membrane associated 1"	O00562	11	67491768-67506263	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 60.9;Enterocytes: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060227	Approved		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA060227: AB_2684226"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.68e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.69e-2)"	6.5	14.3	20.1	19.6	17.6	20.4	3.5	23.2	30.7	6.0	12.1	6.4	11.0	16.0	7.0	7.2	10.0	20.5	8.0	10.6	16.6	21.6	14.7	7.3	8.6	21.9	17.8	14.2	3.0	6.4	9.3	15.0	6.9	18.6	5.6	6.7	15.6	5.2	9.9	4.6	3.5	17.7	5.2	6.3	15.2	13.6	4.9	8.0	9.3	11.1	4.5	14.6	12.1	4.7	1.6	2.1	2.9	6.8	0.2	2.5	2.0	5.7	14.5	8.9	6.5	9.8	5.9	14.5	5.6	10.1	7.0	4.0	13.0	10.5	5.7	13.7	8.1	13.5	15.0	6.8	12.5	2.3	41.2	2.8	7.7	25.0	4.9	7.8	8.7	16.8	7.3	8.0	10.6	7.0	13.1	8.4	8.7	5.9	5.1	5.8	8.6	14.8	20.6	9.1	16.4	6.3	10.7	2.8	7.7	11.7	11.6	8.6	5.5	12.6	17.7	13.8	4.5	3.4	7.7	8.2	12.7	9.8	8.0	4.0	7.6	3.6	5.1	17.8	10.4	4.9	0.0	2.6	1.8	2.5	6.8	2.2	1.6	1.7	2.2	2.1	1.2	0.7	1.7	2.9	0.2	5.3	0.8	1.5	2.0	20.1	17.6	23.2	30.7	16.6	21.6	17.8	14.2	18.6	8.0	3.0	7.2	11.3	4.7	7.2	38.1	6.5	7.6	21.4	6.8	19.2	60.9	4.2	3.3	9.8	4.4	3.3	49.0	0.0	8.0	7.6	4.3	5.7	2.3	3.4	7.5	36.5	10.9	4.3	10.3	10.5	2.0	6.9	3.3	8.2	13.3	14.6	13.5	35.1	1.1	12.9	47.1	0.0	10.2	1.1	5.3	2.9	12.7	11.7	16.6	15.5
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"lymphoid tissue: 169.5"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 51.1;Horizontal cells: 38.1;Late spermatids: 77.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 4.7;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"HEL: 16.1;JURKAT: 20.1;MOLT-4: 29.7;WM-115: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	3.4	5.9	3.3	3.2	7.9	3.5	3.1	9.3	8.0	3.9	3.5	2.4	3.2	3.5	3.6	5.2	3.7	2.5	2.2	4.6	2.8	2.2	3.7	4.3	5.1	6.1	2.4	2.6	14.0	2.5	5.3	4.2	3.0	2.3	2.7	1.6	3.7	2.7	3.1	3.3	3.0	3.6	4.5	2.5	3.3	2.7	14.8	2.2	169.5	2.3	2.2	4.3	4.7	2.7	0.8	0.0	0.1	0.1	4.7	2.3	1.6	2.4	4.9	1.6	2.3	1.1	2.2	9.6	0.4	0.6	1.3	0.7	2.1	2.1	0.0	2.1	0.8	2.7	7.1	1.3	1.2	0.4	0.1	1.5	16.1	2.8	5.7	0.8	0.6	3.4	1.0	2.1	1.7	1.3	6.2	2.5	20.1	3.6	0.2	1.6	1.6	29.7	3.3	1.8	0.7	2.2	8.6	0.1	6.1	2.3	2.6	1.4	0.5	3.5	2.9	2.3	0.9	0.6	1.7	7.4	1.9	2.1	3.1	2.8	0.5	0.5	11.4	4.7	1.2	14.3	0.0	0.0	0.1	2.3	0.0	0.2	0.4	0.6	1.7	0.0	0.8	1.5	1.4	0.0	4.7	0.1	0.0	1.1	1.6	3.3	7.9	9.3	8.0	2.8	2.2	2.4	2.6	2.3	2.2	0.0	5.3	0.8	0.5	3.2	15.9	6.1	2.5	0.0	2.3	8.7	51.1	1.0	1.7	2.8	25.0	6.7	4.3	0.0	3.9	5.0	1.9	0.6	1.1	12.9	0.4	38.1	0.0	6.2	0.8	77.8	1.7	0.6	1.7	1.0	3.7	3.7	3.7	0.0	4.6	2.2	15.5	0.0	2.8	3.6	2.3	1.4	3.1	1.0	2.3	0.4
PLA2G15	"GXVPLA2, LLPL, LYPLA3"	ENSG00000103066	"Phospholipase A2 group XV"	Q8NCC3	16	68245304-68261062	"Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid degradation, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 96.5;Syncytiotrophoblasts: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041702, HPA041727"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		20000000	"Nucleoplasm, Vesicles"		"HPA041702: AB_10794486, HPA041727: AB_10793931"	"unprognostic (3.47e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.12e-3)"	"unprognostic (3.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.40e-3)"	"unprognostic (6.28e-2)"	"unprognostic (3.47e-2)"	23.8	9.1	9.6	6.6	9.4	5.6	19.7	16.4	16.1	5.4	6.2	10.0	4.7	5.0	7.7	11.2	5.7	7.2	8.5	31.3	7.9	8.6	24.1	11.8	15.9	23.1	7.5	9.2	7.4	6.4	11.3	9.2	24.4	7.7	6.2	5.7	8.5	7.6	5.8	39.9	10.0	5.3	8.2	6.8	16.2	6.2	9.3	6.2	11.3	10.4	6.8	4.9	9.1	5.0	3.7	8.8	9.4	18.2	1.3	4.5	7.7	4.6	5.0	4.0	12.6	19.0	13.9	9.2	11.6	15.5	17.6	14.8	11.6	8.7	8.5	14.6	16.5	13.7	7.3	4.2	5.0	8.1	2.4	6.4	2.4	4.9	9.2	10.2	2.3	12.6	9.5	5.7	17.6	2.8	22.4	10.7	4.2	3.5	4.5	11.3	10.1	3.2	7.0	2.5	4.4	5.7	4.7	5.7	26.3	8.8	4.3	1.3	2.6	15.5	4.7	9.5	3.5	12.1	11.4	8.7	15.4	7.5	19.8	7.2	17.0	14.4	10.3	14.0	6.6	5.9	9.4	14.4	9.3	3.1	16.8	3.2	3.3	3.4	4.5	8.8	3.7	4.5	3.7	0.6	1.3	18.2	7.8	3.2	7.7	9.6	9.4	16.4	16.1	7.9	8.6	7.5	9.2	7.7	6.2	6.0	3.5	0.0	2.1	4.2	12.2	19.7	2.5	1.4	4.5	8.7	7.9	17.6	5.0	8.5	1.7	6.3	4.0	0.0	6.2	7.0	6.9	2.5	15.0	10.9	96.5	36.5	0.0	11.1	32.7	4.5	2.0	16.4	11.8	6.4	6.1	4.3	5.7	4.5	1.4	18.1	5.5	0.0	4.1	3.9	2.2	3.0	42.4	4.3	3.3	1.7
PLA2G4A	"cPLA2-alpha, PLA2G4"	ENSG00000116711	"Phospholipase A2 group IVA"	P47712	1	186828953-186988981	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Glycerol metabolism, Leukotriene biosynthesis, Lipid biosynthesis, Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 52.6;parathyroid gland: 63.5;seminal vesicle: 56.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 19.1;Peritubular cells: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 7.1;eosinophil: 7.7;intermediate monocyte: 8.4;myeloid DC: 7.8;non-classical monocyte: 3.9;plasmacytoid DC: 3.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.8;granulocytes: 7.7;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 23.0;OE19: 33.2;RPMI-8226: 28.5;U-2197: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010050, HPA050062, HPA054206"	Approved		Supported	Vesicles,Cytosol		NA	NA		78000	Cytosol	Vesicles	"CAB010050: AB_631312, HPA050062: AB_2681002, HPA054206: AB_2682417"	"prognostic favorable (9.07e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.85e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.90e-2)"	"unprognostic (4.26e-2)"	6.0	8.6	3.4	3.5	5.3	2.2	3.8	1.5	4.7	8.5	10.9	2.9	52.6	5.4	7.7	7.4	7.0	12.3	4.2	6.6	3.3	2.5	6.7	1.1	4.9	5.2	6.5	1.4	5.1	3.8	63.5	2.7	2.9	5.6	10.9	4.2	2.9	5.8	56.1	0.6	6.1	10.3	14.6	7.5	4.2	5.1	2.7	5.3	0.4	2.7	5.9	2.3	19.4	9.4	0.0	7.8	7.7	8.4	1.1	0.2	1.5	0.0	15.8	0.0	0.0	9.9	4.0	0.0	0.6	6.1	0.7	1.3	0.1	6.2	0.0	0.0	0.0	2.8	1.1	9.9	2.9	0.3	4.8	0.2	2.9	23.0	0.0	6.1	4.3	1.5	2.2	2.0	7.9	1.6	1.0	6.6	1.3	6.4	2.3	0.0	0.0	0.0	0.0	0.8	33.2	2.1	0.0	0.0	28.5	0.0	2.1	0.0	0.0	2.3	0.8	2.8	0.3	0.3	5.8	1.3	5.9	0.8	27.0	1.2	0.9	0.0	0.0	2.1	12.8	8.3	0.1	7.1	7.7	0.0	8.4	0.2	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.6	1.1	3.9	3.2	0.0	1.5	3.4	5.3	1.5	4.7	3.3	2.5	6.5	1.4	5.6	5.3	0.0	0.6	0.0	2.8	19.1	0.0	0.8	0.0	1.4	1.2	0.0	0.0	0.1	1.7	1.6	0.7	6.0	1.3	0.0	0.0	0.0	4.3	1.7	10.4	0.0	5.5	0.0	1.2	1.3	8.8	0.6	9.8	6.0	5.0	1.0	1.7	0.0	1.1	2.8	13.8	0.1	0.2	0.0	3.4	0.5	0.1	7.9	0.0	0.0	2.9	10.5
PLEKHM1	KIAA0356	ENSG00000225190	"Pleckstrin homology and RUN domain containing M1"	Q9Y4G2	17	45435900-45490749	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 9.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025018, HPA039473"	Approved		Supported	Nucleoli,Vesicles		NA	NA			Vesicles	Nucleoli	"HPA025018: AB_1855465, HPA039473: AB_2676526"	"unprognostic (1.52e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.28e-6)"	"unprognostic (8.71e-2)"	"unprognostic (3.06e-2)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	8.0	3.6	2.5	3.6	4.5	10.9	5.3	7.6	5.6	6.1	4.1	2.6	0.9	2.2	2.9	2.0	17.2	3.7	3.8	3.9	4.2	1.7	1.7	3.1	4.5	7.3	10.5	2.9	2.5	4.2	3.5	3.6	2.8	4.7	2.6	3.0	3.4	7.6	2.7	6.3	5.8	3.4	2.5	5.3	4.5	3.0	2.4	3.4	6.7	3.8	6.5	10.4	5.2	6.7	2.4	1.3	9.8	1.4	1.3	1.4	0.9	5.2	7.6	1.3	2.5	5.4	2.6	4.7	1.5	3.5	2.7	2.8	2.4	2.8	2.7	4.6	5.0	13.2	1.4	3.1	1.9	0.8	10.6	3.7	0.0	2.8	3.1	5.7	0.0	4.0	10.2	6.0	4.3	7.1	2.3	8.0	2.1	2.6	3.1	4.3	3.3	5.2	1.0	0.8	15.5	5.4	2.3	2.8	2.4	3.9	8.1	2.3	2.1	2.6	2.0	2.9	2.5	4.7	2.3	9.2	6.5	2.5	4.9	2.7	3.2	3.4	1.1	3.7	1.3	2.7	3.8	1.4	1.3	1.4	1.0	0.8	2.4	1.0	1.1	1.3	1.0	0.7	0.6	9.8	1.3	1.3	1.0	1.2	0.9	2.5	4.5	7.6	5.6	4.2	1.7	10.5	2.9	4.7	3.4	11.9	21.5	8.3	16.6	16.0	9.3	7.2	12.7	8.1	12.5	12.2	15.7	3.8	5.0	7.1	4.0	8.7	14.8	23.3	7.0	4.0	7.3	22.8	1.1	6.8	7.8	15.9	13.2	9.2	24.5	1.4	6.6	12.6	6.8	4.6	11.8	6.3	12.8	14.4	7.4	6.3	8.0	0.0	7.1	5.9	3.4	14.3	7.2	13.8	10.1	35.7
PLIN5	"LSDA5, LSDP5, MLDP, OXPAT"	ENSG00000214456	"Perilipin 5"	Q00G26	19	4522531-4535224	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.6;salivary gland: 40.3;skeletal muscle: 40.8"	"Cell type enhanced"	"Detected in many"	16	"Alveolar cells type 2: 37.2;Hepatocytes: 133.7;Ito cells: 46.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 14.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.6;RT4: 5.1;SH-SY5Y: 4.8;T-47d: 10.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA077050			Supported	"Vesicles,Lipid droplets"		NA	NA			"Vesicles, Lipid droplets"		"HPA077050: "	"prognostic favorable (7.68e-4)"	"unprognostic (1.01e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.24e-2)"	"unprognostic (6.06e-3)"	"prognostic favorable (2.81e-4)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-1)"	"prognostic favorable (1.97e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"prognostic favorable (2.16e-4)"	20.9	1.7	8.0	2.9	5.2	3.9	6.5	4.2	5.8	1.8	3.3	2.0	10.5	1.6	1.6	5.5	1.9	3.1	1.9	12.0	7.8	1.4	5.8	44.6	2.8	1.5	3.4	2.6	25.8	30.1	0.5	6.2	0.6	3.7	4.5	0.9	3.4	40.3	4.6	40.8	1.7	1.3	1.5	1.7	1.8	11.5	1.4	4.2	0.0	2.2	6.0	1.1	3.7	5.7	0.6	0.4	14.7	0.5	0.8	0.4	0.1	0.5	0.3	1.1	3.9	2.9	0.1	5.6	0.2	0.2	0.2	0.1	0.4	1.0	0.3	1.2	0.2	0.3	0.4	0.0	0.0	0.0	0.6	0.4	0.3	1.4	1.7	0.7	0.4	0.9	0.7	0.0	0.0	0.1	0.5	0.3	0.3	1.2	0.5	0.4	0.9	0.3	0.9	0.7	0.5	0.5	0.3	0.2	3.5	0.3	5.1	0.7	4.8	0.5	0.8	0.0	0.4	10.6	0.7	1.0	0.6	0.5	0.5	0.3	0.6	0.2	0.2	0.6	1.1	0.2	1.5	0.5	0.8	0.3	0.4	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.4	14.7	0.8	0.3	0.4	0.2	0.1	8.0	5.2	4.2	5.8	7.8	1.4	3.4	2.6	3.7	4.2	8.9	37.2	0.8	13.9	0.5	1.4	30.7	22.9	9.4	18.2	1.8	0.0	0.3	8.3	3.8	1.1	2.7	0.2	0.0	10.5	0.4	0.4	6.9	3.5	133.7	0.4	0.0	0.0	46.1	7.3	0.0	0.3	1.2	0.0	0.0	1.2	6.0	7.6	0.2	2.5	7.8	0.9	12.9	1.0	5.5	5.7	0.9	1.1	1.3	1.2	9.2
PMEPA1	"STAG1, TMEPAI"	ENSG00000124225	"Prostate transmembrane protein, androgen induced 1"	Q969W9	20	57648392-57711536	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Signal transduction inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 60.4;prostate: 67.3"	"Cell type enhanced"	"Detected in many"	9	"Ductal cells: 306.3;Glandular cells: 287.7;Muller glia cells: 308.1;Pancreatic endocrine cells: 506.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.2;plasmacytoid DC: 18.4"	"Group enriched"	"Detected in many"	7	"B-cells: 5.2;dendritic cells: 18.4"	"Cell line enhanced"	"Detected in many"		"SiHa: 40.4;U-2 OS: 26.3;U-251 MG: 92.9;WM-115: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072291			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA072291: AB_2686509"	"unprognostic (2.72e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (5.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.11e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.73e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.32e-3)"	"unprognostic (7.83e-3)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (2.87e-7)"	"unprognostic (1.16e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.87e-3)"	"prognostic unfavorable (7.60e-4)"	27.0	7.8	7.5	10.6	34.8	1.3	9.5	2.6	12.6	60.4	10.8	11.0	4.2	4.4	22.1	6.7	7.1	7.7	21.8	10.7	7.5	8.6	5.3	1.7	8.5	4.5	10.2	5.9	6.2	18.6	2.6	5.6	3.0	12.1	67.3	5.7	21.3	11.6	13.3	17.4	6.8	7.6	17.6	8.1	4.0	5.3	3.2	9.1	1.3	5.4	6.0	6.2	8.4	13.0	5.2	18.4	0.1	0.3	0.0	1.6	0.4	6.0	14.8	0.4	0.7	0.4	0.0	0.1	0.9	0.0	0.3	0.1	0.2	19.2	0.0	3.5	1.4	10.4	23.5	0.3	19.8	0.2	0.1	0.8	0.0	4.1	0.0	0.3	0.0	0.1	0.2	11.1	0.8	2.4	3.3	2.5	13.3	0.1	0.2	1.2	12.5	0.7	0.1	1.8	2.9	1.9	0.0	7.2	2.1	4.8	0.0	3.5	2.7	40.4	24.0	2.8	1.1	3.7	0.7	6.4	3.6	26.3	0.3	92.9	1.1	0.1	0.0	1.6	0.2	46.8	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.6	0.2	0.0	5.2	1.6	0.9	0.1	0.0	0.0	18.4	0.4	0.4	7.5	34.8	2.6	12.6	7.5	8.6	10.2	5.9	12.1	9.1	53.6	35.4	14.7	85.0	148.4	56.2	22.6	114.7	0.0	14.8	10.4	2.0	0.0	3.3	306.3	1.1	39.7	9.5	0.0	53.6	2.0	27.8	287.7	60.9	0.0	5.6	1.6	9.7	16.0	3.4	1.4	2.8	6.7	30.4	10.0	11.5	308.1	506.6	17.5	20.5	1.3	6.6	71.1	116.0	0.0	6.8	156.0	0.1	1.9	9.2	71.5
POLR3H	"KIAA1665, RPC8"	ENSG00000100413	"RNA polymerase III subunit H"	Q9Y535	22	41525804-41544606	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046787	Approved		Supported	Nucleoplasm,Vesicles,Centrosome		NA	NA			Nucleoplasm	"Vesicles, Centrosome"	"HPA046787: AB_2679806"	"unprognostic (1.55e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.43e-2)"	"prognostic favorable (5.41e-4)"	"unprognostic (6.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.70e-1)"	16.8	14.0	30.0	9.1	28.8	5.5	13.5	21.0	27.4	12.1	7.5	15.8	12.6	6.1	10.5	11.7	17.0	19.0	10.3	14.8	24.0	20.5	10.0	18.9	14.7	10.9	22.2	17.6	22.4	13.7	13.1	11.5	7.9	17.2	11.0	6.8	12.1	12.2	14.2	7.7	14.6	6.2	14.4	14.2	7.2	7.9	14.2	16.5	7.0	15.4	8.2	9.3	8.1	9.1	11.6	11.2	0.6	13.8	3.9	10.2	7.5	16.3	11.0	10.2	14.9	11.2	10.2	6.8	13.7	12.8	23.4	18.9	22.2	5.4	13.9	10.8	23.0	13.2	7.5	18.6	22.4	14.7	12.7	23.0	8.3	17.5	10.6	11.6	34.4	14.2	12.7	14.6	30.8	8.3	8.9	11.4	13.9	17.4	8.9	13.0	15.5	8.8	9.4	7.2	21.7	14.3	13.5	8.0	14.5	10.9	9.6	9.8	5.9	17.9	18.2	8.7	6.6	7.2	9.8	10.2	14.0	15.2	24.3	18.1	6.8	12.6	21.0	24.4	12.3	13.3	0.0	10.0	0.1	7.3	13.8	10.2	11.6	7.1	8.6	11.2	10.1	10.0	8.1	0.6	3.9	12.7	10.8	4.4	7.5	30.0	28.8	21.0	26.9	24.0	20.5	22.2	17.6	17.2	16.5	0.0	23.5	18.2	9.8	15.8	16.9	5.1	12.7	9.4	21.6	15.7	15.7	29.8	39.7	26.3	30.8	8.2	2.9	23.3	25.7	23.4	15.5	13.0	11.5	29.7	27.4	20.6	13.7	9.2	6.9	113.5	15.5	10.0	23.6	22.6	4.1	18.5	23.5	7.0	19.1	28.8	20.6	0.0	10.5	44.7	55.2	22.3	15.0	10.2	8.5	11.3
POP7	"RPP2, RPP20"	ENSG00000172336	"POP7 homolog, ribonuclease P/MRP subunit"	O75817	7	100706053-100707495	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021007	Uncertain		Supported	Nucleoli,Vesicles		NA	NA			"Nucleoli, Vesicles"		"HPA021007: AB_10963575"	"unprognostic (3.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.80e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.21e-2)"	"unprognostic (6.73e-2)"	12.3	16.6	20.5	15.1	21.0	25.3	16.1	25.1	33.2	11.3	14.7	8.7	14.0	17.5	13.9	12.5	20.4	13.4	13.9	19.6	18.3	18.1	13.1	31.4	11.7	18.2	16.8	22.0	13.2	21.2	6.6	11.5	18.1	13.3	16.0	8.1	10.0	24.2	15.8	46.4	22.6	17.6	12.3	12.9	12.3	15.5	7.0	9.4	11.0	11.6	20.5	11.8	11.5	12.5	32.1	30.4	46.4	35.6	42.1	37.0	32.0	24.6	24.6	9.9	17.5	5.3	5.1	19.5	14.0	6.6	15.6	15.5	35.9	16.0	20.0	23.6	6.1	17.2	15.7	14.5	16.5	7.7	18.2	43.9	9.0	16.0	34.4	9.0	13.8	11.1	5.9	6.2	15.9	15.7	4.4	8.6	14.3	31.9	17.9	8.1	70.0	34.6	47.3	30.5	15.7	34.0	26.2	10.5	34.0	9.3	13.6	20.0	20.3	11.3	34.9	16.6	9.3	11.5	14.0	8.4	21.6	26.0	42.4	27.5	7.6	20.6	35.9	13.6	23.9	23.4	46.4	35.6	38.2	32.4	34.1	29.4	32.1	32.5	31.6	30.4	26.4	29.9	31.1	21.9	42.1	35.3	27.9	37.0	32.0	20.5	21.0	25.1	33.2	18.3	18.1	16.8	22.0	13.3	9.4	17.9	14.2	18.6	25.5	93.3	23.7	23.0	33.1	25.4	10.3	33.2	5.9	127.6	79.6	64.3	1.9	39.5	51.5	70.0	76.1	144.7	43.7	49.5	17.3	88.3	57.5	30.2	38.6	28.8	23.7	5.6	38.9	27.4	54.0	41.5	44.2	33.8	71.6	45.0	35.0	66.2	18.4	45.3	39.1	7.5	43.1	104.3	116.5	27.4	49.7	41.7
POU2F1	"OCT1, OTF1"	ENSG00000143190	"POU class 2 homeobox 1"	P14859	1	167220829-167427345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002608, HPA058559, HPA064323"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		No	No			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB002608: , HPA058559: AB_2683756, HPA064323: AB_2685245"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-3)"	"unprognostic (4.26e-2)"	"unprognostic (5.67e-6)"	"unprognostic (4.47e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (2.98e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.17e-2)"	6.9	5.7	15.5	7.3	11.9	12.6	7.2	36.4	13.8	7.7	6.6	9.5	5.2	4.1	7.5	8.4	5.3	6.5	4.3	5.1	14.5	6.7	7.0	5.8	6.6	8.2	7.7	10.8	8.1	6.1	15.5	8.3	9.6	7.1	6.7	6.8	12.0	5.5	6.5	10.5	8.8	6.6	5.5	6.3	9.3	6.1	10.1	10.9	7.4	6.9	4.9	9.7	7.6	6.2	7.5	5.9	8.6	5.9	1.4	4.4	2.2	6.4	5.2	13.5	4.1	1.6	1.6	5.5	0.8	1.4	1.6	1.6	7.5	3.7	7.3	3.5	1.3	1.5	5.0	8.2	2.5	2.4	2.9	3.1	5.1	3.6	6.1	1.0	5.6	3.4	1.1	1.4	1.8	3.3	2.0	2.1	5.1	5.4	4.2	2.1	3.4	5.1	3.6	15.7	3.5	2.1	7.5	4.9	3.2	2.8	3.6	8.2	6.2	5.0	3.7	3.3	7.1	4.1	6.9	3.4	3.1	4.9	1.9	3.1	4.0	1.8	16.9	1.4	3.4	3.9	8.6	2.3	2.8	4.4	2.7	3.3	7.5	2.3	2.0	2.5	6.8	3.2	2.4	3.3	1.4	5.9	5.9	2.1	2.2	15.5	11.9	36.4	13.8	14.5	6.7	7.7	10.8	7.1	10.9	11.9	12.1	21.9	10.4	11.8	54.9	13.2	12.7	6.7	10.3	19.2	96.2	15.4	5.0	8.8	23.3	16.6	8.5	0.0	10.1	15.3	13.4	14.9	19.6	11.6	11.2	44.5	23.2	11.1	35.6	28.6	23.9	14.6	6.8	23.4	14.3	47.2	12.6	7.0	19.4	6.9	106.3	25.8	11.9	18.5	40.0	9.7	43.3	13.8	13.0	9.7
PPA1	"IOPPP, PP, PP1, Ppase, SID6-8061"	ENSG00000180817	"Pyrophosphatase (inorganic) 1"	Q15181	10	70202830-70233911	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 942.2;Muller glia cells: 982.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019878, HPA020096"	Supported		Supported	Vesicles		NA	NA		110000	Vesicles		"HPA019878: AB_1855601, HPA020096: AB_1855600"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.86e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.36e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.74e-1)"	46.6	55.5	41.3	36.8	56.0	24.2	88.7	66.8	62.2	34.8	45.7	25.2	43.7	33.2	30.4	59.6	48.6	38.1	31.5	30.0	46.7	54.2	40.7	59.0	39.1	54.6	74.3	47.5	17.9	72.6	23.3	29.5	34.6	60.7	24.4	53.4	26.1	36.8	42.1	37.0	24.6	41.0	32.8	72.7	22.4	32.5	25.1	47.2	20.4	52.0	35.8	44.4	32.7	40.2	21.5	48.9	1.0	17.7	15.5	35.6	25.3	58.1	24.1	21.6	63.7	58.8	51.9	20.3	21.8	41.1	34.2	36.1	73.5	30.9	84.3	19.9	21.7	22.3	47.1	63.2	42.5	35.0	79.2	60.1	23.0	24.4	41.9	37.2	56.7	14.6	34.0	50.9	27.4	73.1	37.6	41.4	42.8	53.7	45.5	32.2	34.1	54.8	53.2	22.5	80.7	67.0	33.6	24.8	49.3	71.4	36.6	65.0	21.9	24.0	94.1	18.6	15.8	23.5	25.5	18.7	9.5	36.2	31.2	41.3	15.0	32.8	61.8	14.7	79.6	8.3	0.0	17.7	0.4	13.3	13.8	35.6	21.5	30.8	23.1	48.9	13.8	34.2	28.9	1.0	15.5	14.5	11.3	30.1	25.3	41.3	56.0	66.8	62.2	46.7	54.2	74.3	47.5	60.7	47.2	208.4	123.3	139.4	261.1	238.0	182.7	75.4	170.7	77.6	178.6	102.9	163.0	265.6	170.8	481.5	21.2	172.8	203.5	23.3	678.8	222.3	156.3	255.5	36.8	132.9	92.5	81.0	156.1	38.1	69.1	22.2	101.5	81.2	172.1	942.2	201.5	982.7	518.3	210.2	110.3	442.0	227.9	64.7	156.5	149.9	174.8	224.7	205.5	113.0	280.4	496.2
PPM1N	FLJ40125	ENSG00000213889	"Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)"	Q8N819	19	45488777-45502510	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 43.7;skeletal muscle: 81.9"	"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 29.5;Extravillous trophoblasts: 60.2;Rod photoreceptor cells: 73.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"non-classical monocyte: 43.7"	"Lineage enriched"	"Detected in all"	10	"monocytes: 43.7"	"Cell line enhanced"	"Detected in many"		"OE19: 16.9;RT4: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043577			Supported	Vesicles		NA	NA			Vesicles		"HPA043577: "	"unprognostic (2.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.53e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.11e-16)"	"unprognostic (3.42e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.86e-3)"	1.7	0.9	5.4	1.2	4.5	1.3	1.9	0.7	4.1	1.3	1.7	0.1	0.7	0.6	1.5	1.0	2.2	0.8	1.0	0.9	3.3	2.3	1.2	1.5	1.5	1.6	2.6	2.2	0.8	0.5	1.3	1.4	2.4	2.7	2.3	1.0	10.6	1.5	1.4	81.9	2.4	1.4	2.6	3.4	15.7	1.7	2.9	3.5	2.5	0.9	0.0	2.4	4.0	1.9	1.9	4.3	2.3	43.7	1.1	2.9	1.9	1.9	5.0	0.9	3.8	4.4	5.9	11.0	1.4	2.2	0.4	1.7	1.2	11.7	7.9	2.4	1.3	3.0	5.5	2.2	1.6	0.7	7.7	3.2	6.3	2.0	1.4	1.1	0.5	13.4	2.5	2.5	2.2	1.3	2.9	0.7	3.1	7.1	7.2	0.8	1.3	2.2	3.4	3.0	16.9	1.1	1.4	1.1	2.2	2.4	21.3	4.3	5.1	0.7	8.1	6.2	6.8	2.8	1.9	1.0	6.2	3.8	3.0	1.0	1.2	3.1	1.6	4.5	1.6	5.4	1.7	1.6	1.0	2.2	7.2	2.0	1.9	1.4	2.2	4.3	1.3	1.6	2.9	2.3	1.1	43.7	0.8	1.5	1.9	5.4	4.5	0.7	4.1	3.3	2.3	2.6	2.2	2.7	3.5	0.0	2.4	10.4	8.5	3.1	9.5	1.6	2.5	0.0	1.2	3.5	29.5	2.7	0.0	2.5	12.0	1.8	5.2	0.0	1.6	60.2	3.8	5.0	6.9	0.8	16.7	1.6	2.9	4.9	10.1	4.5	0.9	14.1	1.7	1.8	3.1	8.1	3.2	2.5	0.7	0.3	73.0	0.0	0.9	1.0	9.8	3.6	7.1	6.9	2.5	7.6
PPP5C	"PP5, PPP5"	ENSG00000011485	"Protein phosphatase 5 catalytic subunit"	P53041	19	46346994-46392981	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Hydrolase, Protein phosphatase"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022641, HPA029065, HPA056933"	Approved		Supported	Vesicles,Cytosol		NA	NA		47000	"Vesicles, Cytosol"		"CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278"	"unprognostic (8.25e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (3.45e-6)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.20e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	18.9	24.7	23.0	18.1	28.8	13.4	15.9	25.2	50.8	20.4	21.1	19.4	15.2	18.0	23.0	15.2	20.1	27.8	20.5	48.2	20.8	23.9	22.6	22.1	17.4	19.3	21.9	29.8	16.7	21.5	26.3	23.9	17.3	34.5	19.5	17.5	19.7	21.0	21.4	40.8	16.4	15.3	23.5	16.2	21.7	20.6	19.0	15.3	15.6	18.1	20.5	16.1	17.1	18.1	10.6	11.1	1.9	14.1	14.0	19.8	8.9	19.5	36.8	22.0	16.6	16.6	17.8	10.2	24.4	19.8	29.6	26.7	26.4	15.6	30.1	13.3	17.7	16.2	16.1	28.9	28.8	8.9	20.8	39.3	25.0	27.0	18.7	18.6	33.8	17.5	16.2	13.6	20.8	15.5	11.4	25.4	25.7	24.0	15.5	16.8	21.2	18.9	63.4	16.6	35.1	20.1	28.2	19.0	24.1	17.7	26.8	31.3	23.0	20.4	26.0	8.7	10.4	16.3	21.6	21.1	13.0	21.6	9.6	25.5	12.5	28.7	36.0	13.9	28.4	21.6	0.0	6.8	1.9	19.8	12.1	12.7	10.6	9.2	15.3	11.1	8.7	8.9	12.0	0.1	14.0	14.1	7.9	9.3	8.9	23.0	28.8	25.2	50.8	20.8	23.9	21.9	29.8	34.5	15.3	6.0	12.2	13.4	14.5	8.4	19.1	4.7	50.9	9.4	10.3	15.7	15.7	20.7	28.2	26.1	1.0	13.4	17.7	0.0	16.8	30.9	14.6	11.3	4.6	22.8	19.0	15.9	14.3	30.7	10.8	1.7	16.1	7.6	15.1	14.4	15.1	19.1	22.4	11.5	17.3	17.3	16.9	38.8	20.6	14.6	39.2	11.5	21.5	17.0	21.3	8.4
PPT1	"CLN1, INCL, PPT"	ENSG00000131238	"Palmitoyl-protein thioesterase 1"	P50897	1	40071461-40097727	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 247.2;Kupffer cells: 246.8;Macrophages: 282.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 88.0;THP-1: 163.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021546	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		130000	"Golgi apparatus, Vesicles"		"HPA021546: AB_1855667"	"unprognostic (5.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (6.98e-8)"	"unprognostic (1.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.08e-2)"	33.3	27.1	37.6	31.0	41.5	33.3	39.7	35.2	41.0	30.3	21.0	31.5	17.2	12.9	31.3	19.4	18.5	20.7	23.2	18.1	32.7	35.8	29.4	18.4	47.3	48.5	35.3	29.1	24.7	17.4	30.4	21.2	25.9	34.6	28.0	26.0	26.3	22.1	23.6	8.3	13.8	16.6	36.5	33.6	61.3	17.9	13.8	29.1	19.8	18.7	14.4	30.0	23.0	19.8	9.3	77.4	59.9	90.0	7.2	19.1	91.6	10.3	7.0	11.3	6.3	13.6	11.6	22.1	5.8	10.4	13.9	17.2	40.1	17.3	11.8	11.3	6.0	11.5	18.1	17.5	10.3	19.1	14.8	18.0	6.2	17.2	19.8	15.4	13.8	14.9	10.9	11.3	11.1	10.3	7.8	18.7	10.1	14.3	17.1	7.8	20.6	7.9	10.3	21.2	15.8	10.8	8.9	15.2	20.5	9.7	18.4	9.0	9.6	11.3	88.0	35.0	11.1	12.7	163.5	6.6	6.8	14.6	6.3	17.1	15.4	32.3	11.3	8.7	33.8	12.3	6.2	90.0	48.2	9.9	77.6	11.8	9.3	14.7	11.5	77.4	9.2	19.1	14.7	59.9	7.2	58.3	7.6	16.8	91.6	37.6	41.5	35.2	41.0	32.7	35.8	35.3	29.1	34.6	29.1	26.8	50.8	34.5	72.3	35.1	45.4	13.0	38.2	38.8	47.8	36.6	15.7	48.8	5.0	52.1	40.9	45.0	3.0	23.3	36.9	52.5	46.0	47.6	82.1	8.3	247.2	23.8	19.1	48.5	246.8	54.3	29.1	282.7	64.1	155.1	8.2	108.8	23.0	7.0	37.1	15.4	24.1	19.4	53.3	13.7	37.9	23.8	34.4	40.8	10.3	29.4
PPT2		ENSG00000221988	"Palmitoyl-protein thioesterase 2"	Q9UMR5	6	32153441-32163680	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 15.7;Syncytiotrophoblasts: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.0;EFO-21: 11.8;HEK 293: 20.4;MCF7: 8.7;RPTEC TERT1: 10.1;SK-MEL-30: 13.3;SuSa: 10.4"									HPA000414			Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA000414: "	"unprognostic (1.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.03e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.41e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.28e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.24e-3)"	8.5	13.1	10.4	9.3	10.6	3.0	9.6	21.9	11.8	16.1	10.5	13.1	11.7	15.8	13.8	14.9	13.7	14.2	10.6	12.3	10.7	7.5	17.8	13.1	14.3	6.6	12.2	7.7	25.1	7.0	3.1	7.7	14.3	9.8	10.5	9.6	16.1	7.2	11.4	19.1	30.9	6.9	10.4	7.1	11.8	15.2	6.4	11.5	11.5	7.4	13.2	8.1	13.9	12.0	0.2	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	16.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.8	0.0	4.8	1.6	2.6	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.1	0.0	1.2	1.3	0.0	7.4	0.0	0.4	1.0	8.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.1	7.0	0.2	13.3	10.4	0.0	0.4	0.0	0.0	6.0	0.0	0.0	0.5	7.1	0.9	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	0.0	0.4	0.0	10.4	10.6	21.9	11.8	10.7	7.5	12.2	7.7	9.8	11.5	0.0	0.3	0.0	2.7	3.0	12.0	5.8	2.5	0.0	3.4	3.5	15.7	11.6	1.7	1.4	0.2	4.6	1.3	0.0	2.6	7.8	4.8	1.0	0.0	3.9	2.4	3.2	4.7	4.9	1.5	1.0	3.7	1.4	6.8	0.0	2.9	7.5	1.3	3.4	2.8	2.3	5.2	0.0	4.7	3.1	4.5	1.9	19.5	1.3	2.8	1.3
PQLC2	FLJ20320	ENSG00000040487	"PQ loop repeat containing 2"	Q6ZP29	1	19312326-19329300	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 31.3;Syncytiotrophoblasts: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057810	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA057810: AB_2683535"	"unprognostic (7.84e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (3.77e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.61e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.46e-2)"	10.9	19.9	11.7	8.5	12.3	18.4	9.4	28.8	16.2	12.2	13.1	16.8	8.6	16.9	11.5	15.5	9.2	8.8	11.1	9.3	10.6	11.2	11.9	20.3	12.1	11.1	14.3	9.1	10.9	19.4	10.0	19.4	24.8	14.4	11.7	7.7	18.9	12.1	11.0	10.9	15.3	16.2	9.3	12.2	12.2	13.3	13.8	10.9	6.2	14.0	9.2	10.5	8.0	9.0	5.1	16.7	7.8	10.1	2.9	3.4	3.5	8.1	8.6	8.1	12.9	7.9	7.5	10.3	10.3	14.2	14.4	12.3	12.5	10.4	2.6	13.5	7.5	20.1	6.2	7.9	9.2	6.5	5.5	9.6	2.0	7.4	13.4	22.7	1.7	3.6	12.3	9.7	20.4	6.5	8.1	5.5	4.7	14.7	6.1	13.8	7.3	1.1	5.7	7.8	2.9	7.7	4.5	10.2	4.6	10.9	5.4	10.0	8.4	7.7	5.2	19.7	7.6	8.8	20.3	7.3	12.1	7.0	20.4	9.1	10.7	7.4	1.4	14.8	10.2	9.8	0.9	8.7	7.8	3.2	7.1	2.4	5.1	3.4	2.7	11.1	5.0	1.0	2.1	5.4	2.9	10.1	16.7	3.1	3.5	11.7	12.3	28.8	16.2	10.6	11.2	14.3	9.1	14.4	10.9	3.0	6.5	6.0	2.9	1.6	11.6	2.2	5.1	2.7	5.7	5.2	5.9	23.5	5.0	14.8	0.4	3.7	9.1	0.0	10.2	15.3	6.1	4.3	3.5	9.8	31.3	6.4	9.9	1.8	6.9	2.3	5.8	7.5	3.3	9.0	5.9	9.8	13.8	5.8	3.2	4.3	8.6	0.0	3.6	7.2	4.1	2.6	50.6	4.3	6.6	2.0
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82823502-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 392.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"	NA	NA		34000000	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favorable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	32.6	45.9	25.0	21.5	22.2	13.1	69.5	19.4	23.8	38.8	17.9	17.9	27.6	11.0	30.7	35.5	32.2	24.6	25.6	66.3	25.8	18.9	52.4	52.5	38.1	95.1	27.0	14.8	27.8	23.4	30.6	19.3	59.8	34.9	25.1	18.4	25.1	38.1	34.5	10.3	26.2	15.7	32.8	45.0	25.1	16.8	17.4	17.7	9.8	27.9	24.2	31.7	39.4	30.1	13.1	50.0	31.2	27.9	12.1	6.2	14.7	7.5	8.3	12.8	25.7	99.0	36.4	15.0	16.2	28.9	15.5	22.8	20.5	15.7	10.9	23.7	23.5	17.6	12.0	11.6	10.7	18.2	9.7	8.4	7.8	11.6	12.7	18.5	7.0	28.6	26.5	8.3	16.2	15.3	38.1	51.4	6.0	8.3	15.4	15.9	3.4	1.0	25.0	7.4	18.5	7.7	5.7	22.2	13.0	21.7	14.0	5.3	11.6	22.2	12.8	9.1	19.7	15.4	9.6	13.3	18.3	18.4	15.8	7.9	14.5	24.6	9.8	7.5	8.5	9.4	15.5	26.4	17.4	5.3	27.9	6.1	9.9	5.3	5.8	50.0	13.1	4.4	6.2	31.2	12.1	21.2	8.9	5.0	14.7	25.0	22.2	19.4	23.8	25.8	18.9	27.0	14.8	34.9	17.7	17.9	14.6	43.2	35.5	27.8	10.0	19.8	43.3	5.3	12.5	59.3	2.0	49.3	24.9	28.4	24.0	120.7	4.9	0.0	10.6	99.1	49.9	26.3	12.7	56.8	72.6	15.9	18.9	392.8	149.3	39.4	40.9	76.3	67.4	54.1	18.6	57.0	10.0	7.0	43.5	76.8	4.3	64.7	26.8	23.6	5.7	30.6	44.3	25.4	19.9	33.8
PSAP	"GLBA, SAP1"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851375	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 2783.3;Kupffer cells: 2077.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2"	"Group enriched"	"Detected in all"	12	"dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1"	"Cell line enhanced"	"Detected in all"		"ASC diff: 260.8;hTERT-RPE1: 353.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		86000000	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	151.5	178.6	106.6	95.1	137.9	79.7	93.3	93.2	143.4	136.7	74.4	134.2	89.5	53.7	116.0	118.2	71.7	88.1	129.7	164.0	99.5	93.7	108.5	119.6	125.5	136.8	135.4	128.0	137.1	93.7	134.8	76.0	165.5	106.7	94.1	73.4	118.2	88.1	117.0	151.6	67.6	63.3	133.5	109.3	159.8	87.4	60.5	126.1	84.4	103.1	54.1	61.4	102.8	76.3	13.4	97.2	80.8	322.1	9.5	12.5	306.2	21.6	40.9	26.6	55.6	260.8	150.1	94.1	39.4	117.3	31.0	37.1	37.8	55.3	11.8	81.4	64.3	52.0	47.5	10.0	32.0	21.9	23.0	18.9	13.8	18.6	21.3	100.5	8.9	79.4	95.4	73.9	31.0	59.5	353.1	55.0	16.7	19.6	57.1	38.4	13.8	39.5	13.4	12.2	27.5	19.9	8.2	15.2	32.8	36.1	37.3	29.6	26.2	36.8	111.8	148.5	36.6	22.7	20.6	71.5	43.9	31.2	29.2	32.1	63.8	48.5	20.9	69.7	17.9	32.1	19.4	252.0	30.1	12.5	322.1	10.3	13.4	10.3	10.8	97.2	11.8	11.3	10.6	80.8	9.5	263.2	48.5	11.3	306.2	106.6	137.9	93.2	143.4	99.5	93.7	135.4	128.0	106.7	126.1	235.2	379.3	166.5	219.5	202.9	179.8	542.8	254.8	219.5	234.3	451.9	119.8	794.0	59.7	786.8	15.8	344.2	354.0	46.7	402.9	741.7	528.5	293.5	382.9	394.5	2783.3	314.6	251.7	411.3	2077.6	30.6	424.6	1465.0	629.3	1297.6	227.4	506.4	336.4	285.1	518.7	243.0	122.0	271.7	278.1	42.5	119.8	173.1	897.4	139.5	183.5	185.3
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome subunit alpha 4"	P25789	15	78540405-78552419	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol		No	No		12000000	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332"	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	41.2	38.8	24.9	36.7	25.8	33.4	33.0	25.3	37.5	32.4	38.0	17.9	23.7	39.4	35.3	32.5	49.9	27.1	24.4	37.7	29.8	27.6	55.7	76.3	37.4	45.1	25.5	26.9	31.2	24.4	20.2	25.9	55.4	33.8	35.3	41.3	19.1	26.0	25.0	60.3	26.3	49.1	36.6	28.1	45.5	31.5	36.5	21.4	61.6	42.6	75.0	44.8	41.3	28.3	29.4	61.9	31.4	75.6	37.7	40.0	61.4	40.8	59.2	51.2	45.1	32.4	30.6	40.2	38.4	30.9	47.4	50.8	61.4	59.6	89.1	56.8	35.3	53.1	55.9	103.3	41.6	45.8	36.5	72.0	74.8	44.3	49.5	52.5	76.0	46.2	24.7	26.1	39.8	39.7	29.2	51.0	49.1	80.2	35.0	38.6	58.7	51.2	71.4	48.2	47.5	34.8	44.6	67.8	29.8	47.9	71.5	45.2	33.0	61.6	45.0	46.8	66.1	41.6	62.6	40.6	35.4	47.2	38.9	65.3	32.0	75.4	84.0	33.2	114.3	39.0	18.8	47.4	31.4	27.8	75.6	28.5	29.4	29.2	29.0	61.9	22.9	23.3	28.3	21.7	37.7	69.7	35.3	40.0	61.4	24.9	25.8	25.3	37.5	29.8	27.6	25.5	26.9	33.8	21.4	119.1	93.9	158.5	221.9	205.7	52.1	151.9	114.7	164.6	121.7	115.1	9.8	396.5	263.6	267.2	515.0	152.3	149.0	93.5	255.0	368.3	172.3	213.0	169.8	170.4	287.4	68.3	140.2	108.6	138.2	238.7	139.8	214.9	126.5	342.7	139.0	49.5	230.5	135.3	138.6	288.5	32.6	148.8	177.5	257.9	168.3	185.9	373.9	156.9	171.4	236.4
PSMD6	"KIAA0107, p44S10, Rpn7, S10"	ENSG00000163636	"Proteasome 26S subunit, non-ATPase 6"	Q15008	3	64010549-64024010	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 401.5;Late spermatids: 551.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"MCF7: 181.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036921, HPA036922"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA		8600	Vesicles	"Golgi apparatus"	"HPA036921: AB_2675383, HPA036922: AB_10670850"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (8.65e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.95e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.22e-3)"	17.1	27.4	16.1	16.3	19.3	33.8	18.4	15.8	24.2	14.5	16.0	13.2	21.4	12.1	17.9	23.1	23.5	14.5	18.7	31.4	16.2	16.8	24.5	29.1	14.2	20.0	18.4	17.7	13.6	100.6	21.9	16.3	22.2	21.1	15.8	16.2	12.3	20.3	20.1	55.9	20.3	12.9	18.0	16.2	17.0	17.4	41.7	16.2	23.5	14.9	32.4	21.8	15.9	15.1	54.1	53.5	62.3	58.1	47.2	59.6	65.6	12.5	13.0	19.3	13.5	13.7	12.2	16.4	17.4	17.5	30.5	22.6	24.3	10.8	17.1	7.6	17.6	21.2	8.6	22.4	19.4	28.8	17.5	13.3	22.9	10.6	16.1	20.1	25.9	15.0	13.1	13.9	25.2	11.1	14.8	19.1	15.7	23.0	11.6	21.4	181.1	17.9	16.3	24.2	20.8	9.2	14.9	13.2	17.0	24.1	18.1	7.0	11.3	12.9	11.5	17.2	17.7	10.1	16.5	15.9	13.6	14.5	19.3	28.3	14.0	20.9	26.2	19.9	24.7	15.5	41.0	51.7	60.2	48.8	58.0	51.0	54.1	55.8	53.1	53.5	49.4	56.2	54.3	62.3	47.2	58.1	37.3	59.6	65.6	16.1	19.3	15.8	24.2	16.2	16.8	18.4	17.7	21.1	16.2	29.8	36.3	40.9	57.5	55.2	35.4	98.4	28.1	53.5	46.6	41.8	21.6	173.1	72.9	84.8	401.5	53.2	21.7	46.7	117.0	81.1	52.4	42.3	43.9	45.0	81.1	31.8	24.8	27.6	38.6	551.8	48.1	48.7	45.5	71.3	23.8	72.2	82.5	27.5	48.1	77.2	37.1	58.2	62.2	226.2	118.2	61.1	243.0	41.5	33.0	57.1
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 211.4;urinary bladder: 163.9"	"Cell type enriched"	"Detected in many"	4	"granulocytes: 205.3"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 53.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 13.0;granulocytes: 14.4;monocytes: 8.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 28.8;ASC TERT1: 22.8;BJ: 27.9;BJ hTERT+: 38.1;HEL: 17.5;HMC-1: 74.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002834, CAB020315"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		25000000	"Golgi apparatus"	Vesicles	"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.20e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (4.03e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.35e-4)"	4.5	1.1	1.8	9.1	3.1	2.6	2.5	0.5	2.7	2.6	35.3	4.6	3.0	3.9	2.5	1.6	25.7	16.7	9.4	4.9	1.9	1.6	3.9	1.8	4.0	1.4	3.5	0.7	3.6	1.0	0.7	2.4	0.8	2.5	60.9	9.3	1.5	1.9	2.3	0.7	55.9	6.5	211.4	4.9	3.6	7.8	1.0	3.1	0.4	1.5	5.3	4.2	163.9	19.5	2.5	13.0	14.4	8.5	1.9	0.1	13.7	0.0	0.1	0.1	0.0	28.8	22.8	0.0	27.9	38.1	0.2	0.2	0.0	0.0	1.0	1.3	4.7	0.0	1.7	0.1	2.5	0.2	0.0	0.0	17.5	0.1	0.0	8.3	1.2	74.3	11.6	0.3	1.4	0.0	0.0	10.3	0.0	0.0	0.0	0.5	0.0	0.0	1.5	0.4	0.0	0.1	0.0	0.3	2.0	3.6	0.0	0.1	0.1	0.1	2.3	0.0	0.1	0.0	2.0	0.2	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	7.6	0.0	12.0	7.6	14.4	0.0	8.5	0.0	1.7	0.0	0.0	13.0	2.5	0.0	0.0	3.5	1.9	6.1	0.9	0.1	13.7	1.8	3.1	0.5	2.7	1.9	1.6	3.5	0.7	2.5	3.1	0.0	10.0	0.9	2.4	8.9	0.0	1.1	0.0	1.4	2.3	40.1	0.0	0.1	0.0	0.5	0.0	6.0	0.0	0.0	0.4	0.2	4.7	1.9	205.3	0.0	25.3	0.0	1.7	36.8	10.7	0.0	1.4	22.9	3.3	4.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	51.3	0.3	0.7	0.5	0.6
PTPN23	"DKFZP564F0923, HD-PTP, KIAA1471"	ENSG00000076201	"Protein tyrosine phosphatase, non-receptor type 23"	Q9H3S7	3	47381011-47413441	"Enzymes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016845	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA016845: AB_1855926"	"unprognostic (1.17e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.07e-2)"	"unprognostic (9.55e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (3.05e-2)"	"unprognostic (4.40e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.68e-2)"	15.9	18.5	23.1	17.4	22.3	19.2	21.6	22.8	25.0	18.1	12.5	21.4	14.6	20.7	20.0	15.1	17.2	17.2	12.8	13.2	17.9	11.7	16.4	13.0	16.8	17.8	24.6	23.7	23.4	19.4	53.4	29.9	17.1	20.5	16.9	10.4	15.2	20.8	19.0	25.7	25.9	16.0	16.0	20.3	19.2	17.9	17.8	22.7	9.7	24.8	9.7	11.1	17.7	18.1	1.4	1.1	3.7	1.2	0.9	1.5	0.8	13.0	18.6	10.4	13.4	13.6	10.5	10.0	11.9	11.9	11.2	9.5	15.7	12.9	9.3	11.0	13.5	19.9	11.7	8.9	12.9	5.4	8.6	9.6	12.8	13.6	14.6	15.0	7.5	17.4	13.9	13.3	14.5	14.9	7.9	13.7	7.9	9.5	12.8	11.9	18.3	7.1	6.3	11.1	9.1	13.1	4.4	5.0	11.2	8.4	25.3	5.5	13.0	10.5	22.4	8.7	6.6	12.8	7.2	13.7	17.1	14.5	23.7	16.8	18.4	12.0	5.4	18.6	7.1	12.1	3.7	1.2	0.0	0.8	0.5	0.6	1.4	0.6	1.3	0.4	0.7	0.6	0.8	1.4	0.9	0.5	1.1	1.5	0.8	23.1	22.3	22.8	25.0	17.9	11.7	24.6	23.7	20.5	22.7	8.9	6.5	1.5	4.4	7.1	11.3	6.2	10.2	10.7	7.9	5.2	13.7	8.5	1.7	9.1	1.4	11.1	14.2	0.0	7.6	6.5	6.1	7.9	2.3	9.6	11.6	15.9	7.0	12.3	11.1	2.1	17.8	7.8	11.8	9.0	15.6	9.2	11.8	8.6	12.7	8.2	13.8	6.5	6.2	7.4	10.9	9.5	7.8	4.3	11.5	6.3
RAB11FIP2	"KIAA0941, nRip11, Rab11-FIP2"	ENSG00000107560	"RAB11 family interacting protein 2"	Q7L804	10	118004916-118046603	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037726	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA037726: AB_10672390"	"unprognostic (1.97e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (9.69e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.17e-1)"	8.8	7.1	11.8	6.4	21.6	12.0	7.2	13.3	19.9	11.4	9.7	7.9	19.0	3.8	23.0	29.8	6.8	12.9	8.6	7.2	10.5	7.1	12.8	5.6	7.7	8.5	8.0	12.9	10.7	7.0	8.6	6.6	8.3	11.5	12.7	5.3	6.9	6.2	27.2	6.5	6.3	6.7	20.0	7.5	7.7	15.5	8.6	8.8	10.0	11.8	3.8	5.6	10.5	13.7	2.3	2.6	1.9	1.2	0.9	2.3	0.4	5.2	6.8	5.7	7.2	9.5	12.2	6.1	10.6	12.3	6.5	6.8	5.5	5.7	10.9	8.5	10.7	4.8	3.7	7.9	4.6	10.1	2.8	8.3	3.9	7.0	3.8	13.8	7.2	4.3	11.9	8.9	9.2	20.3	8.7	4.0	7.1	2.8	9.4	8.4	1.9	5.4	5.4	4.8	2.4	4.8	4.8	20.2	3.6	9.7	4.2	1.3	10.6	7.4	3.0	12.9	7.2	2.3	6.8	5.8	8.8	7.1	10.3	10.4	6.8	5.7	7.1	9.0	12.4	5.4	1.5	1.2	1.4	1.5	0.8	1.4	2.2	1.2	1.5	0.6	2.3	2.3	1.3	1.9	0.9	0.7	2.6	0.6	0.4	11.8	21.6	13.3	19.9	10.5	7.1	8.0	12.9	11.5	8.8	53.6	29.8	9.1	7.7	9.2	29.2	23.6	22.9	6.7	6.8	40.1	27.5	9.0	6.6	10.6	13.5	12.8	4.1	0.0	16.2	7.0	22.4	9.2	3.5	7.7	9.7	36.5	13.9	11.6	25.1	5.0	31.1	14.4	21.9	10.0	6.4	24.9	16.4	5.9	26.9	15.6	29.1	25.8	19.8	10.9	20.9	8.3	4.3	8.6	5.8	5.4
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178137-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles		NA	NA		9900000	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favorable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	28.4	29.2	35.7	29.7	37.3	41.4	37.2	36.5	50.2	29.9	30.3	31.4	38.2	28.5	27.9	26.1	50.1	25.6	25.5	24.3	33.3	34.1	37.0	58.7	57.5	38.0	44.5	34.8	27.5	22.7	38.6	25.2	30.7	35.0	29.5	31.5	20.0	29.2	55.5	28.2	42.4	27.4	24.7	43.0	28.1	31.3	23.5	41.4	23.9	32.4	25.8	34.3	27.7	32.3	19.0	23.3	24.0	30.9	19.2	21.5	15.7	21.6	22.1	28.1	23.5	32.8	35.9	22.2	30.9	24.8	23.9	19.1	17.4	23.6	20.8	18.1	29.5	20.8	41.4	20.0	23.0	27.1	17.9	13.2	22.5	30.7	17.7	22.7	24.0	27.0	22.8	41.6	24.5	27.0	26.5	33.8	19.5	17.0	19.1	35.7	20.5	23.2	19.3	16.7	42.6	25.0	18.5	30.5	24.3	26.3	31.2	24.9	14.6	36.7	32.6	21.0	20.8	34.3	19.0	31.2	25.6	18.8	31.6	21.5	17.2	32.4	21.2	24.1	21.1	33.5	23.4	21.9	24.0	18.0	30.9	17.9	19.0	16.9	19.5	23.3	17.0	20.4	20.2	23.7	19.2	30.2	14.3	21.5	15.7	35.7	37.3	36.5	50.2	33.3	34.1	44.5	34.8	35.0	41.4	148.9	86.3	53.6	73.4	140.4	91.2	33.9	71.4	87.0	89.9	59.3	35.3	75.8	72.9	69.8	30.5	73.0	67.3	0.0	56.3	68.7	55.1	66.3	74.1	102.0	79.3	89.0	57.9	59.5	87.7	24.1	48.1	78.2	104.6	89.2	51.7	90.0	61.8	46.0	53.0	77.8	55.5	58.2	60.8	83.2	110.1	177.0	97.1	57.5	49.0	92.9
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561733	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"OE19: 24.4;SK-BR-3: 35.5;T-47d: 22.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002882, HPA052111, HPA068647"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA002882: , HPA052111: AB_2681732, HPA068647: AB_2686013"	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.48e-4)"	30.9	23.5	3.7	11.9	5.3	11.9	27.5	1.3	4.0	6.9	20.2	5.2	3.0	15.7	6.0	8.8	4.1	6.8	17.8	17.0	5.3	2.5	15.9	38.2	27.8	21.9	7.1	1.8	17.0	14.5	3.2	5.8	12.6	9.1	9.4	8.3	8.5	10.9	3.2	8.8	2.6	23.8	5.0	13.4	32.9	15.0	6.3	3.6	2.5	13.6	1.9	4.2	13.2	13.6	1.9	8.3	13.4	19.4	0.0	3.6	5.6	7.9	1.2	0.8	1.5	5.2	1.4	13.0	0.7	2.5	3.4	5.2	19.2	16.3	0.0	5.8	0.6	4.5	3.0	1.5	5.0	1.8	8.9	1.2	7.9	1.5	8.9	3.3	1.1	2.4	2.9	0.8	1.7	0.5	2.6	1.3	1.3	1.5	0.0	0.7	9.5	0.0	11.4	1.6	24.4	3.5	0.7	0.0	3.6	5.8	10.6	0.2	0.8	1.5	35.5	10.7	2.7	22.4	12.3	0.9	0.8	1.7	0.0	1.1	0.0	0.0	0.0	11.6	15.6	1.7	2.8	19.4	3.5	0.6	17.0	0.7	1.9	1.6	0.5	8.3	1.2	3.6	1.2	13.4	0.0	12.7	0.4	0.4	5.6	3.7	5.3	1.3	4.0	5.3	2.5	7.1	1.8	9.1	3.6	17.9	14.8	6.9	10.7	3.9	0.0	4.5	50.9	22.7	18.2	24.4	0.0	27.9	26.6	49.7	1.2	4.7	33.8	0.0	60.3	51.5	11.3	6.6	20.7	28.0	90.8	0.0	17.3	64.4	71.5	1.7	3.4	32.7	6.8	16.2	21.1	7.4	35.1	10.5	6.0	64.1	1.7	12.9	19.6	0.9	7.5	2.6	16.7	4.3	19.4	7.9
RAB29	"RAB7L, RAB7L1"	ENSG00000117280	"RAB29, member RAS oncogene family"	O14966	1	205767986-205775460	"Predicted intracellular proteins"	"Differentiation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 97.4;Proximal tubular cells: 145.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020822, HPA026303"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB020822: , HPA026303: AB_1856016"	"unprognostic (5.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (9.50e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.60e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.42e-1)"	10.7	14.4	13.8	12.0	16.5	4.0	12.3	5.9	16.2	6.1	10.3	10.4	3.0	6.8	6.9	16.2	11.0	5.1	11.0	9.5	12.6	8.6	46.6	19.9	9.3	20.1	19.0	9.2	5.8	7.9	11.1	8.3	4.6	13.3	9.4	6.7	8.9	15.4	9.6	5.2	4.4	10.4	13.0	20.2	16.8	8.7	3.2	15.9	6.5	21.8	3.1	17.3	13.7	10.8	17.9	11.6	23.5	17.8	32.1	34.8	15.9	8.2	7.7	1.2	5.6	23.0	13.1	4.1	5.9	18.2	12.4	14.9	2.3	12.0	8.9	5.8	10.0	14.7	4.7	13.8	15.5	11.4	36.1	6.4	6.7	3.2	3.9	11.2	6.6	10.0	12.7	10.6	9.9	14.1	10.4	15.6	8.3	6.5	10.3	17.4	3.2	7.1	3.4	5.5	10.4	5.9	1.5	18.3	7.3	14.5	11.5	1.9	5.4	4.1	19.2	15.3	4.6	9.3	5.4	16.2	12.8	6.6	18.5	8.4	16.9	34.5	4.7	13.0	10.9	9.5	23.5	7.7	20.8	34.8	14.8	32.6	17.9	19.5	29.3	11.6	16.6	14.2	24.4	3.1	32.1	17.8	3.5	18.0	15.9	13.8	16.5	5.9	16.2	12.6	8.6	19.0	9.2	13.3	15.9	17.9	15.3	43.0	5.5	0.0	0.4	17.3	28.1	5.3	11.4	29.6	0.0	9.9	24.9	13.4	5.2	11.8	2.6	0.0	8.9	5.2	2.9	11.3	12.7	27.1	27.5	0.0	4.7	12.3	22.5	2.7	13.3	29.4	0.0	97.4	3.0	22.5	8.7	3.5	19.4	145.9	1.4	6.5	2.0	0.9	10.2	0.0	2.4	40.3	5.0	7.1
RAB5B		ENSG00000111540	"RAB5B, member RAS oncogene family"	P61020	12	55973913-55996683	"Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010224, HPA068337"	Approved		Supported	Vesicles		NA	NA		1000000	Vesicles		"CAB010224: AB_2175453, HPA068337: AB_2685974"	"prognostic unfavorable (2.24e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.66e-3)"	"unprognostic (2.09e-1)"	"unprognostic (8.42e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.31e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.49e-1)"	26.6	27.9	39.9	18.3	56.2	14.3	32.9	42.0	67.4	39.2	34.0	73.3	24.0	24.8	41.2	45.0	48.9	37.2	26.0	39.2	39.3	36.2	33.4	31.8	33.7	18.8	42.2	39.3	42.2	22.7	53.2	25.6	32.2	61.8	37.1	38.8	33.5	31.8	47.5	47.1	42.8	29.3	38.2	58.7	21.2	30.9	27.8	41.0	18.3	30.8	27.2	33.8	40.4	35.3	6.9	5.7	21.9	7.2	5.2	8.5	5.8	18.5	12.4	24.9	18.0	41.5	36.4	22.5	17.2	30.8	21.0	17.7	20.2	23.5	10.2	20.7	32.0	16.0	13.7	15.5	23.1	19.8	13.5	12.2	12.0	16.4	11.4	29.9	9.7	19.0	29.4	43.5	19.6	16.8	47.5	26.2	13.1	10.5	30.6	26.4	12.3	12.3	15.1	10.9	15.3	10.7	10.7	15.4	13.3	39.4	30.5	12.5	11.2	22.0	21.9	27.2	29.1	32.0	31.3	21.8	13.8	10.3	10.3	6.6	18.2	14.3	6.5	22.9	9.1	11.7	12.1	7.0	21.9	8.5	6.9	7.9	6.9	6.8	7.4	5.7	5.9	7.9	6.1	20.7	5.2	7.2	5.6	5.4	5.8	39.9	56.2	42.0	67.4	39.3	36.2	42.2	39.3	61.8	41.0	53.6	29.6	26.9	23.2	45.9	32.4	45.6	73.9	9.4	23.9	40.1	49.1	38.2	29.9	42.7	9.0	28.9	49.0	0.0	32.2	36.6	29.4	42.2	19.6	74.9	27.3	15.9	37.4	44.2	44.5	16.0	49.5	23.9	33.7	73.1	46.3	41.4	55.5	45.6	55.9	29.1	30.4	58.2	24.7	37.9	24.0	78.0	73.6	23.5	35.5	46.0
RAB8B		ENSG00000166128	"RAB8B, member RAS oncogene family"	Q92930	15	63189469-63267782	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 177.9;Late spermatids: 271.9;monocytes: 180.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 44.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074534			Supported	Nucleoplasm,Vesicles		NA	NA		5200000	Vesicles	Nucleoplasm	"HPA074534: AB_2686700"	"unprognostic (7.67e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.97e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.47e-2)"	21.8	12.1	15.2	20.9	12.9	50.8	22.6	10.1	12.2	15.8	17.7	11.8	7.6	13.6	14.2	8.6	10.9	12.7	18.4	17.5	19.2	14.4	13.7	11.4	27.7	30.8	15.3	12.9	25.2	5.7	6.6	11.7	22.0	16.9	14.3	9.0	9.8	9.3	11.3	7.5	8.2	21.1	14.3	19.5	33.7	9.8	11.8	11.5	38.8	16.4	4.7	27.8	24.4	23.7	10.7	10.4	30.8	14.5	13.1	19.2	14.3	4.8	4.1	15.7	6.5	30.0	24.8	4.7	4.8	11.0	8.7	17.1	4.4	3.9	13.2	4.4	10.3	10.5	2.4	13.5	6.5	14.7	19.8	2.6	16.6	3.7	2.8	28.0	6.2	10.5	14.9	3.4	16.4	9.6	11.3	22.0	13.8	6.5	12.8	15.9	3.2	10.1	3.4	9.8	4.5	4.0	8.7	21.0	1.9	6.9	22.9	1.3	3.3	7.3	0.9	13.4	10.5	3.5	6.3	24.8	16.3	10.5	8.6	6.4	8.3	8.2	12.5	10.4	17.7	44.1	27.1	14.5	11.9	15.8	13.1	14.4	10.7	12.8	15.0	10.4	10.6	10.0	12.2	30.8	13.1	11.6	1.3	19.2	14.3	15.2	12.9	10.1	12.0	19.2	14.4	15.3	12.9	16.9	11.5	17.9	20.2	18.8	6.9	27.6	1.9	3.1	12.7	8.1	7.9	7.0	11.8	10.5	10.0	19.1	177.9	29.2	2.4	0.0	11.5	84.9	38.5	11.2	38.1	5.5	47.2	19.1	10.3	34.4	65.8	271.9	29.4	57.9	33.7	180.3	4.1	12.8	27.6	0.0	35.7	18.6	12.1	19.4	19.5	43.7	15.9	19.6	31.2	66.1	3.0	20.9
RABEP1	"neurocrescin, RAB5EP, rabaptin-5, RABPT5"	ENSG00000029725	"Rabaptin, RAB GTPase binding effector protein 1"	Q15276	17	5282265-5385812	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004549, HPA019669, HPA024235, HPA024691"	Supported		Supported	Vesicles		NA	NA			Vesicles		"CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021"	"unprognostic (3.22e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.14e-1)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.00e-3)"	19.2	16.7	29.6	18.8	31.1	10.3	31.8	24.1	32.7	16.3	14.2	19.0	12.5	10.9	18.1	18.3	12.7	12.9	15.0	27.4	29.7	25.9	16.6	21.8	13.1	21.1	36.2	24.4	15.5	12.1	38.4	16.3	20.2	31.3	22.2	14.2	10.0	14.8	16.0	41.2	11.6	13.4	20.8	35.6	17.7	15.7	11.8	29.0	21.4	17.6	13.5	25.5	14.5	13.0	37.6	14.2	12.6	19.3	9.1	11.2	6.4	18.1	22.4	23.6	13.2	24.8	24.9	13.0	23.6	17.6	24.7	23.7	19.9	7.6	38.3	19.8	23.8	13.9	14.3	34.5	19.6	35.0	25.2	31.6	23.4	27.8	15.0	23.4	15.3	15.5	19.2	13.5	23.8	30.9	15.0	21.4	19.5	19.9	18.9	21.4	12.6	25.3	12.6	10.9	9.9	10.9	24.0	28.3	12.7	12.5	16.6	10.2	16.0	20.9	20.8	19.8	21.8	37.8	7.0	18.8	21.3	9.9	21.4	27.6	11.1	12.1	20.6	16.5	25.1	14.5	4.9	9.0	8.7	11.2	9.2	9.8	30.2	8.7	10.6	9.2	37.6	11.1	9.7	12.6	9.1	19.3	14.2	8.0	6.4	29.6	31.1	24.1	32.5	29.7	25.9	36.2	24.4	31.3	29.0	32.8	42.6	30.0	28.5	21.3	46.6	80.2	15.3	24.1	45.5	17.4	37.3	31.8	34.9	26.0	5.7	28.5	14.6	0.0	20.5	27.9	29.4	43.8	11.6	25.1	71.8	33.4	15.6	34.4	30.4	4.6	31.4	35.3	28.7	27.1	14.3	85.2	23.9	31.6	26.5	29.4	49.0	25.8	29.9	70.4	72.8	17.8	21.6	29.6	14.6	29.3
RABEP2	"FLJ23282, FRA"	ENSG00000177548	"Rabaptin, RAB GTPase binding effector protein 2"	Q9H5N1	16	28904421-28936526	"Predicted intracellular proteins"	"Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047641	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA047641: AB_2680111"	"unprognostic (4.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.84e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.86e-2)"	"prognostic favorable (1.24e-6)"	"unprognostic (7.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.92e-3)"	4.7	13.7	5.4	19.8	10.0	8.5	6.0	4.4	8.6	5.6	7.8	9.9	17.3	14.3	5.9	7.3	11.6	5.3	14.1	8.7	6.5	5.8	10.8	6.6	6.7	35.5	11.9	6.0	5.5	11.3	10.3	11.2	9.1	8.1	17.3	4.1	11.2	16.7	13.9	5.1	17.8	17.5	7.1	6.9	31.5	9.3	8.8	8.4	8.3	9.2	7.5	23.0	10.2	7.6	14.9	3.6	2.4	3.0	5.1	3.5	2.7	8.3	14.0	3.5	6.5	1.9	3.0	6.3	10.2	6.1	7.2	7.0	9.7	7.6	16.0	16.0	3.8	2.9	10.6	1.3	6.0	1.2	6.1	5.8	6.2	10.0	13.7	4.3	4.4	19.7	5.0	5.1	8.5	1.4	4.1	9.9	4.5	3.0	5.8	5.2	19.4	5.6	10.0	4.6	3.4	6.6	19.8	3.2	10.8	4.8	11.0	5.5	7.0	4.5	21.6	4.4	0.7	17.5	9.7	16.4	11.3	5.4	7.6	9.8	9.1	2.8	12.1	11.8	11.4	8.0	0.5	2.5	2.4	3.5	2.8	2.6	12.2	2.5	3.3	3.6	14.9	2.3	2.1	0.7	5.1	3.0	2.1	2.1	2.7	5.4	10.0	4.4	8.6	6.5	5.8	11.9	6.0	8.1	8.4	3.0	10.6	36.5	13.4	4.5	10.7	1.4	12.7	2.7	4.5	19.2	33.4	20.5	14.9	15.7	0.4	13.1	28.5	0.0	18.1	6.2	7.8	15.9	18.4	3.4	11.2	14.3	16.6	5.5	7.1	0.4	3.7	9.6	10.1	12.6	28.7	8.2	16.4	40.3	6.0	10.3	43.4	12.9	6.9	5.2	5.3	7.3	18.4	18.7	22.9	15.3
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.4	11.3	16.3	14.7	19.0	17.0	15.8	16.6	13.2	13.8	12.1	28.1	8.9	29.1	12.9	17.3	17.0	15.6	27.8	17.3	20.1	17.7	13.5	30.3	14.0	19.8	11.1	35.3	10.2	14.3	13.2	21.5	16.8	13.6	21.0	12.7	32.4	16.1	18.2	10.2	15.6	14.4	20.5	9.3	13.6	14.8	25.0	14.0	12.2	23.1	23.7	10.9	14.7	12.7	16.1	10.2	8.1	16.3	25.0	14.4	19.1	10.1	18.5	13.4	19.8	26.4	11.2	16.0	11.1	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9	71.5	71.1	34.9	25.8	49.5	43.3	85.9	33.1	57.6	70.5	55.8	68.7	22.7	1.7	31.3	59.8	43.8	25.7	0.0	44.1	15.0	32.3	38.2	83.1	49.9	41.1	30.2	102.2	27.0	44.0	22.0	35.6	64.2	45.5	49.5	50.9	18.7	36.5	25.9	52.6	15.4	37.7	45.3	62.9	74.1	59.2	59.2	34.0	44.5	31.5	31.5
RANBP6		ENSG00000137040	"RAN binding protein 6"	O60518	9	6011043-6015625	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043748, HPA052684"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA043748: AB_10796796, HPA052684: AB_2681913"	"unprognostic (1.47e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.89e-2)"	"prognostic favorable (1.34e-7)"	"unprognostic (2.42e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.61e-1)"	10.6	14.6	11.8	12.6	18.1	27.0	11.7	23.7	27.1	8.6	7.2	8.1	8.6	7.5	9.3	7.5	9.8	8.2	7.8	13.6	12.8	15.8	14.2	15.3	8.4	15.8	19.7	17.3	10.4	10.9	16.1	16.2	15.6	32.0	10.4	7.4	5.4	10.1	9.3	15.1	10.0	11.6	10.5	16.0	14.3	10.9	6.1	15.0	22.3	12.6	9.2	16.0	9.3	7.6	4.2	5.2	7.2	11.1	4.8	8.1	4.4	10.9	6.0	12.4	10.5	10.9	8.7	6.7	14.1	9.8	12.1	9.9	3.2	3.4	14.9	3.9	10.8	6.0	6.4	10.8	12.5	13.7	35.1	6.3	38.7	22.7	6.7	6.4	14.6	8.3	9.4	6.9	7.6	7.5	9.7	14.0	13.4	2.9	12.5	11.6	3.6	10.4	23.7	5.5	3.9	5.1	11.2	7.7	7.0	12.8	7.7	6.1	9.0	6.6	5.0	3.7	10.6	7.9	10.0	16.6	11.5	6.9	5.6	13.0	7.4	11.9	14.3	6.5	8.8	4.2	7.2	7.2	6.4	4.6	11.1	4.5	4.2	6.7	4.7	4.5	3.7	7.9	7.5	2.3	4.8	7.7	5.2	8.1	4.4	11.8	18.1	23.7	27.1	12.8	15.8	19.7	17.3	32.0	15.0	8.9	7.2	4.2	5.8	9.2	17.3	22.0	2.5	5.3	19.4	10.4	2.0	7.3	6.6	7.6	1.0	9.3	2.1	0.0	9.3	3.9	5.4	4.5	10.4	11.3	3.8	11.1	9.1	12.3	12.0	0.9	6.1	6.6	1.7	1.8	2.7	14.1	6.0	3.6	6.3	10.9	21.0	0.0	5.1	6.2	7.9	8.3	5.5	7.5	4.5	5.0
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 123.9;monocytes: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA006426: AB_1856070, HPA075984: AB_2686771"	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favorable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	16.2	10.8	18.4	21.5	28.0	19.7	18.5	21.8	19.5	9.6	11.5	13.7	6.0	10.1	11.1	6.9	10.3	11.4	10.2	21.5	17.4	16.0	9.4	9.7	16.9	21.7	13.1	10.2	7.4	24.1	9.0	7.3	28.5	13.5	9.0	10.3	16.8	8.5	10.0	83.3	9.2	13.7	13.2	13.0	16.7	12.0	6.8	11.6	12.4	9.9	8.8	25.9	11.3	12.0	9.2	2.9	5.3	3.9	2.0	6.5	2.3	10.6	12.4	12.6	12.7	12.9	14.0	48.4	9.2	18.9	10.7	7.7	15.4	7.0	19.3	11.6	18.5	23.0	19.5	14.4	12.8	5.4	44.7	5.9	5.6	20.8	8.1	10.9	23.3	26.1	10.6	23.6	14.0	16.7	10.8	19.3	22.5	15.1	38.3	13.8	11.1	16.4	8.3	12.7	10.6	11.3	16.4	29.4	26.8	4.9	12.9	10.7	10.7	13.4	12.8	13.4	13.2	12.2	19.7	20.3	28.8	12.1	18.2	14.0	12.9	11.2	38.1	13.7	10.0	6.9	5.3	2.0	2.6	6.5	3.8	3.7	9.2	4.2	4.2	2.4	5.3	1.1	2.9	2.3	2.0	3.9	2.9	3.0	2.3	18.4	28.0	21.8	18.5	17.4	16.0	13.1	10.2	13.5	11.6	6.0	17.3	13.3	8.3	16.7	18.8	12.5	22.9	20.1	14.8	5.2	13.7	16.3	5.0	6.8	2.1	30.2	16.8	0.0	15.9	28.3	7.6	9.5	19.7	11.3	25.1	123.9	11.6	22.1	24.1	1.5	8.1	48.3	30.4	83.8	12.0	19.1	15.1	14.4	11.3	7.0	13.2	6.5	7.2	4.4	10.7	9.9	43.3	23.5	10.2	10.2
RBSN	ZFYVE20	ENSG00000131381	"Rabenosyn, RAB effector"	Q9H1K0	3	15070073-15099163	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044878	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA044878: AB_10967610"	"unprognostic (6.76e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.38e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.78e-1)"	11.6	8.7	18.0	8.7	19.8	21.4	10.7	19.6	26.1	9.9	10.6	21.9	9.4	6.4	12.9	10.2	12.3	11.2	7.7	12.9	16.6	13.7	7.4	9.3	11.3	8.2	16.6	15.3	18.2	7.1	13.3	7.1	10.6	17.0	10.6	7.5	10.9	7.6	13.1	15.7	13.7	7.7	14.5	16.2	9.2	8.6	11.6	16.7	3.6	15.5	7.6	8.1	9.9	9.6	7.9	4.3	13.6	7.3	3.2	9.5	2.9	8.3	12.3	10.0	13.0	11.1	8.3	26.7	9.3	9.0	11.1	10.1	7.4	5.0	5.9	5.4	12.2	6.5	5.4	12.8	11.2	9.9	7.4	11.4	6.7	14.6	6.0	7.6	6.7	7.5	8.9	12.6	14.2	9.5	6.6	9.0	6.7	10.0	6.9	8.4	11.1	3.6	3.4	8.6	5.4	9.9	4.8	11.5	6.5	5.8	9.6	2.7	9.4	11.3	6.9	8.2	7.7	17.7	5.0	10.9	10.1	10.6	9.8	13.0	6.2	9.2	7.0	9.7	7.6	9.4	9.0	5.4	12.3	5.3	7.3	4.7	5.2	7.2	6.5	4.3	7.9	9.5	6.4	13.6	3.2	6.2	4.1	4.7	2.9	18.0	19.8	19.6	25.3	16.6	13.7	16.6	15.3	17.0	16.7	14.9	14.7	4.5	5.1	0.0	18.9	17.3	5.1	14.7	18.2	3.5	21.6	8.9	5.0	6.8	10.2	10.5	3.3	0.0	8.2	8.4	8.1	9.9	9.3	13.0	9.1	20.6	1.2	9.2	12.9	12.2	17.5	7.5	0.0	5.4	8.9	14.1	8.2	7.0	13.8	5.4	21.0	6.5	6.3	8.9	13.8	0.0	10.8	6.9	6.4	6.7
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: AB_2685350"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.7	12.3	8.3	9.5	32.8	20.1	13.9	10.9	28.2	10.6	15.8	10.8	28.4	8.2	16.0	13.4	19.5	18.8	11.1	14.0	14.9	10.0	8.1	9.9	5.7	10.5	21.8	10.6	14.1	21.2	26.6	8.9	24.2	12.8	11.7	7.9	3.1	16.7	9.4	11.1	7.6	7.0	5.5	19.1	9.6	5.5	8.9	34.8	20.5	9.2	4.4	12.7	9.0	13.6	35.2	6.8	25.9	11.2	12.2	14.4	5.8	15.2	7.0	28.4	18.7	16.9	12.1	9.9	7.7	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2	101.3	59.5	39.3	61.2	65.4	43.7	25.6	38.2	34.8	61.4	45.4	27.5	86.4	36.5	54.3	2.2	62.6	27.6	0.0	62.0	65.2	68.3	63.5	58.9	46.6	172.6	20.6	19.4	77.3	168.9	4.7	70.5	155.4	97.8	42.3	26.4	85.9	48.5	29.6	82.7	59.8	32.2	90.5	50.9	19.7	29.6	63.2	43.8	51.0	24.3	45.5
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917392-7068286	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HMC-1: 51.6;SH-SY5Y: 15.7;SK-MEL-30: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	12.9	28.8	13.3	4.2	21.2	12.1	11.1	45.5	20.7	17.3	5.2	28.7	9.0	3.0	26.0	8.3	4.7	8.4	7.5	8.0	15.6	11.6	7.5	1.8	5.7	7.9	26.5	12.2	20.0	29.7	21.5	12.5	6.2	13.2	8.7	5.7	5.9	4.0	7.4	8.7	5.7	4.1	12.2	21.8	21.1	2.8	5.0	27.1	3.4	3.2	1.2	5.8	5.8	6.5	0.1	0.2	8.7	0.1	0.8	4.1	0.6	0.3	2.2	12.0	2.4	2.7	5.6	9.2	0.0	0.0	0.4	1.1	0.0	0.2	1.1	1.3	0.1	3.5	0.2	3.9	0.0	0.0	0.6	1.0	15.2	0.1	4.5	0.1	0.3	51.6	8.9	0.0	0.8	0.0	0.0	0.0	3.9	6.5	0.2	0.0	1.9	7.8	0.6	4.4	0.3	5.4	6.1	8.7	1.0	0.4	3.9	3.9	15.7	0.2	1.6	15.4	1.6	0.7	1.0	0.0	1.6	4.1	4.2	1.7	4.1	1.3	0.0	6.0	3.4	5.6	1.5	0.1	8.7	2.1	0.0	3.0	0.1	2.1	1.5	0.2	0.1	4.1	2.8	0.4	0.8	0.0	0.0	0.8	0.6	13.3	21.2	45.5	20.3	15.6	11.6	26.5	12.2	13.2	27.1	3.0	3.4	0.5	0.7	2.2	3.6	10.6	2.5	2.7	3.4	0.0	70.7	1.7	1.7	2.7	5.7	7.0	4.2	23.3	5.0	2.7	5.3	3.5	9.2	0.8	3.8	9.5	24.5	28.3	1.0	10.4	4.0	1.0	23.6	1.0	2.5	7.2	4.5	9.1	9.9	0.0	42.2	0.0	3.8	1.6	6.0	1.4	0.9	6.4	2.9	0.2
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes		NA	NA			"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: AB_2685240"	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	13.6	12.3	10.5	11.1	14.5	10.2	9.3	17.5	21.0	12.6	13.1	19.0	9.6	12.2	15.0	9.3	14.2	12.5	8.0	15.5	10.8	10.5	8.3	12.9	11.0	9.0	12.2	9.9	12.8	9.8	14.3	14.1	9.7	12.7	12.0	7.4	15.2	10.4	13.9	23.7	12.3	11.0	13.6	9.5	11.6	11.1	10.3	12.7	16.7	10.2	11.1	11.9	14.3	10.5	2.1	1.9	3.1	2.4	1.7	3.8	1.2	9.7	19.6	4.6	8.3	6.7	5.7	8.7	7.4	6.8	11.7	8.8	15.3	8.7	8.2	5.9	9.0	9.1	6.0	7.5	9.9	6.6	2.9	12.2	12.6	10.8	13.8	6.7	11.3	9.0	8.5	6.8	12.1	7.0	4.1	11.6	9.6	15.7	3.3	6.6	5.3	10.9	4.8	5.0	5.8	15.7	5.2	8.5	6.7	3.4	11.2	9.2	9.3	9.0	14.5	8.2	5.2	9.5	8.3	5.3	24.9	10.6	7.8	9.4	5.3	1.9	8.1	15.1	6.0	15.1	3.1	0.9	0.0	3.8	2.4	2.5	2.1	1.6	1.8	1.9	1.1	2.3	2.2	0.0	1.7	1.3	1.1	3.6	1.2	10.5	14.5	17.5	21.0	10.8	10.5	12.2	9.9	12.7	12.7	0.0	3.8	1.7	2.8	2.9	6.7	3.4	7.6	0.0	0.0	5.2	3.9	3.9	1.7	2.9	5.8	2.6	3.5	0.0	3.2	4.8	3.1	3.4	2.3	5.8	4.2	11.1	5.8	1.8	4.5	8.7	2.8	2.1	1.7	0.0	3.1	4.1	3.7	3.5	4.9	2.6	6.6	0.0	3.0	3.4	3.3	2.6	3.7	5.0	4.6	2.8
RRAGC	"FLJ13311, GTR2"	ENSG00000116954	"Ras related GTP binding C"	Q9HB90	1	38838198-38859823	"Disease related genes, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 187.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018247, HPA055489"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA018247: AB_1856475, HPA055489: AB_2682832"	"unprognostic (2.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (9.97e-9)"	"unprognostic (2.14e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-2)"	27.8	14.0	18.6	11.9	24.1	20.1	36.5	15.9	22.3	13.4	19.4	13.3	11.0	14.1	14.9	11.1	20.7	11.8	13.6	19.0	16.7	13.8	18.8	13.9	15.0	14.2	18.9	14.1	17.6	12.9	13.9	8.9	27.6	21.4	12.6	13.3	11.9	12.7	13.8	15.5	24.6	13.0	17.0	15.6	12.8	12.9	12.7	15.9	11.2	12.9	8.2	16.0	16.0	14.9	4.9	11.3	7.7	3.3	2.0	4.0	2.0	12.1	5.5	7.3	7.9	39.0	26.5	11.3	11.3	23.3	15.5	16.4	4.2	8.1	7.6	6.5	17.6	24.9	7.3	13.6	7.5	12.8	12.3	9.6	7.3	6.8	4.8	47.9	8.5	8.3	23.5	19.0	16.5	21.5	12.3	16.1	8.3	7.4	15.4	22.3	3.3	6.1	4.8	9.3	5.3	9.5	5.9	12.9	5.1	10.9	14.2	3.8	5.7	9.0	6.8	23.6	17.2	6.2	6.5	14.2	18.9	7.8	20.6	9.6	12.1	19.4	9.0	17.6	9.6	9.7	0.5	3.3	6.7	2.5	3.0	4.0	4.6	3.7	3.0	3.1	4.9	3.3	3.1	7.7	2.0	2.3	11.3	3.3	2.0	18.6	24.1	15.9	22.3	16.7	13.8	18.9	14.1	21.4	15.9	29.8	28.3	36.0	36.3	99.5	18.7	21.2	22.9	10.7	11.4	12.2	11.8	70.5	10.0	46.2	51.6	21.1	19.1	23.3	41.7	49.6	38.6	38.8	16.1	10.2	61.8	36.5	13.8	38.1	28.2	37.2	28.4	37.6	50.6	80.2	9.7	40.2	38.6	14.4	35.0	23.7	21.1	19.4	41.2	23.3	25.2	122.8	187.4	20.3	13.0	38.8
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364636-89412270	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 118.0;Distal tubular cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.3;monocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 28.2;SCLC-21H: 14.8;U-266/70: 35.7;U-266/84: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	8.1	8.4	9.2	2.6	12.8	8.9	8.8	22.4	16.3	8.7	3.3	7.9	3.1	2.2	2.1	6.6	12.8	11.9	3.7	29.9	8.6	7.4	21.8	5.0	6.4	2.8	8.5	7.9	2.2	6.4	16.0	11.5	3.4	10.7	5.9	2.4	12.8	38.7	4.2	60.0	5.5	2.1	7.5	12.6	4.4	2.3	6.1	9.2	4.1	23.3	13.9	5.2	9.2	9.3	0.1	0.7	6.3	3.9	0.1	0.6	0.3	0.0	0.7	1.9	1.4	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.7	0.0	10.0	0.0	10.7	0.0	0.0	0.0	5.3	2.4	0.0	0.0	0.8	7.1	8.5	0.2	0.6	0.0	0.0	0.0	0.0	7.4	0.2	28.2	0.0	0.7	3.4	3.5	1.6	0.0	0.7	7.1	10.3	0.1	2.6	0.2	14.8	0.8	0.2	1.0	12.0	0.6	0.3	5.6	0.0	0.8	1.2	5.1	1.3	35.7	16.5	0.0	2.7	5.4	0.8	3.9	1.2	2.6	0.0	1.1	0.1	0.1	0.4	0.0	0.7	0.0	0.3	0.6	6.3	0.1	3.9	0.6	0.0	0.3	9.2	12.8	22.4	9.1	8.6	7.4	8.5	7.9	10.7	9.2	8.9	11.8	7.5	12.1	14.3	18.0	118.0	15.3	13.4	5.7	14.0	29.5	0.4	99.5	14.2	15.2	3.6	0.0	0.0	14.9	1.2	6.0	29.7	4.6	8.6	46.1	44.5	1.2	3.1	19.9	10.4	2.8	8.5	37.1	5.4	0.3	18.0	12.3	0.0	3.9	15.6	14.2	0.0	6.6	8.4	25.7	19.7	0.6	1.5	0.0	25.7
RUBCN	"KIAA0226, rubicon, rundataxin"	ENSG00000145016	"RUN and cysteine rich domain containing beclin 1 interacting protein"	Q92622	3	197671393-197749727	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Endocytosis, Immunity, Phagocytosis"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050908, HPA054497"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA050908: , HPA054497: AB_2682507"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (9.91e-5)"	"unprognostic (1.99e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.23e-1)"	10.7	8.4	19.3	15.5	24.0	10.7	6.8	30.0	24.6	7.9	9.8	12.4	6.4	10.7	9.1	6.5	14.5	7.7	10.4	10.3	18.1	18.8	7.8	5.7	12.4	19.8	14.6	19.4	14.0	11.0	13.3	16.6	8.5	18.3	7.4	8.8	8.3	7.1	11.2	9.7	11.7	12.0	11.4	15.1	22.3	11.3	22.0	15.8	7.9	7.4	7.0	22.3	9.6	8.0	7.8	14.7	12.8	4.1	1.5	4.4	1.2	15.1	3.5	4.3	8.6	7.5	4.3	4.4	7.0	4.6	8.4	7.2	6.3	4.2	17.4	13.8	7.6	8.3	8.3	7.9	3.8	6.9	4.4	7.0	10.6	6.1	2.3	4.3	6.0	8.9	3.5	5.0	7.4	8.8	3.9	5.1	7.4	5.8	43.4	5.6	12.2	7.2	3.8	3.6	4.5	11.7	7.2	4.3	10.8	4.9	6.6	17.3	4.1	5.1	10.0	5.6	2.9	14.8	3.9	6.9	5.1	4.9	13.9	9.3	20.6	16.5	13.2	6.7	11.1	4.4	0.6	2.4	12.8	3.6	3.5	2.3	6.6	3.0	4.4	1.4	7.8	2.2	3.0	2.7	1.5	4.1	14.7	3.6	1.2	19.3	24.0	30.0	24.6	18.1	18.8	14.6	19.4	18.3	15.8	6.0	12.8	22.8	4.6	0.0	17.7	0.0	2.5	1.4	7.9	12.2	17.7	1.5	1.7	5.8	13.1	4.7	3.8	23.3	5.5	3.0	2.7	6.2	2.3	3.9	7.7	20.6	0.0	11.1	12.6	11.4	4.6	8.5	0.0	105.6	3.6	15.3	6.3	0.0	6.0	2.2	13.7	6.5	0.0	21.4	15.6	0.0	5.4	6.9	3.1	10.0
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550558-179610026	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"		NA	NA		9600	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	20.9	27.9	19.7	24.7	22.4	21.1	36.9	22.4	18.9	18.2	20.2	16.9	27.9	16.9	22.5	16.9	25.9	18.8	20.7	14.8	19.7	14.8	23.9	17.5	20.8	23.1	18.8	17.1	19.4	19.8	22.6	21.5	17.3	19.7	20.9	15.5	16.4	21.2	18.3	26.7	24.2	18.8	17.5	14.7	27.9	18.6	12.2	20.5	20.1	27.3	14.1	20.1	20.7	34.3	3.2	3.4	7.9	4.5	1.2	2.9	21.5	7.2	12.0	6.4	8.4	12.4	10.3	7.3	12.9	9.2	7.7	9.0	11.6	17.0	11.8	7.4	15.7	8.9	6.7	11.7	16.9	9.1	37.3	8.8	20.6	9.2	8.3	12.7	11.4	11.3	10.3	9.3	5.1	14.9	13.5	8.3	6.7	8.3	11.3	6.9	22.0	12.1	7.9	6.8	7.9	5.6	10.9	4.6	10.9	12.8	11.9	6.4	9.2	18.9	12.3	6.7	8.5	9.8	14.0	10.0	10.2	3.4	5.4	10.1	7.0	10.8	21.2	9.3	20.7	9.3	7.4	3.4	7.9	1.7	3.6	1.0	2.7	2.0	1.7	3.0	3.2	1.4	1.8	5.9	1.2	4.5	3.4	2.9	21.5	19.7	22.4	22.4	18.9	19.7	14.8	18.8	17.1	19.7	20.5	32.8	25.0	14.2	10.0	9.2	9.7	19.3	20.4	38.8	31.8	14.0	19.6	18.9	8.3	18.0	5.6	17.8	13.0	0.0	12.5	12.9	13.5	12.4	28.9	12.4	28.1	11.1	10.4	8.0	29.4	3.2	21.3	26.8	10.1	38.7	17.2	13.6	18.3	18.1	25.5	25.0	11.0	6.5	16.5	10.9	7.4	9.9	17.7	13.8	13.4	8.1
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236888-101241518	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.9"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 89.9;Ito cells: 114.2;Muller glia cells: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 19.4;HUVEC TERT2: 54.9;TIME: 30.5;U-251 MG: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	72.3	8.4	24.7	16.6	26.2	9.7	46.3	21.6	21.8	13.3	10.5	9.5	2.5	5.7	12.1	5.0	14.7	11.5	17.6	43.5	22.9	15.4	8.9	20.5	35.7	24.5	23.2	14.0	7.9	11.0	13.4	4.7	29.6	21.2	8.9	7.0	9.3	7.5	5.6	21.7	8.2	9.8	19.0	11.0	35.2	8.0	5.8	13.9	4.4	17.0	8.7	15.7	15.2	18.5	27.4	0.2	88.9	0.2	33.4	49.8	30.8	3.6	0.0	3.9	0.0	0.4	9.3	0.0	19.4	3.5	11.8	4.2	0.0	0.1	0.0	4.8	6.7	0.0	0.0	0.5	0.2	7.9	1.3	0.4	1.3	0.1	0.0	1.8	0.0	0.8	12.5	0.0	0.0	0.9	0.5	54.9	1.1	0.0	4.0	3.7	0.0	4.6	0.0	1.0	0.1	1.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	30.5	2.0	0.7	0.4	37.6	0.3	0.0	0.2	0.2	0.0	0.1	88.9	0.1	4.9	49.8	0.1	40.2	25.1	45.3	44.1	0.2	27.4	35.7	36.2	1.4	33.4	0.2	0.2	26.8	30.8	24.7	26.2	21.6	16.8	22.9	15.4	23.2	14.0	21.2	13.9	0.0	12.8	17.1	0.1	6.8	0.0	16.9	2.5	0.0	2.3	0.0	0.0	5.5	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.3	8.4	0.5	7.0	6.0	7.6	0.0	0.0	114.2	6.9	0.0	0.9	1.5	5.0	14.4	0.0	38.0	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.4	0.7	4.4	2.2	9.2	0.0	0.4
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508927-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 66.1;Hepatocytes: 23.7;Undifferentiated cells: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.7;Hep G2: 33.3;K-562: 22.4;RH-30: 15.7;WM-115: 11.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067811	Uncertain		Supported	Vesicles		No	No			Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	1.6	2.2	1.6	3.4	5.7	0.2	4.9	1.4	4.7	3.9	7.1	0.7	1.9	3.6	10.9	2.2	15.9	1.7	6.6	2.4	2.7	3.4	26.5	12.8	8.0	0.5	1.9	2.2	1.4	2.4	17.3	13.9	14.6	14.1	3.0	10.1	9.8	4.9	3.3	0.8	3.6	5.4	4.0	1.3	1.7	5.5	10.9	2.6	0.0	3.0	6.3	6.5	2.6	3.9	0.7	0.5	1.8	0.4	0.6	0.5	0.1	5.7	0.7	0.8	1.1	0.0	0.0	0.0	1.9	0.7	0.1	0.1	8.7	0.0	0.3	1.9	0.0	0.3	0.0	0.1	1.3	0.2	0.0	1.0	0.4	0.8	33.3	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.0	3.7	0.0	22.4	0.3	2.6	0.0	0.0	0.0	0.1	4.4	1.5	0.0	15.7	3.3	0.0	1.2	0.3	0.0	0.5	0.1	1.5	0.1	0.0	0.0	2.6	0.2	0.8	0.2	0.7	0.0	0.5	0.0	0.0	0.0	11.0	1.8	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.7	0.5	0.4	1.1	0.6	0.4	0.5	0.2	0.1	1.6	5.7	1.4	4.7	2.7	3.4	1.9	2.2	14.1	2.6	3.0	5.1	0.5	4.1	1.5	66.1	2.4	0.0	0.0	0.0	17.4	2.0	0.1	8.3	1.5	0.3	2.8	4.4	0.0	0.2	0.2	6.6	1.3	0.0	23.7	0.7	0.0	16.3	4.9	1.0	0.5	0.3	0.6	0.0	0.0	9.3	12.1	0.3	0.0	3.2	15.9	2.4	0.0	0.9	0.5	0.1	1.4	0.2	0.0	22.8	3.5
SAYSD1	"C6orf64, FLJ11101"	ENSG00000112167	"SAYSVFN motif domain containing 1"	Q9NPB0	6	39104064-39115189	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 52.7"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 85.1;Spermatocytes: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007959		Approved	Supported	Vesicles		NA	NA			Vesicles		"HPA007959: AB_1078359"	"unprognostic (2.65e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-3)"	8.2	7.2	7.2	5.7	8.7	5.9	11.2	7.1	9.0	7.9	7.3	8.1	6.9	8.8	7.9	10.5	6.5	8.1	9.3	6.7	7.3	6.9	8.1	8.3	6.3	8.2	9.3	6.5	8.4	9.5	4.9	6.1	6.1	7.0	8.5	7.2	6.4	11.1	8.0	5.6	6.6	8.6	6.3	7.0	6.8	6.9	52.7	7.3	18.2	8.4	5.1	9.0	6.2	7.7	14.8	9.3	19.4	12.2	11.7	19.1	9.5	11.4	7.4	6.7	7.9	11.1	14.7	6.9	5.3	5.8	6.4	6.8	10.6	8.1	10.4	7.6	6.9	9.1	7.9	5.8	5.0	6.8	6.5	10.5	6.8	4.5	9.2	9.0	7.7	10.3	10.1	12.4	2.5	6.4	4.5	5.9	15.8	11.5	6.4	7.1	15.7	12.2	12.8	5.8	7.5	3.8	1.7	8.1	4.1	13.4	8.1	18.8	7.6	9.2	8.0	8.1	5.6	13.1	10.2	7.6	8.5	6.2	2.6	6.8	0.1	3.2	12.8	4.9	11.2	6.2	7.6	9.0	19.4	12.2	12.2	14.2	13.1	13.3	11.0	9.3	14.8	19.1	15.8	4.3	11.7	11.9	7.4	17.3	9.5	7.2	8.7	7.1	9.0	7.3	6.9	9.3	6.5	7.0	7.3	3.0	5.9	9.3	11.4	13.7	5.5	17.5	17.8	12.0	5.7	17.4	7.9	28.7	14.9	19.4	85.1	11.3	11.8	0.0	18.9	26.3	17.4	17.9	8.1	18.7	23.2	6.4	8.1	3.1	15.6	40.0	19.0	12.2	11.8	9.0	15.0	13.7	14.7	7.0	18.0	23.0	3.6	6.5	10.3	202.1	11.9	14.4	10.3	10.2	18.4	11.5
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		110000	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	28.8	27.9	15.7	32.2	21.9	22.6	38.7	7.6	16.5	20.9	37.8	27.6	24.6	37.7	22.5	27.9	54.7	24.7	27.0	18.8	14.8	10.1	34.2	37.8	28.8	42.1	24.2	11.6	20.5	32.1	42.7	17.6	47.8	17.4	20.3	37.1	17.5	56.4	31.9	18.5	36.1	47.5	17.1	20.1	39.4	33.2	29.2	20.1	25.8	29.2	28.3	38.4	21.4	25.8	37.8	59.5	46.9	51.3	36.6	47.0	47.4	12.8	16.8	7.2	11.2	22.1	11.5	21.7	13.2	16.8	14.1	15.2	24.1	30.4	10.6	17.5	19.9	20.4	46.8	21.5	16.5	5.9	41.8	21.1	26.8	9.8	16.5	16.7	13.7	51.7	14.8	29.4	13.3	9.7	11.2	13.7	12.4	8.8	20.1	9.8	19.6	6.9	15.8	7.2	32.2	10.9	12.2	6.7	36.4	16.3	18.5	7.5	7.5	10.8	19.2	12.1	11.1	26.4	22.1	12.7	12.2	7.3	13.1	15.3	13.9	20.4	10.8	11.4	32.5	8.9	46.9	51.3	39.4	46.6	48.3	37.6	37.8	42.7	46.9	37.8	32.5	35.6	38.2	34.6	36.6	50.3	59.5	47.0	47.4	15.7	21.9	7.6	16.5	14.8	10.1	24.2	11.6	17.4	20.1	68.5	27.7	38.8	31.5	15.5	6.0	13.3	12.7	37.5	34.2	38.4	2.0	132.9	13.3	51.4	106.8	33.7	86.4	0.0	81.6	53.9	35.5	43.7	77.3	25.6	142.9	6.4	35.8	25.2	59.2	43.9	29.7	61.4	30.4	45.9	66.5	37.9	72.2	69.1	21.5	40.9	7.7	25.8	22.5	46.6	23.8	19.4	114.1	37.3	57.4	47.7
SCAMP3	C1orf3	ENSG00000116521	"Secretory carrier membrane protein 3"	O14828	1	155255979-155262430	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071167			Supported	Vesicles		NA	NA			Vesicles		"HPA071167: AB_2686352"	"unprognostic (4.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.18e-2)"	23.6	41.8	21.0	20.8	25.6	16.8	28.8	22.5	35.5	21.9	19.0	36.1	26.8	24.1	20.7	17.8	27.1	21.9	21.5	37.8	19.8	20.2	33.3	40.8	23.4	25.5	27.1	26.3	22.6	41.5	41.5	20.0	37.0	26.2	23.0	17.3	26.0	33.0	28.1	45.3	30.0	20.9	18.9	30.4	27.0	24.4	14.5	26.4	21.6	27.3	23.6	27.3	23.9	20.8	32.2	32.5	25.6	35.0	29.9	28.7	30.0	13.9	30.0	9.1	18.1	22.2	17.4	9.3	16.8	19.9	19.0	17.9	16.4	19.9	12.9	25.1	19.5	18.6	21.8	13.1	12.7	7.0	17.7	24.0	9.1	19.6	13.3	22.2	17.1	15.5	15.3	16.3	23.8	10.9	12.6	15.8	13.3	16.2	31.4	20.5	27.9	15.8	15.9	17.5	24.0	32.9	13.6	7.4	39.8	11.3	12.5	11.8	23.8	11.7	27.4	19.4	9.0	29.6	26.8	12.9	21.4	12.1	22.0	24.8	41.8	38.8	16.1	21.0	18.4	24.6	25.6	29.0	23.2	28.7	31.1	25.6	32.2	26.6	26.8	31.6	30.5	24.6	26.3	2.6	29.9	35.0	32.5	26.6	30.0	21.0	25.6	22.5	35.5	19.8	20.2	27.1	26.3	26.2	26.4	14.9	36.2	29.6	20.5	34.0	17.4	31.9	28.1	20.1	28.4	31.4	3.9	72.8	8.3	46.2	1.4	29.2	26.9	0.0	60.3	45.7	27.2	20.1	24.3	33.4	50.8	17.5	28.9	28.8	21.0	4.3	15.8	24.5	23.6	54.1	21.9	20.0	40.9	24.3	17.7	21.2	10.5	12.9	21.7	10.7	3.4	35.0	59.6	32.4	24.2	19.7
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681353-51721031	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 118.3"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 115.1;Cone photoreceptor cells: 96.2;Horizontal cells: 139.8;Intestinal endocrine cells: 142.5;Rod photoreceptor cells: 63.1"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"NTERA-2: 20.4;SCLC-21H: 48.9;SH-SY5Y: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"	NA	NA		4800000	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239"	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	1.7	12.9	29.6	2.1	25.4	1.7	1.7	33.4	118.3	1.5	2.4	6.5	0.0	2.9	1.5	1.6	1.6	1.6	1.6	1.5	22.6	23.5	1.5	1.5	1.8	1.7	13.6	37.7	1.5	11.5	1.4	23.7	1.5	27.1	1.6	2.8	1.3	1.5	1.4	1.5	1.8	2.6	1.7	13.2	1.5	8.7	2.9	7.3	0.0	2.1	0.0	1.5	1.6	0.1	0.9	1.2	1.9	0.5	0.3	0.8	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	20.4	0.0	0.0	0.1	0.0	0.1	0.0	0.2	48.9	23.1	0.1	0.1	0.0	6.6	0.0	1.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.1	4.3	0.4	0.4	0.6	0.8	0.2	0.5	0.9	0.6	0.4	0.4	0.7	0.5	0.6	1.9	0.3	0.5	1.2	0.2	0.2	29.6	25.4	33.4	40.6	22.6	23.5	13.6	37.7	27.1	7.3	0.0	0.0	0.0	0.0	0.2	115.1	0.2	0.0	0.0	0.0	0.0	96.2	0.0	1.7	0.4	13.3	0.6	0.0	0.0	0.9	0.0	0.2	0.5	0.0	0.0	0.4	139.8	142.5	1.8	0.0	9.2	0.0	0.0	1.7	11.8	0.2	11.7	8.7	0.0	0.4	0.0	63.1	0.0	0.1	15.8	4.9	0.0	0.0	0.0	0.2	0.0
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321178	"Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	25.2	30.7	19.0	24.2	24.7	20.6	25.5	16.2	24.9	37.9	47.0	22.6	38.1	47.7	29.6	30.8	30.1	24.7	41.6	30.6	19.5	20.7	33.2	58.3	27.0	19.9	24.7	17.5	24.7	66.8	22.3	48.1	44.1	20.2	23.2	27.9	22.3	63.5	33.4	42.6	25.5	57.1	32.0	21.9	25.9	27.2	26.4	20.5	29.0	38.2	32.8	28.6	25.8	24.2	26.9	60.8	29.1	44.6	23.2	27.7	41.2	21.2	32.3	26.0	10.0	42.3	47.0	86.4	43.6	53.3	51.0	58.9	26.7	17.5	19.5	20.0	69.0	28.7	8.7	33.4	38.8	26.2	16.9	34.7	23.8	26.2	64.4	58.1	27.1	21.1	41.6	31.4	53.3	33.2	37.6	60.4	26.2	25.4	28.9	39.3	43.9	26.4	29.8	29.5	27.7	39.2	25.7	18.6	34.6	31.0	16.0	14.6	18.2	19.1	17.8	17.0	22.8	22.9	26.4	45.1	21.0	24.0	31.3	37.3	24.0	33.3	45.1	39.7	38.1	34.6	28.0	44.6	28.1	24.5	38.4	27.2	26.9	24.6	23.7	60.8	22.2	20.3	21.2	29.1	23.2	29.5	54.2	27.7	41.2	19.0	24.7	16.2	24.9	19.5	20.7	24.7	17.5	20.2	20.5	44.7	52.3	27.4	45.1	34.9	14.7	37.0	17.8	72.3	47.8	26.2	9.8	98.1	56.3	69.8	20.2	33.5	63.9	0.0	95.6	135.9	66.7	49.4	41.6	54.2	93.9	11.1	39.7	36.8	34.0	6.8	49.5	49.1	25.3	67.7	75.6	30.7	74.0	53.4	49.5	72.3	20.1	12.9	43.2	42.4	36.5	35.1	141.0	40.1	67.8	50.4
SEC23B	"CDA-II, CDAII, CDAN2, HEMPAS"	ENSG00000101310	"Sec23 homolog B, coat complex II component"	Q15437	20	18507482-18561415	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008216, HPA069974"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA008216: AB_1079895, HPA069974: AB_2686223"	"unprognostic (4.47e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.21e-2)"	11.8	32.9	16.5	16.5	19.0	17.2	21.3	13.5	20.0	21.8	16.9	28.8	40.9	12.8	11.2	29.2	24.0	17.4	14.3	8.2	16.2	14.8	27.1	32.8	17.4	15.3	22.3	12.3	13.2	43.1	32.8	31.8	13.1	18.0	19.4	18.9	15.6	69.5	46.3	4.4	14.9	14.9	10.8	22.0	19.7	20.5	23.4	18.3	19.2	34.3	12.7	20.8	12.8	12.5	27.5	44.1	50.8	38.4	32.9	34.1	36.6	24.7	28.0	15.9	14.7	10.7	12.0	35.6	21.0	14.4	26.4	22.8	24.3	22.9	11.5	13.9	16.1	34.2	26.7	27.8	38.6	28.6	13.8	12.6	18.7	11.1	36.3	21.8	26.1	23.9	9.1	23.0	38.3	49.1	14.9	16.2	10.3	21.7	25.4	18.0	25.6	17.9	13.8	14.7	35.8	30.2	18.6	24.1	36.0	24.4	25.1	25.1	17.9	24.7	56.7	23.1	21.1	24.9	27.7	13.3	16.6	9.0	18.5	25.7	32.2	44.3	17.7	14.1	14.1	23.1	50.8	38.4	42.1	24.7	38.4	34.1	27.5	25.3	26.4	44.1	22.2	23.0	24.1	19.6	32.9	35.9	33.4	29.1	36.6	16.5	19.0	13.5	20.0	16.2	14.8	22.3	12.3	18.0	18.3	14.9	38.7	20.8	17.5	10.2	20.2	2.8	15.3	40.2	29.6	29.6	15.7	28.9	49.7	32.6	60.6	9.5	18.6	23.3	29.3	25.0	12.1	30.3	16.1	21.9	37.1	12.7	18.9	15.4	37.0	4.5	13.3	26.2	21.9	27.1	28.0	23.0	29.5	23.0	9.9	40.7	18.8	19.4	8.2	34.1	18.3	12.4	55.0	16.0	18.8	24.3
SEC24C	KIAA0079	ENSG00000176986	"SEC24 homolog C, COPII coat complex component"	P53992	10	73744384-73772161	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040196, HPA040213"	Supported		Supported	Vesicles		NA	NA			Vesicles		"HPA040196: AB_10796449, HPA040213: AB_10796451"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (8.46e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.06e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.71e-2)"	"unprognostic (8.34e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.77e-2)"	20.6	34.2	17.8	24.8	24.7	10.8	21.2	30.2	33.5	28.7	23.4	29.4	22.6	22.3	29.1	30.7	49.6	25.5	25.8	23.5	18.3	16.2	25.1	44.9	23.1	23.3	25.8	18.9	28.3	27.6	46.6	35.3	39.1	21.7	29.2	23.6	27.1	35.9	39.7	33.6	25.2	25.1	27.2	18.2	28.9	25.7	29.8	23.6	30.1	31.2	28.4	38.3	24.4	28.3	9.3	12.5	15.4	15.0	14.9	26.3	13.4	21.1	21.4	16.9	30.3	18.5	15.2	13.9	16.0	27.3	21.6	20.3	19.7	14.4	16.8	13.3	21.3	14.8	18.4	23.6	21.2	18.7	22.3	16.8	15.6	15.6	20.8	14.7	23.4	21.9	12.9	23.5	18.9	23.6	27.4	22.2	13.4	18.4	24.6	21.1	18.9	17.4	16.1	10.6	20.1	78.5	19.0	13.7	13.7	14.3	12.1	6.1	15.8	12.5	43.9	17.5	16.6	32.3	20.8	21.6	9.1	16.6	17.6	18.4	25.1	24.3	25.0	26.0	23.9	10.5	15.4	10.5	9.0	20.4	15.0	26.3	9.3	12.2	15.8	12.5	7.3	9.0	11.8	8.0	14.9	12.4	10.4	7.5	13.4	17.8	24.7	30.2	33.5	18.3	16.2	25.8	18.9	21.7	23.6	32.8	25.8	9.0	4.6	7.7	13.4	1.7	20.4	2.7	18.2	14.0	15.7	15.2	3.3	12.5	6.1	7.1	20.6	0.0	16.5	13.6	7.8	9.4	21.9	16.3	15.1	14.3	18.4	16.0	10.0	4.8	10.9	11.6	5.0	8.2	16.3	10.4	20.0	14.1	11.0	7.7	14.2	6.5	8.2	9.8	7.8	9.9	21.1	16.6	14.5	6.7
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	25.1	11.4	33.1	23.3	59.0	73.6	24.1	46.9	52.7	26.5	32.8	19.8	32.4	32.7	20.7	93.6	15.3	12.1	32.6	31.0	36.6	33.3	13.0	19.9	19.7	51.7	58.7	21.3	25.4	70.4	39.5	40.3	46.4	45.7	42.8	14.8	30.3	32.5	47.0	22.0	28.0	17.2	22.6	26.9	10.5	20.9	17.9	24.2	42.6	14.5	21.4	23.8	18.7	32.5	30.3	35.2	25.3	24.1	43.7	34.8	18.1	30.5	29.4	24.4	10.4	44.9	34.8	25.7	39.9	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3	98.3	74.0	44.9	45.0	53.8	48.4	69.9	50.9	80.3	120.6	45.4	51.1	47.9	23.2	54.7	22.3	50.3	62.5	23.3	61.8	70.7	94.4	74.7	70.7	86.8	41.3	39.7	36.8	58.3	42.7	13.0	128.9	48.4	49.0	43.3	90.1	43.6	63.6	38.6	118.5	55.5	61.5	51.8	81.2	28.3	33.4	64.7	68.2	34.8	46.5	74.0
SEC31B	"DKFZP434M183, SEC31B-1, SEC31L2"	ENSG00000075826	"SEC31 homolog B, COPII coat complex component"	Q9NQW1	10	100486642-100519864	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 34.2;Collecting duct cells: 10.4;Cone photoreceptor cells: 37.3;Horizontal cells: 38.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 12.4;JURKAT: 12.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035882, HPA040819, HPA060052"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles, Cytosol"		"HPA035882: AB_10795246, HPA040819: AB_10794151, HPA060052: "	"unprognostic (1.23e-1)"	"unprognostic (3.13e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.10e-4)"	"unprognostic (8.23e-3)"	"prognostic unfavorable (6.41e-7)"	"unprognostic (2.31e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.01e-4)"	2.8	2.4	3.3	3.2	5.0	6.4	2.6	12.1	11.8	2.7	2.8	5.4	4.3	1.9	3.0	3.5	1.4	2.9	2.6	5.6	3.1	3.6	2.7	3.4	2.4	4.3	3.3	5.6	3.9	0.8	3.9	5.0	2.4	6.3	2.9	2.7	6.1	2.8	2.5	13.6	2.4	2.9	3.2	3.4	4.9	1.9	16.2	3.4	0.0	2.6	5.2	3.6	2.3	1.9	0.9	0.0	0.1	0.2	0.0	2.1	0.1	0.2	0.2	2.8	0.9	0.9	1.6	0.3	0.5	1.3	0.2	0.9	0.3	0.4	0.6	0.8	0.0	0.1	0.3	1.5	0.4	0.8	3.5	0.8	1.4	1.8	0.3	1.2	1.0	1.2	2.4	1.4	0.2	1.7	12.4	0.5	12.5	0.3	1.7	0.0	0.0	1.8	3.1	0.0	0.2	0.6	2.7	0.1	1.1	0.9	0.0	0.2	0.9	0.3	0.0	0.6	2.1	0.7	0.3	0.0	0.4	0.4	0.3	0.2	1.3	0.6	0.8	0.1	3.4	0.4	0.0	0.1	0.0	0.5	0.2	2.1	0.0	0.0	0.4	0.0	0.9	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	3.3	5.0	12.1	11.8	3.1	3.6	3.3	5.6	6.3	3.4	6.0	5.0	0.0	0.8	1.0	34.2	6.5	5.1	2.7	2.3	10.4	37.3	1.0	0.0	0.4	0.9	2.1	2.1	0.0	0.2	0.3	1.9	1.8	1.1	6.4	1.9	38.1	5.2	3.1	4.3	0.8	3.1	1.8	1.7	3.6	3.9	4.3	0.3	0.0	3.9	0.6	6.7	0.0	1.2	7.5	3.2	1.0	0.7	2.6	4.0	0.9
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell type enhanced"	"Detected in many"	18	"Basal keratinocytes: 856.4;Suprabasal keratinocytes: 1062.2;Urothelial cells: 663.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 147.0;HBEC3-KT: 48.5;hTCEpi: 102.0;hTERT-HME1: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"	NA	NA		660000	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavorable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavorable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.4	0.0	0.0	147.0	0.0	48.5	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	102.0	0.0	25.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	10.7	0.0	0.0	0.0	0.0	10.7	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	229.2	856.4	0.0	0.2	0.0	16.0	20.5	3.5	0.0	0.2	0.0	0.1	7.6	0.0	5.4	0.0	0.0	0.2	8.7	51.7	0.0	0.0	0.0	0.0	3.4	0.0	0.0	15.2	0.6	0.2	59.1	0.0	3.2	0.0	9.5	46.0	0.0	0.0	0.0	0.0	14.4	2.6	0.6	1062.2	0.1	0.0	7.0	663.3
SGK3	"SGK2, SGKL"	ENSG00000104205	"Serum/glucocorticoid regulated kinase family member 3"	Q96BR1	8	66667596-66862022	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006699, HPA027146"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA006699: , HPA027146: AB_1856745"	"prognostic favorable (5.52e-6)"	"prognostic favorable (8.28e-4)"	"unprognostic (8.52e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (9.51e-2)"	"unprognostic (8.86e-3)"	"prognostic favorable (9.65e-4)"	"unprognostic (1.94e-2)"	"unprognostic (8.95e-2)"	"unprognostic (4.55e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.29e-3)"	6.5	5.9	13.9	8.7	20.9	7.7	23.9	9.8	14.8	12.0	10.0	24.0	8.7	8.6	8.0	10.3	7.6	7.8	7.8	5.4	16.1	10.2	14.9	13.6	9.9	8.5	28.8	9.3	9.8	15.6	29.2	14.8	5.9	14.6	7.8	10.7	17.2	7.0	7.7	6.1	12.4	10.8	6.0	32.8	8.2	7.2	8.9	21.9	8.3	17.3	4.3	6.8	6.1	8.0	5.8	13.8	21.4	15.7	6.9	13.3	8.0	11.6	3.0	0.5	1.9	3.5	7.0	6.5	7.4	7.1	4.1	4.3	5.3	7.8	8.8	1.8	8.1	11.0	3.8	6.1	4.3	5.1	4.9	10.3	7.9	2.2	5.2	3.5	7.1	9.4	3.3	3.9	1.9	6.8	3.8	6.5	7.0	1.5	4.2	7.7	1.8	5.6	4.4	1.7	6.7	4.1	9.8	4.4	5.9	5.4	2.6	2.5	2.0	3.3	5.0	11.2	5.2	23.5	14.2	7.7	3.9	3.4	3.3	2.8	5.2	10.1	10.1	4.5	12.0	4.0	21.4	15.7	6.2	8.1	9.3	13.3	3.7	8.4	8.5	13.8	5.8	9.0	6.9	2.5	6.9	4.4	7.7	5.3	8.0	13.9	20.9	9.8	14.8	16.1	10.2	28.8	9.3	14.6	21.9	6.0	22.6	7.8	5.6	11.7	1.7	5.6	7.6	16.0	11.4	10.4	17.7	7.0	13.3	5.8	0.6	9.8	10.5	0.0	15.8	1.2	4.5	8.9	14.0	18.3	21.3	0.0	15.5	17.2	34.8	1.1	3.7	32.9	8.5	45.1	7.0	3.5	12.1	9.7	7.4	30.7	1.6	0.0	3.1	4.1	11.3	13.8	4.0	15.8	8.2	4.7
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"		No	No			Vesicles	"Intermediate filaments"	"HPA074783: AB_2732268"	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favorable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.1	5.6	16.1	6.0	7.6	7.2	20.5	9.9	15.2	7.1	6.1	8.9	0.0	1.0	21.2	4.1	4.9	4.5	8.0	16.9	0.0	2.6	4.3	14.0	3.2	13.7	1.5	0.1	4.5	4.4	13.0	10.4	19.4	9.4	1.6	0.0	0.0	14.1	3.0	1.5	1.4	2.8	9.5	5.3	2.2	1.8	0.3	7.0	5.8	4.2	5.1	5.1	8.0	2.0	2.5	2.6	0.6	8.4	7.2	5.6	12.0	7.2	0.5	0.0	0.0	8.2	1.5	8.6	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3	59.6	33.6	6.2	32.4	30.5	2.1	5.2	45.9	34.8	45.5	26.2	0.0	9.8	10.0	35.2	4.4	11.2	52.9	0.0	55.1	19.0	14.9	71.6	10.3	7.6	6.5	0.0	30.1	8.6	6.5	3.1	11.2	7.5	3.3	1.8	26.8	11.3	54.5	27.9	11.3	13.3	0.9	64.7	42.1	2.3	7.5	11.0	11.0	0.0	28.8	55.9
SLC15A3	"hPTR3, PHT2"	ENSG00000110446	"Solute carrier family 15 member 3"	Q8IY34	11	60937084-60952530	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Hofbauer cells: 82.1;monocytes: 92.8;Muller glia cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 36.4;BJ hTERT+ SV40 Large T+ RasG12V: 44.2;HHSteC: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047880, HPA057642"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA047880: AB_10959455, HPA057642: AB_2683487"	"unprognostic (5.61e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (8.79e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.78e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	27.2	7.5	7.7	23.5	8.3	36.8	9.3	2.0	7.0	11.0	16.3	10.6	8.1	9.0	10.3	7.4	12.0	8.6	15.4	11.1	8.2	5.4	8.9	9.1	30.1	24.2	12.2	5.9	16.1	6.6	1.9	5.0	26.6	9.8	10.2	6.7	13.2	5.8	5.5	4.0	4.2	14.0	9.7	12.6	40.0	9.8	5.0	8.3	8.6	5.6	6.5	19.3	11.4	9.3	5.0	10.8	15.0	12.5	0.1	1.4	2.2	3.4	0.1	1.3	0.0	7.7	5.5	13.4	0.8	13.5	36.4	44.2	0.0	1.7	5.6	0.1	5.9	9.3	1.1	0.0	0.4	1.3	5.6	0.0	0.1	0.1	0.2	21.4	0.2	0.5	3.9	0.1	9.8	0.0	0.1	2.1	0.0	0.0	1.1	2.3	0.2	0.0	0.8	6.4	0.0	0.2	2.4	0.1	1.7	0.0	0.8	0.0	0.0	1.7	6.8	0.6	0.3	2.8	4.3	0.0	0.2	1.1	0.8	0.1	0.0	0.0	3.5	2.3	0.1	9.7	0.0	9.5	0.9	0.1	12.5	0.1	5.0	0.0	0.0	6.0	2.4	1.3	1.4	15.0	0.1	6.4	10.8	0.0	2.2	7.7	8.3	2.0	7.0	8.2	5.4	12.2	5.9	9.8	8.3	8.9	19.9	9.3	0.2	1.4	1.3	1.7	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.3	5.5	10.1	0.0	0.0	1.9	10.4	4.1	0.2	15.0	2.4	82.1	4.8	0.0	16.0	47.0	2.9	7.5	37.0	1.7	92.8	0.9	202.1	1.2	0.9	4.6	0.0	4.2	12.9	3.5	0.5	0.7	1.3	2.2	0.0	0.9	0.3
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell type enriched"	"Detected in some"	22	"granulocytes: 603.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 91.2"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.2	91.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3	8.9	27.6	0.0	0.0	1.6	0.6	0.2	0.0	1.4	4.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.4	603.6	0.0	0.7	0.0	8.5	11.6	1.8	0.0	0.6	0.6	1.7	0.0	0.0	0.3	0.1	0.0	4.6	0.0	0.7	0.0	0.2	0.2	0.1	2.4	0.0	0.0	0.0	0.0
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	9.9	30.9	10.2	10.2	19.3	16.3	8.4	9.1	18.0	11.6	8.2	12.6	14.1	8.7	11.6	14.6	6.9	9.2	10.0	5.1	9.4	30.5	12.4	6.9	12.8	14.3	10.5	17.4	18.3	7.9	14.9	25.6	21.1	17.2	11.8	5.1	15.6	12.2	14.8	6.5	13.1	11.9	11.6	9.3	17.3	7.3	4.8	7.3	1.8	18.1	4.9	6.7	9.8	14.1	0.4	1.3	0.1	2.3	0.1	4.9	1.9	0.5	8.2	9.7	7.5	4.9	3.6	11.2	4.7	5.9	10.6	6.6	9.4	1.7	0.1	9.6	4.9	7.7	3.1	5.4	3.5	4.2	11.2	9.7	0.0	10.4	8.7	12.9	0.0	1.5	6.6	5.7	5.1	2.3	1.0	8.9	1.9	4.0	11.9	6.2	7.7	0.4	0.2	4.3	2.3	8.0	0.4	1.0	4.3	9.6	9.0	3.8	11.9	4.7	11.8	12.2	15.8	14.1	0.2	6.6	8.6	5.0	7.3	0.5	13.5	5.1	1.3	4.4	0.0	6.8	0.0	2.3	0.0	1.8	0.9	2.6	0.4	3.2	2.6	1.3	0.2	4.9	2.0	0.1	0.1	0.3	0.0	4.0	1.9	10.2	19.3	9.1	18.0	9.4	30.5	10.5	17.4	17.2	7.3	6.0	12.0	0.9	9.3	4.0	28.0	2.0	0.0	2.7	5.7	12.2	55.0	12.2	1.7	6.3	0.4	14.1	3.9	0.0	5.3	7.0	8.2	9.4	1.1	2.0	14.0	3.2	9.8	6.2	5.9	0.2	15.8	8.3	3.3	2.8	2.5	21.0	3.9	3.5	11.7	4.8	37.6	32.3	4.7	0.2	1.5	4.1	21.7	5.7	2.8	5.2
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709487-46736347	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 51.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041015	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041015: AB_2677252"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	4.7	4.6	2.6	4.3	3.3	0.1	8.7	2.1	3.1	11.4	6.7	2.7	6.7	2.6	5.4	6.6	4.8	5.6	10.2	6.7	3.3	1.4	2.6	51.5	4.8	3.4	2.2	2.0	7.1	22.9	15.0	4.2	8.3	3.8	18.0	8.8	9.8	11.5	11.0	2.1	2.4	3.0	9.7	2.3	1.9	12.4	3.4	1.0	0.8	18.1	4.5	4.6	7.1	5.7	0.0	0.0	13.8	0.0	0.3	0.0	0.0	0.0	0.0	4.7	4.8	19.5	16.7	14.3	9.1	12.4	4.2	5.1	0.3	16.0	0.0	6.9	16.5	0.0	0.1	0.0	0.4	2.0	0.0	0.1	1.3	0.0	7.6	13.8	0.0	0.0	24.2	0.4	2.6	0.0	4.9	1.7	0.0	0.1	0.0	7.2	16.6	0.0	0.4	1.7	20.0	1.2	0.0	0.7	0.0	0.0	4.3	0.0	0.7	1.8	3.0	24.8	3.5	2.3	3.7	1.0	9.1	4.0	7.2	1.1	0.1	0.0	0.0	0.0	0.0	1.9	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.6	3.3	2.1	3.1	3.3	1.4	2.2	2.0	3.8	1.0	6.0	4.6	0.0	6.8	0.6	0.0	2.2	10.2	33.5	11.4	1.8	0.0	1.9	0.0	5.2	0.1	4.1	2.2	0.0	4.9	12.8	11.7	28.1	5.8	41.2	0.9	0.0	3.5	9.2	2.8	0.9	24.5	0.3	1.7	0.0	60.1	5.6	5.1	2.9	16.3	0.7	0.5	12.9	3.9	0.4	0.2	0.9	1.7	0.0	6.6	10.2
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211578742	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 53.3"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	11.4	16.6	9.3	7.5	11.4	15.5	17.3	5.2	13.6	13.0	15.3	6.9	4.9	17.2	7.1	7.6	9.0	9.2	12.9	6.1	9.7	7.9	13.4	53.3	12.0	3.5	9.5	8.0	9.5	8.9	8.8	4.8	9.3	8.7	7.3	8.9	7.7	5.9	9.2	3.6	13.9	28.1	7.5	8.3	10.7	6.4	12.5	5.5	3.1	11.0	5.2	4.4	7.7	8.4	0.5	2.5	3.9	4.2	1.3	1.7	1.0	4.7	6.9	3.8	4.9	16.6	7.7	33.7	13.0	9.6	6.9	6.9	3.0	22.6	2.6	11.4	11.9	9.6	8.1	5.7	7.5	8.3	6.7	4.3	2.1	14.1	6.9	9.3	7.4	4.8	11.5	19.0	8.8	14.4	10.4	4.2	1.6	8.4	12.5	8.5	4.3	1.4	4.6	11.7	5.1	5.5	4.5	1.8	9.6	21.5	12.7	3.8	6.7	12.7	6.7	29.0	7.5	3.4	9.7	6.8	5.2	12.1	17.3	10.3	5.5	8.4	2.2	4.8	7.5	4.5	3.9	3.9	1.3	1.2	4.2	1.7	0.5	0.9	0.8	2.5	0.3	0.9	1.2	0.4	1.3	3.2	1.7	0.8	1.0	9.3	11.4	5.2	13.6	9.7	7.9	9.5	8.0	8.7	5.5	8.9	9.8	5.1	7.2	25.3	10.9	17.9	17.8	6.7	2.3	34.9	5.9	9.8	1.7	5.4	21.7	18.0	37.9	46.7	10.7	27.0	15.0	12.6	4.7	83.9	29.4	6.4	9.1	15.4	33.3	2.8	9.2	15.1	20.3	5.4	23.6	26.5	7.9	31.7	7.1	29.5	8.5	6.5	11.6	33.0	9.4	40.4	20.5	10.2	20.5	11.4
SLC38A9	FLJ90709	ENSG00000177058	"Solute carrier family 38 member 9"	Q8NBW4	5	55625845-55773194	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.2"	"Cell type enhanced"	"Detected in many"	20	"Cytotrophoblasts: 168.8;Early spermatids: 189.6;Syncytiotrophoblasts: 518.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043785, HPA061702"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA043785: AB_10961859, HPA061702: "	"unprognostic (4.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.49e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.87e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-1)"	7.2	6.3	8.2	6.9	8.0	5.2	6.8	9.9	9.7	6.4	7.5	9.2	6.7	6.6	7.5	5.9	9.0	5.8	7.1	3.9	6.2	6.4	6.7	13.5	6.4	8.4	9.4	6.4	6.9	18.2	10.1	11.8	44.2	8.6	5.9	8.5	6.7	7.6	5.3	5.2	6.2	7.1	7.2	8.8	8.9	7.7	15.8	8.5	13.3	7.1	5.7	11.4	8.7	6.9	10.8	10.8	7.4	11.8	8.9	10.0	6.4	8.1	8.3	6.9	9.3	9.6	9.9	49.9	6.8	9.6	8.3	13.7	13.3	11.2	13.3	11.6	5.6	13.6	10.1	9.3	8.0	10.9	7.1	8.7	4.2	8.9	8.9	15.4	7.5	5.1	12.0	9.7	9.2	10.8	6.0	9.3	8.7	9.1	8.9	7.7	6.9	9.4	7.2	12.8	3.1	7.5	7.2	11.6	13.4	11.2	6.5	3.8	6.1	7.0	4.3	11.6	10.1	9.4	15.3	12.6	1.7	5.6	12.2	7.1	9.6	19.6	8.0	4.3	7.7	4.7	4.8	11.8	7.4	7.8	10.2	10.0	10.8	6.3	9.0	10.8	6.2	9.2	7.7	2.9	8.9	7.5	10.8	8.1	6.4	8.2	8.0	9.9	9.7	6.2	6.4	9.4	6.4	8.6	8.5	6.0	1.9	9.5	3.9	2.9	5.4	2.0	15.3	4.0	7.9	8.7	7.9	168.8	1.7	7.8	189.6	6.8	4.0	0.0	9.9	52.8	5.4	4.1	2.3	18.4	23.0	1.6	4.1	9.8	10.6	73.4	6.9	8.2	5.0	8.2	5.0	5.1	9.5	7.0	4.6	5.7	7.9	6.5	4.5	14.0	4.3	3.0	518.4	8.7	5.2	4.2
SLC48A1	"FLJ20489, hHRG-1, HRG1"	ENSG00000211584	"Solute carrier family 48 member 1"	Q6P1K1	12	47753916-47782753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.7"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065396, HPA073994"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA065396: , HPA073994: "	"unprognostic (9.60e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.63e-3)"	"prognostic favorable (1.34e-6)"	"unprognostic (1.45e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-2)"	16.2	13.5	27.8	5.0	33.5	7.7	10.7	12.5	39.5	13.1	8.3	90.7	6.7	5.6	11.9	12.7	13.9	21.9	11.5	12.8	32.7	20.8	18.5	6.3	11.7	4.9	44.1	27.9	35.6	10.6	24.3	6.4	13.2	38.6	9.3	8.2	7.4	13.2	18.1	16.7	14.7	5.3	12.7	44.5	11.3	7.7	5.1	39.7	4.9	35.6	6.1	6.0	9.9	7.6	7.1	8.5	23.7	11.9	1.2	5.4	4.0	4.5	14.2	2.2	17.0	14.9	6.4	5.0	3.3	7.3	3.1	3.2	4.5	12.4	2.8	42.7	9.1	6.3	18.2	2.9	3.8	2.4	23.1	2.8	19.3	11.9	6.1	8.5	5.1	11.5	3.8	7.7	4.5	5.5	16.4	8.8	7.9	5.0	11.3	2.0	9.5	2.4	5.2	1.5	8.5	7.0	2.4	0.6	15.1	12.6	12.2	2.9	1.3	4.4	5.5	3.1	4.3	18.4	4.8	4.8	4.5	6.0	8.4	2.3	9.1	5.6	0.8	5.8	24.5	2.6	0.0	11.9	7.8	3.6	8.5	3.2	7.1	4.4	3.7	8.5	6.3	5.4	4.4	23.7	1.2	4.8	1.6	3.4	4.0	27.8	33.5	12.5	39.5	32.7	20.8	44.1	27.9	38.6	39.7	8.9	9.1	3.7	8.4	6.0	10.5	14.3	10.2	1.4	5.7	48.8	2.0	8.0	19.9	8.5	7.7	21.5	6.7	0.0	8.5	1.7	9.9	11.0	1.1	10.4	20.5	14.3	8.1	12.9	14.9	10.4	30.2	9.3	5.0	40.5	12.9	19.3	6.7	7.0	21.5	27.0	10.3	6.5	8.5	4.3	9.6	10.5	3.0	2.5	7.6	10.1
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7"	"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.7	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.7	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1	14.9	5.3	0.0	0.4	0.1	0.2	0.8	0.0	1.4	3.4	1.8	0.0	90.5	0.0	0.0	2.3	0.5	1.0	0.0	0.0	7.0	1.6	0.3	2.3	0.0	8.4	0.0	0.0	2.5	0.6	1.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.4	0.3	0.9	0.0	1.4	0.0	0.4	0.3	89.0	0.0	0.0	0.3
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 31.5;Horizontal cells: 27.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.3	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	1.8	0.0	0.1	1.3	0.8	0.2	0.1	0.0	0.2	7.2	0.0	0.0	0.2	1.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	7.2	2.1	0.0	0.1	0.0	0.3	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3	3.0	2.1	0.0	0.3	0.3	31.5	0.8	0.0	5.3	4.5	0.0	2.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.2	2.3	1.0	0.0	27.0	1.7	0.0	0.0	0.4	2.0	0.9	3.3	0.0	0.0	1.8	0.1	0.0	2.5	0.0	3.9	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	4.3	5.7	16.4	4.7	27.6	4.0	3.1	15.3	35.1	5.2	5.2	7.8	1.6	7.5	5.7	3.2	5.6	5.2	4.8	7.2	19.1	24.3	6.2	3.9	5.7	4.7	15.0	15.6	7.4	3.3	9.3	8.6	4.0	22.3	3.6	5.5	4.6	3.3	4.6	5.5	4.1	6.5	6.5	9.5	4.8	5.2	5.1	4.0	3.6	5.9	1.7	5.8	4.7	3.2	5.3	6.8	3.2	8.4	5.9	13.9	6.0	13.2	7.0	7.4	2.7	10.5	10.2	13.3	10.7	11.5	9.2	19.5	6.1	10.6	9.9	24.4	12.3	13.7	7.9	9.6	9.6	13.4	7.7	8.7	2.7	11.2	3.6	5.5	7.7	9.4	5.6	8.5	15.2	7.5	6.6	7.8	9.7	4.9	14.1	10.1	5.8	10.2	2.2	4.2	4.9	9.5	6.9	11.0	10.0	6.6	6.6	6.6	5.0	7.7	0.8	6.2	6.6	3.2	6.0	11.1	11.5	8.2	17.0	13.7	6.8	15.1	8.7	7.0	13.2	6.4	2.2	6.0	3.2	8.1	8.4	13.9	5.3	9.5	7.9	6.8	4.0	10.6	7.9	2.6	5.9	6.6	4.3	8.0	6.0	16.4	27.6	15.3	25.9	19.1	24.3	15.0	15.6	22.3	4.0	3.0	4.8	4.2	1.3	6.6	13.4	8.1	17.8	0.0	1.2	12.2	7.9	2.2	0.0	4.0	0.6	4.6	8.0	0.0	5.1	2.1	4.7	2.1	1.1	7.8	8.9	46.1	10.3	8.6	12.9	0.9	5.2	8.8	8.5	2.8	3.4	13.2	4.6	5.8	4.2	4.9	7.0	0.0	4.9	5.0	12.3	5.9	2.4	7.7	5.0	2.2
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599252-46759172	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 42.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	1.7	7.2	4.4	3.8	42.0	4.4	7.9	7.0	12.4	1.8	1.2	1.8	1.2	1.7	1.2	3.8	3.2	2.5	2.2	2.3	3.3	7.1	3.3	4.1	1.8	7.8	3.6	4.3	6.3	4.6	11.5	13.6	1.4	12.7	6.5	1.3	2.3	7.3	2.9	10.0	2.9	2.7	1.0	2.7	4.7	8.2	1.3	8.2	2.8	6.9	1.7	8.2	2.3	2.2	4.3	6.0	2.1	0.6	1.4	0.7	0.5	7.0	5.4	0.8	2.4	0.9	5.4	3.1	6.7	8.4	4.0	3.3	5.5	7.7	15.5	2.1	10.7	7.9	3.3	5.2	7.6	7.4	8.1	2.8	1.6	2.1	2.2	3.3	0.7	12.8	3.4	1.0	11.4	7.6	19.2	5.7	5.4	0.1	0.3	5.5	10.6	1.7	0.8	3.7	3.4	6.5	6.9	0.3	0.2	3.1	7.9	5.8	0.7	3.4	5.2	1.5	6.8	6.9	0.3	0.3	8.7	2.9	1.3	3.9	1.6	0.4	7.8	12.3	0.1	2.8	1.0	0.6	0.3	0.6	0.6	0.4	3.4	0.7	0.3	2.4	4.3	0.4	0.5	2.1	1.4	0.6	6.0	0.7	0.5	4.4	42.0	7.0	8.3	3.3	7.1	3.6	4.3	12.7	8.2	3.0	8.0	17.9	7.5	0.6	10.1	4.5	2.5	0.0	3.4	15.7	3.9	5.5	0.0	15.3	0.0	0.5	0.0	0.0	12.2	0.3	0.4	18.2	0.0	4.9	6.6	12.7	2.4	0.6	4.7	0.4	0.9	9.1	1.7	9.0	1.0	6.6	12.5	0.0	0.4	1.7	3.4	6.5	0.8	0.0	0.9	0.9	6.1	0.5	0.8	11.2
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 165.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	23.4	25.9	19.9	16.0	21.9	16.6	26.7	25.2	30.1	20.1	23.3	16.1	17.8	17.7	23.8	37.0	17.1	17.8	17.4	17.4	19.5	24.2	33.2	41.0	23.8	17.7	21.6	18.0	17.9	27.7	27.2	35.5	29.6	30.8	21.1	22.2	19.9	17.7	20.2	9.6	17.1	31.0	15.8	20.7	24.6	26.8	49.1	17.1	16.1	26.1	11.2	18.2	22.6	15.1	8.9	16.4	20.0	24.1	13.4	13.3	8.9	15.0	9.2	15.1	22.1	34.5	25.4	15.8	19.3	26.7	15.2	23.5	16.6	25.5	19.8	23.9	24.8	29.7	20.4	10.3	19.9	24.1	17.5	6.1	21.6	12.8	24.8	28.5	20.2	22.5	22.1	15.1	17.7	18.0	28.2	27.0	7.8	21.9	17.2	32.9	17.5	1.2	38.7	6.1	23.6	10.4	8.1	30.8	9.4	37.0	27.9	6.6	15.1	11.8	26.1	17.9	20.9	16.2	36.3	24.0	12.0	7.5	15.0	20.0	17.3	27.4	7.3	24.7	23.9	24.2	18.1	13.6	20.0	13.3	20.3	10.0	8.9	9.0	11.9	16.4	8.8	8.2	10.3	6.3	13.4	24.1	4.8	10.2	8.9	19.9	21.9	25.2	30.1	19.5	24.2	21.6	18.0	30.8	17.1	86.4	38.0	17.1	16.6	13.1	35.5	12.3	17.8	32.1	28.4	21.0	53.0	44.7	5.0	28.9	45.3	24.0	24.4	0.0	36.5	25.9	25.0	15.8	30.1	26.6	31.1	14.3	30.6	27.6	34.8	10.7	18.1	25.4	27.0	39.7	28.0	32.8	30.0	24.6	27.6	23.7	39.0	19.4	21.6	165.5	8.4	12.9	47.3	25.3	25.3	15.2
SNX15		ENSG00000110025	"Sorting nexin 15"	Q9NRS6	11	65027408-65040572	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"granulocytes: 8.1;Intestinal endocrine cells: 7.5;monocytes: 12.6;Undifferentiated cells: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038955	Approved		Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoli, Cytosol"	"Vesicles, Plasma membrane"	"HPA038955: AB_10672834"	"unprognostic (2.00e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.93e-1)"	"unprognostic (9.61e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.06e-3)"	"unprognostic (4.45e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.79e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.68e-4)"	17.9	13.6	17.1	12.7	18.3	11.6	23.5	25.7	21.9	13.2	22.7	16.7	9.5	19.7	14.2	8.9	15.9	11.4	13.9	15.1	16.2	14.3	15.7	9.8	14.1	14.7	16.3	14.5	18.3	17.7	13.7	8.4	9.5	13.4	15.1	11.6	11.2	15.6	15.4	25.2	17.2	20.4	15.0	17.6	11.3	13.5	7.6	15.8	12.4	14.4	10.1	11.5	14.9	12.5	7.7	8.0	10.9	18.3	3.2	7.1	5.7	17.4	12.9	8.4	8.2	10.2	7.5	4.7	1.7	7.9	13.8	12.7	10.2	13.7	17.8	9.9	10.0	17.4	9.8	9.8	8.7	3.8	26.8	8.1	8.9	10.6	17.0	11.0	4.6	14.4	6.3	13.1	14.6	8.5	7.7	8.2	13.1	15.0	11.4	7.2	10.5	16.3	20.7	9.1	6.8	12.8	13.5	5.0	19.2	10.2	3.8	15.2	11.5	14.9	13.5	12.9	4.0	13.7	10.7	16.1	14.0	13.5	14.1	7.4	12.3	21.1	17.0	13.7	7.3	4.8	7.8	11.3	10.9	6.9	13.6	5.6	7.7	7.1	6.1	8.0	6.1	5.2	4.7	1.6	3.2	18.3	5.5	6.7	5.7	17.1	18.3	25.7	21.9	16.2	14.3	16.3	14.5	13.4	15.8	0.0	3.5	0.0	0.0	0.9	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	4.7	0.0	0.4	4.2	0.0	2.7	0.4	0.4	0.0	8.1	0.0	0.9	0.0	7.5	0.0	0.0	0.0	0.0	0.1	0.0	12.6	3.1	0.2	3.5	5.1	0.4	0.5	0.4	0.0	0.3	0.0	0.0	0.4	0.3	1.0	6.0	0.0
SNX16		ENSG00000104497	"Sorting nexin 16"	P57768	8	81799581-81842866	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 68.5;Horizontal cells: 52.4;Late spermatids: 97.8;Spermatocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024730, HPA024731, HPA024817"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313"	"unprognostic (5.50e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.41e-3)"	"unprognostic (3.21e-3)"	"unprognostic (7.54e-3)"	"unprognostic (1.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.73e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.65e-1)"	11.7	5.9	6.6	5.8	10.0	9.5	16.2	13.1	14.8	13.7	9.8	3.0	4.2	6.9	10.7	8.1	18.8	7.2	11.9	8.3	7.3	9.6	14.8	7.6	12.1	6.2	11.2	11.4	10.8	4.9	7.9	12.1	5.7	10.2	13.2	7.3	3.8	8.8	8.6	6.6	11.7	11.8	11.7	11.4	17.1	9.4	15.6	8.7	15.3	18.7	7.5	6.5	10.0	15.9	4.5	5.0	11.6	6.1	3.2	6.5	2.6	8.3	2.8	4.3	4.1	14.5	9.3	5.1	10.6	13.4	9.3	13.9	2.1	6.8	1.4	6.1	7.4	11.3	7.3	3.8	4.7	15.1	10.9	2.1	4.4	3.6	4.2	11.2	1.8	7.9	7.1	8.0	4.2	8.5	10.9	7.6	5.3	2.7	16.5	22.9	4.9	9.3	3.4	1.6	8.5	4.2	3.9	6.1	1.5	9.4	4.2	6.9	5.6	2.0	2.8	5.5	7.7	7.4	3.7	4.3	13.0	9.6	9.3	4.8	10.1	7.5	3.5	5.6	5.7	10.4	11.6	6.1	7.1	2.9	3.8	2.7	2.3	3.7	2.4	5.0	4.5	4.3	3.8	8.3	3.2	3.1	4.0	6.5	2.6	6.6	10.0	13.1	14.8	7.3	9.6	11.2	11.4	10.2	8.7	6.0	6.5	2.7	10.9	22.3	4.0	7.0	5.1	12.0	11.4	5.2	3.9	1.6	5.0	5.2	68.5	9.0	4.2	0.0	5.4	3.2	6.7	11.0	8.1	2.9	5.2	52.4	2.9	12.9	8.5	97.8	21.6	8.4	3.3	1.0	5.0	4.5	5.8	5.7	15.2	5.6	5.0	19.4	10.3	55.1	10.9	28.0	8.2	5.3	4.6	18.2
SNX25	SBBI31	ENSG00000109762	"Sorting nexin 25"	Q9H3E2	4	185204237-185370185	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 113.6"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6"	"Group enriched"	"Detected in many"	4	"B-cells: 3.6;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036928			Supported	Vesicles		NA	NA			Vesicles		"HPA036928: AB_10669720"	"unprognostic (9.20e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.89e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.55e-3)"	3.0	3.7	2.6	2.9	5.3	0.1	4.6	11.9	4.2	2.7	5.6			1.1	3.3	2.8	3.1	4.7	3.9	4.4	3.3	5.6	5.6	4.1	15.1	4.9	4.6		3.4	4.6	7.2	5.7	5.6		7.9	3.0		2.8	4.3	4.8	2.5	3.5	3.1	2.1	4.2	2.6	5.9			8.5		6.0	3.8	2.2	3.6	0.2	0.0	0.2	0.6	1.5	0.2	5.8	3.1	3.9	5.6	10.6	7.9	5.9	18.0	8.6	9.1	7.6	2.6	4.1	16.8	2.0	12.8	6.3	2.3	4.5	3.9	10.3	27.8	7.5	2.8	3.8	6.1	6.2	1.9	4.1	5.4	4.3	7.9	4.4	18.4	7.9	3.1	5.9	16.9	12.0	1.7	0.7	3.3	3.2	0.8	3.0	2.4	4.5	4.2	22.1	2.2	8.5	6.2	3.7	1.0	14.7	5.9	2.1	2.4	15.2	5.2	3.4	5.0	7.8	15.3	6.2	3.6	8.6	1.4	6.5	0.0	0.0	0.0	0.6	0.2	1.0	2.5	1.3	1.5	0.0	3.6	0.4	0.9	0.0	0.6	0.0	0.2	0.8	0.2											23.8	113.6	3.7	3.4	4.2	14.7	6.0	0.0	6.7	10.3	5.2	29.5	3.4	0.0	5.2	5.6	8.9	4.5	0.0	2.2	4.0	3.3	8.0	1.1	7.3	1.6	6.4	0.0	9.2	3.5	3.4	8.9	2.2	20.3	1.0	4.7	5.8	3.5	0.0	9.2	2.1	15.9	0.0	5.1	3.7	17.6	5.4	4.7	5.0	2.4	3.8
SNX5		ENSG00000089006	"Sorting nexin 5"	Q9Y5X3	20	17941597-17968980	"Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 118.1"	"Low region specificity"	"Detected in all"							"CAB020679, HPA051187, HPA076450"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB020679: , HPA051187: AB_2681379, HPA076450: "	"unprognostic (6.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (2.30e-10)"	"unprognostic (1.67e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.99e-1)"	23.0	30.7	19.0	29.1	19.7	26.5	20.6	12.8	17.8	17.4	21.1	16.4	16.3	27.3	17.9	40.9	18.5	17.0	17.3	20.0	17.2	14.0	35.9	30.3	18.7	43.8	20.4	14.8	29.4	18.7	17.7	15.4	24.4	15.6	17.6	22.9	17.8	18.1	14.8	34.9	14.5	23.6	14.0	21.8	46.4	18.2	9.8	17.8	25.6	64.4	19.6	27.3	20.5	19.0	32.8	28.8	33.4	34.5	15.2	26.7	19.5	18.8	20.6	8.7	9.6	6.2	10.8	52.6	15.1	8.5	9.7	11.1	19.9	26.8	31.2	9.4	9.5	13.7	21.2	12.2	23.7	13.3	7.9	10.9	27.8	8.5	118.1	9.7	19.4	33.5	10.2	10.5	10.5	19.2	7.5	14.0	21.2	13.3	21.1	11.6	14.7	17.1	17.2	9.3	16.2	10.3	20.3	22.4	23.2	11.9	22.0	8.8	5.0	14.4	22.1	19.4	6.9	12.0	12.6	11.0	15.4	19.1	9.5	18.8	15.0	22.8	25.3	7.5	7.1	13.4	23.5	23.5	33.4	23.8	32.0	21.6	32.8	21.8	23.2	28.8	30.5	13.2	19.2	1.9	15.2	34.5	14.8	26.7	19.5	19.0	19.7	12.8	17.8	17.2	14.0	20.4	14.8	15.6	17.8	59.6	101.6	83.8	38.6	28.2	17.4	36.7	30.6	65.6	69.4	47.1	25.5	82.3	135.9	37.8	33.2	40.9	63.8	0.0	38.8	119.4	48.4	34.2	122.9	35.9	128.5	15.9	30.4	138.7	140.1	11.4	56.4	75.4	25.3	50.5	44.0	63.6	33.9	63.1	48.4	192.8	17.6	19.4	35.9	14.7	42.1	28.2	65.7	54.9	90.2	45.8
SNX8	Mvp1	ENSG00000106266	"Sorting nexin 8"	Q9Y5X2	7	2251770-2354318	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 87.3;Late spermatids: 250.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057296, HPA060194"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA057296: AB_2683401, HPA060194: AB_2684219"	"unprognostic (2.22e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.35e-1)"	14.3	7.3	11.7	13.9	12.8	10.1	15.6	11.1	14.2	6.8	8.4	11.4	4.8	11.7	7.3	9.9	11.3	7.7	11.0	14.0	12.0	9.6	8.2	9.1	10.7	24.1	12.7	9.6	9.1	10.8	4.7	7.9	15.4	10.9	4.7	7.8	12.9	8.5	3.9	9.9	9.9	9.6	6.5	17.0	33.1	7.7	20.5	12.5	4.9	9.5	6.9	18.9	9.5	8.5	18.2	13.1	4.5	10.2	1.2	2.0	4.8	15.9	15.6	6.4	8.9	9.0	8.8	15.2	7.8	11.6	13.2	16.4	11.0	12.5	9.3	3.2	9.2	42.0	4.3	5.5	4.2	6.7	2.3	5.2	5.2	6.3	9.0	22.9	5.0	8.6	17.5	5.0	16.1	6.3	3.6	4.9	7.4	10.2	11.0	10.7	10.4	1.7	5.3	11.6	8.9	7.8	8.2	13.3	4.2	3.1	7.5	3.1	8.2	7.1	19.6	11.1	7.4	14.6	10.9	7.4	11.1	29.7	18.2	10.1	7.2	8.8	8.6	11.0	6.8	30.0	4.5	9.4	3.0	1.8	10.2	1.4	15.5	1.4	1.9	13.1	18.2	1.4	1.6	1.6	1.2	9.6	3.4	2.0	4.8	11.7	12.8	11.1	14.2	12.0	9.6	12.7	9.6	10.9	12.5	6.0	10.3	18.0	6.1	4.6	10.0	9.2	10.2	1.4	0.0	3.5	7.9	14.2	11.6	12.1	87.3	8.4	9.1	0.0	26.0	13.0	10.4	5.5	11.6	6.4	65.1	20.6	5.8	61.4	32.7	250.8	11.2	46.6	13.5	65.9	9.6	6.1	20.3	8.6	12.4	11.5	11.6	0.0	2.8	10.4	27.9	5.4	36.3	5.3	8.0	8.2
SPG21	"ACP33, BM-019, GL010, MAST"	ENSG00000090487	"SPG21, maspardin"	Q9NZD8	15	64963021-64990310	"Disease related genes, Predicted intracellular proteins"			"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 47.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040407, HPA040436"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA040407: AB_2676965, HPA040436: AB_10796454"	"unprognostic (7.47e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.40e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.19e-1)"	34.2	34.0	22.4	27.6	24.3	28.2	48.6	12.6	23.7	31.1	28.7	25.1	38.7	23.8	31.6	73.3	29.4	34.9	30.6	25.3	23.4	22.9	39.2	66.3	33.3	40.4	25.7	17.8	35.6	25.3	26.3	28.4	48.2	18.8	30.0	28.3	33.7	31.9	47.0	35.4	28.9	37.8	30.4	29.3	31.7	31.1	26.8	19.3	33.5	50.1	28.9	26.1	31.4	24.7	9.4	20.4	47.7	35.8	3.9	5.5	11.5	22.3	33.4	16.9	31.9	43.7	43.3	21.1	14.0	47.7	27.9	32.6	14.9	34.8	25.7	21.9	32.7	41.4	29.9	48.3	32.8	26.6	10.5	15.5	22.2	22.6	26.9	55.4	21.0	19.8	29.4	37.6	22.1	41.9	27.3	33.3	29.7	18.4	21.0	34.0	31.8	19.2	18.4	18.6	50.3	17.5	20.1	18.1	45.0	28.6	27.1	20.7	18.5	16.5	35.2	31.7	34.9	24.0	35.8	16.2	23.7	24.7	33.7	20.9	15.0	25.5	15.1	30.7	55.8	19.9	2.1	35.8	3.8	4.0	21.3	3.7	9.4	3.8	4.1	20.4	8.1	5.5	3.1	47.7	3.9	17.2	6.6	4.3	11.5	22.4	24.3	12.6	23.7	23.4	22.9	25.7	17.8	18.8	19.3	8.9	45.9	54.6	61.1	66.5	14.3	25.4	58.6	33.5	26.1	68.0	35.3	166.4	116.0	80.1	5.4	60.2	47.1	0.0	64.4	77.8	71.7	84.8	27.7	107.5	144.0	19.1	62.2	36.8	139.1	8.1	80.3	130.4	75.9	24.4	57.1	18.1	59.2	108.9	84.5	153.7	17.7	38.8	55.6	36.9	53.7	72.4	156.0	43.6	65.2	80.2
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765808	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA036062: AB_10611670, HPA067304: AB_2685820"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	20.5	23.5	6.9	18.0	8.6	15.0	23.3	6.2	8.1	16.4	29.3	10.8	15.3	24.9	14.5	17.9	18.7	13.0	14.9	37.6	7.8	5.3	23.3	44.8	19.2	23.9	8.3	6.1	13.2	32.7	61.0	11.8	32.2	14.4	14.7	26.9	14.9	21.7	15.5	63.1	15.8	39.2	20.5	8.5	21.2	18.3	10.2	7.4	21.6	15.6	17.4	17.7	19.7	13.9	9.8	19.4	24.0	27.3	11.9	15.4	22.4	15.4	26.9	10.5	13.8	41.4	24.7	16.5	24.9	41.8	22.9	32.7	31.1	17.9	9.6	18.6	48.7	34.4	23.3	12.6	15.1	25.6	19.6	7.7	18.2	18.4	16.0	34.2	11.3	29.8	21.4	27.8	18.9	30.6	17.0	22.5	10.5	13.7	37.8	30.2	35.6	5.3	4.3	4.5	24.8	6.1	6.5	16.2	21.1	31.4	36.0	8.4	9.5	15.0	29.0	16.8	22.0	20.6	22.4	27.4	37.0	14.9	23.7	29.3	15.4	26.3	10.6	16.7	19.0	25.3	21.2	26.9	24.0	15.4	24.6	9.7	9.8	12.6	13.9	19.4	9.3	7.2	11.5	19.4	11.9	27.3	17.1	15.4	22.4	6.9	8.6	6.2	8.1	7.8	5.3	8.3	6.1	14.4	7.4	44.7	34.7	37.5	70.0	38.2	14.8	64.5	58.6	29.4	37.5	64.6	19.6	118.1	19.9	75.9	11.3	46.7	152.1	0.0	145.2	68.6	45.2	72.3	45.0	111.7	79.3	7.9	36.9	43.0	60.6	5.6	41.4	67.0	30.4	170.5	66.7	31.2	103.1	123.8	34.3	42.8	17.0	25.8	39.1	30.5	14.8	33.9	171.1	48.4	59.7	82.4
SPPL3	"DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4"	ENSG00000157837	"Signal peptide peptidase like 3"	Q8TCT6	12	120762510-120904371	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004194, HPA059958"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA004194: AB_2667171, HPA059958: AB_2684179"	"unprognostic (3.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.96e-3)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.54e-2)"	"unprognostic (9.40e-2)"	17.8	15.3	18.9	12.8	23.1	13.9	19.4	21.8	31.4	25.2	20.4	25.6	18.4	14.0	23.1	13.3	39.5	23.3	18.2	13.9	17.4	18.3	18.3	14.9	20.8	21.5	19.2	20.6	25.9	19.6	42.4	14.3	21.9	16.5	16.9	21.7	19.1	19.2	22.7	13.8	48.3	18.5	23.5	17.1	19.0	14.2	34.7	20.8	25.2	24.7	22.2	20.6	19.8	29.3	4.1	6.3	7.3	2.9	2.8	4.4	1.5	12.4	12.5	18.9	11.8	25.0	16.9	13.3	9.6	28.6	20.7	16.7	12.9	12.8	11.5	0.1	16.7	18.4	15.3	19.2	20.7	21.5	9.1	11.8	9.8	7.4	9.8	26.5	11.3	12.8	17.0	33.2	17.7	16.7	24.6	20.3	17.8	10.8	5.8	17.8	11.0	15.1	9.1	12.6	11.7	8.8	9.0	15.9	8.2	16.2	35.5	13.0	14.0	18.3	8.4	14.4	21.1	25.5	7.9	15.1	9.6	13.2	5.9	7.1	13.5	24.2	11.2	14.3	9.4	15.9	7.3	2.9	2.6	3.2	2.8	4.4	3.2	4.0	4.0	4.9	4.1	3.9	4.3	5.5	2.8	2.4	6.3	3.1	1.5	18.9	23.1	21.8	31.4	17.4	18.3	19.2	20.6	16.5	20.8	17.9	17.3	21.4	28.0	48.9	33.5	17.7	17.8	8.1	13.6	38.4	25.5	32.4	1.7	16.9	6.4	28.1	32.5	0.0	21.2	21.9	34.3	27.4	4.6	27.7	32.0	35.0	26.0	32.5	31.3	6.2	26.4	27.5	25.3	13.6	36.3	27.5	19.2	31.7	32.9	18.7	22.1	12.9	21.7	48.8	40.1	74.0	54.0	16.0	33.6	30.8
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907308	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: AB_2674090"	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favorable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	13.9	45.2	42.9	19.6	41.7	18.2	16.3	51.9	66.5	16.5	27.7	32.7	22.3	26.1	19.4	41.5	42.4	18.9	28.7	33.9	37.3	33.6	18.9	20.4	27.9	21.1	21.7	38.4	22.7	29.7	34.2	17.4	15.8	34.2	22.8	20.9	25.4	29.0	20.0	17.2	32.9	22.3	19.8	24.7	16.0	30.2	13.5	21.0	15.6	14.3	20.5	26.1	17.1	19.0	9.6	8.4	2.0	5.5	1.8	6.4	4.9	18.4	13.2	35.2	32.7	20.7	27.7	19.7	6.2	20.8	7.3	15.1	15.5	24.5	33.0	8.8	15.1	27.1	31.8	20.1	41.0	5.2	9.2	21.9	16.5	23.3	15.4	34.6	24.0	11.2	25.9	23.3	19.2	24.1	16.9	14.4	18.7	16.9	39.9	7.7	23.5	17.4	18.2	22.3	23.1	10.2	20.2	20.1	52.9	30.5	19.5	14.3	10.7	14.2	26.2	26.3	21.5	16.4	42.9	15.3	9.9	18.6	4.6	7.3	29.2	14.8	26.3	9.7	18.3	15.1	0.0	5.5	2.0	6.4	4.9	4.4	9.6	3.5	4.6	6.6	7.3	3.2	3.6	1.0	1.8	4.0	8.4	2.1	4.9	42.9	41.7	51.9	66.5	37.3	33.6	21.7	38.4	34.2	21.0	41.7	33.4	16.0	10.9	14.4	35.6	26.3	38.2	21.4	18.2	55.8	9.8	22.2	3.3	17.6	15.3	9.8	40.6	0.0	37.7	17.9	14.6	18.9	12.7	20.4	12.4	54.0	47.2	6.7	13.8	5.3	29.1	8.0	6.8	21.6	38.3	18.8	30.8	24.6	25.8	4.5	16.2	19.4	18.4	7.7	15.8	24.6	30.6	13.1	31.8	20.2
STAM	STAM1	ENSG00000136738	"Signal transducing adaptor molecule"	Q92783	10	17644125-17715914	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"T-reg: 33.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034399, HPA043882"	Supported		Supported	Vesicles		NA	NA			Vesicles		"CAB034399: AB_2197486, HPA043882: AB_2678713"	"unprognostic (1.09e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (3.44e-6)"	"unprognostic (1.39e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.02e-1)"	13.5	16.7	16.8	9.3	21.8	58.5	10.8	23.2	25.4	12.9	9.4	22.7	6.3	11.4	15.0	8.9	14.5	9.6	12.2	23.7	18.4	18.4	14.3	9.5	14.6	10.3	18.6	16.1	15.5	17.2	14.4	13.4	11.7	24.5	12.8	11.0	16.1	12.7	9.4	26.0	11.5	9.7	12.3	20.7	8.8	13.3	10.8	15.0	25.1	15.2	12.5	13.0	13.7	10.6	2.4	4.3	17.2	3.6	7.2	33.4	2.9	14.9	9.6	13.5	6.8	16.5	12.2	5.4	20.8	10.0	21.2	17.2	12.7	15.0	4.1	3.1	17.4	15.7	8.3	13.3	11.1	17.3	4.8	6.8	39.2	8.6	22.7	18.1	2.9	21.0	11.3	14.6	17.3	14.9	14.9	10.8	28.8	13.5	5.6	23.4	5.6	15.7	2.9	7.3	10.6	4.8	8.4	12.5	5.5	9.8	6.1	6.2	10.5	11.8	9.0	18.7	12.7	13.4	4.8	12.2	11.9	11.8	19.8	9.3	3.6	4.9	7.0	13.7	4.8	7.6	17.2	3.5	5.4	2.9	3.6	2.7	2.4	6.2	3.0	4.3	1.7	4.5	3.6	2.9	7.2	3.2	2.6	33.4	2.9	16.8	21.8	23.2	25.4	18.4	18.4	18.6	16.1	24.5	15.0	11.9	18.9	7.8	5.2	20.4	16.1	23.4	7.6	14.7	14.8	15.7	9.8	8.7	5.0	13.1	2.8	9.0	5.4	0.0	11.5	8.5	16.9	8.8	30.1	6.2	13.1	9.5	10.9	9.8	10.3	2.7	8.9	11.9	18.6	5.4	7.3	13.3	22.5	5.8	5.6	12.1	14.2	25.8	10.0	12.9	10.9	18.3	20.6	12.5	7.4	5.5
STAM2	Hbp	ENSG00000115145	"Signal transducing adaptor molecule 2"	O75886	2	152116801-152175992	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 107.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035528, HPA035529"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA035528: AB_10601606, HPA035529: AB_10672868"	"unprognostic (1.53e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.03e-2)"	17.8	19.1	17.2	12.4	19.9	4.9	21.3	16.1	19.5	19.6	16.7	17.6	17.2	15.1	18.5	16.0	17.8	21.6	15.6	16.1	15.3	15.4	24.6	17.8	17.6	13.0	19.9	14.4	20.6	20.5	23.1	34.0	16.7	20.4	22.1	18.4	14.5	19.5	19.3	14.3	17.6	19.6	19.8	20.0	14.0	18.8	24.3	21.2	16.0	23.8	13.2	14.7	19.5	16.6	2.3	3.3	14.0	6.5	2.5	2.2	1.7	5.4	5.3	5.0	6.0	13.1	15.7	5.3	11.4	13.2	7.4	9.5	5.2	5.2	7.2	9.2	16.2	6.5	5.6	5.5	10.5	12.0	8.8	4.4	5.1	3.7	7.9	15.0	7.5	10.1	11.9	10.2	13.8	18.7	10.8	7.9	4.9	3.3	5.1	15.1	5.4	4.0	5.9	3.1	4.1	7.7	3.2	6.1	3.9	11.6	9.5	2.6	4.1	6.3	5.7	9.4	5.8	7.6	7.0	10.4	16.6	5.3	13.0	6.9	4.3	4.3	4.6	12.5	6.1	9.0	14.0	3.5	4.4	1.9	4.7	1.8	1.7	2.0	2.0	2.7	2.3	1.7	2.1	8.8	2.5	6.5	3.3	2.2	1.7	17.2	19.9	16.1	19.5	15.3	15.4	19.9	14.4	20.4	21.2	23.8	24.4	5.2	9.3	12.2	10.1	27.1	7.6	68.3	35.2	15.7	15.7	6.6	19.9	12.8	107.8	9.8	14.8	0.0	12.2	11.8	13.1	14.9	25.5	13.5	14.5	1.6	7.9	20.3	24.5	38.6	14.7	14.8	13.5	17.2	16.2	13.6	17.2	17.3	14.5	11.4	12.0	25.8	11.3	26.5	19.2	11.5	16.9	6.9	11.9	13.1
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637065-39663484	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	22.2	34.8	23.3	27.5	28.0	33.5	22.8	27.7	30.1	17.1	23.7	38.1	21.7	26.6	20.6	20.7	22.4	25.6	27.7	17.8	21.0	16.8	18.2	24.0	27.0	31.5	28.5	25.7	21.5	32.7	21.9	23.7	26.9	25.7	19.0	9.7	17.9	21.4	26.7	20.8	24.5	34.2	15.8	27.8	32.3	25.3	26.7	26.1	33.0	21.1	15.1	24.8	28.8	18.7	15.3	23.2	35.3	21.2	21.4	25.3	17.4	7.9	12.6	5.7	10.1	6.9	8.4	8.5	6.5	8.5	8.5	7.8	7.4	13.1	7.1	14.2	5.9	10.5	15.2	3.4	7.7	1.9	9.6	12.9	4.8	5.5	8.6	9.7	9.7	10.8	9.1	6.3	9.6	4.6	6.5	8.2	9.9	11.1	9.2	7.8	7.0	9.1	9.2	6.3	5.4	6.9	7.2	9.8	10.5	5.8	9.0	7.2	7.7	4.9	89.9	16.1	4.0	10.6	11.6	7.7	12.0	8.3	13.1	12.2	8.8	10.8	5.7	10.7	10.5	12.3	12.5	21.2	29.3	25.3	19.6	18.5	11.9	18.3	19.0	23.2	15.3	18.4	16.9	35.3	21.4	15.6	10.8	20.4	17.4	23.3	28.0	27.7	30.1	21.0	16.8	28.5	25.7	25.7	26.1	3.0	9.8	21.7	11.2	14.7	13.5	3.0	20.4	5.3	3.4	10.4	35.3	24.1	8.3	20.7	2.3	23.3	21.4	0.0	30.9	31.1	16.0	17.5	18.5	10.6	45.2	17.5	26.4	42.4	36.6	4.1	15.8	20.8	5.0	17.2	11.7	17.0	30.5	15.8	12.4	8.7	13.2	12.9	9.5	8.4	13.9	14.8	33.4	34.8	12.4	16.9
STARD3NL	"MENTHO, MGC3251"	ENSG00000010270	"STARD3 N-terminal like"	O95772	7	38178222-38230671	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019204	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA019204: AB_2197800"	"unprognostic (1.55e-3)"	"unprognostic (2.80e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (2.20e-4)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (9.64e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (8.48e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	18.3	15.6	28.9	15.3	26.5	23.4	20.3	16.1	37.7	23.2	14.6	22.5	11.8	12.7	23.3	19.8	9.6	19.4	15.5	18.2	27.9	36.7	23.8	11.8	22.4	15.8	34.6	19.4	17.8	11.1	9.5	19.7	33.7	29.8	29.3	16.7	16.4	10.0	16.1	10.6	4.5	13.7	22.9	33.1	17.6	11.8	21.7	15.3	13.4	23.2	5.9	10.2	17.3	16.0	14.4	21.0	27.0	23.4	34.2	27.8	20.8	11.5	12.4	27.5	17.8	19.0	19.0	9.6	19.0	19.7	18.8	24.8	9.8	18.4	9.1	19.2	17.3	57.6	12.6	15.1	14.4	28.6	8.2	13.1	18.5	6.9	13.4	16.8	20.3	21.7	17.8	7.1	19.9	15.9	21.6	34.1	25.2	21.0	16.0	28.8	7.1	11.4	32.7	19.4	9.7	9.9	14.1	25.6	4.2	26.3	10.9	11.1	25.9	6.5	17.3	17.9	39.7	12.1	26.9	23.2	12.9	18.5	20.1	26.7	17.1	17.2	3.4	26.2	36.2	41.9	14.4	23.4	27.0	27.8	20.0	12.7	14.4	11.7	20.5	21.0	14.1	9.9	19.4	26.3	34.2	21.5	14.9	11.6	20.8	28.9	26.5	16.1	37.7	27.9	36.7	34.6	19.4	29.8	15.3	17.9	38.9	35.0	46.4	18.4	8.0	15.9	12.7	17.4	15.9	29.6	11.8	43.7	26.6	28.6	97.7	36.8	10.2	0.0	30.1	76.6	25.5	61.8	23.1	10.5	57.9	4.8	20.6	48.5	50.4	71.1	17.0	44.7	25.3	13.6	20.3	25.1	30.1	22.9	24.4	41.1	11.2	12.9	41.8	40.2	33.6	14.2	35.4	46.8	21.1	42.2
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"prostate: 100.2"	"Cell type enriched"	"Detected in many"	4	"Glandular cells: 110.4"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 13.4;CAPAN-2: 28.9;U-138 MG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029115, HPA055603"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	10.7	4.1	6.2	9.7	14.5	1.3	13.6	8.7	18.2	7.0	8.3	2.3	2.2	5.7	5.4	3.6	9.1	7.5	8.8	9.4	5.1	5.2	6.5	3.6	10.8	1.6	3.2	11.1	19.5	6.4	10.3	17.6	1.4	6.0	100.2	7.0	3.8	6.8	6.7	2.3	3.5	5.9	9.0	2.9	3.0	9.2	2.3	1.6	1.6	5.8	1.2	2.5	10.4	19.9	1.1	0.4	1.3	0.4	0.3	0.2	0.0	1.8	13.4	0.3	3.8	7.2	7.0	0.2	1.6	3.5	0.2	0.5	2.5	28.9	0.0	0.2	4.4	5.4	1.1	2.9	2.1	0.5	0.0	2.9	0.0	0.0	0.7	0.6	0.0	0.0	5.1	0.4	7.0	1.4	5.8	3.6	0.0	0.0	0.2	4.0	0.0	0.0	0.4	5.5	0.0	1.5	0.0	0.0	0.1	6.3	3.9	0.3	1.3	2.1	0.0	0.1	0.6	10.2	0.0	3.0	16.8	3.8	2.3	1.4	0.0	0.0	0.0	7.3	0.0	0.7	1.3	0.4	0.5	0.2	0.2	0.1	1.1	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.3	0.2	0.4	0.0	0.0	6.2	14.5	8.7	18.2	5.1	5.2	3.2	11.1	6.0	1.6	0.0	0.6	0.0	20.8	4.2	5.1	11.6	17.8	16.0	13.6	12.2	2.0	0.0	0.0	0.6	0.4	1.8	11.8	0.0	6.6	0.0	17.5	110.4	0.0	4.9	0.0	1.6	15.1	2.5	0.0	0.4	14.4	1.7	0.0	0.0	12.5	26.2	8.6	25.8	14.5	8.6	1.2	0.0	6.2	1.0	3.4	4.6	0.0	0.0	12.7	19.6
SULT2B1	HSST2	ENSG00000088002	"Sulfotransferase family 2B member 1"	O00204	19	48552075-48599425	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 53.7;Suprabasal keratinocytes: 120.1;Urothelial cells: 113.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 27.6;MCF7: 16.9;OE19: 44.8;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA041724, HPA043539, HPA076510"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: "	"unprognostic (6.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.28e-3)"	"unprognostic (8.74e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.01e-6)"	"unprognostic (7.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.77e-2)"	0.1	0.1	0.1	0.3	0.1	0.0	4.0	0.1	0.2	28.7	0.8	0.0	9.2	2.9	2.2	5.2	91.8	0.3	2.3	0.0	0.1	0.1	2.5	0.1	6.5	0.0	0.2	0.0	0.1	0.2	0.8	0.1	11.4	0.0	6.9	0.0	0.0	12.4	6.9	0.2	45.7	13.4	0.0	0.1	0.0	0.7	0.2	0.0	0.5	1.1	79.6	78.6	0.6	32.0	0.7	1.5	2.5	1.0	1.1	3.1	0.9	4.5	5.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	27.6	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.9	0.0	0.2	0.0	44.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.3	0.1	0.0	13.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.8	0.4	2.1	0.9	3.1	0.4	1.8	1.4	0.7	0.7	0.6	1.2	1.4	1.1	1.0	1.5	1.1	0.9	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	17.9	0.3	0.0	28.4	21.4	0.0	0.6	2.5	4.0	13.6	8.7	0.0	2.8	0.0	11.1	0.0	0.3	8.6	0.0	1.0	2.7	2.0	53.7	0.0	0.0	0.6	0.0	4.6	0.0	0.0	0.2	0.3	0.2	11.8	0.0	7.1	1.2	10.8	7.0	0.0	0.8	0.6	0.0	2.8	0.2	7.5	120.1	1.6	0.0	2.6	113.8
SYBU	"FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL"	ENSG00000147642	Syntabulin	Q9NX95	8	109573978-109691791	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 82.7"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 47.0;Horizontal cells: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	21	"memory B-cell: 9.4;naive B-cell: 4.4"	"Lineage enriched"	"Detected in single"	29	"B-cells: 9.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.5;PC-3: 15.2;SK-BR-3: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053057	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA053057: AB_2682028"	"unprognostic (4.69e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-1)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.05e-3)"	"unprognostic (6.89e-2)"	"unprognostic (4.27e-2)"	17.6	19.7	18.2	2.5	25.5	0.8	13.3	36.8	31.3	7.7	8.7	4.0	11.5	7.1	3.4	7.9	4.1	12.8	6.9	2.6	15.2	23.0	3.3	26.6	5.2	3.1	13.5	17.9	5.5	82.7	1.6	12.4	2.1	14.7	5.1	12.5	3.5	12.6	10.0	2.5	5.3	7.4	5.1	7.2	1.2	8.7	1.7	5.1	0.3	7.6	1.1	5.1	2.9	3.8	9.4	0.1	0.0	0.0	0.0	0.3	0.1	5.2	2.6	2.1	0.0	0.3	0.3	1.5	1.8	0.0	0.0	0.0	4.7	3.1	0.4	0.3	1.4	0.7	13.5	0.4	3.6	0.0	0.0	7.3	0.0	7.9	4.7	3.5	0.0	0.0	1.3	4.6	0.0	4.4	0.2	1.9	0.3	0.2	0.9	2.0	0.1	0.1	0.0	0.4	4.6	15.2	0.0	0.0	0.0	5.8	1.2	10.2	1.1	4.8	31.0	1.0	1.6	3.9	0.2	2.7	0.2	1.1	0.0	0.8	0.9	0.0	0.3	6.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	9.4	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	18.2	25.5	36.8	31.3	15.2	23.0	13.5	17.9	14.7	5.1	8.9	4.8	2.0	1.9	5.0	47.0	2.0	22.9	14.7	15.9	10.4	7.9	2.9	3.3	4.2	0.7	5.8	4.1	0.0	8.1	1.0	4.1	14.5	0.0	33.1	0.3	90.6	33.2	3.7	1.5	0.0	2.0	0.2	1.7	1.0	22.2	1.6	4.6	13.1	0.4	0.0	6.3	0.0	4.4	0.1	0.4	2.9	0.6	0.0	11.7	2.6
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607785-85643792	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		77000	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	29.1	28.3	27.9	31.3	36.2	30.4	28.4	35.6	37.9	32.9	29.4	19.2	31.8	20.4	32.7	18.9	48.8	24.5	21.9	31.3	29.3	19.0	25.2	31.3	25.7	35.0	31.9	23.1	26.2	34.9	37.5	27.9	31.3	28.2	23.1	29.6	17.3	31.4	32.8	41.4	27.2	23.7	53.5	28.1	24.7	25.4	19.8	30.1	38.1	42.0	29.8	41.7	31.2	39.4	13.2	20.9	4.6	20.0	18.1	18.6	12.6	32.2	24.2	40.4	23.5	26.6	31.7	25.6	47.9	39.5	43.5	43.2	39.6	21.3	76.3	34.9	46.1	34.6	31.3	59.1	47.5	76.3	26.2	27.1	68.0	29.2	27.2	22.5	83.0	29.3	25.9	27.4	49.7	51.2	23.5	45.8	22.9	68.1	36.0	50.2	35.5	38.8	35.4	38.7	31.2	25.8	58.3	64.6	32.4	35.6	51.8	38.1	30.9	33.3	28.2	19.6	25.2	24.4	51.7	42.0	29.5	24.1	30.9	57.2	22.5	44.4	50.3	27.0	50.2	41.0	1.0	13.0	4.6	17.7	18.6	18.6	13.2	16.8	15.9	20.9	11.9	15.3	16.6	1.6	18.1	20.0	15.5	16.7	12.6	27.9	36.2	35.6	37.9	29.3	19.0	31.9	23.1	28.2	30.1	107.2	97.5	44.7	111.8	131.7	43.4	77.5	48.4	87.0	134.2	43.6	15.7	88.7	46.4	116.0	77.9	92.0	42.3	0.0	85.9	107.5	80.8	88.9	59.0	74.1	86.4	58.8	54.4	52.8	60.2	17.6	68.1	69.2	50.6	61.3	65.0	37.9	106.5	45.6	60.5	62.1	40.3	19.4	102.9	77.7	58.0	123.8	98.7	52.5	77.4	123.7
SYT13	KIAA1427	ENSG00000019505	"Synaptotagmin 13"	Q7L8C5	11	45240301-45286319	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.1;gallbladder: 18.8"	"Cell type enriched"	"Detected in many"	8	"Intestinal endocrine cells: 323.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"A549: 11.5;NTERA-2: 5.4;RPTEC TERT1: 35.1;SCLC-21H: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046224, HPA056602"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA046224: AB_10961288, HPA056602: AB_2683185"	"unprognostic (4.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (7.79e-5)"	"unprognostic (1.00e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.13e-2)"	0.4	4.5	15.8	1.5	15.1	0.4	0.5	19.0	38.1	0.3	10.6	1.2	0.0	10.9	0.6	0.3	0.4	0.5	18.8	4.5	11.8	19.5	8.0	0.6	0.8	0.4	10.6	15.1	0.4	6.4	0.4	9.4	0.4	27.9	2.0	11.2	0.9	1.4	0.4	0.5	0.5	11.1	1.1	2.2	0.5	9.2	1.8	0.3	0.0	1.8	0.0	0.3	0.4	0.2	0.2	0.0	1.4	0.0	0.2	0.2	0.0	0.0	11.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	35.1	0.0	9.3	0.4	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.0	15.8	15.1	19.0	31.1	11.8	19.5	10.6	15.1	27.9	0.3	0.0	0.0	0.0	0.2	0.0	1.1	8.1	15.3	0.0	0.0	3.5	23.6	0.0	5.0	1.2	3.1	0.0	10.0	0.0	0.5	0.0	0.0	4.2	0.0	0.0	0.0	1.6	323.7	0.0	0.0	8.2	0.3	0.0	0.0	0.0	30.8	0.5	5.3	17.5	0.0	0.3	1.5	0.0	0.0	1.9	0.2	0.0	0.0	0.0	38.3	0.1
SYT14	"FLJ34198, sytXIV"	ENSG00000143469	"Synaptotagmin 14"	Q8NB59	1	209938174-210171389	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 28.8;Cone photoreceptor cells: 25.5;Horizontal cells: 49.3;Rod photoreceptor cells: 28.8;Spermatogonia: 19.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.0;GAMG: 8.8;SCLC-21H: 6.8;TIME: 10.8;U-138 MG: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036963			Supported	Vesicles		NA	NA			Vesicles		"HPA036963: AB_10670378"	"unprognostic (1.38e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.90e-4)"	"unprognostic (1.97e-1)"	"unprognostic (4.43e-5)"		"unprognostic (1.92e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.81e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.30e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.33e-3)"	0.7	3.2	5.9	0.8	7.4	0.8	0.6	17.4	10.2	0.6	0.7	3.8	0.0	0.7	1.4	0.8	0.6	0.6	0.6	0.6	4.5	2.6	0.9	0.6	0.7	0.7	3.3	5.9	0.8	1.2	0.6	31.1	0.6	5.0	0.8	0.8	1.1	0.6	0.6	0.7	0.7	0.7	0.7	2.4	0.7	0.9	9.5	3.0	0.0	15.9	0.0	0.6	0.6	0.4	2.0	0.8	2.1	0.5	1.1	0.8	0.1	3.3	0.1	0.0	0.0	0.3	0.0	0.0	2.7	13.0	2.7	1.4	0.0	0.2	0.0	0.1	0.3	8.8	4.1	0.0	0.0	3.3	0.5	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	1.9	5.7	1.7	0.5	0.0	0.0	0.0	4.9	0.0	0.0	0.0	4.5	0.0	1.8	0.0	0.1	0.1	0.2	3.0	6.8	3.1	0.0	0.0	5.6	1.0	0.0	0.1	10.8	8.2	3.9	0.7	1.4	0.1	0.1	0.0	0.7	0.0	1.9	2.1	0.4	0.6	0.8	0.2	0.4	0.6	0.5	0.4	0.3	2.0	0.4	0.6	1.8	1.1	0.5	0.8	0.4	0.1	5.9	7.4	17.4	10.2	4.5	2.6	3.3	5.9	5.0	3.0	0.0	0.0	0.0	0.1	0.0	28.8	1.6	0.0	0.0	0.0	0.0	25.5	0.0	3.3	0.1	12.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	49.3	0.0	0.0	0.0	3.2	0.6	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.3	28.8	0.0	0.0	4.9	19.3	0.0	0.0	0.0	0.0	0.1
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 64.3"	"Low region specificity"	"Detected in all"							"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		Yes	No			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: AB_2685833"	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	20.0	31.2	31.9	24.4	33.8	10.6	22.0	18.1	32.8	16.0	20.2	22.5	17.0	17.3	16.2	21.9	24.3	18.8	15.0	22.9	28.6	27.5	32.1	21.6	20.7	48.4	28.8	20.5	23.3	19.3	23.6	20.7	18.0	29.0	19.6	20.7	26.1	23.2	16.7	35.1	37.3	20.0	17.8	37.3	26.2	35.8	22.4	29.3	24.0	14.9	17.9	19.9	16.7	15.4	5.3	7.5	26.4	8.2	5.5	8.9	6.0	10.5	11.5	13.0	14.5	10.8	9.1	7.9	8.5	9.3	8.0	6.8	11.9	22.1	17.0	5.0	10.1	20.3	7.7	21.8	19.5	9.8	4.7	7.1	28.5	7.6	12.4	7.5	12.8	64.3	7.0	27.7	7.5	12.4	10.2	7.5	16.2	26.9	6.1	9.6	6.9	19.7	13.0	17.6	12.7	13.0	24.8	17.1	18.4	11.9	7.5	19.9	14.2	7.0	7.7	26.1	10.6	10.6	12.3	7.4	8.8	6.7	7.7	12.5	11.8	27.4	17.5	8.3	16.6	8.4	1.7	8.2	3.5	5.9	5.3	8.9	5.2	6.4	6.3	6.9	5.3	4.9	4.5	26.4	5.5	2.4	7.5	7.5	6.0	31.9	33.8	18.1	28.0	28.6	27.5	28.8	20.5	29.0	29.3	6.0	15.3	5.2	6.6	8.0	8.4	3.4	10.2	5.3	11.4	14.0	13.7	10.5	16.6	9.8	45.7	4.7	10.4	0.0	8.7	6.1	5.1	11.2	7.0	21.7	20.9	23.8	6.3	7.4	37.2	22.1	6.6	13.2	18.6	6.4	15.6	10.6	9.0	14.0	8.1	19.2	6.3	0.0	5.2	15.8	18.9	10.5	13.7	15.0	16.6	9.1
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	22.2	20.9	24.8	21.3	24.7	21.1	17.7	25.5	25.1	21.0	13.3	25.7	14.5	10.3	17.4	15.9	16.4	22.4	18.5	16.2	24.4	20.0	19.9	13.9	16.9	20.4	25.9	14.9	28.3	17.2	35.3	27.8	16.5	21.4	14.2	13.7	16.6	13.9	17.0	10.3	15.2	13.8	17.7	31.3	24.3	12.9	17.3	24.7	10.0	29.1	9.7	21.2	17.8	20.7	13.5	9.7	12.3	8.6	4.2	8.7	4.6	11.7	13.2	10.9	10.2	21.5	31.7	11.9	12.7	18.6	8.3	7.2	6.4	10.7	21.9	13.8	25.7	12.8	3.7	9.5	15.4	17.4	19.2	3.7	21.0	5.3	7.4	13.8	20.3	18.3	20.4	18.5	18.0	11.0	18.8	18.9	13.0	13.1	20.3	20.2	7.9	9.9	4.6	8.9	7.6	13.9	21.9	14.0	15.6	12.5	9.2	4.1	19.3	24.3	5.7	8.6	10.7	16.1	17.0	20.4	23.1	10.4	11.9	13.8	11.8	15.9	21.3	17.8	19.4	21.6	10.2	8.6	12.3	6.7	7.1	8.7	11.7	5.1	4.8	9.7	13.5	3.9	4.4	11.5	4.2	6.4	6.3	5.5	4.6	24.8	24.7	25.5	24.6	24.4	20.0	25.9	14.9	21.4	24.7	14.9	31.2	20.1	17.0	16.4	19.3	16.2	25.5	17.4	39.8	14.0	9.8	12.9	5.0	14.3	52.3	25.4	9.5	23.3	8.7	14.6	17.4	9.9	17.4	16.4	18.6	33.4	12.6	39.3	34.9	30.1	28.4	26.6	13.5	10.0	12.3	23.0	10.9	11.2	28.7	13.5	21.3	6.5	10.5	17.0	26.2	14.9	6.9	14.9	11.7	18.7
TECPR1	"DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358"	ENSG00000205356	"Tectonin beta-propeller repeat containing 1"	Q7Z6L1	7	98214624-98252251	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 63.9"	"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021061	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA021061: AB_1847687"	"unprognostic (8.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (9.05e-3)"	"unprognostic (5.00e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (2.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.12e-2)"	6.5	4.7	11.5	8.9	10.6	5.2	6.3	9.0	15.8	4.1	5.9	6.2	5.1	8.4	4.5	5.5	5.8	4.8	7.6	5.9	10.4	9.0	4.6	5.4	9.0	11.0	6.8	12.8	4.0	63.9	4.2	10.2	7.7	9.8	6.9	4.9	8.0	29.5	5.0	6.9	5.4	8.1	4.6	8.5	11.2	9.3	3.3	7.0	6.4	5.9	5.9	6.4	5.1	5.4	3.4	4.1	6.1	7.4	1.6	8.7	3.1	3.0	4.2	5.9	12.8	5.1	3.1	4.4	6.3	3.5	5.0	6.2	4.0	3.8	2.5	10.2	7.2	6.2	1.9	4.0	2.9	2.1	5.9	5.7	3.6	5.9	4.2	6.1	4.3	7.0	5.4	2.4	4.8	3.8	4.7	17.5	10.5	2.3	14.1	3.8	4.9	6.2	4.5	2.3	6.0	4.1	5.2	6.0	17.6	3.8	3.3	10.7	11.9	3.7	11.2	5.9	4.5	3.4	6.2	17.9	4.8	8.2	12.2	5.2	18.0	6.4	1.2	9.9	3.8	8.9	2.6	4.7	1.4	3.9	5.2	2.4	3.4	5.1	3.1	2.9	3.2	8.7	7.2	6.1	1.6	7.4	4.1	5.1	3.1	11.5	10.6	9.0	15.8	10.4	9.0	6.8	12.8	9.8	7.0	8.9	17.3	10.5	1.9	2.1	33.6	8.2	7.6	5.3	6.8	5.2	100.1	4.4	1.7	5.7	2.0	17.9	11.8	0.0	11.4	7.4	4.1	5.1	8.1	6.7	11.2	30.2	28.2	18.4	21.9	1.6	6.6	7.6	1.7	10.8	20.9	10.0	9.0	11.4	3.2	2.9	66.4	0.0	4.4	4.2	3.8	1.6	2.9	10.2	6.0	2.5
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413429	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029206			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	14.7	10.4	5.4	22.0	8.7	4.5	11.4	5.8	6.6	8.9	24.1	11.2	7.7	27.7	12.9	11.3	9.4	7.9	15.7	9.3	6.3	3.5	9.4	9.2	14.1	15.0	7.7	3.0	9.2	8.7	28.2	11.7	7.0	7.3	10.8	18.1	8.1	11.4	8.3	13.4	10.0	38.3	10.9	12.2	19.5	11.1	3.6	8.7	14.2	11.2	6.6	20.8	9.7	10.9	4.2	8.3	7.8	4.4	0.9	1.8	0.5	7.0	2.8	3.2	3.5	19.9	8.3	5.6	4.8	4.5	2.9	4.1	6.1	7.4	5.5	3.3	13.4	5.7	7.0	2.6	9.5	5.1	6.9	2.7	6.7	6.1	4.1	6.0	5.5	12.1	11.5	9.0	6.0	4.6	13.4	13.5	5.2	2.3	4.4	10.6	4.3	4.1	3.8	1.3	19.8	2.6	9.1	7.8	1.9	9.8	10.1	1.0	1.3	3.8	9.8	3.1	8.9	5.3	3.7	13.8	11.6	8.1	4.3	1.4	9.9	5.6	3.6	2.7	5.2	4.2	4.1	4.0	0.2	1.8	4.4	1.7	2.9	0.8	1.6	1.3	4.2	0.9	1.1	7.8	0.9	4.4	8.3	1.3	0.5	5.4	8.7	5.8	6.6	6.3	3.5	7.7	3.0	7.3	8.7	8.9	13.1	6.2	4.1	2.5	0.1	2.8	7.6	13.4	5.7	1.8	2.0	1.7	1.7	3.6	0.2	3.6	18.8	0.0	4.4	2.0	1.7	5.2	10.4	4.2	5.7	0.0	4.1	8.0	8.9	0.0	4.6	11.8	5.0	3.6	11.6	3.7	5.2	11.9	3.5	2.9	2.1	0.0	3.3	0.0	0.7	1.3	1.6	4.4	7.4	4.2
TFG	"FLJ36137, SPG57, TF6"	ENSG00000114354	"TRK-fused gene"	Q92734	3	100709331-100748966	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019473, HPA052206"	Approved		Supported	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"HPA019473: AB_1857936, HPA052206: AB_2681760"	"unprognostic (1.14e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (3.31e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.45e-2)"	36.4	40.3	27.2	21.9	33.8	29.7	31.0	28.1	40.5	31.2	34.7	33.3	44.2	52.5	31.2	45.8	46.7	29.0	40.8	46.2	28.1	30.7	44.6	68.6	29.9	25.4	28.2	21.5	33.5	49.2	52.3	45.1	63.3	33.7	27.5	40.7	31.9	39.6	45.8	38.6	31.0	67.1	37.5	31.7	28.3	28.9	33.5	23.0	27.6	43.6	42.9	41.2	29.5	30.1	25.8	27.8	43.2	28.4	27.7	26.8	21.8	48.7	26.6	33.1	21.0	41.8	47.4	40.9	35.3	47.5	46.2	55.1	33.5	24.4	6.5	26.0	43.8	35.8	36.6	35.6	40.3	55.0	30.0	20.9	24.5	20.5	31.1	46.8	18.1	14.7	38.8	54.4	27.6	48.8	42.9	40.8	11.5	17.6	18.1	47.6	34.1	15.9	14.3	31.5	45.4	40.0	14.0	19.4	21.2	56.0	32.9	26.2	24.0	23.2	30.2	41.1	28.7	35.6	24.6	27.3	27.9	33.8	12.8	25.5	15.5	15.6	23.4	44.6	19.8	32.7	43.2	28.3	27.0	21.8	28.4	26.4	25.8	22.6	24.4	27.8	22.9	21.6	21.6	18.7	27.7	26.4	19.4	26.8	21.8	27.2	33.8	28.1	40.5	28.1	30.7	28.2	21.5	33.7	23.0	56.6	28.8	33.5	90.7	121.3	43.5	83.1	53.5	36.1	40.9	34.9	23.6	186.8	116.0	161.1	64.7	63.1	162.1	23.3	94.6	171.9	101.9	94.0	76.1	59.6	75.5	54.0	50.5	51.0	25.1	36.9	65.6	40.7	60.8	142.5	99.4	86.6	108.9	83.4	69.6	72.7	59.0	38.8	84.4	49.9	48.5	104.0	237.9	28.8	82.9	98.7
TIPRL	"dJ69E11.3, MGC3794, TIP41, TIPRL1"	ENSG00000143155	"TOR signaling pathway regulator"	O75663	1	168178933-168202114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027995, HPA054282"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA027995: AB_10602900, HPA054282: AB_2682435"	"unprognostic (3.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (1.45e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.61e-2)"	19.6	22.3	17.0	18.6	29.6	29.7	21.4	18.4	29.1	19.4	21.9	11.2	12.9	18.9	25.9	17.7	28.5	17.5	17.1	23.1	17.4	20.5	22.9	38.3	16.2	20.2	18.0	19.3	21.6	22.2	23.8	31.9	19.8	23.1	19.9	22.7	11.4	17.9	18.6	32.0	16.2	23.2	23.5	16.0	19.0	16.1	22.8	12.4	35.2	17.8	21.1	21.2	23.3	18.5	17.7	21.5	36.2	21.4	19.3	23.9	17.7	26.2	11.5	18.1	16.4	14.8	21.5	10.8	19.7	20.8	21.6	19.4	17.8	19.6	18.4	27.2	18.8	16.1	31.8	13.4	19.1	20.9	17.7	13.7	17.8	11.9	8.5	26.0	35.4	24.7	17.3	24.7	18.8	25.2	14.4	22.7	29.4	25.6	26.2	18.6	9.1	31.6	18.4	14.5	36.8	20.6	15.5	18.5	25.2	19.4	13.0	11.7	26.2	15.2	21.6	38.6	21.5	23.6	36.5	20.6	18.3	21.0	17.1	26.5	28.7	29.7	41.1	11.9	23.5	20.9	36.2	18.7	24.2	16.2	21.4	16.2	17.7	19.0	17.2	21.5	17.7	17.1	16.9	24.2	19.3	21.4	16.1	23.9	17.7	17.0	29.6	18.4	29.1	17.4	20.5	18.0	19.3	23.1	12.4	23.8	14.8	32.8	35.9	42.7	25.6	43.2	22.9	29.4	23.9	21.0	15.7	37.2	24.9	58.5	31.5	34.6	29.9	0.0	77.6	52.7	32.1	27.7	39.3	31.6	57.2	49.3	23.1	33.7	19.7	8.9	34.8	40.9	28.7	62.3	33.7	41.8	57.8	20.1	35.7	54.3	18.4	25.8	36.3	133.2	39.6	36.5	24.3	35.2	36.5	31.3
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 155.8;Ito cells: 174.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 29.6;EFO-21: 62.5;GAMG: 12.4;HUVEC TERT2: 20.7;NTERA-2: 14.9"					"Low region specificity"	"Detected in all"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	17.9	4.8	7.1	4.0	8.8	0.1	14.4	3.7	7.3	7.9	3.5	1.7	4.7	3.1	7.6	7.2	5.4	5.6	9.0	10.8	8.4	6.2	26.6	9.7	7.4	8.0	9.3	1.5	5.4	8.0	4.2	7.4	14.1	12.3	9.1	2.9	11.9	3.5	5.6	9.3	2.7	3.9	12.3	7.4	34.6	3.5	2.6	8.2	0.6	12.0	5.7	4.0	6.0	5.8	0.9	0.6	1.2	0.4	2.8	0.5	0.0	0.0	29.6	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	62.5	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.9	20.7	0.0	0.0	0.0	1.9	0.2	0.0	0.0	14.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	1.2	0.4	0.4	0.3	0.2	0.1	0.5	0.4	0.2	0.0	0.9	0.4	0.5	0.5	2.8	0.3	0.6	0.1	0.0	7.1	8.8	3.7	7.3	8.4	6.2	9.3	1.5	12.3	8.2	0.0	4.1	2.2	0.0	2.9	0.1	1.1	7.6	1.4	0.0	1.8	0.0	0.0	8.3	21.2	0.3	155.8	0.0	0.0	0.2	0.0	0.9	1.0	1.1	0.6	0.1	0.0	0.0	174.3	13.0	1.0	2.0	0.2	1.7	1.0	0.0	0.6	1.2	0.0	6.3	25.4	0.0	0.0	2.1	0.0	0.2	2.5	0.0	1.3	0.0	0.4
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274192-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	64.3	34.6	26.5	22.1	45.0	23.0	84.3	11.0	38.3	35.7	42.2	43.1	33.7	41.8	35.0	30.0	86.8	25.1	50.3	34.6	21.0	17.2	50.7	69.3	46.7	34.3	37.5	13.7	27.9	87.6	31.3	15.0	92.7	40.9	31.6	40.1	23.9	40.1	43.7	53.2	49.5	70.6	41.2	50.3	22.7	57.8	13.2	32.5	9.4	66.4	42.1	36.3	57.7	54.5	17.0	19.6	60.3	43.5	13.0	24.0	33.6	26.9	9.7	0.5	7.2	63.1	26.6	29.0	26.5	32.7	15.7	18.1	24.8	66.9	6.2	19.3	38.9	29.9	46.1	9.0	59.4	15.5	22.2	3.7	39.0	6.7	29.8	28.6	0.5	38.5	25.2	55.8	32.1	41.0	16.8	16.6	1.0	24.3	11.6	27.3	1.1	0.4	6.7	0.4	55.7	8.8	0.9	4.3	4.8	21.1	85.0	0.5	0.5	8.7	32.5	18.4	6.0	8.7	5.9	25.1	28.2	7.8	13.0	9.6	5.6	6.5	2.7	27.8	6.2	15.9	60.3	27.7	59.9	24.0	36.2	20.5	17.0	22.0	19.5	19.6	14.0	14.7	15.8	35.5	13.0	43.5	5.3	23.5	33.6	26.5	45.0	11.0	38.3	21.0	17.2	37.5	13.7	40.9	32.5	68.5	24.6	28.7	69.9	72.6	1.9	23.1	86.6	8.1	29.6	66.3	0.0	126.2	11.6	144.8	0.6	46.0	183.5	23.3	245.6	121.5	63.2	108.4	48.5	40.1	94.3	0.0	21.8	25.2	35.2	1.9	50.0	57.9	43.9	14.4	54.8	22.4	239.0	105.2	55.9	32.3	1.7	12.9	47.2	0.7	12.3	88.3	235.9	34.8	41.2	229.1
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584531-123598577	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	31.3	31.9	15.7	21.8	21.2	23.5	32.0	13.2	21.5	38.5	31.6	20.4	41.1	27.6	33.4	49.0	41.3	27.4	28.9	41.7	15.7	17.1	32.6	120.1	28.1	29.4	18.2	16.7	37.4	135.4	18.1	36.3	40.0	18.9	33.3	32.8	23.8	90.2	38.0	46.3	27.4	34.2	30.5	22.5	25.6	32.4	17.8	15.0	24.0	49.2	23.8	30.0	34.0	27.8	32.4	69.3	58.9	40.9	39.5	61.2	36.2	41.9	37.4	24.9	43.0	56.8	50.4	59.3	73.0	59.0	46.5	36.9	37.3	36.6	36.0	39.2	72.7	31.9	42.1	33.6	39.3	48.9	27.0	29.0	38.8	22.7	48.1	107.9	52.8	33.5	42.3	65.7	39.9	54.3	66.7	43.4	24.6	39.1	24.7	47.4	31.1	28.0	43.4	35.9	36.3	33.7	29.1	40.6	41.8	56.7	63.6	31.0	26.8	48.9	49.1	48.3	31.5	83.3	42.9	41.1	39.7	25.1	38.3	40.8	54.7	50.7	30.5	46.9	35.0	46.8	58.9	39.8	39.6	46.8	40.9	61.2	32.4	42.4	44.1	44.2	27.2	34.6	40.3	31.5	39.5	37.8	69.3	38.3	36.2	15.7	21.2	13.2	21.5	15.7	17.1	18.2	16.7	18.9	15.0	44.7	63.4	116.9	242.8	370.8	48.2	119.4	201.2	64.3	75.1	146.5	19.6	243.2	99.5	277.5	9.2	101.5	131.7	0.0	218.6	589.4	362.9	393.4	91.1	470.6	200.1	46.1	163.9	139.3	120.4	10.9	168.0	156.4	359.4	130.8	234.1	92.4	213.4	161.4	144.2	138.8	38.3	161.7	234.9	97.7	158.0	436.1	377.9	163.0	207.2	283.9
TMEM135	FLJ22104	ENSG00000166575	"Transmembrane protein 135"	Q86UB9	11	87037844-87323758	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 42.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056685, HPA069473"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA056685: AB_2683208, HPA069473: AB_2686139"	"unprognostic (1.55e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.02e-4)"	"unprognostic (3.48e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.80e-1)"	31.6	28.9	10.5	9.5	12.0	5.9	23.3	11.4	14.8	8.3	14.3	12.8	18.9	21.8	15.1	7.8	7.4	8.4	12.6	12.6	9.9	11.3	16.5	31.2	11.7	9.8	13.8	10.2	14.1	9.2	14.7	24.4	13.5	12.9	15.4	12.1	12.8	16.9	17.8	14.9	7.5	20.1	11.1	11.2	8.3	10.1	15.7	11.4	14.1	15.0	6.4	7.0	10.7	9.9	5.9	7.0	2.2	6.0	8.4	10.4	4.5	4.2	6.9	4.9	6.7	15.8	15.2	6.2	3.3	8.5	4.0	8.4	12.2	19.2	12.0	8.5	4.2	9.2	4.1	6.6	8.0	4.2	10.5	4.1	9.6	7.3	42.3	8.8	5.2	5.0	17.4	4.8	5.2	3.6	5.0	9.9	11.9	8.8	16.5	4.2	3.4	12.8	6.1	5.8	22.0	5.9	6.7	3.9	9.5	8.8	13.2	2.5	6.3	5.1	14.6	7.0	9.5	20.9	5.8	5.2	4.3	5.3	14.8	2.5	6.9	12.4	13.0	3.0	5.9	7.8	0.9	5.8	1.7	9.7	6.0	8.5	5.9	6.3	10.4	6.6	5.2	7.1	6.8	2.2	8.4	2.7	7.0	6.5	4.5	10.5	12.0	11.4	14.8	9.9	11.3	13.8	10.2	12.9	11.4	8.9	6.9	1.5	3.9	3.8	5.8	4.6	0.0	1.4	6.8	1.8	3.9	1.7	5.0	2.6	2.2	6.3	12.6	0.0	2.9	7.1	7.5	9.3	9.2	14.7	4.3	1.6	3.5	8.6	6.3	5.2	6.6	4.2	5.0	3.6	6.5	5.0	2.9	6.2	6.7	8.4	4.2	32.3	5.3	2.1	3.6	4.3	1.3	3.2	7.8	3.7
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 49.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040189, HPA040228"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Nucleoplasm, Golgi apparatus"	"HPA040189: AB_10793959, HPA040228: "	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	7.1	5.6	32.4	4.8	49.2	3.1	8.6	5.3	36.6	13.4	10.1	4.2	6.5	10.9	8.4	3.9	6.3	5.8	7.3	5.3	18.5	8.7	3.3	6.4	6.7	3.4	5.5	23.3	5.6	18.5	8.1	21.5	6.5	11.2	9.4	11.5	4.3	22.4	10.0	4.9	7.0	12.6	7.8	7.3	7.6	16.3	16.0	8.5	2.3	9.7	2.1	3.2	9.9	7.0	1.0	2.1	7.7	3.4	3.9	4.7	1.4	10.2	5.9	8.4	12.9	22.3	20.5	16.1	23.2	13.6	12.1	13.9	10.0	12.6	4.3	12.0	19.2	26.0	15.2	12.4	15.3	19.3	6.3	8.9	8.0	8.8	21.1	18.2	10.0	7.7	16.9	15.1	13.5	18.3	18.3	19.4	6.2	15.2	5.4	19.8	6.2	4.4	12.5	6.5	20.4	7.6	4.3	9.7	4.9	11.6	8.0	24.9	17.1	17.0	16.0	11.1	12.1	6.1	14.1	18.4	12.6	8.5	20.8	20.0	3.2	2.2	4.8	15.2	12.6	11.9	7.7	2.2	5.7	4.7	2.3	3.6	0.9	2.7	3.7	1.6	1.0	2.4	3.2	1.6	3.9	3.4	2.1	2.6	1.4	32.4	49.2	5.3	36.6	18.5	8.7	5.5	23.3	11.2	8.5	11.9	31.5	2.4	11.3	18.1	13.4	14.8	20.4	5.3	7.9	15.7	17.7	7.7	3.3	22.0	3.2	24.0	29.3	0.0	28.2	10.9	15.0	29.8	10.5	18.6	8.9	19.1	42.6	20.3	14.2	4.0	12.0	13.6	13.5	4.6	34.5	6.0	36.3	28.1	16.6	4.8	14.4	6.5	17.1	14.2	22.6	18.3	4.3	20.1	24.4	29.1
TMEM35A	"FLJ14084, TMEM35"	ENSG00000126950	"Transmembrane protein 35A"	Q53FP2	X	101078720-101096364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;seminal vesicle: 46.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.5;HUVEC TERT2: 32.3;SH-SY5Y: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048583	Enhanced	Supported	Supported	"Vesicles,Focal adhesion sites,Cytosol"		NA	NA			Vesicles	"Focal adhesion sites, Cytosol"	"HPA048583: AB_2680451"	"unprognostic (7.98e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.49e-4)"	"unprognostic (5.91e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.37e-3)"	3.6	6.7	12.8	1.7	28.2	0.7	1.3	21.2	28.6	3.3	17.3	2.5	6.8	3.5	7.4	3.9	10.4	4.3	3.6	1.1	14.4	33.8	1.1	0.7	2.6	0.8	12.2	10.0	7.7	0.9	6.1	1.5	0.8	30.0	20.5	9.1	2.9	1.0	46.4	1.3	0.9	4.1	11.8	3.9	1.3	3.4	1.8	2.3	0.0	1.3	0.0	0.9	13.3	2.7	0.2	0.0	0.2	0.1	0.6	0.8	0.4	0.0	0.0	3.4	0.0	2.5	6.5	0.0	0.6	0.4	0.3	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	2.2	0.0	1.1	0.0	4.7	32.3	0.0	0.0	0.0	4.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	8.3	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.2	0.5	0.2	0.0	0.0	0.6	0.4	0.2	0.6	0.1	0.0	0.8	0.4	12.8	28.2	21.2	28.6	14.4	33.8	12.2	10.0	30.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNRC6A	"CAGH26, GW182, KIAA1460, TNRC6"	ENSG00000090905	"Trinucleotide repeat containing 6A"	Q8NDV7	16	24610209-24827632	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Horizontal cells: 166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015305, HPA017869"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA015305: AB_1850454, HPA017869: AB_1850456"	"unprognostic (2.64e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.35e-2)"	17.3	23.6	14.7	23.2	15.1	10.2	17.0	25.0	19.3	20.8	17.0	15.6	17.2	10.5	26.6	23.1	12.5	20.2	12.6	13.4	11.3	9.4	13.0	17.0	14.0	16.7	14.5	10.9	26.7	20.1	42.6	25.4	12.6	16.2	16.4	12.8	17.8	16.6	18.6	26.5	16.5	16.0	27.5	19.4	14.2	15.8	11.4	14.7	15.9	19.6	14.9	13.8	16.4	16.4	5.4	5.2	2.3	2.7	3.3	3.9	1.3	11.5	16.2	19.2	10.4	16.6	22.1	10.9	19.8	16.1	14.5	15.9	11.8	9.7	11.7	8.6	19.8	14.9	13.1	23.8	16.7	21.9	11.9	12.3	11.7	17.8	16.2	14.3	11.9	8.3	22.1	8.7	18.9	12.5	17.9	19.8	7.8	17.7	7.5	18.7	13.6	10.0	7.9	27.4	5.6	8.1	19.6	14.9	10.6	11.0	10.8	9.4	13.1	13.9	8.6	7.6	15.2	9.9	7.9	18.1	18.6	12.8	9.1	13.9	16.5	13.0	19.6	17.3	7.5	13.3	2.3	2.7	1.9	3.0	1.6	2.5	5.2	2.9	2.7	1.0	5.4	3.9	2.7	1.5	3.3	1.6	5.2	2.9	1.3	14.7	15.1	25.0	19.3	11.3	9.4	14.5	10.9	16.2	14.7	35.7	51.8	48.1	14.8	31.0	84.5	67.4	58.6	22.7	38.7	43.6	111.9	18.0	14.9	20.3	16.0	35.8	32.0	23.3	21.0	12.6	36.1	20.9	38.1	104.9	18.0	166.8	53.7	65.1	54.2	8.1	63.9	27.5	28.7	23.4	36.7	48.9	23.3	33.4	76.4	12.2	83.3	19.4	26.9	44.2	27.2	25.1	6.9	31.7	32.1	14.0
TOR1A	"DQ2, DYT1"	ENSG00000136827	"Torsin family 1 member A"	O14656	9	129812944-129824134	"Disease related genes, Predicted intracellular proteins"		"Chaperone, Hydrolase"	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012473, HPA051195"	Approved		Supported	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			"Nuclear membrane, Vesicles"		"CAB012473: AB_2240792, HPA051195: AB_2681382"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.67e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.99e-1)"	19.8	26.8	17.8	21.9	19.3	28.0	37.5	19.9	28.4	18.8	19.0	15.5	17.8	15.2	22.5	19.6	15.0	17.4	22.7	18.0	18.4	19.7	20.9	47.1	19.3	34.4	16.1	14.3	20.4	18.8	15.2	15.9	28.9	15.6	20.8	21.3	14.9	18.9	24.7	15.8	17.8	21.0	24.0	15.9	23.1	18.1	11.7	11.3	32.8	22.6	11.9	18.2	21.0	16.1	17.3	24.1	53.3	28.8	24.9	24.0	27.2	13.3	20.1	14.9	17.1	22.6	22.0	19.8	31.3	38.8	28.0	24.1	13.0	19.7	16.5	18.5	40.4	19.2	31.6	14.2	20.7	23.1	26.1	13.6	14.7	21.1	12.9	28.6	32.4	27.4	29.8	21.1	26.4	19.2	25.8	30.0	26.7	26.1	13.3	30.7	33.5	23.1	31.5	22.3	15.7	23.0	12.1	23.5	16.7	22.9	17.2	11.2	19.9	32.4	12.7	17.1	17.5	25.4	25.5	26.5	27.8	15.9	20.6	23.9	15.3	33.8	15.1	20.6	18.8	22.2	30.0	28.8	53.3	24.0	26.4	20.1	17.3	20.6	21.6	24.1	12.9	17.7	18.3	28.2	24.9	21.3	22.1	22.4	27.2	17.8	19.3	19.9	28.4	18.4	19.7	16.1	14.3	15.6	11.3	8.9	10.2	22.0	14.3	15.7	10.7	7.8	20.4	13.4	19.4	14.0	2.0	42.7	13.3	38.6	0.4	17.7	12.1	0.0	43.7	54.7	23.7	18.0	21.9	21.2	41.6	20.6	18.5	14.1	12.3	1.0	11.8	30.3	13.5	56.9	17.9	18.9	34.7	21.5	14.5	14.0	7.9	32.3	13.4	5.9	9.1	16.2	44.6	26.7	15.3	16.9
TP53I3	PIG3	ENSG00000115129	"Tumor protein p53 inducible protein 3"	Q53FA7	2	24077433-24085861	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.0"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 190.0;Paneth cells: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	6	"T-47d: 115.8"					"Low region specificity"	"Detected in all"			"CAB017479, HPA022012, HPA028742"	Enhanced		Supported	Vesicles		NA	NA		200000	Vesicles		"CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456"	"unprognostic (3.66e-2)"	"unprognostic (1.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.57e-3)"	10.3	9.5	2.7	11.7	2.7	6.3	6.3	2.5	3.6	12.0	42.1	3.6	10.5	18.4	8.5	7.0	43.2	6.1	17.8	5.0	1.6	3.2	28.2	11.5	15.7	5.3	2.1	2.0	4.7	20.3	4.0	4.6	13.0	3.3	6.6	15.5	6.7	11.3	6.9	4.9	2.8	55.0	6.1	2.3	5.6	9.0	41.3	1.9	8.6	9.0	10.6	9.0	8.2	21.8	3.6	11.1	11.4	13.4	0.2	0.4	4.0	5.0	16.6	9.7	4.0	7.7	17.2	7.1	5.0	6.2	4.4	6.1	4.2	9.1	0.6	2.9	8.3	1.2	1.5	2.5	8.9	2.7	3.8	0.3	1.4	5.8	10.8	5.0	0.6	2.9	18.6	14.2	11.8	2.9	9.1	19.8	3.0	1.2	4.3	18.5	3.3	0.9	0.1	7.4	5.7	6.8	1.8	8.6	0.1	7.4	7.9	1.4	6.2	6.6	1.5	1.0	8.2	115.8	1.0	14.5	5.0	12.3	3.4	2.5	2.0	1.2	0.5	1.7	0.0	1.3	7.3	13.4	11.4	0.2	8.5	0.1	3.6	0.2	0.4	11.1	2.6	0.0	0.3	2.8	0.2	3.8	4.8	0.3	4.0	2.7	2.7	2.5	3.6	1.6	3.2	2.1	2.0	3.3	1.9	26.8	28.9	12.6	28.1	4.1	0.7	9.6	53.5	5.3	19.4	40.1	0.0	37.7	92.9	83.6	104.8	14.5	144.3	0.0	119.0	24.8	16.4	11.1	12.7	11.0	42.3	0.0	76.2	22.7	23.6	190.0	7.2	21.7	13.5	27.1	44.3	6.7	79.6	164.1	8.5	62.2	1.9	19.4	12.5	18.5	8.9	6.0	24.1	3.8	54.0	39.6
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	16.0	18.2	18.3	22.3	20.6	28.5	39.1	28.7	25.6	22.1	29.4	9.1	21.1	37.3	20.4	18.3	32.9	21.9	36.9	21.0	18.3	14.8	21.3	47.3	18.3	40.9	13.4	14.7	19.3	41.6	17.7	20.3	19.5	12.8	16.2	16.9	13.0	24.4	23.1	25.5	32.2	37.8	28.8	14.1	21.4	25.1	13.2	10.6	26.1	20.3	30.9	21.9	21.9	28.9	6.7	12.3	7.7	13.9	3.0	7.1	5.2	20.7	26.6	15.2	27.2	15.8	29.8	17.9	16.0	20.2	18.9	17.1	32.3	26.8	13.3	19.0	20.4	12.1	24.4	14.2	28.4	7.2	21.0	18.2	19.0	35.4	24.7	20.9	20.2	27.6	29.5	23.8	18.2	23.9	15.6	36.5	26.4	20.3	18.0	18.0	47.5	20.7	23.5	29.9	28.7	13.0	38.7	25.3	26.7	15.2	11.2	30.7	25.5	13.4	25.8	17.5	8.3	29.3	24.9	27.5	23.0	32.4	21.4	17.4	26.1	19.3	17.6	13.1	13.1	17.8	3.7	10.0	7.7	5.4	13.9	5.0	6.7	5.3	5.7	12.3	4.9	3.8	4.5	6.9	3.0	9.4	6.0	7.1	5.2	18.3	20.6	28.7	25.6	18.3	14.8	13.4	14.7	12.8	10.6	0.0	8.6	11.9	15.5	25.5	14.6	3.4	17.8	4.0	4.5	14.0	5.9	20.5	14.9	35.4	3.8	23.9	60.0	0.0	51.6	30.1	20.0	27.8	9.2	26.1	37.6	35.0	32.6	23.4	38.3	9.1	23.0	18.8	10.1	35.1	35.9	10.5	45.1	40.3	20.8	18.9	8.9	6.5	16.0	4.8	21.5	28.4	22.3	12.9	33.8	29.6
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102642310-102660680	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	31.7	18.4	26.1	23.9	25.2	17.0	18.0	26.1	31.6	31.8	19.5	22.9	15.4	15.8	18.0	14.3	17.8	21.6	19.8	25.0	23.2	18.0	27.2	21.9	23.0	25.4	20.1	20.0	19.3	35.9	24.7	14.7	17.5	16.3	17.4	8.1	19.4	28.5	18.5	34.8	14.6	23.7	13.6	15.7	22.5	21.2	11.7	21.9	48.3	26.6	14.5	30.3	21.4	15.9	9.0	11.9	17.8	5.3	5.5	7.2	3.9	26.9	6.3	6.3	10.2	6.9	14.1	5.8	9.7	19.7	10.5	8.5	11.4	32.6	8.7	26.0	21.5	4.6	9.9	4.2	13.0	8.7	8.8	8.2	21.9	5.3	26.0	17.6	4.9	8.8	16.1	7.2	23.1	13.7	35.0	14.0	4.5	4.1	13.1	8.2	17.5	9.3	16.4	3.4	9.8	12.9	4.6	14.1	4.3	12.5	19.0	3.8	7.4	5.3	6.6	12.8	7.4	18.8	9.8	25.9	14.2	6.3	7.9	21.7	11.9	7.8	5.0	21.6	12.3	3.6	10.7	4.8	2.6	6.8	4.4	6.7	9.0	7.2	5.3	4.1	7.0	6.4	5.5	17.8	5.5	5.3	11.9	6.9	3.9	26.1	25.2	26.1	31.6	23.2	18.0	20.1	20.0	16.3	21.9	53.6	64.6	14.3	12.5	27.9	37.2	34.1	33.1	37.5	36.4	83.7	7.9	10.3	34.9	50.3	0.9	21.5	18.8	0.0	39.1	2.9	23.8	18.6	8.1	24.1	21.7	27.0	20.7	26.4	31.7	0.4	28.7	27.1	16.9	46.9	30.1	22.7	48.9	17.5	32.2	40.0	14.3	12.9	24.3	2.3	5.3	19.9	9.2	17.5	20.4	18.7
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751526	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.7"	"Cell type enhanced"	"Detected in many"	10	"monocytes: 342.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 19.4"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 19.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	Vesicles	Nucleoplasm	"HPA041934: AB_2677754, HPA072625: AB_2732206, HPA073886: AB_2732244"	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favorable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	19.7	10.7	6.0	9.2	7.2	2.3	16.8	3.7	5.4	25.6	19.1	4.5	20.6	9.7	17.8	16.7	44.8	12.0	17.6	18.1	6.5	1.9	14.0	4.5	19.5	5.4	6.7	3.5	22.4	12.9	7.0	4.8	25.4	7.0	19.2	6.6	20.2	16.1	18.3	103.7	10.4	10.1	20.9	6.7	7.1	11.3	8.7	5.4	2.8	31.7	21.6	21.7	24.3	26.5	1.5	19.4	0.1	0.7	1.6	0.9	0.4	26.8	16.3	5.7	8.6	22.5	23.7	20.6	17.4	20.1	19.9	17.4	22.1	15.5	0.5	23.5	14.6	16.1	20.0	12.9	25.3	11.8	16.9	5.2	8.7	15.4	16.8	18.5	0.4	2.8	27.3	17.2	17.7	13.6	26.3	20.4	1.2	12.7	7.4	14.5	9.1	2.3	6.0	12.1	16.8	13.9	3.9	11.8	7.8	16.7	13.4	0.0	6.6	22.8	10.3	6.5	13.9	10.7	4.7	39.7	13.4	24.0	34.9	18.2	7.8	4.2	2.6	21.7	2.5	8.7	0.0	0.7	0.0	0.5	0.1	0.7	1.2	0.2	0.9	3.8	1.5	0.3	0.2	0.1	1.6	0.1	19.4	0.0	0.4	6.0	7.2	3.7	5.4	6.5	1.9	6.7	3.5	7.0	5.4	26.8	20.3	3.7	99.7	75.9	13.2	7.5	17.8	9.4	30.7	15.7	35.3	6.1	5.0	41.3	9.7	37.9	25.1	0.0	33.6	32.8	73.7	86.2	27.8	3.4	8.7	0.0	7.5	38.1	4.0	10.0	51.8	30.9	35.4	342.7	15.5	11.4	60.8	24.3	33.9	18.2	16.8	32.3	85.5	1.9	5.9	72.8	11.9	4.3	21.7	106.3
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533123	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA		170000	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	56.8	10.3	15.4	17.2	14.1	22.0	45.1	5.2	16.8	30.0	14.1	15.1	28.1	13.3	18.9	22.4	44.6	22.2	15.1	15.2	13.4	7.7	22.9	16.0	32.9	47.4	18.8	10.8	21.7	14.4	12.3	7.4	39.0	13.0	20.0	12.3	22.7	24.8	16.5	11.3	33.3	17.3	15.3	16.5	28.2	12.6	12.9	14.5	16.0	26.2	19.1	26.7	30.5	28.4	4.4	10.1	16.2	47.7	26.1	29.0	21.3	21.9	32.5	30.2	10.4	46.5	14.9	14.2	11.3	21.7	12.3	9.0	31.3	12.8	7.1	21.8	6.1	4.4	22.9	8.4	20.5	10.1	12.5	3.2	20.1	3.8	26.8	15.6	7.5	4.9	14.3	18.2	12.4	22.7	22.4	45.9	7.3	11.1	5.2	3.5	18.8	10.8	5.3	6.9	13.7	0.0	37.5	3.5	1.1	48.3	31.5	6.5	9.9	4.5	31.5	34.8	10.8	12.7	18.0	64.7	3.1	12.9	3.0	7.9	2.5	9.3	2.5	10.2	15.1	13.6	3.8	14.8	16.0	29.0	30.4	13.2	4.4	22.7	25.7	10.1	4.2	27.1	25.2	16.2	26.1	47.7	4.0	17.9	21.3	15.4	14.1	5.2	16.8	13.4	7.7	18.8	10.8	13.0	14.5	14.9	59.8	19.7	37.8	31.0	1.9	11.8	35.7	9.4	17.0	31.4	72.6	5.4	6.6	35.7	1.9	70.2	22.1	0.0	21.7	57.5	18.8	31.3	7.0	17.9	43.6	3.2	61.8	166.3	95.3	1.7	36.2	45.9	13.5	14.4	32.7	26.6	48.5	11.5	38.5	7.2	7.0	97.0	20.8	3.9	20.0	31.9	6.4	40.7	24.8	62.8
UBAP1	UBAP	ENSG00000165006	"Ubiquitin associated protein 1"	Q9NZ09	9	34179005-34252523	"Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019804	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA019804: AB_1858494"	"unprognostic (1.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.63e-1)"	"prognostic favorable (7.49e-6)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.17e-1)"	26.4	34.6	25.7	17.5	25.0	81.9	28.6	29.1	29.5	24.2	26.0	26.5	14.5	16.6	25.3	20.0	40.5	20.4	22.9	34.4	24.0	23.6	25.6	38.6	27.7	17.3	27.0	20.0	26.8	20.7	26.7	19.2	26.8	25.5	20.4	19.0	21.5	19.4	24.3	62.3	22.6	24.6	26.4	26.3	21.4	20.9	33.5	26.0	17.2	23.6	22.1	25.4	29.2	29.5	10.5	17.8	45.9	19.6	17.4	26.5	19.2	20.9	11.8	13.6	14.8	25.3	15.7	11.5	16.8	23.7	18.9	25.8	12.8	8.8	14.7	7.6	25.1	16.1	10.8	18.9	26.5	18.3	21.1	8.5	13.1	26.5	13.3	23.1	14.5	17.5	19.4	44.0	22.4	29.5	28.8	20.9	14.5	10.0	14.7	17.6	8.8	13.4	20.4	14.8	14.5	17.7	12.1	9.7	8.5	40.5	14.0	7.8	10.9	18.7	19.5	8.6	12.7	9.5	14.5	14.8	9.7	15.0	14.5	15.6	7.3	9.1	15.5	19.5	11.8	28.5	9.0	19.6	24.1	15.4	17.1	26.5	10.5	15.5	16.1	17.8	8.8	15.1	12.3	45.9	17.4	14.5	9.9	19.1	19.2	25.7	25.0	29.1	29.5	24.0	23.6	27.0	20.0	25.5	26.0	62.5	24.2	13.9	57.1	41.7	12.9	11.4	12.7	25.4	38.7	7.0	23.6	29.1	16.6	29.7	56.8	17.9	20.6	23.3	35.1	29.2	28.2	45.4	24.4	20.8	19.3	6.4	15.4	12.9	17.1	45.7	27.0	22.9	23.6	20.8	15.4	23.6	35.8	23.0	40.0	15.8	11.4	19.4	28.6	21.7	20.6	51.6	74.9	25.4	16.8	59.0
UBE2A	"HHR6A, RAD6A, UBC2"	ENSG00000077721	"Ubiquitin conjugating enzyme E2 A"	P49459	X	119574467-119591083	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Syncytiotrophoblasts: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (2.27e-3)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.12e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.07e-4)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (2.20e-6)"	"unprognostic (9.54e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.92e-2)"	24.8	20.6	26.7	23.1	24.6	16.8	32.5	20.2	24.2	23.7	32.8	23.9	20.2	21.7	23.8	26.7	37.2	20.3	21.2	42.2	23.6	22.1	32.2	26.6	22.8	26.3	26.8	19.7	18.7	17.2	24.3	18.2	112.4	24.7	20.4	30.2	20.0	21.0	22.6	46.8	23.6	29.2	27.9	29.1	25.1	20.4	17.0	19.5	36.3	23.2	32.8	31.5	26.7	24.0	21.0	29.0	34.1	36.3	12.8	21.2	17.4	31.1	26.3	16.6	14.0	29.0	35.8	15.5	32.4	28.9	38.5	36.6	13.6	21.5	24.7	32.9	35.6	64.7	22.5	23.6	17.1	37.2	34.2	14.0	10.9	21.0	12.1	26.6	27.2	18.8	24.4	24.5	37.0	16.1	27.2	26.7	22.1	13.4	22.1	43.6	33.0	42.0	25.8	27.6	32.9	29.8	21.5	17.6	23.0	31.1	20.5	12.7	13.1	43.0	19.8	23.5	21.6	17.3	23.9	26.0	24.8	11.1	48.9	36.5	21.4	34.8	24.3	26.4	34.6	19.3	16.5	22.7	34.1	18.1	35.4	14.3	21.0	15.7	15.8	29.0	18.8	10.0	14.3	30.1	12.8	36.3	23.0	21.2	17.4	26.7	24.6	20.2	24.2	23.6	22.1	26.8	19.7	24.7	19.5	95.3	39.2	51.3	71.2	110.8	14.0	62.9	48.4	83.0	53.4	38.4	29.5	150.4	86.2	88.0	32.0	62.8	76.2	46.7	89.2	129.6	86.9	77.3	55.4	31.6	116.0	7.9	43.7	44.2	59.6	10.6	34.2	89.3	79.2	168.7	43.9	37.6	102.2	80.7	38.2	92.2	34.3	45.3	103.2	39.1	30.0	111.8	425.3	58.0	43.9	88.5
UBE2B	"HHR6B, RAD6B, UBC2"	ENSG00000119048	"Ubiquitin conjugating enzyme E2 B"	P63146	5	134371179-134391992	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 83.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 83.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003875, HPA051765, HPA065898"			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane"	"Vesicles, Cytosol"	"HPA003875: AB_2667061, HPA051765: AB_2681597, HPA065898: AB_2685577"	"unprognostic (1.98e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.39e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.64e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.42e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.52e-2)"	17.7	27.7	20.4	17.0	16.6	25.9	22.8	16.2	28.3	13.8	18.0	7.9	11.6	14.4	19.4	17.0	25.6	13.6	18.3	59.2	20.3	16.4	17.8	19.8	21.8	18.7	13.8	18.7	16.7	26.4	7.8	16.2	27.8	17.6	15.4	15.1	10.2	16.1	18.5	106.5	15.9	16.2	21.6	15.1	16.6	14.1	21.7	12.7	13.2	18.2	34.0	16.3	19.2	22.8	9.6	8.8	83.3	14.1	9.6	14.6	10.5	35.5	9.3	19.6	18.6	17.1	18.5	31.6	26.7	14.1	17.2	20.5	28.3	23.9	19.4	32.3	17.0	47.0	14.2	14.8	19.7	18.8	30.7	16.0	10.6	25.9	30.3	20.0	12.6	21.9	15.9	27.0	15.6	13.2	23.2	14.7	16.2	19.5	35.3	15.5	20.7	20.0	33.4	8.4	10.6	8.9	20.2	21.6	27.0	15.4	27.5	26.5	20.6	21.0	9.9	46.4	22.2	21.3	34.8	29.1	20.0	14.0	26.9	29.2	29.5	40.3	27.4	22.6	23.9	19.9	34.7	11.5	31.2	9.4	12.5	8.6	9.6	12.0	9.5	7.9	9.6	14.6	12.3	83.3	9.6	14.1	8.8	14.1	10.5	20.4	16.6	16.2	28.3	20.3	16.4	13.8	18.7	17.6	12.7	68.5	53.6	80.6	311.1	324.0	73.3	287.9	109.5	50.9	37.5	71.5	76.6	127.7	145.9	138.0	194.0	119.9	104.0	210.2	148.2	103.0	162.4	304.2	116.3	90.1	106.8	82.6	126.4	82.3	121.3	244.2	143.5	139.6	215.9	189.4	109.5	124.2	180.7	129.8	106.4	130.7	89.5	148.8	178.2	201.6	171.6	323.2	605.1	89.5	82.7	405.3
UHRF1BP1L	KIAA0701	ENSG00000111647	"UHRF1 binding protein 1 like"	A0JNW5	12	100028455-100142848	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039671, HPA075150"	Uncertain		Uncertain	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA039671: AB_10794201, HPA075150: "	"unprognostic (4.80e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.94e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-2)"	14.9	13.9	15.9	11.4	19.9	31.9	10.8	16.9	26.0	9.5	10.0	8.7	5.3	9.9	9.3	8.8	10.2	8.0	10.6	10.4	18.0	13.7	14.7	28.0	10.6	9.7	14.8	12.0	11.1	4.7	21.5	15.3	13.7	22.6	11.1	9.6	6.9	8.7	11.2	26.2	8.4	11.1	11.2	13.7	11.8	9.0	15.2	9.8	10.0	13.0	8.1	8.1	16.7	8.4	3.8	8.4	22.9	8.4	3.7	3.7	3.4	11.3	12.4	6.9	7.1	10.7	15.3	13.8	17.8	17.9	14.4	10.6	9.2	3.9	9.9	4.7	18.1	8.4	4.4	12.9	6.0	14.0	26.2	6.4	6.6	9.9	10.6	9.9	12.4	10.8	8.6	5.1	17.3	12.0	13.4	10.0	6.9	5.2	10.3	14.0	6.3	7.9	10.7	11.9	3.9	11.3	9.0	12.3	9.7	7.4	20.1	11.8	7.4	13.5	15.6	5.3	6.2	13.9	14.2	7.9	16.0	8.5	13.7	12.4	12.2	20.8	13.9	8.0	9.4	9.6	12.5	7.6	4.9	2.6	8.4	3.7	3.8	2.9	2.9	8.4	3.4	2.5	3.0	22.9	3.7	6.8	5.1	3.2	3.4	15.9	19.9	16.9	26.0	18.0	13.7	14.8	12.0	22.6	9.8	26.8	8.3	9.8	13.2	11.3	10.8	11.5	2.5	30.8	19.4	8.7	3.9	3.9	5.0	4.8	17.2	6.8	8.0	0.0	5.0	7.4	14.6	16.5	23.1	17.4	9.8	14.3	5.2	6.2	17.7	2.1	6.6	20.6	10.1	8.2	2.8	5.8	4.2	7.0	7.4	12.2	11.3	0.0	9.7	19.8	21.5	10.2	9.2	12.5	4.7	10.2
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 70.2;granulocytes: 43.9;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 56.1;HMC-1: 58.2;SK-BR-3: 39.8"	"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"	"Not detected"	"Not detected"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol		NA	NA		14000000	Cytosol	Vesicles	"HPA067117: AB_2685784, HPA073525: AB_2686615"	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	4.5	3.3	2.9	17.1	5.2	31.3	4.5	4.1	3.1	5.2	5.2	2.8	1.4	4.5	3.8	1.8	11.5	5.2	8.7	13.0	1.8	1.6	2.6	4.9	30.1	24.9	4.5	1.6	8.7	5.5	0.3	5.3	67.1	3.2	3.1	2.6	2.6	8.0	3.9	3.2	3.0	7.6	2.8	3.7	33.8	7.2	2.2	3.3	23.6	2.4	9.3	24.7	7.0	8.2	4.0	6.9	24.8	13.6	8.2	11.5	7.9	8.4	3.2	0.1	0.0	0.1	0.2	10.7	0.0	0.0	0.0	0.0	8.2	19.1	0.7	10.2	0.0	1.4	2.9	0.0	0.5	0.0	0.1	0.1	56.1	24.9	5.2	0.9	21.4	58.2	0.1	0.4	0.1	0.5	0.5	3.8	9.8	19.4	0.2	0.0	14.4	22.6	10.7	0.2	15.0	0.4	7.2	0.2	0.3	0.3	3.4	0.0	15.6	3.6	39.8	0.2	0.1	10.7	12.1	10.6	0.1	15.1	0.1	0.0	0.3	1.3	0.9	0.1	6.8	0.0	24.8	8.0	16.4	11.5	9.4	10.4	4.0	6.7	8.1	6.9	2.2	5.3	6.9	22.4	8.2	13.6	4.0	6.0	7.9	2.9	5.2	4.1	3.1	1.8	1.6	4.5	1.6	3.2	3.3	41.7	11.7	22.2	1.7	1.0	11.3	70.2	10.2	0.0	5.7	3.5	19.6	2.8	0.0	6.2	3.9	5.7	20.0	0.0	5.3	8.4	2.3	1.1	43.9	0.8	46.9	4.8	5.8	4.3	22.7	0.0	2.6	18.4	1.7	13.6	2.3	5.8	27.8	10.5	1.4	0.6	15.5	0.0	1.4	1.4	0.9	1.3	21.6	30.5	2.2	2.0
VAMP7	"SYBL1, TI-VAMP, VAMP-7"	ENSG00000124333	"Vesicle associated membrane protein 7"	P51809	X	155881293-155943769	"Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036733	Approved		Supported	Vesicles		NA	NA		14000	Vesicles		"HPA036733: AB_10672228"	"unprognostic (7.54e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.15e-3)"	"unprognostic (2.70e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.95e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.97e-1)"	11.9	12.7	43.9	9.5	51.2	13.4	51.9	21.2	41.1	38.4	9.3	2.5	2.5	9.6	36.5	6.6	10.4	8.5	9.3	26.9	46.8	12.5	61.4	20.5	10.3	9.8	50.6	44.8	34.5	7.9	12.8	35.0	68.7	58.5	9.4	10.5	2.5	8.3	9.0	12.0	9.3	11.3	12.0	63.0	8.4	8.4	5.6	47.6	2.5	10.4	2.5	11.6	10.2	26.1	6.6	13.5	34.8	13.8	11.2	11.0	10.6	22.4	9.8	6.8	14.0	18.8	18.1	18.2	17.5	15.6	15.9	32.2	10.6	14.8	31.3	32.6	21.0	18.0	8.1	15.2	12.3	21.1	13.0	13.3	13.0	14.6	7.5	21.1	26.6	20.4	16.8	12.3	17.7	16.3	13.9	17.6	13.8	27.7	17.4	17.9	11.3	10.3	15.2	4.8	16.8	14.5	7.9	13.3	23.2	21.0	11.3	5.1	14.9	10.3	10.5	15.3	18.6	10.2	22.4	18.5	14.6	15.3	20.9	24.8	40.1	50.6	43.8	12.8	32.7	16.2	34.8	12.9	19.7	8.3	13.8	10.5	6.5	9.9	10.2	13.5	6.6	9.2	9.8	11.2	11.2	12.8	7.7	11.0	10.6	43.9	51.2	21.2	41.1	46.8	12.5	50.6	44.8	58.5	47.6	3.0	8.6	21.6	11.9	17.4	6.6	9.9	7.6	4.0	9.1	7.0	5.9	42.4	34.9	22.9	5.2	19.6	15.5	46.7	22.8	35.9	25.1	14.3	31.1	21.3	28.1	6.4	12.7	19.6	24.4	4.9	16.4	30.8	18.6	24.4	14.5	10.4	23.3	14.0	18.4	39.8	4.1	25.8	22.8	23.4	25.8	16.9	58.4	26.6	14.5	14.2
VBP1	"PFD3, PFDN3"	ENSG00000155959	"VHL binding protein 1"	P61758	X	155197007-155239817	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB006260, HPA023230"	Approved		Supported	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"CAB006260: AB_425740, HPA023230: AB_1858727"	"unprognostic (1.55e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.85e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.80e-1)"	17.3	19.2	37.8	15.5	28.0	24.5	18.4	26.1	32.5	14.9	16.9	20.6	12.5	12.8	14.9	16.3	17.8	13.8	13.3	35.9	35.4	36.8	22.9	17.4	13.0	21.0	40.9	25.6	15.3	11.8	18.3	22.0	16.9	33.9	18.2	19.2	10.1	11.1	15.6	50.5	10.9	14.3	16.4	46.0	13.9	12.5	8.7	22.9	21.0	18.4	25.6	22.0	16.9	12.8	15.0	18.4	37.0	12.6	13.8	21.6	15.7	35.6	12.9	28.1	18.6	11.6	16.1	8.1	17.7	13.8	23.4	36.7	15.3	18.3	45.9	38.0	14.9	35.9	14.1	40.6	16.6	30.4	24.1	28.5	19.3	20.4	11.9	13.9	31.0	15.2	12.0	19.9	19.5	24.7	12.5	21.5	23.1	37.6	27.3	26.2	14.8	29.2	27.8	16.2	33.5	27.7	25.1	22.3	26.8	20.2	16.3	30.5	18.5	12.1	14.4	19.6	20.5	12.3	24.1	12.4	18.7	23.2	31.8	43.7	30.9	44.8	80.3	16.6	38.5	22.9	8.5	11.6	37.0	14.4	12.6	16.5	15.0	16.9	17.2	18.4	11.8	19.6	20.7	13.6	13.8	10.4	15.1	21.6	15.7	37.8	28.0	26.1	31.9	35.4	36.8	40.9	25.6	33.9	22.9	47.6	23.2	62.5	65.5	50.9	53.7	75.4	20.4	37.5	35.2	36.6	19.6	64.6	162.5	59.1	2.1	43.8	23.1	46.7	50.6	83.0	57.1	54.4	46.2	21.2	60.3	30.2	22.5	25.2	28.8	3.9	38.9	49.5	43.9	101.0	29.1	54.2	44.5	40.4	37.4	82.3	34.9	45.3	49.9	40.8	99.9	45.9	57.4	60.9	38.8	52.0
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450628	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 249.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: AB_2676652, HPA043947: AB_2678744"	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favorable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	16.4	14.5	16.5	15.9	22.3	7.0	23.5	36.8	27.7	17.1	21.1	13.6	12.8	23.8	22.4	12.9	24.6	16.6	18.0	20.3	15.4	13.0	22.6	20.2	17.5	15.6	16.2	18.5	20.0	19.0	14.4	20.1	21.7	25.9	20.1	24.7	18.2	21.6	18.3	23.4	44.6	27.9	23.7	13.8	22.3	15.7	4.2	13.8	18.1	20.0	16.8	18.1	20.3	21.7	14.4	14.9	13.9	19.2	19.4	19.3	11.8	3.8	6.4	11.3	7.4	11.8	16.5	9.7	8.8	6.8	8.9	5.4	7.5	12.7	13.5	4.7	12.6	5.7	10.8	8.9	10.6	10.0	10.0	8.6	15.8	10.1	6.7	14.0	21.2	17.2	11.5	20.9	6.1	10.0	10.0	9.0	17.6	11.6	11.9	17.2	4.9	15.4	21.3	10.7	15.1	3.3	16.2	6.4	8.2	15.7	10.0	5.8	12.2	6.2	14.9	13.4	13.8	8.7	35.4	14.0	5.8	6.9	5.7	9.9	8.9	11.1	14.3	5.9	15.0	13.3	13.9	13.5	10.9	12.1	14.8	19.3	14.4	13.3	15.1	14.3	12.3	12.4	13.2	3.7	19.4	19.2	14.9	14.3	11.8	16.5	22.3	36.8	27.7	15.4	13.0	16.2	18.5	25.9	13.8	77.4	38.5	35.3	43.5	38.0	114.4	71.9	38.2	33.5	47.8	31.4	113.9	51.3	58.0	31.0	1.2	57.1	58.8	0.0	25.7	34.0	26.8	47.9	42.8	49.9	37.6	49.3	47.8	33.7	36.4	1.9	46.1	34.1	27.0	27.9	56.5	33.0	27.4	59.4	49.1	58.0	249.2	45.3	28.3	8.4	18.5	50.8	31.9	37.6	49.4	40.0
VPS53	"FLJ10979, HCCS1"	ENSG00000141252	"VPS53, GARP complex subunit"	Q5VIR6	17	508668-721717	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 237.4;Late spermatids: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 15.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022988, HPA024446"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA022988: AB_1848679, HPA024446: AB_1848680"	"unprognostic (8.62e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (1.08e-5)"	"unprognostic (1.39e-2)"	"unprognostic (9.08e-3)"	"unprognostic (3.12e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.56e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.31e-1)"	10.0	9.7	15.7	9.0	19.3	13.0	8.8	34.5	21.6	10.5	11.4	11.5	11.7	8.5	10.2	9.1	16.3	10.0	9.2	9.1	13.4	14.0	10.0	8.8	11.1	8.0	11.8	17.5	10.6	8.8	14.4	13.0	10.4	15.9	10.8	12.0	9.3	9.6	11.3	13.9	19.6	9.1	10.5	10.3	9.2	13.5	13.5	11.7	12.2	14.7	6.0	12.5	8.9	9.9	2.8	2.8	15.5	7.2	1.2	2.3	0.8	9.4	13.2	5.9	6.3	9.1	7.1	3.2	10.0	5.7	9.9	8.1	7.9	3.1	6.4	5.9	9.7	6.0	9.4	8.2	8.1	10.9	6.0	9.2	5.3	9.9	5.8	5.7	4.8	6.9	6.8	5.4	8.7	6.3	6.2	8.2	6.5	4.7	6.2	7.9	4.7	6.0	1.8	4.7	3.6	5.1	8.8	2.7	3.5	6.5	10.0	4.2	6.8	11.8	4.4	5.1	5.7	4.5	2.1	13.9	6.2	4.5	9.1	6.4	3.8	2.5	3.9	9.0	3.0	4.9	15.5	2.0	2.3	2.3	3.5	1.6	1.9	1.8	1.8	1.7	2.8	1.8	1.9	2.4	1.2	7.2	2.8	1.0	0.8	15.7	19.3	34.5	21.6	13.4	14.0	11.8	17.5	15.9	11.7	11.9	23.4	12.8	12.1	22.7	47.2	15.5	15.3	18.7	27.3	38.4	66.8	8.1	1.7	14.5	237.4	14.3	19.3	0.0	15.8	6.2	12.3	15.8	23.1	14.7	18.3	60.4	23.6	16.5	18.4	133.5	17.3	19.0	10.1	18.0	21.4	20.4	20.3	14.0	21.5	7.9	53.1	6.5	13.3	29.9	19.0	33.9	7.4	24.5	16.6	14.8
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224689	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		22000	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	18.8	19.5	20.5	15.5	28.2	17.2	20.6	25.0	39.3	17.2	22.0	18.5	9.6	24.2	16.0	17.1	31.4	17.9	14.9	21.2	19.8	20.3	24.9	29.9	13.5	19.3	20.1	20.7	15.3	15.6	16.3	21.7	30.5	30.7	16.8	26.3	11.2	19.4	13.5	48.6	20.9	32.7	17.0	24.0	20.8	14.6	12.9	18.2	33.6	18.0	24.3	24.0	18.4	19.7	29.0	30.9	58.6	38.1	30.9	30.1	36.1	18.4	15.9	26.0	39.8	23.0	25.3	18.0	42.0	25.1	38.5	36.8	26.9	14.5	30.2	28.4	37.6	29.3	23.7	27.6	28.6	53.4	20.4	24.3	32.7	17.1	32.1	17.0	50.7	19.0	20.9	33.6	38.4	24.9	20.7	24.6	23.6	30.3	15.2	32.1	27.0	32.9	26.4	19.5	23.9	18.3	30.3	20.9	18.4	29.6	20.6	27.3	21.2	23.6	18.2	21.1	22.7	19.7	34.6	17.8	17.4	24.2	29.0	30.1	15.0	25.9	34.4	11.4	28.4	26.4	58.6	31.0	49.5	23.5	38.1	30.1	29.0	26.8	27.4	30.9	26.6	29.8	29.9	19.1	30.9	37.4	19.0	25.7	36.1	20.5	28.2	25.0	39.3	19.8	20.3	20.1	20.7	30.7	18.2	20.8	16.9	15.6	15.3	22.3	9.1	37.0	10.2	40.2	25.0	15.7	0.0	28.5	14.9	26.8	2.2	15.7	29.3	0.0	24.4	30.4	20.0	13.7	11.6	22.7	24.3	11.1	20.7	8.0	20.8	2.1	10.9	15.6	8.5	18.0	24.5	21.3	24.7	17.5	11.7	24.5	10.8	6.5	8.2	20.6	25.7	27.0	26.5	16.2	23.7	15.3
VTI1A	"MVti1, Vti1-rp2, Vti1a"	ENSG00000151532	"Vesicle transport through interaction with t-SNAREs 1A"	Q96AJ9	10	112446998-112818744	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054108	Supported		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA054108: AB_2682382"	"unprognostic (9.81e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (6.50e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic favorable (7.27e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.61e-1)"	16.8	12.8	14.5	17.9	17.9	25.2	14.6	16.7	18.6	10.0	13.8	14.3	14.4	15.2	11.8	11.6	21.1	9.5	10.3	13.1	13.4	11.1	15.4	11.8	15.7	15.4	12.8	12.2	10.5	12.8	17.4	13.7	11.0	14.6	11.4	17.0	11.2	14.3	13.6	18.4	17.1	16.5	12.8	12.7	16.0	12.3	9.8	13.0	18.8	14.2	9.7	19.6	13.1	15.6	7.3	6.8	14.8	11.7	7.3	8.8	5.5	11.0	9.2	8.8	12.0	13.7	12.1	5.2	11.8	15.0	9.7	10.9	10.4	11.5	11.5	4.6	13.5	8.2	13.3	7.5	9.5	13.2	14.4	6.6	9.9	6.8	10.9	9.7	13.7	14.5	9.2	12.3	10.9	22.9	10.9	10.2	11.9	9.0	14.5	12.8	7.6	10.9	10.6	3.7	8.8	5.4	11.5	12.7	5.1	10.1	9.9	4.0	7.7	8.4	7.4	7.8	7.7	6.6	7.7	14.3	7.6	6.5	9.2	13.2	6.3	8.8	13.5	12.4	12.7	7.3	8.9	8.9	11.9	7.5	11.7	7.0	7.3	6.3	6.0	6.8	6.7	6.2	6.4	14.8	7.3	10.4	6.4	8.8	5.5	14.5	17.9	16.7	18.6	13.4	11.1	12.8	12.2	14.6	13.0	11.9	10.1	18.0	12.4	10.0	16.9	10.6	7.6	13.4	12.5	5.2	41.2	6.9	6.6	11.1	32.9	11.1	16.3	23.3	21.6	9.8	7.6	10.6	18.5	7.3	16.5	20.6	17.7	7.4	17.0	60.8	6.4	21.7	11.8	13.6	8.7	5.4	21.2	8.4	5.3	7.8	20.1	0.0	9.8	10.7	7.0	14.3	12.0	20.3	9.9	15.7
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"liver: 321.7"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 4765.6"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"					"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	11	"CACO-2: 168.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	NA	NA	606000000000	32000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.6	2.2	0.0	0.0	0.0	321.7	0.0	0.0	0.0		0.0	0.6	0.0	0.0	2.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4			0.0		0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.1	168.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.7	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	15.5	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.9	0.0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0.0	0.2	0.0	0.1											0.0	0.6	55.9	0.0	0.0	10.7	14.7	1151.5	0.0	0.0	0.0	72.6	2.6	3.3	14.8	0.0	0.7	0.0	233.6	17.1	1.6	7.6	0.0	0.0	4765.6	4.3	36.5	0.0	116.0	117.8	0.0	0.0	0.0	0.0	35.1	0.0	4.8	38.2	0.0	1.4	2.2	24.6	0.0	2.0	0.3	0.4	0.0	8.0	0.7	0.0	0.0
VWCE	"FLJ32009, URG11, VWC1"	ENSG00000167992	"Von Willebrand factor C and EGF domains"	Q96DN2	11	61258286-61295424	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 19.8;ovary: 10.7"	"Cell type enhanced"	"Detected in many"	11	"Cone photoreceptor cells: 27.5;Hepatocytes: 14.0;Rod photoreceptor cells: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.7;Hep G2: 19.3;HSkMC: 11.4;REH: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA040401, HPA043921"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol	"Secreted - unknown location"	NA	NA		1300000	Nucleoplasm	"Vesicles, Cytosol"	"HPA040401: AB_2676963, HPA043921: AB_2678731"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.96e-3)"	"unprognostic (9.27e-4)"	"unprognostic (1.21e-2)"	"unprognostic (4.01e-4)"	"unprognostic (3.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.58e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-1)"	2.9	1.1	0.9	0.6	1.3	2.3	3.1	0.7	1.3	2.8	1.0	1.4	3.4	0.5	1.4	2.9	1.5	5.7	1.4	1.0	1.3	1.2	0.6	19.8	0.8	0.3	0.4	1.1	10.7	0.1	0.5	0.5	9.1	0.3	1.8	0.6	1.3	1.7	1.0	1.9	0.9	1.1	1.2	0.2	0.9	0.3	1.8	0.5	6.5	0.8	1.0	1.0	1.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.2	1.1	0.4	0.2	1.8	0.0	0.3	5.7	0.0	0.3	0.0	0.4	0.1	0.0	2.0	0.0	0.1	0.4	0.0	0.5	0.0	19.3	1.1	0.0	0.1	11.4	0.5	0.5	0.0	0.1	1.8	2.6	0.2	0.3	0.3	0.1	4.2	0.0	1.6	0.0	0.0	10.9	0.1	0.0	0.1	0.1	0.4	0.9	0.0	0.1	0.6	2.0	0.7	0.0	0.5	0.2	0.3	0.5	0.1	0.2	0.4	0.9	0.8	0.2	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.7	1.3	1.3	1.2	0.4	1.1	0.3	0.5	3.0	1.7	0.0	1.5	1.5	3.2	0.7	0.0	5.3	2.3	0.0	27.5	0.9	0.0	0.1	0.4	2.2	0.0	0.0	0.4	2.2	1.4	0.4	3.5	14.0	1.1	0.0	1.7	3.1	4.0	0.0	6.4	2.2	1.7	1.8	0.0	3.2	0.0	0.0	1.8	0.3	17.1	0.0	0.5	0.9	3.0	1.9	3.7	0.5	0.1	0.7
WASHC1	"FAM39E, FLJ00038, WASH1"	ENSG00000181404	"WASH complex subunit 1"	A8K0Z3	9	14521-73865	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 57.6;Cytotrophoblasts: 30.8;Distal tubular cells: 43.1;Proximal tubular cells: 37.7;Syncytiotrophoblasts: 35.8"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA002689	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA002689: AB_1078803"	"unprognostic (9.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (5.00e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.37e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.02e-1)"	1.7	1.5		0.8		2.4	0.4		0.5	0.4	1.1			1.9	4.1	5.4	3.3	3.3	1.2	2.5			1.5	0.0	1.4	2.1			2.5	0.8	0.0		0.6		3.2	0.0		1.2	5.0	4.2	3.7	1.3	3.8		2.1	1.3	0.3			0.3		0.3	0.2		3.5	5.7	4.9	8.7	5.0	5.0	3.4	11.5	7.0	4.3	9.0	7.5	5.1	10.7	10.8	9.6	5.9	5.0	6.7	7.1	4.7	5.8	4.1	5.6	14.2	6.3	4.9	2.3	4.9	11.6	4.6	5.0	7.0	4.2	9.3	8.5	3.8	3.7	3.0	4.1	15.3	1.8	4.3	10.3	18.1	1.8	3.4	9.5	7.7	7.9	7.6	14.8	6.5	5.8	6.0	4.3	8.1	4.8	13.1	5.8	13.1	6.9	5.6	7.4	8.9	7.1	8.0	8.3	3.5	9.1	8.2	6.4	3.7	7.5	10.1	7.4	2.4	5.9	4.9	5.0	6.2	3.9	3.5	4.0	4.1	5.7	3.3	4.2	3.4	3.6	5.0	8.7	5.1	4.2	3.4											20.8	22.7	0.0	0.0	0.0	0.0	0.0	0.0	14.7	13.6	57.6	0.0	30.8	43.1	11.8	0.0	0.0	0.0	0.0	13.6	21.5	0.0	0.0	15.1	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	8.2	0.0	0.0	11.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133506	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 35.7;Ciliated cells: 76.3;Club cells: 42.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	24.0	21.0	15.8	31.4	19.3	24.7	27.1	22.5	18.3	19.1	21.2	16.2	12.6	19.4	22.8	15.3	15.7	15.5	14.4	42.9	17.6	13.9	26.1	12.1	20.7	20.2	15.3	15.8	22.5	14.0	21.2	27.0	17.7	22.0	16.7	23.0	13.1	17.5	16.5	15.5	19.2	21.3	16.8	14.6	27.4	16.2	9.4	14.8	27.0	21.4	9.8	20.2	18.4	27.4	6.6	9.0	11.7	13.9	9.0	12.5	8.8	11.1	5.4	9.2	10.8	37.6	21.0	7.5	13.1	27.8	19.5	20.8	12.5	16.7	9.8	8.2	19.5	18.3	12.2	13.3	11.0	19.3	9.4	9.7	7.0	10.8	12.5	26.2	11.9	12.2	21.6	13.9	21.3	13.5	20.5	14.7	8.4	11.3	9.9	23.4	7.9	6.5	19.5	7.5	7.1	25.5	10.0	13.4	5.8	13.4	12.8	3.2	9.9	12.2	11.3	17.4	14.2	14.0	8.2	21.5	10.0	8.4	28.1	10.7	10.3	20.3	8.4	21.9	21.9	4.0	1.2	10.7	11.7	12.0	13.9	12.5	6.6	10.2	11.0	9.0	6.5	10.2	7.4	5.1	9.0	8.2	5.3	10.4	8.8	15.8	19.3	22.5	18.3	17.6	13.9	15.3	15.8	22.0	14.8	35.7	22.0	0.0	0.0	0.0	0.0	0.0	0.0	76.3	42.1	14.0	0.0	6.6	0.0	14.2	0.0	0.0	0.0	0.0	13.5	5.7	0.0	0.0	14.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	10.0	0.0	0.0	12.2	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792961	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 26.2;Ciliated cells: 45.5;Collecting duct cells: 22.7;granulocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	17.2	15.8	10.0	33.6	15.7	30.1	27.2	24.9	17.1	16.7	15.8	10.7	15.9	12.2	18.3	17.0	12.3	13.2	13.6	23.2	14.2	10.2	20.6	12.8	17.3	14.8	16.0	8.4	20.2	10.1	22.7	16.5	13.4	16.2	13.4	18.5	13.0	15.3	24.0	17.1	14.8	17.0	15.8	14.0	15.5	12.5	10.1	15.3	19.4	14.9	13.2	14.6	19.3	14.8	10.7	11.4	17.2	20.3	12.2	13.4	11.6	11.2	12.2	9.9	11.3	25.9	23.0	6.0	13.3	21.9	15.7	15.2	7.4	11.1	9.3	9.1	19.6	15.0	10.3	11.1	6.1	15.9	8.7	9.2	9.6	15.2	5.7	27.5	9.6	12.0	21.7	14.8	17.0	12.8	15.5	16.2	7.9	15.3	7.4	19.3	5.9	6.4	16.7	7.2	6.8	1.9	8.1	14.6	4.8	11.7	17.8	4.8	10.9	15.4	7.8	18.6	10.6	10.5	9.7	27.2	8.2	8.8	21.7	8.9	10.5	16.2	9.3	11.6	23.2	4.3	12.5	16.9	11.0	13.0	18.2	12.5	10.7	10.8	13.4	11.4	9.6	10.8	9.7	17.2	12.2	20.3	8.4	10.1	11.6	10.0	15.7	24.9	17.1	14.2	10.2	16.0	8.4	16.2	15.3	32.8	26.2	0.0	0.0	0.0	0.0	0.0	0.0	45.5	21.6	22.7	0.0	6.2	3.3	10.9	0.0	0.0	0.0	0.0	12.1	5.4	0.0	0.0	27.9	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	18.0	0.0	0.0	10.6	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0
WDFY2	ZFYVE22	ENSG00000139668	"WD repeat and FYVE domain containing 2"	Q96P53	13	51584455-51767707	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA050094			Supported	Vesicles		NA	NA			Vesicles		"HPA050094: "	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.49e-4)"	"unprognostic (1.47e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.48e-1)"	9.0	16.5	11.0	9.9	11.6	21.9	12.8	6.3	9.6	9.3	4.7	20.2	11.1	3.9	9.0	15.2	16.1	8.9	8.6	6.6	11.0	7.0	7.8	12.5	9.1	9.0	17.1	7.5	10.9	26.4	23.1	11.7	9.6	11.0	7.1	4.7	6.7	8.5	16.7	3.1	29.4	5.7	6.9	11.2	10.6	8.4	14.4	16.7	9.6	10.4	13.3	10.1	6.4	12.0	4.5	13.1	5.4	8.8	3.8	3.3	3.3	1.1	2.1	9.3	3.7	4.6	9.6	3.1	9.0	5.7	4.7	3.7	1.3	1.3	3.6	0.9	6.1	3.0	4.0	5.1	16.0	8.9	2.9	2.8	7.7	2.9	10.8	3.6	5.2	3.6	7.7	7.7	10.4	11.9	7.6	2.0	3.9	2.1	1.9	7.6	2.4	3.5	11.8	11.1	2.5	3.1	4.7	3.7	2.4	5.9	3.0	2.6	6.3	2.6	4.0	4.1	8.1	1.9	12.4	7.6	8.9	1.7	4.3	6.2	1.2	2.0	2.6	10.2	5.4	10.9	4.8	8.1	3.9	2.4	8.7	3.3	4.0	2.6	2.0	13.1	4.5	2.3	2.9	5.4	3.8	8.8	12.0	3.3	3.3	11.0	11.6	6.3	9.3	11.0	7.0	17.1	7.5	11.0	16.7	14.9	18.7	15.4	17.7	20.7	30.2	5.9	2.5	17.4	26.1	27.9	119.8	23.9	23.2	14.6	33.4	9.2	6.2	0.0	20.7	28.3	13.3	9.6	27.8	17.0	23.6	35.0	13.2	30.1	52.3	15.7	36.5	30.9	11.8	10.8	5.2	37.4	18.7	3.4	20.5	5.0	53.1	25.8	11.7	28.4	14.9	23.7	11.7	16.6	6.8	14.4
WDR24	"C16orf21, DKFZp434F054, JFP7"	ENSG00000127580	"WD repeat domain 24"	Q96S15	16	684622-690444	"Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039506	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA039506: AB_10795148"	"unprognostic (9.07e-2)"	"unprognostic (2.67e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.15e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.05e-1)"	"prognostic favorable (3.75e-6)"	"unprognostic (5.38e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.82e-2)"	8.8	11.6	10.9	9.8	11.3	9.3	9.2	18.9	17.6	7.6	7.8	8.2	6.5	12.1	10.2	10.2	9.4	9.3	8.5	9.9	9.5	7.8	9.0	15.7	15.3	17.7	8.7	11.1	12.8	14.5	17.0	11.9	9.2	8.8	10.3	3.6	8.8	16.2	8.8	16.9	13.5	10.2	10.0	10.6	13.3	10.5	17.6	9.5	17.9	11.8	7.9	6.5	9.2	7.8	7.1	7.7	6.5	10.3	4.3	10.7	7.1	4.4	10.3	4.8	6.6	4.6	3.3	8.4	5.6	5.0	7.0	6.1	11.2	6.6	6.9	9.8	2.5	1.9	7.0	4.6	5.5	1.5	11.6	14.6	4.7	13.8	4.3	7.3	5.7	7.4	5.8	3.7	5.0	4.2	3.7	3.8	6.8	9.2	7.8	2.6	16.3	10.0	4.2	7.3	2.3	8.1	14.9	3.9	12.7	2.3	3.1	11.9	5.4	6.4	11.0	6.2	2.3	10.0	5.8	5.6	5.2	5.4	5.6	5.4	16.9	15.3	11.3	3.3	5.7	7.1	6.5	7.5	4.0	10.7	4.5	8.7	7.1	6.9	7.8	7.7	6.4	8.2	7.7	1.8	4.3	10.3	6.2	8.9	7.1	10.9	11.3	18.9	17.6	9.5	7.8	8.7	11.1	8.8	9.5	6.0	3.8	4.5	2.2	1.0	4.5	3.3	2.5	20.1	4.5	7.0	2.0	5.6	6.6	4.4	13.1	2.2	6.7	23.3	4.7	3.7	2.0	3.3	4.6	7.8	4.4	20.6	9.7	2.5	8.1	30.6	5.2	2.9	0.0	3.6	5.3	5.6	3.7	2.8	2.8	5.4	2.1	19.4	2.3	19.5	8.5	1.4	6.2	3.2	4.1	1.6
WDR48	"KIAA1449, P80, SPG60"	ENSG00000114742	"WD repeat domain 48"	Q8TAF3	3	39051998-39096671	"Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038421, HPA058015"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA038421: AB_10670780, HPA058015: AB_2683580"	"unprognostic (1.95e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.14e-3)"	"unprognostic (9.87e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.14e-2)"	"prognostic favorable (1.63e-7)"	"unprognostic (2.41e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.69e-2)"	16.0	15.0	16.3	9.2	22.0	22.3	13.9	22.3	24.2	15.4	14.0	15.4	19.0	10.1	19.9	9.1	11.9	14.1	10.5	11.8	16.4	14.0	16.5	11.9	10.5	12.1	17.3	16.3	17.0	12.1	21.1	20.2	16.0	20.4	14.5	12.4	9.4	14.0	17.4	14.7	11.3	12.0	14.4	17.4	10.9	11.9	36.8	18.0	21.9	20.4	7.0	15.2	22.6	11.9	12.2	10.1	16.7	12.8	14.9	13.2	9.7	4.9	8.0	17.1	9.9	11.4	13.4	6.5	7.6	10.6	10.0	12.4	5.6	5.4	14.7	4.6	10.2	7.5	5.9	15.4	9.7	10.5	35.6	17.6	13.2	12.1	7.4	4.5	9.8	5.9	8.8	8.9	11.1	11.8	14.6	10.7	9.1	14.9	12.7	7.1	4.5	10.1	3.7	15.8	6.3	9.9	4.1	8.7	10.1	8.5	11.4	11.9	13.4	6.5	12.1	9.3	14.4	6.9	9.8	9.1	7.6	5.3	7.3	7.2	12.9	22.2	10.6	8.1	7.3	6.6	16.7	6.6	7.2	11.2	9.6	10.5	10.9	11.5	12.4	10.1	12.2	12.4	10.7	9.3	14.9	12.8	6.7	13.2	9.7	16.3	22.0	22.3	24.2	16.4	14.0	17.3	16.3	20.4	18.0	14.9	22.4	9.9	11.9	15.7	19.1	21.5	5.1	22.7	18.2	10.4	15.7	13.4	14.9	13.6	57.2	18.3	15.5	0.0	10.5	10.2	15.3	15.7	23.1	9.0	7.4	20.6	21.2	11.1	9.2	48.4	17.3	14.3	13.5	19.0	13.7	21.8	11.2	12.4	15.6	11.6	16.9	25.8	17.3	76.5	57.7	18.4	18.0	13.8	11.2	13.1
WDR81	"CAMRQ2, FLJ33817, PPP1R166, SORF-2"	ENSG00000167716	"WD repeat domain 81"	Q562E7	17	1716523-1738599	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023044, HPA063703"	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA023044: AB_1858822, HPA063703: "	"unprognostic (1.00e-1)"	"unprognostic (4.67e-2)"	"unprognostic (6.63e-2)"	"unprognostic (4.90e-3)"	"unprognostic (6.10e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.60e-2)"	"prognostic favorable (3.30e-4)"	"unprognostic (3.26e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.43e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.90e-2)"	12.7	12.2	8.9	12.1	8.4	10.7	22.9	7.0	11.7	12.6	9.1	10.5	26.4	11.3	14.9	11.6	7.4	12.8	9.3	9.0	8.4	4.3	9.6	22.7	17.2	21.4	9.2	4.4	18.5	8.3	3.5	9.9	8.9	8.5	11.9	4.6	10.6	10.1	21.8	13.1	16.7	12.7	11.6	5.0	19.0	8.4	6.3	8.2	17.3	8.1	5.2	10.3	11.6	16.2	2.8	6.9	5.1	5.0	4.2	3.0	1.9	0.5	10.8	1.5	7.3	10.5	5.8	8.0	0.6	0.1	0.4	0.0	1.4	4.0	4.2	5.8	4.3	5.6	10.2	5.3	7.2	0.3	7.9	11.3	0.1	7.4	4.9	18.0	3.4	6.6	14.5	7.4	5.2	3.2	2.1	4.0	3.4	0.3	5.4	6.0	5.2	1.1	5.8	3.4	3.2	7.6	5.5	2.5	5.6	3.0	1.5	2.1	4.6	3.9	3.3	12.6	0.1	4.9	5.0	6.0	4.2	5.0	6.7	5.5	0.4	0.9	2.4	6.5	5.5	2.9	0.0	3.1	5.1	2.6	5.0	3.0	2.8	2.7	2.6	3.8	2.3	1.8	2.4	0.6	4.2	4.3	6.9	2.4	1.9	8.9	8.4	7.0	11.7	8.4	4.3	9.2	4.4	8.5	8.2	11.9	9.3	4.7	2.5	2.3	4.7	2.6	5.1	4.0	3.4	0.0	3.9	2.1	1.7	2.5	0.5	2.9	5.9	0.0	3.8	1.7	3.1	2.4	4.6	20.9	20.3	4.8	1.2	5.5	17.2	0.4	15.3	9.1	0.0	5.4	4.0	2.8	4.7	3.4	14.2	11.1	1.7	19.4	2.0	0.5	1.5	1.5	1.9	2.9	3.5	1.3
WDR83	MORG1	ENSG00000123154	"WD repeat domain 83"	Q9BRX9	19	12666800-12675832	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042629, HPA042838"	Uncertain		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			Vesicles	"Nucleoplasm, Centrosome"	"HPA042629: AB_10794763, HPA042838: AB_10794173"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.56e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (3.12e-4)"	6.4	7.8	10.2	6.2	9.1	8.8	6.5	17.2	14.5	7.1	5.2	9.1	2.3	4.9	5.8	6.1	5.9	11.3	5.2	9.2	8.5	8.9	8.1	5.9	6.0	8.3	12.4	11.6	9.2	11.6	9.4	6.7	4.9	9.1	6.9	2.6	7.7	14.6	6.9	4.6	11.3	6.3	3.8	7.0	7.4	7.1	9.2	10.6	11.7	9.2	2.6	5.8	6.0	5.7	8.8	19.4	5.4	11.1	17.6	11.3	8.6	4.9	8.3	4.7	6.5	9.3	3.5	3.8	4.7	4.4	5.7	6.0	9.6	4.3	7.5	6.9	4.2	3.2	5.6	5.5	7.3	1.0	7.6	12.2	5.9	5.5	6.0	7.4	8.2	7.0	6.4	5.9	4.6	3.8	3.8	5.7	16.3	5.2	0.8	2.6	18.8	11.9	6.7	3.8	5.8	14.4	8.5	6.1	7.0	5.4	5.9	9.9	6.6	5.1	7.0	4.1	2.7	3.9	8.1	3.1	6.4	2.0	5.1	4.9	19.1	12.8	3.3	10.0	6.3	4.1	4.5	11.1	4.6	9.2	9.6	10.7	8.1	8.9	8.6	11.1	8.8	8.7	11.3	5.4	17.6	4.7	19.4	9.8	8.6	10.2	9.1	17.2	14.5	8.5	8.9	12.4	11.6	9.1	10.6	0.0	15.6	12.6	11.4	13.7	20.5	4.2	12.7	10.7	7.9	17.4	11.8	11.1	14.9	13.6	13.8	10.5	9.3	0.0	15.2	11.6	11.0	13.4	13.9	7.2	11.5	19.1	9.2	9.2	11.6	43.7	14.7	14.8	15.1	18.0	6.7	15.0	11.1	5.9	17.0	22.6	20.4	19.4	13.2	25.0	16.9	14.1	7.6	16.2	8.1	12.2
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234516-27308633	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	14.7	17.5	20.2	11.1	22.0	13.2	12.1	21.8	28.4	15.0	15.3	20.7	14.1	13.3	14.5	9.1	12.4	21.1	11.0	29.1	18.0	15.0	13.6	13.0	14.3	13.3	15.8	16.1	15.8	22.3	49.3	12.3	10.9	19.7	14.3	10.1	29.6	20.6	16.5	51.1	20.9	14.2	12.8	15.1	13.2	15.2	28.3	16.5	21.0	19.4	12.1	14.0	15.0	12.3	1.3	1.5	5.6	0.8	0.8	3.3	1.2	13.0	5.7	9.3	0.9	13.3	11.1	3.9	8.1	13.6	8.7	10.6	1.9	13.2	11.1	9.8	16.1	6.5	6.8	8.7	12.3	7.5	15.3	15.0	11.5	6.6	5.2	12.0	5.9	15.6	10.5	20.2	10.8	9.9	15.9	11.8	3.7	11.7	11.9	9.1	7.2	9.6	14.5	4.4	8.7	12.5	4.8	7.0	12.3	10.2	2.9	13.7	11.8	10.5	4.5	9.5	7.3	6.7	10.4	10.0	7.1	4.4	10.1	3.9	17.2	9.2	5.4	14.6	11.4	8.5	0.3	0.5	5.6	3.3	0.8	1.3	1.3	0.8	1.4	1.5	0.8	0.6	1.5	4.8	0.8	0.6	1.0	0.9	1.2	20.2	22.0	21.8	28.4	18.0	15.0	15.8	16.1	19.7	16.5	8.9	12.5	5.1	9.7	11.4	24.2	12.2	7.6	6.7	5.7	29.6	51.1	10.4	8.3	13.9	22.7	7.1	16.7	0.0	12.2	4.0	7.2	12.5	1.1	15.5	11.3	20.6	16.0	17.8	18.9	50.8	15.8	9.7	10.1	14.4	19.3	16.1	13.2	5.8	15.6	14.3	68.8	6.5	8.1	34.9	5.7	15.2	13.7	13.8	15.5	12.8
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	39.4	35.3	47.9	35.9	21.7	29.2	35.3	43.7	28.2	46.0	39.4	46.9	29.7	57.9	30.6	29.9	46.8	33.5	73.0	30.3	67.7	35.3	26.9	57.0	36.3	29.3	15.7	57.4	39.0	16.4	22.7	36.3	39.6	34.9	37.5	29.2	65.7	33.8	42.3	20.8	47.7	25.2	55.7	47.2	27.1	42.8	54.7	35.2	20.9	30.0	38.3	20.4	42.5	35.9	21.3	50.4	29.4	28.4	25.0	43.2	49.1	35.1	42.9	27.5	45.3	84.0	26.8	49.3	38.9	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3	38.7	36.3	31.8	27.6	46.2	69.7	57.0	43.3	46.8	28.4	29.6	90.3	46.3	11.6	24.4	3.2	40.7	19.3	70.0	22.5	42.3	40.9	34.4	40.5	48.0	49.4	68.3	43.4	42.4	46.3	8.0	31.1	53.2	35.4	49.5	31.2	34.0	26.3	17.5	29.0	20.8	102.5	19.4	43.7	64.6	88.2	49.7	25.2	42.9	37.6	38.3
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682427-42702349	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 128.1;testis: 426.5"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 6931.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Supported		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		870000	Cytosol	Vesicles	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavorable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	47.5	20.6	15.6	36.4	18.4	57.6	35.2	13.7	14.4	27.9	44.5	21.2	20.1	25.6	35.1	36.4	40.0	25.6	32.5	57.8	15.2	12.3	33.1	38.1	35.3	49.8	17.6	13.2	30.2	36.7	9.4	12.2	26.1	15.5	32.0	33.1	31.1	26.6	23.0	128.1	22.5	27.1	50.0	21.0	47.9	33.2	426.5	15.9	53.2	31.4	64.1	37.2	39.4	41.0	23.5	26.9	21.8	40.5	11.6	23.0	10.6	92.5	54.6	87.4	87.6	85.2	77.1	77.9	68.3	63.6	95.0	74.6	74.7	86.5	117.5	71.7	68.6	40.6	56.0	98.4	103.6	94.4	62.7	91.3	119.8	108.4	95.9	68.7	160.8	89.8	70.9	89.3	94.8	117.4	52.1	78.5	98.4	124.6	51.2	88.4	58.3	181.7	156.6	197.1	59.5	73.8	110.0	157.1	126.9	94.0	68.5	120.9	85.2	67.0	90.7	127.6	97.4	30.2	320.5	61.2	67.5	115.2	91.4	138.9	75.1	94.1	133.7	63.9	120.6	71.6	4.3	18.1	21.8	16.3	37.8	19.9	23.5	19.5	15.8	26.9	20.1	16.8	17.2	3.3	11.6	40.5	20.9	23.0	10.6	15.6	18.4	13.7	14.4	15.2	12.3	17.6	13.2	15.5	15.9	160.8	193.6	710.2	1008.1	1241.5	227.0	1010.1	351.6	187.4	286.6	308.8	141.4	639.1	1235.1	944.3	6931.7	600.7	713.3	817.7	771.6	1697.6	856.8	736.8	377.2	465.4	1556.8	114.4	564.5	393.5	1134.6	2234.4	695.5	1494.6	858.7	964.0	841.6	220.6	737.9	799.5	757.7	816.8	432.4	459.2	1265.4	2608.0	287.2	1138.5	402.6	588.8	1140.5	1354.3
YIF1A	"54TM, FinGER7, YIF1, YIF1P"	ENSG00000174851	"Yip1 interacting factor homolog A, membrane trafficking protein"	O95070	11	66284580-66289170	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014840, HPA076194"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA014840: AB_2217189, HPA076194: "	"unprognostic (9.35e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (8.70e-4)"	16.0	19.7	11.3	12.4	11.7	6.4	18.9	8.0	16.5	17.3	21.4	19.3	18.5	26.1	19.4	24.8	18.5	16.4	24.6	20.1	9.8	9.2	26.2	138.8	16.5	16.0	12.8	9.4	21.2	55.2	18.9	26.8	24.7	12.3	16.8	17.9	16.5	24.4	19.2	32.3	14.3	32.1	19.1	15.2	12.8	19.4	16.9	10.7	16.4	28.2	26.4	17.7	18.2	13.7	27.4	40.4	5.5	38.9	13.3	23.6	26.1	20.8	34.6	10.8	19.6	36.5	39.4	19.8	30.7	33.0	26.3	26.0	32.7	25.7	17.8	30.2	43.1	29.8	31.8	16.4	28.9	21.0	20.2	18.9	11.0	26.9	40.5	40.8	15.4	16.8	27.1	39.3	27.1	44.1	21.3	24.5	17.9	20.5	31.3	22.8	50.6	18.5	16.4	10.9	39.0	36.1	14.3	16.5	53.0	22.2	19.0	15.8	15.6	16.6	28.8	27.2	14.3	42.3	11.5	21.6	22.2	18.8	44.7	14.2	21.0	21.7	15.9	34.8	14.7	24.4	4.9	28.0	5.5	21.8	38.9	23.6	27.4	18.8	20.3	33.2	22.6	15.1	17.2	2.8	13.3	37.2	40.4	15.2	26.1	11.3	11.7	8.0	16.5	9.8	9.2	12.8	9.4	12.3	10.7	35.7	49.5	40.9	73.7	32.1	25.8	28.6	66.2	69.6	35.2	43.6	21.6	105.1	54.7	124.9	21.6	45.3	78.6	0.0	130.4	213.7	96.8	110.9	29.9	155.3	96.6	25.4	84.0	49.7	32.3	35.0	69.9	39.6	69.2	37.9	97.4	73.4	109.8	89.6	77.4	112.8	27.8	38.8	58.4	32.7	49.9	40.5	129.1	42.6	93.3	84.8
YIPF5	"FinGER5, SMAP-5"	ENSG00000145817	"Yip1 domain family member 5"	Q969M3	5	144158159-144170714	"Predicted membrane proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042338, HPA073622"	Supported		Supported	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Endoplasmic reticulum, Golgi apparatus, Vesicles"	Nucleoplasm	"HPA042338: AB_2677953, HPA073622: AB_2686618"	"prognostic unfavorable (7.83e-5)"	"unprognostic (1.13e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.12e-5)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (2.89e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.79e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.49e-2)"	26.6	26.6	18.4	14.7	21.2	15.8	22.5	19.2	22.6	23.9	22.2	17.2	22.5	26.5	25.7	22.0	27.2	18.9	19.0	18.3	15.1	18.5	23.0	27.8	20.4	21.0	16.2	20.5	19.6	41.7	21.5	45.3	37.1	21.8	16.8	23.4	18.9	32.7	18.3	11.9	24.5	30.5	25.2	19.7	18.8	23.8	20.7	16.2	14.0	20.2	21.2	20.1	24.1	19.9	22.3	27.2	28.8	28.1	23.7	36.7	23.4	11.5	7.7	10.1	8.0	24.2	26.2	9.2	39.5	26.9	17.8	28.8	12.3	12.2	6.3	19.1	42.8	20.5	10.7	9.6	19.4	24.1	8.8	8.3	4.7	13.5	12.5	19.6	10.4	7.8	19.8	18.2	15.9	13.1	30.8	16.9	7.0	4.9	10.7	24.0	6.0	5.1	5.9	6.5	7.4	8.5	5.4	15.0	10.5	11.1	10.3	6.9	8.5	13.7	7.4	17.5	10.7	15.3	6.9	64.9	21.0	10.2	20.3	15.5	9.7	16.1	8.0	20.1	10.0	15.3	25.6	21.0	28.8	30.3	28.1	34.3	22.3	31.0	33.6	25.0	21.5	32.8	30.8	15.6	23.7	25.4	27.2	36.7	23.4	18.4	21.2	19.2	22.6	15.1	18.5	16.2	20.5	21.8	16.2	35.7	24.3	40.2	21.0	26.2	39.5	19.3	22.9	49.5	26.1	19.2	31.4	48.9	26.6	36.5	8.3	38.7	36.0	46.7	60.0	68.2	45.1	27.2	35.8	30.5	33.0	31.8	14.3	33.2	27.9	5.3	32.8	24.3	28.7	34.3	44.6	54.8	46.2	31.9	31.8	30.4	43.2	38.8	28.8	78.4	48.5	22.7	56.4	34.5	25.2	18.5
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type containing 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.7	5.2	6.3	9.3	8.0	6.8	7.3	13.2	9.7	8.8	13.2	5.8	7.1	8.7	6.4	5.6	36.4	10.5	6.9	7.7	6.2	7.1	10.8	2.3	4.7	6.9	5.4	5.2	5.8	14.0	10.9	20.1	9.4	9.4	7.1	14.7	6.4	11.2	5.9	2.1	14.9	12.3	4.9	4.7	6.3	14.4	11.2	4.8	15.0	7.7	18.2	27.5	15.3	14.5	6.3	4.3	23.4	5.8	4.3	7.5	3.5	15.9	7.6	7.3	6.2	2.6	3.0	7.0	7.7	7.1	8.6	10.0	4.6	3.8	8.2	5.3	6.4	19.4	24.4	10.4	5.0	9.5	10.1	9.1	4.3	4.8	3.7	6.0	5.8	7.4	3.4	6.0	3.6	5.1	8.1	54.4	11.5	4.1	4.1	8.8	5.2	7.4	4.7	6.0	15.1	7.0	8.2	10.1	1.9	8.9	10.6	12.7	9.3	9.2	11.2	4.1	7.3	5.3	6.7	15.6	7.7	5.4	11.7	6.1	3.5	10.8	7.5	9.2	6.0	13.4	7.4	3.5	23.4	6.8	5.8	6.1	6.3	5.3	7.5	4.3	4.2	5.1	6.5	4.4	4.3	4.6	4.2	6.8	3.5	6.3	8.0	13.2	9.7	6.2	7.1	5.4	5.2	9.4	4.8	8.9	12.5	4.9	19.3	21.5	10.4	32.9	10.2	33.5	21.6	15.7	9.8	7.5	5.0	17.2	73.0	9.3	13.5	0.0	17.0	15.7	10.6	33.7	11.5	0.8	5.5	15.9	15.0	9.2	5.9	36.4	7.2	7.4	3.3	29.7	21.1	61.2	17.7	14.0	2.1	2.2	8.5	0.0	5.6	38.7	22.6	31.7	5.3	8.7	18.7	44.2
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type containing 17"	Q8IUH5	12	76763588-76853696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 16.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	7.9	7.8	10.0	5.8	14.0	11.3	8.8	18.1	18.1	8.0	5.9	9.2	3.8	3.6	12.0	6.8	6.4	7.0	5.5	6.4	8.7	6.5	9.1	13.1	5.4	7.1	11.3	10.7	11.5	5.2	9.5	10.3	8.7	13.2	7.9	5.4	5.9	5.7	7.3	5.4	5.9	6.4	8.0	10.0	7.1	6.1	6.4	11.6	7.5	6.2	4.1	5.7	5.6	6.3	3.8	16.3	5.8	2.2	1.7	3.6	1.4	5.2	6.4	20.1	10.2	12.1	12.8	9.8	10.6	8.8	7.1	6.2	5.0	3.8	7.3	6.4	10.3	7.0	4.9	7.9	6.6	11.0	6.0	8.4	10.5	7.9	7.7	8.2	10.5	9.4	12.0	6.9	6.6	9.9	23.8	8.1	10.0	11.3	3.4	9.2	4.9	7.5	14.1	14.9	2.3	7.4	10.2	7.1	7.8	8.1	8.0	7.9	13.6	11.6	4.3	6.8	18.1	9.5	10.6	11.1	9.7	7.3	5.9	6.0	5.4	5.3	7.9	3.6	5.0	10.0	5.7	2.1	5.2	3.6	2.2	2.9	2.6	2.9	2.7	2.6	3.8	3.1	2.6	5.8	1.7	2.1	16.3	1.2	1.4	10.0	14.0	18.1	13.8	8.7	6.5	11.3	10.7	13.2	11.6	29.8	16.5	7.3	9.8	6.4	45.0	18.5	10.2	18.7	19.4	12.2	37.3	14.4	0.0	7.7	7.3	19.6	4.1	23.3	4.0	8.2	15.1	9.9	40.4	9.8	7.6	27.0	18.4	18.4	13.2	10.6	18.7	14.9	5.0	7.2	5.9	26.4	6.4	5.5	19.8	4.4	32.3	0.0	16.0	17.4	22.1	4.8	4.7	10.9	5.2	4.5
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	20.7	19.1	22.4	14.9	26.0	18.7	19.8	51.3	25.5	19.8	19.7	23.4	13.0	11.3	26.0	14.8	17.3	20.1	14.3	16.0	20.1	11.9	18.7	22.9	16.4	16.9	25.4	19.9	31.1	15.4	28.9	46.7	16.9	23.9	17.2	14.7	14.1	20.6	15.5	33.2	16.9	15.8	18.4	22.7	16.0	17.3	21.0	29.7	26.0	22.5	11.2	16.1	26.6	17.8	14.8	10.2	32.4	12.8	11.8	14.1	6.0	14.8	21.5	33.1	15.4	19.5	21.4	25.5	17.0	19.8	14.5	13.1	20.5	14.6	24.5	15.9	15.5	22.7	12.6	30.7	17.5	21.2	24.9	17.1	32.2	23.5	18.6	16.9	29.4	21.9	13.6	17.1	15.6	29.1	20.8	22.3	16.6	32.2	14.5	21.1	14.9	20.7	21.7	28.6	22.4	13.8	17.7	50.1	17.1	15.5	22.8	25.5	16.8	21.0	14.8	21.5	34.5	13.8	18.2	22.8	18.0	26.3	13.3	17.1	11.9	18.3	24.3	15.1	19.3	19.5	32.4	10.1	18.7	11.4	9.5	10.6	14.5	10.6	10.4	7.9	14.8	14.1	10.3	17.1	11.8	12.8	10.2	8.9	6.0	22.4	26.0	51.3	25.5	20.1	11.9	25.4	19.9	23.9	29.7	62.5	96.8	21.9	49.0	28.2	107.5	95.4	33.1	95.0	67.1	38.4	115.8	33.4	16.6	33.6	9.1	50.4	34.1	0.0	35.4	23.2	45.8	52.3	76.3	39.4	28.2	63.5	36.9	35.0	35.3	11.0	69.6	45.7	21.9	49.5	31.9	69.1	35.4	26.0	60.1	17.0	107.8	32.3	40.0	110.7	64.1	26.5	42.0	42.7	33.6	45.0